Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
DEFB105A	"DEFB-5, DEFB105"	ENSG00000186562	"Defensin beta 105A"	Q8NG35	8	7821966-7823889	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	438	"epididymis: 227.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;NB-4: 12.5;SH-SY5Y: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																							0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0			0.0	0.0	227.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2		0.4	0.0	0.0	0.0	0.0		0.1	0.0		0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB123	DEFB-23	ENSG00000180424	"Defensin beta 123"	Q8N688	20	31440519-31450257	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	403	"epididymis: 39.9;testis: 75.3"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;U-2197: 1.4"	"Cancer enriched"	"Detected in single"	17	"testis cancer: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in other tissues"																				"unprognostic (9.16e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	75.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB105B		ENSG00000186599	"Defensin beta 105B"	Q8NG35	8	7487669-7489593	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	396	"epididymis: 150.1"	"Cell line enriched"	"Detected in single"	12	"NB-4: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																							0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	150.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0
DEFB106B		ENSG00000187082	"Defensin beta 106B"	Q8N104	8	7482504-7486400	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	362	"epididymis: 164.2"	"Cell line enriched"	"Detected in single"	55	"NB-4: 5.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045592	Supported				"Secreted in male reproductive system"					"HPA045592: AB_2679378"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	164.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB128	DEFB-28	ENSG00000185982	"Defensin beta 128"	Q7Z7B8	20	187853-189681	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	239	"epididymis: 186.7"	"Group enriched"	"Detected in some"	26	"BEWO: 2.8;NB-4: 3.1;RPMI-8226: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"								"Secreted in male reproductive system"																							0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	186.7	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0
SPAG11B	"EDDM2B, EP2, EP2C, EP2D, HE2"	ENSG00000164871	"Sperm associated antigen 11B"	Q08648	8	7442684-7463674	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	232	"epididymis: 362.2"	"Group enriched"	"Detected in some"	11	"BEWO: 5.5;NB-4: 12.3;RPMI-8226: 5.7;SH-SY5Y: 5.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA023842, HPA057479"	Supported		Approved	"Golgi apparatus"	"Secreted in male reproductive system"			"Golgi apparatus"	"Golgi apparatus"	"HPA023842: AB_2732429, HPA057479: "																		0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0			0.0	0.4	362.2	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.1	0.0		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.6	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0										
SPAG11A	"EDDM2A, HE2"	ENSG00000178287	"Sperm associated antigen 11A"	Q6PDA7	8	7847876-7868867	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	225	"epididymis: 332.8"	"Cell line enriched"	"Detected in some"	4	"NB-4: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA023842, HPA057479"	Supported		Approved	"Golgi apparatus"	"Secreted in male reproductive system"			"Golgi apparatus"	"Golgi apparatus"	"HPA023842: AB_2732429, HPA057479: "																		0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	332.8	1.4	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0
DEFB110	"DEFB-10, DEFB-11, DEFB111"	ENSG00000203970	"Defensin beta 110"	Q30KQ9	6	50009138-50021981	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	158	"epididymis: 149.7"	"Cell line enriched"	"Detected in single"	6	"NB-4: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"																							0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.0	0.9	0.0	0.1	149.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.0
DEFB118	"C20orf63, DEFB-18, dJ1018D12.3, ESC42"	ENSG00000131068	"Defensin beta 118"	Q96PH6	20	31368618-31373923	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	147	"epididymis: 167.4"	"Group enriched"	"Detected in some"	5	"BEWO: 2.8;NB-4: 4.4;RPMI-8226: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042634	Enhanced				"Secreted in male reproductive system"					"HPA042634: AB_10797505"														"unprognostic (3.24e-1)"				0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	167.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFB113	DEFB-13	ENSG00000214642	"Defensin beta 113"	Q30KQ7	6	49968677-49969625	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	139	"epididymis: 34.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted in male reproductive system"																							0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1			0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB121	DEFB-21	ENSG00000204548	"Defensin beta 121"	Q5J5C9	20	31404845-31412838	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	133	"epididymis: 201.9"	"Cell line enriched"	"Detected in single"	79	"NB-4: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																							0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	201.9	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
AL163195.3		ENSG00000259060			14	20582892-20609795	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	115	"epididymis: 10.8;testis: 12.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB107A	"DEFB-7, DEFB107"	ENSG00000186572	"Defensin beta 107A"	Q8IZN7	8	7811720-7815716	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	100	"epididymis: 77.2"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045626	Approved				"Secreted in male reproductive system"					"HPA045626: AB_2679396"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.1			0.0	0.3	77.2	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB107B	HsT21816	ENSG00000198129	"Defensin beta 107B"	Q8IZN7	8	7495846-7509311	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	95	"epididymis: 78.7"	"Cell line enhanced"	"Detected in single"		"NB-4: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045626	Approved				"Secreted in male reproductive system"					"HPA045626: AB_2679396"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.3	78.7	0.1	0.8	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0
DEFB114	DEFB-14	ENSG00000177684	"Defensin beta 114"	Q30KQ6	6	49960249-49964105	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	67	"epididymis: 39.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted in male reproductive system"																							0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	39.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
RNASE9	"h461, RAK1"	ENSG00000188655	"Ribonuclease A family member 9 (inactive)"	P60153	14	20556093-20560931	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	63	"epididymis: 56.1"	"Cell line enhanced"	"Detected in some"		"HEL: 1.6;NB-4: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																							0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	56.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
DEFB119	"DEFB-19, DEFB-20, DEFB120"	ENSG00000180483	"Defensin beta 119"	Q8N690	20	31377164-31390603	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	61	"epididymis: 218.6;testis: 126.7"	"Cell line enhanced"	"Detected in some"		"NB-4: 5.0;RPMI-8226: 3.1;SCLC-21H: 1.2;SH-SY5Y: 2.4"	"Cancer enriched"	"Detected in single"	67	"testis cancer: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043059	Supported				"Secreted in male reproductive system"					"HPA043059: AB_10797025"															"unprognostic (2.03e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	218.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	126.7	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	1.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB127	"bA530N10.2, C20orf73, DEF-27"	ENSG00000088782	"Defensin beta 127"	Q9H1M4	20	157470-159163	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	56	"epididymis: 170.3"	"Group enriched"	"Detected in some"	27	"BEWO: 3.0;NB-4: 2.9;SH-SY5Y: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted in male reproductive system"																							0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.0	3.0	0.0	0.1	170.3	0.1	0.1	0.0	0.1	0.1	0.1	1.2	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFB112	DEFB-12	ENSG00000180872	"Defensin beta 112"	Q30KQ8	6	50043575-50048651	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	54	"epididymis: 58.5"	"Cell line enriched"	"Detected in single"	29	"NB-4: 2.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																							0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.1			0.0	0.0	58.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CDY2A	CDY2	ENSG00000182415	"Chromodomain Y-linked 2A"	Q9Y6F7	Y	18025787-18028597	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	50	"epididymis: 3.8;testis: 6.0"	"Cell line enriched"	"Detected in single"	12	"U-266/84: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA066682	Supported									"HPA066682: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
EPPIN-WFDC6	SPINLW1-WFDC6	ENSG00000249139	"EPPIN-WFDC6 readthrough"	O95925	20	45536986-45547426	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	48	"epididymis: 25.8;testis: 68.0"	"Cell line enhanced"	"Detected in single"		"U-87 MG: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA067335	Supported				"Secreted in male reproductive system"					"HPA067335: "										"unprognostic (1.46e-3)"					"unprognostic (6.38e-2)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.9	25.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	68.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFB104B		ENSG00000177023	"Defensin beta 104B"	Q8WTQ1	8	7470308-7475082	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	46	"epididymis: 108.2"	"Cell line enriched"	"Detected in single"	15	"SH-SY5Y: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045292	Supported				"Secreted in male reproductive system"					"HPA045292: AB_2679288"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.1	108.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
BSPH1	"BSP1, ELSPBP2"	ENSG00000188334	"Binder of sperm protein homolog 1"	Q075Z2	19	47968046-47992170	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"epididymis: 97.1"	"Group enriched"	"Detected in some"	5	"BEWO: 1.2;HMC-1: 1.3;NB-4: 4.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA048335	Enhanced				"Secreted in male reproductive system"					"HPA048335: AB_2732546"																		0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0			0.0	0.0	97.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB104A	"DEFB-4, DEFB104, DEFB4"	ENSG00000176782	"Defensin beta 104A"	Q8WTQ1	8	7836471-7841242	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	45	"epididymis: 110.0"	"Cell line enriched"	"Detected in single"	15	"SH-SY5Y: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045292	Supported				"Secreted in male reproductive system"					"HPA045292: AB_2679288"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	110.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
RNASE12	RAI1	ENSG00000258436	"Ribonuclease A family member 12 (inactive)"	Q5GAN4	14	20590193-20590823	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	43	"epididymis: 143.2"	"Group enriched"	"Detected in some"	5	"NB-4: 3.6;SH-SY5Y: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044175, HPA059465"	Enhanced				"Secreted in male reproductive system"					"HPA044175: AB_10960390, HPA059465: AB_2732638"																		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0			0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.6	0.0		0.3	0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ELSPBP1	"E12, EDDM12, HE12"	ENSG00000169393	"Epididymal sperm binding protein 1"	Q96BH3	19	47994651-48025153	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"epididymis: 279.8"	"Group enriched"	"Detected in some"	5	"HMC-1: 14.2;NB-4: 7.7"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.9"	"Region enriched"	"Detected in single"	11	"hypothalamus: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA044256, HPA050341"	Enhanced				"Secreted in male reproductive system"					"HPA044256: AB_2678879, HPA050341: AB_2681097"					"unprognostic (1.51e-1)"				"unprognostic (1.11e-1)"						"unprognostic (1.87e-1)"			0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.1	279.8	0.0	0.0	0.0	0.0	0.1	1.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	1.8	0.1	0.0	0.0	0.0
RNASE13	RAL1	ENSG00000206150	"Ribonuclease A family member 13 (inactive)"	Q5GAN3	14	21032820-21034785	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"epididymis: 95.8"	"Cell line enhanced"	"Detected in single"		"NB-4: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in male reproductive system"						"unprognostic (2.54e-1)"				"unprognostic (2.52e-1)"		"unprognostic (2.86e-1)"			"unprognostic (8.40e-2)"	"unprognostic (1.93e-1)"		"unprognostic (7.15e-2)"	"unprognostic (1.63e-3)"		"unprognostic (5.20e-4)"	"unprognostic (1.47e-2)"	0.5	0.2	0.2	0.2	0.2	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.4	95.8	0.2	0.2	0.2	0.2	0.2	0.0	0.2	2.8	0.5	0.2	0.2	0.2	0.2	0.9	0.0	0.2	0.2	0.2	0.2	0.0	0.2	1.3	0.2	0.5	0.5	0.2	0.2	0.2	1.9	0.0	1.8	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
TEDDM1	"EDDM9, Epdd1, HE9, TMEM45C"	ENSG00000203730	"Transmembrane epididymal protein 1"	Q5T9Z0	1	182398117-182400616	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	33	"epididymis: 128.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;NB-4: 4.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 1.3"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.8"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in many"														"unprognostic (4.21e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.22e-2)"		"unprognostic (6.71e-4)"		"unprognostic (4.43e-3)"		"unprognostic (2.86e-2)"	"unprognostic (4.57e-2)"	"unprognostic (4.20e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.99e-3)"	0.1	0.0	0.1	0.1	0.2	0.0	0.4	1.3	0.1	0.5	0.1	0.1	1.8	0.0	0.4	128.3	0.1	0.7	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	1.0	0.3	0.0	0.3	0.1	0.1	0.4	0.0	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.0	2.3	0.1	0.1	0.3	0.1	0.1	0.1	0.6	0.9	0.4	3.8	0.5	0.4	0.6	0.1	0.0	0.2	0.1	0.2	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.2	0.7	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.4	0.1	4.2	0.2	0.0	0.0	0.1	0.9	0.0	0.0	0.4	0.3	0.4	0.2	0.1	0.4	0.4	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.3	0.0	0.0	1.3	0.5	1.0	0.6	0.1	0.4	0.1	0.2	0.1	0.1	0.9	0.5	0.3	3.8	0.4	0.5	0.4	0.1	0.1	0.1	0.2	1.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1
AC133551.1		ENSG00000274175			Unmapped	17234-19833	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	30	"epididymis: 11.7;testis: 3.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.7;EFO-21: 2.1;HEL: 1.5;HMC-1: 1.3;K-562: 2.2;RPMI-8226: 1.3;U-2 OS: 1.8;U-266/84: 3.5"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.1		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	11.7	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	3.7			0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	1.8	0.0	0.0	0.3	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB133		ENSG00000214643	"Defensin beta 133"	Q30KQ1	6	49946021-49950265	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	30	"epididymis: 18.2"	"Cell line enriched"	"Detected in single"	42	"K-562: 4.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MAGEB3	CT3.5	ENSG00000198798	"MAGE family member B3"	O15480	X	30230436-30237492	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"epididymis: 20.5;testis: 7.8"	"Cell line enriched"	"Detected in single"	13	"U-266/70: 6.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA072203	Approved									"HPA072203: AB_2686492"															"unprognostic (3.34e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8			0.0		0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	6.9	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0										
NXF2	"CT39, TAPL-2"	ENSG00000269405	"Nuclear RNA export factor 2"	Q9GZY0	X	102247161-102326719	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"epididymis: 16.7;testis: 12.4"	"Cell line enriched"	"Detected in single"	52	"U-266/84: 27.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA002079	Uncertain									"HPA002079: AB_1079515"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	16.7	0.0	0.4	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	12.4			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NPFF	FMRFAL	ENSG00000139574	"Neuropeptide FF-amide peptide precursor"	O15130	12	53506690-53507638	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	28	"epididymis: 154.7"	"Cell line enriched"	"Detected in some"	7	"HHSteC: 17.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebellum: 2.0;hypothalamus: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"pons and medulla: 11.9"	"Region enriched"	"Detected in all"	8	"cerebellum: 143.2"						"Secreted in male reproductive system"																							0.3	0.1	0.1	0.1	0.3	0.0	0.1	2.0	0.1	0.5	0.2	0.1	1.1	0.2	0.1	154.7	0.1	0.2	0.1	0.1	0.1	1.4	0.1	0.1	0.5	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	5.5	0.2	0.1	1.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.7	0.2	0.8	0.2	0.0	0.0	0.2	0.1	0.2	0.0	0.3	0.1	1.9	0.4	0.8	0.2	0.0	0.3	0.2	0.5	1.9	0.1	0.0	0.2	0.0	0.2	2.4	0.0	0.0	0.3	0.0	0.3	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	2.0	0.1	0.1	1.4	0.1	0.1	0.3	0.1
PATE1	PATE	ENSG00000171053	"Prostate and testis expressed 1"	Q8WXA2	11	125746293-125749867	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	28	"ductus deferens: 426.3;epididymis: 222.7;seminal vesicle: 185.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.8;NB-4: 6.4;RPMI-8226: 1.6;SH-SY5Y: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076587	Approved				"Secreted in male reproductive system"					"HPA076587: AB_2732316"																		0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.3	0.2	0.3	0.2	0.0	426.3	0.0	0.2	222.7	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	10.0	0.0	0.0	0.2	185.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.4	0.0	0.0	0.2	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	6.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0
ZNF705G		ENSG00000215372	"Zinc finger protein 705G"	A8MUZ8	8	7355517-7385558	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	28	"epididymis: 1.3;testis: 4.3"	"Cell line enriched"	"Detected in single"	20	"LHCN-M2: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																				"unprognostic (1.71e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MAGEB4	"CT3.6, MGC33144"	ENSG00000120289	"MAGE family member B4"	O15481	X	30242052-30244193	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	27	"epididymis: 26.3;testis: 18.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA030456	Enhanced									"HPA030456: AB_10602707"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SYNDIG1L	"capucin, IFITMD4, TMEM90A"	ENSG00000183379	"Synapse differentiation inducing 1 like"	A6NDD5	14	74405893-74426102	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	27	"brain: 78.1;epididymis: 20.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.4;U-266/70: 1.8;U-266/84: 2.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"basal ganglia: 78.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	8	"basal ganglia: 251.1"	"Region enriched"	"Detected in many"	6	"basal ganglia: 71.7"	"HPA042594, HPA048487"	Uncertain									"HPA042594: AB_2678069, HPA048487: AB_2680416"	"unprognostic (5.75e-2)"	"unprognostic (9.96e-3)"	"unprognostic (2.25e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.08e-3)"	"unprognostic (5.72e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.85e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.34e-2)"	0.6	0.4	0.3	0.4	78.1	0.2	0.6	0.0	4.0	0.5	0.6	1.1	0.0	0.3	0.6	20.1	0.5	0.4	0.7	0.4	2.4	1.6	0.6	0.3	1.8	0.4	3.5	0.2	0.4	0.5	0.2	0.0	0.3	0.5	0.6	0.6	0.1	0.4	0.6	0.3	0.5	0.9	0.8	0.4	0.4	0.3	0.4	16.6	0.0	0.3	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.9	0.0	0.9	0.0	0.1	0.5	0.0	0.0	0.5	0.0	0.8	0.0	0.4	0.1	0.3	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.2	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.8	2.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.3	78.1	0.0	4.0	2.4	1.6	3.5	0.2	0.5	16.6
EPPIN	"CT71, dJ461P17.2, EPPIN1, EPPIN2, EPPIN3, SPINLW1, WAP7, WFDC7"	ENSG00000101448	"Epididymal peptidase inhibitor"	O95925	20	45540626-45547752	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"epididymis: 89.0;testis: 72.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.4;U-87 MG: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.1"	"Low lineage specificity"	"Detected in many"											HPA067335	Supported				"Secreted in male reproductive system"					"HPA067335: "	"unprognostic (1.17e-1)"	"unprognostic (1.79e-1)"		"unprognostic (3.08e-3)"				"unprognostic (1.06e-2)"		"unprognostic (3.75e-2)"				"unprognostic (1.69e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.00e-2)"		0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.4	0.0	0.0	0.3	0.0	0.5	89.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	72.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	1.5	0.4	3.1	0.7	0.5	0.8	0.1	1.9	0.2	1.0	1.0	0.9	1.6	1.3	2.2	0.1	0.3	0.1	1.3	0.7	1.5	0.9	0.2	0.8	0.3	0.0	0.1	1.4	0.3	1.1	1.3	1.1	0.3	0.6	2.2	0.5	0.5	0.4	0.3	0.2	1.6	5.4	0.5	1.2	0.6	2.1	2.2	0.5	1.8	0.6	1.3	0.2	0.6	1.1	1.4	0.7	0.4	1.1	1.2	1.5	1.8	1.9	1.6	2.4	1.3	1.8	2.0	0.9	6.6	0.6	2.2	3.1	0.7	0.4	0.8	0.1	0.5	0.5	0.3	0.4	0.2	1.5	0.5	0.4	1.4	0.5	0.4	0.4	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
CST11	"CST8L, CTES2, dJ322G13.6"	ENSG00000125831	"Cystatin 11"	Q9H112	20	23450403-23452857	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	25	"epididymis: 76.3"	"Cell line enhanced"	"Detected in single"		"RT4: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053399	Enhanced				"Secreted in male reproductive system"					"HPA053399: AB_2682136"						"unprognostic (9.42e-2)"				"unprognostic (2.21e-2)"								0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	76.3	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WFDC10A	"C20orf146, dJ688G8.3, WAP10"	ENSG00000180305	"WAP four-disulfide core domain 10A"	Q9H1F0	20	45629526-45631196	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	25	"epididymis: 62.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;CACO-2: 2.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.6"	"Cell type enriched"	"Detected in single"	7	"naive CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.2"					"Not detected"	"Not detected"								"Secreted in male reproductive system"								"unprognostic (1.76e-1)"											"unprognostic (2.95e-1)"				0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.5	0.0	0.1	62.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	1.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0
LIPI	"CT17, LPDL, mPA-PLA1beta, PLA1C, PRED5"	ENSG00000188992	"Lipase I"	Q6XZB0	21	14108813-14210891	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"epididymis: 113.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 3.1;REH: 2.0;SH-SY5Y: 1.9"	"Cancer enriched"	"Detected in single"	6	"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in male reproductive system"						"unprognostic (2.60e-2)"	"unprognostic (3.49e-1)"		"unprognostic (1.12e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.08e-2)"		"unprognostic (1.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.64e-13)"	"unprognostic (2.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	1.0	0.0	0.6	0.0	1.2	113.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	1.4	0.0	0.0	4.7	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.9	0.0	0.0	1.5	0.9	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.4	0.8	0.2	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	3.1	1.5	0.4	2.0	0.5	1.0	0.0	0.0	0.3	1.9	0.7	0.1	0.1	0.1	0.1	0.0	0.5	0.3	0.8	0.2	0.3	0.0	0.3	0.3	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANO3	"C11orf25, DYT23, GENX-3947, TMEM16C"	ENSG00000134343	"Anoctamin 3"	Q9BYT9	11	26309599-26663288	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"brain: 83.1;epididymis: 47.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.3;U-2 OS: 2.8;U-2197: 7.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"basal ganglia: 83.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 142.2"	"Region enriched"	"Detected in many"	5	"basal ganglia: 149.8"	HPA041629	Uncertain									"HPA041629: AB_10793969"	"unprognostic (7.01e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.94e-1)"	"unprognostic (9.29e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-4)"	"unprognostic (9.48e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.01e-1)"	2.8	1.2	6.4	0.5	83.1	0.4	0.6	0.2	13.3	1.1	0.6	0.1	0.0	0.6	0.6	47.3	0.5	0.7	2.0	0.5	7.0	0.6	1.4	1.4	0.8	0.5	1.1	5.4	0.5	0.7	0.5	0.3	0.5	5.9	0.5	0.6	0.0	0.6	0.6	0.4	0.5	0.5	0.7	0.5	0.8	0.5	1.9	9.0	0.0	1.4	0.0	0.5	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	2.1	2.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.5	0.4	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.8	7.5	0.0	0.7	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	83.1	0.2	13.3	7.0	0.6	1.1	5.4	5.9	9.0
DEFB135		ENSG00000205883	"Defensin beta 135"	Q30KP9	8	11982321-11984590	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	23	"epididymis: 30.8"	"Group enriched"	"Detected in some"	4	"HEK 293: 1.8;MCF7: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted in male reproductive system"																							0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.5	0.3	0.3	0.1	0.0	0.0	0.0
OVCH2	OVTN	ENSG00000183378	"Ovochymase 2 (gene/pseudogene)"		11	7689438-7706421	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	23	"epididymis: 60.7"	"Cell line enriched"	"Detected in some"	7	"REH: 21.9"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 0.2"						"Secreted in male reproductive system"						"unprognostic (1.59e-2)"	"unprognostic (3.74e-1)"		"unprognostic (8.03e-2)"		"unprognostic (9.77e-2)"		"unprognostic (1.85e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (9.27e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.22e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	60.7	0.0	0.0	0.0	0.0	0.0		1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.6	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.6	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	21.9	0.0	0.1	0.2	2.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0										
DEFB115	DEFB-15	ENSG00000215547	"Defensin beta 115"	Q30KQ5	20	31257664-31259632	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in single"	22	"epididymis: 5.4"	"Cell line enriched"	"Detected in single"	60	"U-2 OS: 5.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA053160	Uncertain				"Secreted in male reproductive system"					"HPA053160: AB_2682062"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0			0.0	0.0	5.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
POU3F3	"BRN1, OTF8"	ENSG00000198914	"POU class 3 homeobox 3"	P20264	2	104855511-104858574	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 18.9;epididymis: 27.2;kidney: 23.7;seminal vesicle: 12.1"	"Group enriched"	"Detected in some"	6	"AF22: 27.0;AN3-CA: 25.8;HEK 293: 10.0;RPTEC TERT1: 30.6;SH-SY5Y: 8.5"	"Group enriched"	"Detected in some"	6	"glioma: 21.5;renal cancer: 24.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052792, HPA056039, HPA067151"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA052792: AB_2681951, HPA056039: AB_2683018, HPA067151: AB_2685790"	"unprognostic (3.05e-2)"		"unprognostic (1.07e-1)"	"prognostic unfavourable (4.26e-5)"	"unprognostic (9.66e-2)"	"unprognostic (1.97e-1)"			"unprognostic (4.69e-1)"	"unprognostic (1.16e-1)"			"unprognostic (7.28e-2)"	"unprognostic (1.15e-3)"	"unprognostic (7.15e-2)"			0.2	0.2	9.0	0.1	8.6	0.0	0.1	4.3	18.9	0.0	0.3			0.0	0.0	27.2	0.0	0.0	0.0	0.0	9.9	6.0	23.7	0.0	0.0	0.1	8.9		0.1	0.0	0.0	0.0	0.0		0.0	0.1		0.0	12.1	0.0	0.5	0.0	0.0	10.0	0.0	0.1	0.1			0.0		0.1	0.0	0.0	0.4	0.4	0.9	0.2	0.3	0.2	0.0	0.0	0.0	27.0	25.8	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	3.2	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	2.8	0.6	0.0	30.6	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.4	0.0	0.0										
TP53TG3F		ENSG00000278848	"TP53 target 3 family member F"	Q9ULZ0	16	33459045-33462249	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	21	"epididymis: 11.6;testis: 3.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.3;EFO-21: 1.8;HEL: 3.5;HMC-1: 2.0;K-562: 1.9;RPMI-8226: 1.6;U-2 OS: 2.6;U-266/84: 3.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.1		0.0		0.0	0.0		0.2	0.0	0.0			0.0	0.0	11.6	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.3		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	3.8			0.0		0.0	0.0		0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.4	0.0	0.0	0.5	2.6	0.0	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0										
EDDM3B	"FAM12B, HE3-BETA"	ENSG00000181552	"Epididymal protein 3B"	P56851	14	20768427-20770948	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"epididymis: 261.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.7;NB-4: 7.1;RPMI-8226: 1.6;SH-SY5Y: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA001323	Enhanced				"Secreted in male reproductive system"					"HPA001323: AB_1848377"	"unprognostic (2.40e-2)"																	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.1	0.1	0.2	0.1	0.0	12.9	0.0	0.2	261.1	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.8	0.9	0.2	0.4	0.1	0.0	0.2	0.1	0.1	3.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFB130A	"DEFB-30, DEFB130, DEFB30"	ENSG00000232948	"Defensin beta 130A"	P0DP74	8	12310962-12318316	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	19	"epididymis: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																							0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DEFB130B		ENSG00000233050	"Defensin beta 130B"	P0DP73	8	12064389-12071747	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	19	"epididymis: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																							0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DNAJC5G	"CSP-gamma, FLJ40417"	ENSG00000163793	"DnaJ heat shock protein family (Hsp40) member C5 gamma"	Q8N7S2	2	27275421-27281499	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	19	"epididymis: 35.8;testis: 58.0"	"Cell line enhanced"	"Detected in some"		"A-431: 2.9;HAP1: 3.9;HMC-1: 1.7;SH-SY5Y: 2.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"							HPA041445	Approved									"HPA041445: AB_2677485"	"unprognostic (1.43e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.75e-4)"	"unprognostic (2.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.97e-2)"	0.1	0.7	0.5	0.1	0.1	0.0	0.1	0.1	2.1	0.4	0.1	0.1	0.1	0.0	0.3	35.8	0.1	0.2	0.1	1.3	0.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	58.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.5	0.9	2.4	0.9	0.4	0.7	0.8	2.9	1.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.1	0.3	0.0	1.5	0.1	0.9	1.7	0.0	0.0	0.0	0.7	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.0	1.6	1.6	0.4	0.0	0.4	0.3	2.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.4	0.3	0.0	0.0	1.6	0.9	0.6	0.3	0.5	0.2	0.2	0.3	0.3	0.1	0.5	0.7	0.3	2.4	0.4	0.6	0.9	0.2	0.8	0.5	0.1	0.1	2.1	0.4	0.0	0.1	0.1	0.1	0.1
LCN6		ENSG00000267206	"Lipocalin 6"	P62502	9	136744011-136748528	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	19	"epididymis: 261.0"	"Group enriched"	"Detected in some"	6	"NB-4: 4.6;REH: 14.6"	"Cancer enriched"	"Detected in some"	10	"thyroid cancer: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"						"unprognostic (4.05e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.83e-4)"	"unprognostic (3.41e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.45e-1)"	4.5	0.5	0.4	1.3	0.6	1.1	4.4	0.4	0.6	5.1	1.6	0.4	13.9	0.5	10.1	261.0	1.5	6.5	1.8	8.3	0.4	0.0	0.8	0.5	1.1	0.6	0.6	0.5	2.6	1.0	0.6	0.3	0.5	0.6	3.4	0.6	0.6	2.0	1.2	1.5	0.5	3.1	1.4	0.7	1.0	3.1	3.2	0.4	0.3	2.2	0.4	0.5	2.9	3.8	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	14.6	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.4	0.6	0.4	0.0	0.6	0.5	0.6	0.4
RNASE11	"C14orf6, RAJ1"	ENSG00000173464	"Ribonuclease A family member 11 (inactive)"	Q8TAA1	14	20583559-20609884	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	18	"epididymis: 106.3;testis: 33.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;NB-4: 2.7;RPMI-8226: 1.4;SH-SY5Y: 1.3;U-937: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA003724	Uncertain				"Secreted in male reproductive system"					"HPA003724: AB_1079817"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	106.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WFDC8	"C20orf170, dJ461P17.1, WAP8"	ENSG00000158901	"WAP four-disulfide core domain 8"	Q8IUA0	20	45551153-45579326	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"epididymis: 103.1"	"Cell line enriched"	"Detected in some"	6	"U-87 MG: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA042710, HPA071119"	Enhanced				"Secreted in male reproductive system"					"HPA042710: AB_2732501, HPA071119: AB_2732172"				"unprognostic (5.63e-3)"						"unprognostic (1.09e-2)"				"unprognostic (2.34e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.07e-2)"		0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.0	5.6	0.0	1.0	103.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.7	0.0	0.0	0.1	0.1	1.0	0.6	1.0	0.9	0.7	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.1	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	7.7	0.0	0.1	0.6	0.9	0.2	0.3	0.3	0.2	0.2	0.2	0.1	0.1	1.0	0.4	0.4	1.0	0.7	0.4	0.6	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
DEFB106A	"DEFB-6, DEFB106"	ENSG00000186579	"Defensin beta 106A"	Q8N104	8	7825172-7829053	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	17	"epididymis: 22.0"	"Group enriched"	"Detected in some"	32	"BEWO: 2.9;RPMI-8226: 1.9;SH-SY5Y: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045592	Supported				"Secreted in male reproductive system"					"HPA045592: AB_2679378"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	22.0	0.1	1.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0
PATE2	"C11orf38, LVLF3112, PATE-M, UNQ3112"	ENSG00000196844	"Prostate and testis expressed 2"	Q6UY27	11	125776113-125778819	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"ductus deferens: 56.1;epididymis: 112.4;seminal vesicle: 44.9"	"Cell line enhanced"	"Detected in some"		"NB-4: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"								"Secreted in male reproductive system"						"unprognostic (3.28e-1)"				"unprognostic (7.26e-2)"	"unprognostic (2.95e-1)"		"unprognostic (1.18e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.84e-3)"		"unprognostic (1.55e-2)"		"unprognostic (5.08e-1)"	"unprognostic (2.55e-1)"			0.1	0.1	0.4	0.0	1.0	0.1	0.1	0.7	0.6	0.1	0.2	0.0	56.1	0.0	0.1	112.4	0.0	0.1	0.0	0.2	0.5	0.9	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.0	44.9	0.1	0.0	0.0	0.0	0.4	0.0	0.1	4.2	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.5	0.2	1.6	0.6	0.2	1.0	0.0	0.9	0.0	0.2	0.7	0.4	0.0	1.7	0.5	0.2	0.6	0.3	0.4	0.8	0.2	0.6	0.5	0.4	0.1	0.3	0.8	0.7	0.3	0.7	1.1	0.0	0.0	0.7	1.4	0.0	0.1	0.7	0.5	0.0	0.6	1.7	0.1	1.6	0.5	4.4	1.6	1.6	1.2	0.1	1.9	0.7	0.7	0.4	0.5	2.6	1.6	0.3	1.4	2.0	2.7	0.8	0.6	0.9	0.6	0.9	0.5	0.8	1.5	0.7	1.5	0.7	0.6	0.6	0.3	0.6	0.2	0.3	0.2	0.1	0.2	0.5	1.0	0.3	1.6	0.2	0.3	0.2	0.3	0.0	0.4	1.0	0.7	0.6	0.5	0.9	1.1	0.0	0.0	0.0
DEFB129	"bA530N10.3, C20orf87, DEFB-29"	ENSG00000125903	"Defensin beta 129"	Q9H1M3	20	227258-229886	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"epididymis: 223.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;NB-4: 7.0;RPMI-8226: 1.6;SH-SY5Y: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA014581	Supported				"Secreted in male reproductive system"					"HPA014581: AB_2732410"																		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	14.0	0.0	0.2	223.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.1	0.6	0.1	0.0	0.1	0.1	0.1	1.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
WFDC9	"dJ688G8.2, WAP9"	ENSG00000180205	"WAP four-disulfide core domain 9"	Q8NEX5	20	45607939-45631268	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"epididymis: 162.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;NB-4: 4.7;SH-SY5Y: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"basal ganglia: 0.5;thalamus: 0.9"	"Not detected"	"Not detected"								"Secreted in male reproductive system"																							0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.5	0.1	0.1	0.0	10.1	0.0	0.1	162.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.3	0.1	0.0	0.1	0.1	0.1	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.0
NXF2B	bA353J17.1	ENSG00000269437	"Nuclear RNA export factor 2B"	Q9GZY0	X	102360396-102439932	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"epididymis: 18.9"	"Cell line enriched"	"Detected in single"	52	"U-266/84: 27.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA002079	Uncertain									"HPA002079: AB_1079515"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	18.9	0.0	1.0	0.0	0.0			0.0	0.0	0.2	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ADAM7	"EAPI, GP-83"	ENSG00000069206	"ADAM metallopeptidase domain 7"	Q9H2U9	8	24440930-24526970	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"epididymis: 309.9"	"Group enriched"	"Detected in some"	31	"BEWO: 4.3;NB-4: 10.8;RPMI-8226: 2.8;SH-SY5Y: 3.3"	"Group enriched"	"Detected in some"	16	"prostate cancer: 1.0;renal cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA008879	Enhanced				"Intracellular and membrane"					"HPA008879: AB_10601789"												"unprognostic (1.03e-3)"	"unprognostic (3.96e-4)"					0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	21.7	0.0	0.1	309.9	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	1.3	0.1	0.3	0.1	0.0	0.1	0.1	0.1	6.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFB126	"bA530N10.1, C20orf8, DEFB-26"	ENSG00000125788	"Defensin beta 126"	Q9BYW3	20	142369-145751	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"epididymis: 255.5"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.9;RPMI-8226: 1.6;SH-SY5Y: 1.5;SK-BR-3: 1.8;SK-MEL-30: 1.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"											"unprognostic (1.16e-1)"		"unprognostic (1.21e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.41e-2)"			"unprognostic (2.32e-1)"		"unprognostic (1.47e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.0	18.2	0.0	0.1	255.5	0.3	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.3	0.1	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.5	0.0	1.8	1.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SPINK13	"HESPINTOR, LiESP6, MGC149260, SPINK5L3"	ENSG00000214510	"Serine peptidase inhibitor, Kazal type 13 (putative)"	Q1W4C9	5	148268180-148286254	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	14	"ductus deferens: 85.5;epididymis: 86.8;seminal vesicle: 26.7"	"Cell line enriched"	"Detected in some"	20	"HeLa: 99.6"	"Group enriched"	"Detected in some"	6	"cervical cancer: 0.9;lung cancer: 0.9;renal cancer: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA036456	Uncertain		Approved	"Nucleoplasm,Plasma membrane"	"Secreted in male reproductive system"			"Plasma membrane"	"Plasma membrane"	"HPA036456: AB_10673496"	"unprognostic (5.22e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.44e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.43e-3)"		"unprognostic (1.25e-3)"	"unprognostic (5.01e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (4.03e-10)"	"unprognostic (4.31e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.95e-2)"	0.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	2.2	0.0	85.5	0.0	0.4	86.8	0.1	1.0	0.1	0.8	0.0	0.1	2.1	0.0	0.1	0.1	0.0	0.0	1.4	0.4	0.0	1.0	0.1	0.0	4.0	0.0	0.0	0.1	26.7	0.1	0.2	0.0	0.1	0.0	0.0	2.9	2.7	0.0	0.0	0.4	0.1	0.1	0.4	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	99.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.0	0.0	0.0	0.0	4.9	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CLPSL2	"C6orf126, dJ510O8.5, UNQ3045"	ENSG00000196748	"Colipase like 2"	Q6UWE3	6	35776594-35779552	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	13	"epididymis: 124.8"	"Cell line enriched"	"Detected in some"	6	"T-47d: 12.3"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	25	"plasmacytoid DC: 2.4"	"Lineage enriched"	"Detected in single"	25	"dendritic cells: 2.4"									HPA051655	Approved				"Secreted in male reproductive system"					"HPA051655: "	"unprognostic (2.38e-1)"	"unprognostic (3.65e-1)"	"unprognostic (6.39e-3)"	"unprognostic (9.38e-2)"	"unprognostic (4.03e-2)"			"unprognostic (2.47e-1)"		"unprognostic (4.85e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.17e-2)"		"unprognostic (3.95e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.37e-1)"	0.0	0.0	0.4	0.0	0.2	0.0	0.7	0.0	1.1	0.0	0.0	0.0	2.3	0.0	0.0	124.8	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	9.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.3	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.0	0.4	0.5	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.3	1.3	1.1	0.3	0.0	0.0	0.0	0.0	1.1	0.8	0.0	0.6	0.0	12.3	1.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.4	0.4	0.2	0.0	1.1	0.8	0.1	0.2	0.2	0.0	0.0
MMP21		ENSG00000154485	"Matrix metallopeptidase 21"	Q8N119	10	125766453-125775821	"Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	13	"epididymis: 37.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;NB-4: 1.2;U-266/70: 2.1;U-266/84: 1.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"												"Secreted to extracellular matrix"						"unprognostic (1.32e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.89e-2)"	"unprognostic (3.62e-2)"	"unprognostic (9.70e-8)"	"unprognostic (1.30e-2)"	"unprognostic (7.69e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.18e-1)"	0.2	0.1	0.1	0.1	0.4	0.1	0.3	0.7	0.0	0.1	0.2			0.1	0.1	37.6	0.1	0.4	0.2	0.9	0.0	0.4	0.1	1.0	0.1	0.1	0.0		2.8	0.8	0.0	0.3	0.0		0.6	0.1		0.5	0.1	0.0	0.1	0.5	0.1	0.0	0.7	0.2	0.1			0.6		0.1	0.2	0.0	1.1	0.0	0.0	0.1	0.5	0.6	0.0	0.1	0.0	0.0	0.8	0.3	0.0	1.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.7	0.5	0.0	0.0	0.2	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	2.1	1.7	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	1.1	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0										
PAGE4	"CT16.7, GAGEC1, PAGE-4"	ENSG00000101951	"PAGE family member 4"	O60829	X	49829260-49833973	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"epididymis: 129.2;placenta: 199.4;prostate: 58.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.8;U-266/70: 8.4;U-266/84: 30.7"	"Group enriched"	"Detected in some"	17	"liver cancer: 14.8;prostate cancer: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA023880	Enhanced		Approved	"Golgi apparatus,Vesicles"				Vesicles	Vesicles	"HPA023880: AB_1854930"				"unprognostic (8.56e-2)"			"unprognostic (1.47e-1)"			"unprognostic (1.04e-1)"		"unprognostic (4.82e-3)"			"unprognostic (5.37e-2)"			0.2	0.7	0.5	0.1	0.1	0.0	0.1	0.2	0.2	0.6	0.1	0.2	5.7	0.0	6.6	129.2	0.1	6.8	0.1	0.1	0.4	0.5	0.8	0.1	0.2	0.1	0.1	0.2	0.9	0.1	0.0	0.6	199.4	0.2	58.4	0.0	0.1	0.1	9.8	0.8	0.1	0.1	2.4	0.2	0.1	0.1	2.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	6.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.2	0.2	0.4	0.5	0.1	0.2	0.2	0.1
CLPSL1	"C6orf127, dJ510O8.6"	ENSG00000204140	"Colipase like 1"	A2RUU4	6	35781017-35793675	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	12	"epididymis: 123.5;pancreas: 103.6"	"Cell line enriched"	"Detected in single"	17	"T-47d: 13.6"	"Group enriched"	"Detected in some"	6	"breast cancer: 3.6;cervical cancer: 1.0;endometrial cancer: 2.8;ovarian cancer: 1.8;pancreatic cancer: 3.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA073155	Enhanced				"Secreted in male reproductive system"					"HPA073155: AB_2686576"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"		"unprognostic (4.75e-1)"				"unprognostic (2.54e-1)"		"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"			"unprognostic (1.97e-1)"	"unprognostic (6.60e-2)"		"unprognostic (7.06e-3)"	0.1	0.1	1.6	0.0	0.2	0.0	0.8	0.1	0.9	0.1	0.1	0.0	9.6	0.0	0.1	123.5	0.1	0.1	0.0	0.1	1.8	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.1	103.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	13.6	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.1	0.9	1.8	0.1	0.2	0.0	0.0	0.0
DEFB131B		ENSG00000225805	"Defensin beta 131B"	A0A096LNP1	11	71878453-71884561	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"epididymis: 36.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 17.4"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.0"	"Low lineage specificity"	"Detected in many"																"Secreted in male reproductive system"						"unprognostic (5.87e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.78e-2)"		"unprognostic (7.44e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.09e-3)"	"unprognostic (7.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.62e-1)"	0.0	0.0		0.2		0.0	0.0		0.1	0.0	0.0			0.5	0.0	36.6	0.0	0.0	1.2	0.0			0.0	0.0	0.0	0.7			0.4	0.0	0.0		0.0		0.0	0.0		0.1	0.0	0.0	0.8	0.1	0.0		0.0	0.0	0.1			1.5		0.0	0.9		0.3	3.0	0.8	0.7	1.4	1.2	0.0	0.6	0.0	3.6	1.4	0.0	0.0	0.4	3.7	0.0	0.0	0.0	4.4	4.1	3.5	1.3	0.0	3.8	0.0	0.0	0.0	2.8	2.9	3.7	2.1	2.5	0.0	4.6	1.7	0.0	0.0	0.0	0.0	0.0	8.4	6.0	0.0	3.3	2.0	1.2	1.1	5.7	3.9	17.4	1.1	0.0	1.1	4.0	1.6	3.4	2.0	3.4	3.5	0.4	2.1	1.3	3.6	2.5	0.3	3.0	1.0	4.7	2.1	4.1	0.8	0.8	0.7	0.0	1.2	0.0	0.0	0.0	0.7	0.0	0.4	0.3	0.4	0.6	0.0	1.4	0.5	3.0	0.9	0.0										
LRCOL1		ENSG00000204583	"Leucine rich colipase like 1"	A6NCL2	12	132603150-132610543	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"epididymis: 54.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;BJ hTERT+ SV40 Large T+: 1.2;RPMI-8226: 1.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"						"unprognostic (5.09e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.38e-2)"	"prognostic favourable (7.04e-4)"	"unprognostic (4.54e-2)"	"unprognostic (6.08e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (6.50e-6)"	"unprognostic (1.46e-3)"	"unprognostic (9.63e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.00e-3)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	4.4	0.1	0.0	54.8	0.0	0.2	0.4	0.0	0.2		0.1	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.5	1.2	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0										
SPINT4	"C20orf137, dJ601O1.1"	ENSG00000149651	"Serine peptidase inhibitor, Kunitz type 4"	Q6UDR6	20	45722351-45725830	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"epididymis: 134.6"	"Group enriched"	"Detected in some"	5	"NB-4: 4.5;U-87 MG: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046703	Enhanced				"Secreted in male reproductive system"					"HPA046703: AB_2732530"														"unprognostic (3.61e-1)"				0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	11.5	0.0	0.1	134.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	2.1	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CHRNG	ACHRG	ENSG00000196811	"Cholinergic receptor nicotinic gamma subunit"	P07510	2	232539727-232546403	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"epididymis: 16.7;skeletal muscle: 40.0"	"Group enriched"	"Detected in some"	18	"HSkMC: 4.9;RH-30: 13.7"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (2.26e-1)"	"unprognostic (8.97e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.38e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.19e-6)"	"unprognostic (6.13e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.24e-2)"	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.6	0.0	40.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	0.6	0.3	0.5	0.5	1.1	0.8	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.2	0.1	0.1	0.1	13.7	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.5	0.2	0.2	0.2	0.7	0.2	0.4	0.5	0.2	0.6	0.8	0.8	0.2	1.1	0.2	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WFDC13	"C20orf138, dJ601O1.3, WAP13"	ENSG00000168634	"WAP four-disulfide core domain 13"	Q8IUB5	20	45702016-45708817	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	11	"epididymis: 92.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.9;RT4: 3.3;U-87 MG: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"naive CD4 T-cell: 3.1"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.1"														"Secreted in male reproductive system"						"unprognostic (2.53e-1)"		"unprognostic (1.30e-2)"					"unprognostic (7.84e-3)"		"unprognostic (7.96e-3)"	"unprognostic (2.04e-1)"		"unprognostic (1.02e-11)"	"unprognostic (1.17e-1)"		"unprognostic (1.44e-2)"	"unprognostic (2.22e-2)"	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.2	0.0	8.3	0.0	0.1	92.8	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.4	0.0	3.1	1.3	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.2	0.0	3.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.3	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0
PATE3	"HEL-127, PATE-DJ"	ENSG00000236027	"Prostate and testis expressed 3"	B3GLJ2	11	125788111-125791600	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"epididymis: 86.5"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.7;RPMI-8226: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in male reproductive system"																							0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.3	0.2	0.1	0.1	0.0	8.7	0.0	0.1	86.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	3.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	2.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.0
SLC22A11	OAT4	ENSG00000168065	"Solute carrier family 22 member 11"	Q9NSA0	11	64555626-64572875	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"epididymis: 22.2;kidney: 47.6;placenta: 64.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.8;CACO-2: 1.1;Hep G2: 3.4"	"Group enriched"	"Detected in some"	14	"liver cancer: 3.7;renal cancer: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA026076	Enhanced									"HPA026076: AB_1854756"	"unprognostic (8.21e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (3.68e-5)"	"unprognostic (4.62e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-3)"	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	4.4	0.0	0.1	22.2	0.1	0.1	0.0	0.1	0.1	0.1	47.6	0.4	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.1	64.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0
TCP10L2	bA517H2.3	ENSG00000166984	"T-complex 10 like 2"	B9ZVM9	6	167146414-167196913	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	9	"epididymis: 5.2;testis: 14.8"	"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB034197, HPA044709"	Uncertain									"CAB034197: AB_2202388, HPA044709: AB_10961410"			"unprognostic (5.07e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"		"unprognostic (2.52e-1)"			"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.40e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.4	0.0	0.0	0.6	0.0	5.2	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	14.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
ADGRG2	"EDDM6, GPR64, HE6, TM7LN2"	ENSG00000173698	"Adhesion G protein-coupled receptor G2"	Q8IZP9	X	18989309-19122637	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 202.4"	"Cell line enhanced"	"Detected in some"		"A549: 6.1;BEWO: 7.7;HeLa: 6.4;NTERA-2: 6.7;SH-SY5Y: 7.0;U-2197: 15.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA001478, HPA050029"	Enhanced		Approved	"Plasma membrane,Cytosol"		7900000	7900000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA001478: AB_1078923, HPA050029: AB_2680996"	"unprognostic (3.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-7)"	"unprognostic (6.37e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	4.4	0.3	0.4	0.9	0.2	0.2	2.8	0.1	0.2	0.8	1.0	0.1	6.6	0.2	0.5	202.4	0.9	6.9	1.4	1.8	0.6	0.6	0.7	0.9	1.7	3.1	0.2	0.2	0.9	0.9	24.8	1.9	0.6	0.3	3.2	0.2	1.6	9.6	0.8	0.6	0.3	1.4	0.6	0.2	1.2	3.5	4.7	0.2	2.7	1.8	0.6	1.9	1.1	1.5	0.1	0.2	0.9	0.6	0.0	0.2	0.0	0.2	6.1	0.0	0.0	0.1	0.9	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	6.4	0.2	0.9	0.0	0.0	0.1	0.1	0.0	1.2	0.0	0.0	0.2	0.0	1.0	0.0	2.3	6.7	2.0	0.0	0.1	4.4	0.0	1.2	2.3	7.0	1.5	0.1	0.0	0.1	0.1	0.1	0.2	0.4	15.3	2.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.9	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.7	0.0	0.6	0.1	0.0	0.0	0.4	0.2	0.1	0.2	0.6	0.6	0.2	0.2	0.3	0.2
HDC		ENSG00000140287	"Histidine decarboxylase"	P19113	15	50241947-50266026	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	8	"blood: 83.5;brain: 36.0;epididymis: 36.9"	"Group enriched"	"Detected in some"	4	"HEL: 59.8;HMC-1: 143.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	52	"hypothalamus: 36.0"	"Cell type enriched"	"Detected in single"	835	"basophil: 83.5"	"Lineage enriched"	"Detected in single"	835	"granulocytes: 83.5"	"Region enriched"	"Detected in many"	5	"hypothalamus: 51.5"	"Low region specificity"	"Detected in all"			HPA038891	Enhanced		Approved	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA038891: AB_10673231"	"unprognostic (4.97e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.93e-7)"	"unprognostic (4.18e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	1.7	0.2	0.2	5.1	0.4	2.4	1.1	0.2	0.3	2.7	1.9	0.2	1.2	2.1	3.1	36.9	2.7	0.6	6.6	2.1	0.2	36.0	0.6	0.8	4.9	2.3	0.6	0.1	0.4	0.5	0.3	0.7	0.2	0.3	2.2	1.9	3.0	0.9	1.3	1.8	1.8	2.4	5.4	0.2	0.4	6.9	2.4	0.2	0.4	0.3	0.4	1.7	1.8	2.7	0.0	0.0	83.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	59.8	0.0	0.0	0.0	0.1	143.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.3	0.2	36.0	0.6	0.1	0.3	0.2
KRT71	"K6IRS1, KRT6IRS, KRT6IRS1"	ENSG00000139648	"Keratin 71"	Q3SY84	12	52543909-52553147	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"epididymis: 10.8;skin 1: 42.7"	"Cell line enriched"	"Detected in single"	14	"CACO-2: 11.6"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049404	Enhanced					180000000	180000000			"HPA049404: AB_2680748"	"unprognostic (9.12e-2)"	"unprognostic (2.38e-1)"				"unprognostic (1.21e-1)"		"unprognostic (1.04e-1)"		"unprognostic (1.51e-1)"	"unprognostic (2.18e-1)"			"unprognostic (1.47e-1)"		"unprognostic (3.14e-1)"	"unprognostic (1.69e-2)"	1.4	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT74	"K6IRS4, KRT5C, KRT6IRS4"	ENSG00000170484	"Keratin 74"	Q7RTS7	12	52565782-52573825	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"epididymis: 11.9;skin 1: 17.2"	"Cell line enriched"	"Detected in single"	6	"HaCaT: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"memory CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"					"Low region specificity"	"Detected in some"			HPA048596	Enhanced									"HPA048596: AB_2680457"		"unprognostic (6.75e-3)"		"unprognostic (3.93e-1)"		"unprognostic (1.60e-1)"		"unprognostic (2.49e-2)"		"unprognostic (9.46e-2)"		"unprognostic (2.29e-1)"			"unprognostic (8.54e-2)"		"unprognostic (1.02e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	11.9	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	17.2	0.1	0.1	0.4	0.1	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRTAP5-8	"KRTAP5-2, KRTAP5.8, UHSKerB"	ENSG00000241233	"Keratin associated protein 5-8"	O75690	11	71538025-71539207	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	8	"epididymis: 3.4;kidney: 7.1;skin 1: 8.7;testis: 2.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;RT4: 4.1"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (9.72e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.99e-1)"	"unprognostic (6.92e-2)"		"unprognostic (2.89e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.14e-1)"		"unprognostic (3.62e-2)"	"unprognostic (2.21e-3)"	0.0	0.1	0.2	0.1	0.6	0.0	0.3	0.3	0.4	0.0	0.2			0.3	0.0	3.4	0.0	0.1	0.2	0.0	0.2	0.3	7.1	0.1	0.2	0.1	0.2		0.0	0.0	0.1	0.0	0.0		0.0	0.2		0.1	0.2	0.4	8.7	0.4	0.0	0.1	0.1	0.0	2.7			0.1		0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.7	0.5	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0										
LCN8	LCN5	ENSG00000204001	"Lipocalin 8"	Q6JVE9	9	136754386-136758543	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"epididymis: 72.1"	"Cell line enriched"	"Detected in some"	6	"REH: 7.0"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Region enriched"	"Detected in single"	7	"cerebellum: 5.3"	"Group enriched"	"Detected in some"	57	"memory B-cell: 5.3;naive B-cell: 9.3"	"Lineage enriched"	"Detected in single"	72	"B-cells: 9.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 0.6"						"Secreted in male reproductive system"									"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"					"unprognostic (6.71e-2)"			"unprognostic (2.11e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.00e-1)"		0.0	0.0	0.2	0.1	0.0	0.0	0.0	5.3	0.7	0.1	0.0	0.0	2.5	0.0	0.2	72.1	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.5	0.0	0.0	0.9	0.0	0.6	0.0	0.0	1.9	0.0	0.2	0.0	0.0	9.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	7.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	5.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0
PRR23D1		ENSG00000255251	"Proline rich 23 domain containing 1"	E9PI22	8	7539628-7542450	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"epididymis: 35.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.2;BJ hTERT+ SV40 Large T+: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0			0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	1.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0										
PRR23D2		ENSG00000255378	"Proline rich 23 domain containing 2"	P0DMB1	8	7778591-7781413	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"epididymis: 35.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.2;BJ hTERT+ SV40 Large T+: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0			0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.2		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	1.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0										
TP53TG3C		ENSG00000205457	"TP53 target 3C"	Q9ULZ0	16	33193659-33196858	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	8	"brain: 3.0;epididymis: 4.3;testis: 3.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.3;REH: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.1	0.1	0.8	0.1	1.3	0.1	0.1	3.0	1.3	0.1	0.1			0.1	0.1	4.3	0.3	0.1	0.1	0.1	0.6	1.3	0.1	0.1	0.1	0.1	0.8		0.1	0.1	0.1	0.3	0.4		0.1	0.1		0.2	0.1	0.1	0.2	0.1	0.1	2.0	0.1	0.1	3.9			0.1		0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.2	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4										
USP51		ENSG00000247746	"Ubiquitin specific peptidase 51"	Q70EK9	X	55484616-55489202	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 34.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"eosinophil: 2.4;naive CD4 T-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA001942	Uncertain		Approved	"Nucleoli fibrillar center,Cytosol"				Cytosol	Cytosol	"HPA001942: AB_1080536"	"unprognostic (1.19e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-3)"	"unprognostic (8.08e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.07e-3)"	"unprognostic (5.69e-2)"	"prognostic favourable (5.70e-4)"	"unprognostic (1.01e-3)"	"unprognostic (1.27e-1)"	"prognostic favourable (2.63e-5)"	"unprognostic (2.81e-3)"	"unprognostic (5.92e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-1)"	0.6	2.7	2.0	0.3	2.9	0.1	0.9	2.3	1.8	1.4	0.6			0.0	1.8	34.1	0.2	3.4	0.3	1.0	1.8	3.7	2.2	0.5	0.7	0.4	1.6		4.1	0.8	3.6	1.8	1.3		1.3	0.3		0.3	1.5	0.0	0.5	0.5	1.1	1.4	0.9	0.3	1.3			3.2		0.5	0.7	0.5	0.9	0.0	2.4	0.0	0.6	2.4	0.1	0.0	0.9	5.7	1.7	2.9	1.5	0.0	0.9	0.5	1.1	1.3	1.8	0.8	0.0	6.9	1.2	0.3	1.5	0.6	1.8	1.8	0.1	1.5	0.3	0.0	1.2	3.5	0.3	5.9	0.1	0.6	0.0	0.4	4.4	4.4	0.9	3.8	3.4	1.8	7.2	0.3	4.9	1.1	2.2	1.4	0.2	0.0	1.1	1.6	0.2	5.4	1.4	1.8	0.3	2.3	3.1	0.6	0.2	7.0	2.7	1.4	1.5	2.0	1.5	0.0	0.0	2.4	0.3	0.0	0.0	0.6	0.6	0.0	0.0	0.9	2.4	0.2	0.0	0.6	0.0	0.0	0.0	0.1										
BRS3	"BB3, BB3R"	ENSG00000102239	"Bombesin receptor subtype 3"	P32247	X	136487887-136493780	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"epididymis: 27.4"	"Cell line enhanced"	"Detected in single"		"U-266/70: 1.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basal ganglia: 3.6;hypothalamus: 2.8"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.2;naive CD8 T-cell: 1.0"	"Group enriched"	"Detected in many"	11	"B-cells: 1.2;T-cells: 1.0"	"Group enriched"	"Detected in some"	9	"basal ganglia: 1.6;hypothalamus: 7.1"	"Low region specificity"	"Detected in all"															"unprognostic (1.49e-1)"			"unprognostic (1.31e-1)"					"unprognostic (2.07e-1)"	"unprognostic (1.79e-2)"		"unprognostic (3.73e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-1)"		"unprognostic (5.59e-2)"	0.1	0.1	0.1	0.1	3.6	0.0	0.5	0.4	0.4	0.3	0.1	0.1	0.1	0.0	0.2	27.4	0.1	2.4	0.1	0.1	0.1	2.8	0.1	0.1	0.1	0.1	0.1	0.1	2.9	0.3	0.0	0.3	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.2	0.1	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.2	0.1	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.4	0.4	0.1	2.8	0.1	0.1	0.3	0.1
C11orf40	NOV1	ENSG00000171987	"Chromosome 11 open reading frame 40"	Q8WZ69	11	4571423-4577820	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	7	"epididymis: 2.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.5;RPMI-8226: 1.4;SK-MEL-30: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCDC17	FLJ33084	ENSG00000159588	"Coiled-coil domain containing 17"	Q96LX7	1	45620044-45624057	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"epididymis: 24.5;fallopian tube: 31.0;lung: 23.0;ovary: 9.6"	"Cell line enhanced"	"Detected in some"		"BJ: 2.3;HAP1: 2.3;MOLT-4: 1.8;RPMI-8226: 3.0;U-138 MG: 2.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.4"	"Region enriched"	"Detected in single"	4	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA028338	Enhanced									"HPA028338: AB_10669641"	"unprognostic (3.53e-5)"	"unprognostic (7.40e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.55e-3)"	"unprognostic (3.31e-1)"	"unprognostic (9.21e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.91e-1)"	"unprognostic (8.37e-7)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.91e-3)"	0.0	0.0	0.1	0.1	0.2	0.4	0.0	0.0	0.0	3.2	0.1	0.4	0.0	0.2	0.5	24.5	0.0	31.0	0.0	0.0	0.2	0.1	0.0	0.1	23.0	0.1	0.0	0.0	9.6	0.1	0.0	1.6	0.2	1.4	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.1	0.1	1.1	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	2.3	0.1	0.4	1.0	1.3	0.3	0.0	0.1	0.0	0.3	2.3	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.3	1.8	0.1	1.0	0.0	0.1	0.0	3.0	1.1	0.0	0.2	0.4	0.0	0.0	0.2	0.9	0.0	0.0	2.0	1.2	0.7	0.0	0.0	0.3	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.0	0.0	1.4	0.3
CD52	"CDW52, EDDM5, HE5"	ENSG00000169442	"CD52 molecule"	P31358	1	26317957-26320523	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"blood: 495.7;epididymis: 978.9"	"Group enriched"	"Detected in some"	9	"Daudi: 74.4;REH: 108.7;U-266/84: 108.6;U-698: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																						"prognostic favourable (1.85e-5)"	"unprognostic (3.28e-3)"	"unprognostic (1.93e-2)"	"prognostic favourable (2.06e-4)"	"unprognostic (4.18e-2)"	"prognostic favourable (4.45e-4)"	"unprognostic (9.11e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.73e-3)"	"unprognostic (6.27e-2)"	"unprognostic (4.58e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (5.85e-4)"	"unprognostic (3.64e-1)"	"unprognostic (6.14e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.26e-1)"	9.5	0.9	0.8	23.0	1.4	5.7	4.7	0.3	0.8	0.9	3.7	0.3	93.2	1.0	1.1	978.9	2.9	1.5	2.2	1.5	0.6	0.2	3.5	3.2	43.4	54.6	0.8	0.6	0.8	1.0	0.0	0.7	0.7	0.7	1.7	2.5	1.3	5.7	2.9	0.4	1.9	39.6	1.1	1.2	98.7	2.7	5.3	0.4	24.7	3.2	2.1	30.4	4.3	1.7	292.0	87.6	258.4	194.6	94.3	308.1	495.7	0.2	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	0.0	0.0	0.0	0.0	74.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.1	0.0	0.7	11.6	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.4	0.8	6.6	0.3	0.0	108.7	0.1	1.6	0.0	0.0	0.2	1.0	0.0	0.1	0.1	0.0	1.3	0.1	0.0	0.2	0.0	0.1	0.3	108.6	120.3	0.0	1.8	0.0	12.4	126.8	258.4	194.7	194.6	155.1	292.0	244.1	190.3	87.6	273.7	166.6	171.2	9.6	94.3	167.6	28.6	308.1	495.7	0.8	1.4	0.3	0.8	0.6	0.2	0.8	0.6	0.7	0.4
CES5A	"CAUXIN, CES4C1, CES5, CES7, FLJ31547"	ENSG00000159398	"Carboxylesterase 5A"	Q6NT32	16	55846154-55956031	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"epididymis: 43.4"	"Cell line enriched"	"Detected in single"	44	"U-266/70: 13.0"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted in male reproductive system"									"unprognostic (2.07e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.34e-2)"	"unprognostic (4.82e-2)"		"unprognostic (3.78e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.12e-2)"		"unprognostic (1.72e-7)"	"unprognostic (1.55e-2)"	"unprognostic (2.27e-1)"			0.1	0.1	0.7	0.1	0.6	0.0	0.1	0.1	0.8	0.1	0.1	0.1	3.6	0.0	0.1	43.4	0.1	0.0	1.4	0.1	0.8	0.5	0.1	6.6	0.1	0.1	1.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.3	0.1	1.2	0.1	0.1	1.8	0.1	0.0	1.7	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.1	0.8	0.8	0.5	1.4	0.1	0.1	0.1
EDDM3A	"FAM12A, HE3-ALPHA"	ENSG00000181562	"Epididymal protein 3A"	Q14507	14	20745892-20748380	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"ductus deferens: 61.8;epididymis: 129.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;NB-4: 3.3;SH-SY5Y: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.2"									HPA049952	Approved				"Secreted in male reproductive system"					"HPA049952: AB_2680970"	"unprognostic (1.42e-1)"				"unprognostic (9.88e-2)"								"unprognostic (8.56e-3)"		"unprognostic (2.10e-1)"			0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	61.8	0.0	0.1	129.9	0.1	0.2	0.0	0.1	0.1	0.1	1.5	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.2	14.7	0.1	0.1	0.1	0.0	0.1	0.4	0.4	4.7	0.0	0.0	0.1	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
EIF4E1B	FLJ36951	ENSG00000175766	"Eukaryotic translation initiation factor 4E family member 1B"	A6NMX2	5	176630682-176646641	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 8.9;epididymis: 5.6"	"Cell line enriched"	"Detected in some"	7	"T-47d: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA045045	Approved									"HPA045045: AB_2679197"	"unprognostic (6.54e-2)"				"unprognostic (1.53e-2)"					"unprognostic (7.44e-2)"	"unprognostic (5.26e-2)"				"unprognostic (1.86e-1)"			0.2	1.0	3.4	0.2	1.4	0.5	0.3	4.0	8.9	0.2	0.2	0.0	0.0	0.2	0.2	5.6	0.2	0.4	0.2	0.3	3.6	2.3	0.3	0.2	0.2	0.2	2.3	2.4	0.2	0.2	0.2	0.8	0.3	0.7	0.2	0.2	1.0	0.2	0.2	0.2	0.2	0.4	0.2	0.5	0.2	0.2	1.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.4	4.0	8.9	3.6	2.3	2.3	2.4	0.7	0.0
KHDC3L	"C6orf221, ECAT1"	ENSG00000203908	"KH domain containing 3 like, subcortical maternal complex member"	Q587J8	6	73362677-73364171	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 4.1;epididymis: 1.5;lung: 3.0;lymphoid tissue: 4.4;testis: 4.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.0;HMC-1: 1.5;NTERA-2: 2.1"	"Cancer enriched"	"Detected in single"	3155	"testis cancer: 254.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043699	Uncertain									"HPA043699: AB_10960564"					"unprognostic (1.39e-2)"					"unprognostic (1.37e-1)"					"unprognostic (1.67e-1)"	"unprognostic (4.36e-1)"		0.2	0.5	1.2	0.2	2.1	0.0	0.2	4.1	0.9	0.2	0.2	0.2	0.2	0.1	0.2	1.5	0.3	0.1	0.2	0.2	2.1	0.6	0.2	0.2	3.0	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.6	0.3	4.9	0.2	4.4	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	2.1	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.8	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.1	4.1	0.9	2.1	0.6	0.4	0.2	0.2	0.2
LY6L		ENSG00000261667	"Lymphocyte antigen 6 family member L"	H3BQJ8	8	143080457-143083001	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	7	"epididymis: 48.8"	"Cell line enriched"	"Detected in single"	8	"BEWO: 1.1"	"Cancer enriched"	"Detected in single"	6	"prostate cancer: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																				"unprognostic (5.25e-2)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	48.8	0.0	0.0	0.0	0.0	0.0	0.2	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0
NPC2	"EDDM1, HE1, NP-C2"	ENSG00000119655	"NPC intracellular cholesterol transporter 2"	P61916	14	74476192-74494177	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"epididymis: 982.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 146.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 769.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 139.0;granulocytes: 44.2;monocytes: 112.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000835	Enhanced				"Secreted to blood"	63000000	63000000			"HPA000835: AB_1079499"	"unprognostic (1.27e-3)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (4.83e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (6.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.11e-3)"	"prognostic unfavourable (2.66e-4)"	"unprognostic (1.97e-1)"	"prognostic favourable (6.55e-4)"	"unprognostic (1.42e-1)"	34.8	23.7	9.0	14.7	12.2	13.9	27.2	2.4	7.6	21.1	16.0	12.5	92.3	11.9	16.8	982.9	17.1	14.9	17.5	34.1	9.1	9.9	29.2	13.6	65.0	48.8	15.1	6.7	25.3	14.6	4.5	21.3	22.1	25.5	17.8	14.4	39.8	21.8	54.0	9.4	16.6	19.1	12.1	26.5	30.0	13.6	26.6	10.6	7.6	49.8	15.9	15.4	16.4	18.1	18.7	139.0	44.2	112.5	6.3	12.2	67.2	30.2	19.1	12.7	16.1	146.9	43.2	40.1	21.8	73.6	19.3	43.1	32.6	38.2	7.3	16.1	17.0	60.0	16.4	40.5	17.0	11.8	12.8	3.0	9.9	25.0	32.8	4.8	56.5	43.8	34.4	17.4	33.6	24.9	3.0	57.1	18.6	12.7	7.4	7.4	6.6	30.7	3.6	22.8	25.0	43.9	66.2	0.5	8.9	31.3	11.6	27.3	19.8	20.7	27.0	27.3	37.4	39.6	19.2	26.6	45.4	2.6	29.1	15.2	15.3	34.1	83.8	17.9	6.6	112.5	6.2	18.7	9.2	6.6	39.1	17.0	9.0	7.5	44.2	6.3	76.2	139.0	12.2	67.2	9.0	12.2	2.4	7.6	9.1	9.9	15.1	6.7	25.5	10.6
RBM11		ENSG00000185272	"RNA binding motif protein 11"	P57052	21	14216130-14228372	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"brain: 20.6;epididymis: 55.3"	"Cell line enhanced"	"Detected in some"		"HEL: 3.7;NTERA-2: 2.9;REH: 2.8;SK-BR-3: 3.1;U-266/70: 2.9;WM-115: 2.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA045885			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA045885: "	"unprognostic (1.95e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.44e-4)"	"unprognostic (2.18e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.92e-4)"	"unprognostic (5.74e-2)"	"unprognostic (1.16e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.69e-1)"	"unprognostic (9.24e-3)"	1.2	1.8	5.0	1.4	5.8	1.5	1.5	2.3	7.3	1.0	1.2	1.9	0.6	1.3	1.8	55.3	1.6	2.1	1.2	1.3	5.9	6.1	1.4	1.0	1.2	1.3	6.1	4.3	3.5	1.4	2.2	5.4	1.1	9.7	1.6	1.1	2.8	1.5	2.2	1.0	1.1	1.0	1.4	20.6	1.5	1.3	2.5	6.1	0.0	2.4	0.0	1.2	1.1	0.9	0.3	0.0	0.0	0.1	0.0	4.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.3	1.1	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	1.6	1.1	0.0	2.9	0.0	2.8	0.0	0.0	0.7	1.1	0.3	0.0	0.4	3.1	0.0	0.6	0.6	0.0	0.0	1.1	0.0	0.0	2.9	0.0	0.4	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.6	0.0	0.0	0.3	4.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	5.8	2.3	7.3	5.9	6.1	6.1	4.3	9.7	6.1
SCGB2B2	"SCGB4A2, SCGBL"	ENSG00000205209	"Secretoglobin family 2B member 2"	Q4G0G5	19	34593329-34675699	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	7	"epididymis: 4.1;pancreas: 12.7;skin 1: 5.9;testis: 15.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											HPA046806	Uncertain				"Secreted - unknown location"					"HPA046806: AB_10962373"	"unprognostic (9.99e-2)"	"unprognostic (3.62e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.38e-5)"	"unprognostic (4.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-1)"	0.6	0.7	0.7	0.6	0.6	0.0	1.2	0.6	0.9	0.6	0.6	0.6	0.6	0.7	0.6	4.1	1.3	0.7	0.6	0.6	0.7	0.7	0.6	0.7	0.7	0.6	0.6	0.6	0.6	12.7	0.3	0.6	0.6	1.0	0.6	0.2	0.6	0.6	0.6	1.1	5.9	0.6	0.6	0.9	0.6	0.4	15.9	0.6	0.6	1.0	0.6	0.6	1.0	0.6	0.6	0.3	1.4	0.3	0.3	0.8	0.1	0.7	1.3	1.2	0.7	0.8	0.4	1.4	0.8	0.8	0.3	0.4	4.0	0.6	0.5	0.6	0.1	0.7	1.3	1.2	0.3	1.5	0.6	0.7	2.1	1.0	0.4	0.3	0.9	0.5	1.3	0.1	0.7	0.0	0.2	4.3	0.3	1.3	0.6	1.9	0.5	0.7	1.0	1.0	0.5	0.8	1.5	1.2	1.1	0.8	0.7	0.6	1.3	0.5	0.8	1.5	1.0	1.0	0.3	3.8	1.8	1.3	0.5	0.2	2.3	1.4	0.3	0.1	0.8	0.0	0.4	0.3	0.5	0.3	0.3	0.6	0.8	0.5	0.3	0.3	0.1	0.1	0.3	0.1	0.7	0.6	0.6	0.9	0.7	0.7	0.6	0.6	1.0	0.6
TP53TG3B		ENSG00000261509	"TP53 target 3B"	Q9ULZ0	16	33360274-33363478	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"epididymis: 21.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.4;HMC-1: 3.5;K-562: 2.0;SH-SY5Y: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0			0.0	0.0	21.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
WFDC6	"C20orf171, dJ461P17.11, WAP6"	ENSG00000243543	"WAP four-disulfide core domain 6"	Q9BQY6	20	45534196-45539495	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"epididymis: 79.9;testis: 25.5"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 7.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"						"unprognostic (3.68e-3)"			"unprognostic (2.21e-3)"				"unprognostic (1.26e-2)"		"unprognostic (8.74e-2)"					"unprognostic (2.91e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.1	0.1	0.1	7.6	0.0	0.2	79.9	0.1	2.8	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.0	25.5	0.1	0.1	0.3	0.1	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
AC136612.1		ENSG00000275869	"TP53 target 3 family member E "		Unmapped	933862-936467	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	6	"epididymis: 2.1;testis: 6.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.7;HMC-1: 1.6;K-562: 2.9;U-2 OS: 2.5;U-266/84: 3.7"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	2.1	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.3	0.0		0.7		0.0	0.0		0.0	0.0	0.0	0.2	0.0	0.0		0.0	0.0	6.8			0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.5	0.7	0.0	0.4	0.0	0.0	2.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.3	0.7	0.5	0.0	0.0	0.4	2.5	0.2	0.0	1.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.7	0.4	0.0	0.5	0.0	0.0	0.6	0.0										
DACH2		ENSG00000126733	"Dachshund family transcription factor 2"	Q96NX9	X	86148458-86832604	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 29.5;epididymis: 9.3;fallopian tube: 8.0"	"Cell line enriched"	"Detected in some"	7	"HAP1: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							"HPA000258, HPA001367"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA000258: AB_1078618, HPA001367: "	"unprognostic (5.73e-3)"		"unprognostic (3.22e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.71e-2)"	"unprognostic (6.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.01e-3)"	"unprognostic (2.63e-2)"	0.9	0.9	7.9	0.6	29.5	0.6	0.6	0.2	17.8	1.0	0.8	0.3	0.0	1.2	1.2	9.3	0.7	8.0	0.6	0.6	13.5	10.8	2.4	0.6	0.9	0.6	3.4	10.4	1.4	1.1	0.7	1.3	0.6	11.8	1.5	0.7	1.6	0.7	0.8	0.6	0.7	1.3	0.8	0.7	0.6	1.4	0.7	1.7	0.0	0.7	0.0	0.6	1.4	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	29.5	0.2	16.8	13.5	10.8	3.4	10.4	11.8	1.7
KIAA1210		ENSG00000250423	KIAA1210	Q9ULL0	X	119078635-119150579	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 24.6;seminal vesicle: 12.3;testis: 19.8"	"Group enriched"	"Detected in some"	9	"Daudi: 2.1;MCF7: 4.1;SK-BR-3: 2.2;U-2 OS: 2.5"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.3"					"Group enriched"	"Detected in some"	5	"basophil: 2.0;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.0"									"HPA000551, HPA048322"	Enhanced									"HPA000551: AB_1079165, HPA048322: AB_2680358"	"unprognostic (2.48e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.26e-4)"	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.7	24.6	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.1	0.0		2.7	0.0		0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8			0.0		0.0	0.1	0.0	0.2	0.2	2.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	2.2	0.2	0.1	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	1.2	0.3	0.1	0.2	0.0	0.0										
LEFTY1	"LEFTB, LEFTYB"	ENSG00000243709	"Left-right determination factor 1"	O75610	1	225886282-225911382	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 12.1;epididymis: 19.0;intestine: 26.6;pancreas: 46.5"	"Cell line enriched"	"Detected in some"	6	"NTERA-2: 33.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.8"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	35	"basophil: 12.1"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 12.1"									"HPA047883, HPA056210"	Approved				"Secreted in other tissues"					"HPA047883: AB_2680200, HPA056210: AB_2683067"	"unprognostic (2.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.76e-2)"	"unprognostic (6.13e-2)"	"prognostic unfavourable (2.48e-6)"	"unprognostic (2.78e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.61e-2)"	0.2	0.0	0.6	4.5	1.1	0.0	0.2	1.2	0.9	0.6	26.6	0.2	1.5	0.0	0.7	19.0	0.4	0.1	0.2	0.2	0.6	0.7	3.6	0.2	0.3	0.2	0.2	0.2	2.0	46.5	0.0	0.3	0.3	0.2	0.6	15.1	0.3	0.5	1.6	0.2	0.0	0.8	0.4	0.2	0.2	0.4	2.1	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0.0	0.0	12.1	0.0	0.3	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	3.5	0.3	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.7	0.6	1.1	1.2	0.9	0.6	0.7	0.2	0.2	0.2	0.2
MAGEH1	APR1	ENSG00000187601	"MAGE family member H1"	Q9H213	X	55452105-55453566	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"epididymis: 207.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA011324	Uncertain		Approved	Nucleoli				Nucleoli	Nucleoli	"HPA011324: "	"unprognostic (2.50e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.07e-2)"	"prognostic unfavourable (1.37e-4)"	"unprognostic (3.95e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.13e-2)"	"unprognostic (9.93e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"prognostic favourable (2.60e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.52e-1)"	8.3	13.2	21.5	7.6	21.6	3.0	8.1	19.9	29.7	13.5	7.5	14.4	13.8	5.2	13.3	207.1	5.2	19.2	8.3	10.2	22.8	32.1	11.4	8.7	10.2	9.0	19.8	20.6	16.1	11.9	9.0	22.5	9.2	17.9	20.8	5.9	11.4	8.9	19.6	5.7	5.6	6.3	11.8	17.2	8.1	9.3	18.2	15.3	10.8	12.4	5.2	7.5	8.5	10.0	9.4	14.0	9.5	8.5	8.3	26.0	9.4	0.0	2.5	14.8	0.0	23.9	14.5	0.2	16.0	14.8	4.4	11.9	0.0	3.3	0.0	22.0	16.0	2.2	5.6	6.0	7.0	18.4	0.9	4.9	0.0	2.0	7.9	0.2	6.4	12.0	0.5	2.5	1.8	6.7	2.7	19.8	4.8	9.5	13.1	4.2	4.2	3.0	8.3	1.8	10.4	8.0	0.0	0.1	11.2	0.0	4.3	6.6	2.1	3.7	7.8	6.1	7.1	3.7	0.8	11.8	14.8	2.0	11.4	6.9	7.7	5.0	4.4	9.5	11.3	6.8	10.1	9.4	18.7	12.9	6.7	8.8	26.0	16.1	0.6	8.3	8.5	14.0	24.7	9.4	21.5	21.6	19.9	28.4	22.8	32.1	19.8	20.6	17.9	15.3
METTL21C	"C13orf39, LOC196541"	ENSG00000139780	"Methyltransferase like 21C"	Q5VZV1	13	102685744-102694504	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"epididymis: 28.8;skeletal muscle: 8.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;CACO-2: 1.6;HSkMC: 3.0;NB-4: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"																		"unprognostic (2.07e-1)"					"unprognostic (1.63e-6)"		"unprognostic (2.64e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.8	0.0	0.0			0.0	0.8	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	1.0		0.8	0.0		0.0	1.8	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.1	0.5	0.0	1.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR6B3	"OR6B3P, OR6B3Q"	ENSG00000178586	"Olfactory receptor family 6 subfamily B member 3"	Q8NGW1	2	240045077-240047027	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	6	"brain: 1.6;epididymis: 6.5;testis: 2.3"	"Cell line enhanced"	"Detected in single"		"HaCaT: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047529	Uncertain									"HPA047529: AB_2680077"																		0.1	0.0	0.8	0.0	0.5	0.0	0.3	0.0	0.1	0.0	0.0			0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	1.3		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.3			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRY	"PRY1, PTPN13LY"	ENSG00000169789	"PTPN13-like, Y-linked"	O14603	Y	22490397-22514637	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"blood: 1.9;epididymis: 2.3;testis: 1.4"	"Cell line enhanced"	"Detected in some"		"A549: 3.0;HDLM-2: 2.2;SK-MEL-30: 1.5"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	6	"memory CD4 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"T-cells: 1.9"									HPA046366	Uncertain									"HPA046366: AB_2679639"																		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.0		0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SLC30A3	ZNT3	ENSG00000115194	"Solute carrier family 30 member 3"	Q99726	2	27253684-27275817	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 28.7;epididymis: 41.0;testis: 19.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.8;Hep G2: 11.7;REH: 18.9;RH-30: 9.8"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	9	"amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6"	"Group enriched"	"Detected in many"	7	"amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9"	"HPA060505, HPA067637, CAB079044"	Enhanced	Approved	Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol				Vesicles	Vesicles	"CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875"	"unprognostic (2.05e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.65e-12)"	"unprognostic (3.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.63e-4)"	0.5	1.9	15.8	0.5	11.4	0.5	0.4	0.4	28.7	0.5	0.5	0.0	1.9	0.4	0.5	41.0	0.4	0.7	0.4	5.0	10.2	0.8	0.4	0.5	0.5	0.8	1.1	12.1	0.5	0.4	0.6	0.4	0.4	1.6	0.6	0.5	0.7	0.4	0.9	0.4	0.4	0.5	0.5	0.7	0.5	0.4	19.5	0.0	0.0	0.4	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	1.1	0.0	1.5	0.0	0.2	0.1	0.0	0.0	1.0	1.0	0.3	0.4	0.0	0.0	0.0	0.2	8.8	0.0	0.2	0.0	1.0	5.0	0.2	11.7	0.2	0.1	2.0	0.0	0.0	0.5	0.0	0.7	1.4	0.0	0.1	3.8	0.0	0.3	1.4	0.0	18.9	9.8	1.0	0.0	0.0	0.0	0.6	2.3	0.0	0.0	0.0	0.7	0.0	0.2	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	15.8	11.4	0.4	28.7	10.2	0.8	1.1	12.1	1.6	0.0
SNTN	"FLJ44379, S100AL"	ENSG00000188817	"Sentan, cilia apical structure protein"	A6NMZ2	3	63652668-63679020	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 26.6;fallopian tube: 73.9;lung: 29.5;ovary: 18.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.5;RH-30: 2.6;SH-SY5Y: 3.6"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.9;lung cancer: 0.8;ovarian cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 1.2"	"HPA043322, HPA058399"	Enhanced									"HPA043322: AB_10793945, HPA058399: AB_2683705"	"unprognostic (9.70e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-3)"				"unprognostic (4.34e-3)"		"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.73e-1)"		"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"		"unprognostic (8.43e-3)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.0	0.5	0.0	0.0	1.1	26.6	0.0	73.9	0.0	0.0	0.6	0.3	0.0	0.0	29.5	0.0	0.0	0.0	18.5	0.1	0.0	1.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	5.8	0.0	0.1	0.0	0.0	0.9	0.4	1.6	0.2	0.4	0.5	0.1	0.3	0.2	0.6	0.8	0.1	1.5	0.5	0.0	0.0	0.0	0.3	0.2	0.9	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.1	0.5	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.2	0.0	0.4	2.6	0.2	0.2	0.4	0.3	3.6	0.1	0.4	0.0	0.1	0.3	0.0	0.7	0.6	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.6	1.6	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.3	0.0	0.9	0.5	0.4	1.1	0.4	0.2	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.3	0.0	0.0	0.6	0.0
SPAG8	"BS-84, CT142, HSD-1, hSMP-1, SPAG3"	ENSG00000137098	"Sperm associated antigen 8"	Q99932	9	35808045-35812272	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 32.7;epididymis: 9.7;fallopian tube: 30.0;testis: 23.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"basal ganglia: 8.6;pons and medulla: 32.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA068012	Enhanced									"HPA068012: AB_2685941"	"unprognostic (1.01e-4)"	"unprognostic (3.52e-3)"	"unprognostic (6.36e-3)"	"prognostic favourable (2.15e-4)"	"unprognostic (2.62e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.37e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-3)"	1.0	1.4	2.4	0.9	8.6	1.1	1.1	1.1	3.5	3.7	1.3	9.1	2.7	1.4	1.6	9.7	1.2	30.0	1.6	2.6	4.1	3.2	1.2	0.8	2.9	1.2	1.6	2.8	2.5	1.2	2.2	3.9	1.0	32.7	1.4	0.8	2.5	1.3	3.5	1.3	1.1	1.0	1.0	2.2	1.2	1.2	23.6	4.4	0.9	2.9	0.4	0.9	1.7	0.7	1.3	3.0	4.2	1.8	2.3	2.7	1.0	0.1	0.2	0.0	0.4	4.2	1.4	0.0	0.5	0.2	1.4	0.5	0.8	0.2	0.0	0.0	0.2	1.0	0.4	1.9	0.2	0.9	0.3	1.3	0.2	0.1	0.3	0.0	0.4	1.1	0.8	1.6	0.8	1.2	0.1	1.5	1.5	0.8	0.3	0.1	0.4	0.8	0.4	0.5	1.3	1.5	0.0	1.5	0.9	0.1	0.1	0.4	0.9	1.5	1.2	0.3	0.6	0.7	0.1	0.5	0.6	0.1	2.1	1.2	0.9	4.2	1.8	0.0	1.6	1.2	0.5	0.2	1.3	1.8	3.0	1.3	0.9	2.5	0.0	2.3	0.1	0.1	2.7	1.0	2.4	8.6	1.1	3.5	4.1	3.2	1.6	2.8	32.7	4.4
VPREB3	8HS20	ENSG00000128218	"V-set pre-B cell surrogate light chain 3"	Q9UKI3	22	23752743-23754468	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 90.4;epididymis: 27.9;intestine: 32.7;lymphoid tissue: 77.9"	"Group enriched"	"Detected in some"	45	"Daudi: 56.9;REH: 67.3;U-698: 17.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	730	"memory B-cell: 79.9;naive B-cell: 90.4"	"Lineage enriched"	"Detected in single"	775	"B-cells: 90.4"	"Not detected"	"Not detected"							HPA003041	Supported				"Intracellular and membrane"					"HPA003041: AB_1080577"	"unprognostic (2.06e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.79e-2)"	"unprognostic (6.63e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.84e-2)"	"unprognostic (8.44e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.12e-1)"	0.5	9.2	0.7	62.6	0.9	7.5	0.3	0.7	0.8	0.3	1.3	0.3	0.2	0.2	0.3	27.9	2.3	0.1	0.7	0.4	0.6	0.7	1.1	0.9	1.2	77.9	0.8	0.2	0.3	0.3	0.1	1.4	0.3	0.2	0.6	0.9	0.4	4.8	0.2	0.8	0.4	32.7	0.2	0.5	31.6	1.4	1.4	0.2	1.6	0.8	1.0	36.0	3.1	0.2	90.4	0.0	0.1	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	56.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.1	0.2	0.0	0.2	67.3	0.1	1.0	0.0	0.0	0.1	0.2	0.0	0.1	0.8	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.3	0.0	17.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.9	0.0	0.0	0.0	90.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.7	0.9	0.7	0.8	0.6	0.7	0.8	0.2	0.2	0.2
AC004832.3		ENSG00000249590			22	30409255-30428990	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	5	"epididymis: 32.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 16.9;hTERT-HME1: 10.5;HUVEC TERT2: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.9;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.9"																																					0.7	1.5	1.6	2.7	1.2	0.2	1.0	0.6	0.9	1.2	1.0	1.0	4.7	5.5	0.7	32.4	0.6	0.8	1.0	0.8	1.0	1.4	2.3	6.4	1.1	0.6	1.9	0.6	1.0	1.2	1.2	0.6	0.9	0.8	2.4	2.1	0.8	1.7	0.6	0.6	0.9	3.9	0.6	1.5	0.6	1.5	1.3	0.6	0.6	1.6	0.6	1.9	0.7	0.7	0.2	0.5	0.2	0.1	0.0	2.9	0.7	3.6	0.0	1.9	1.6	0.4	1.7	0.0	0.0	3.2	5.1	6.4	0.0	2.1	0.6	0.7	1.1	5.2	1.8	16.9	7.3	0.0	0.0	0.0	0.0	0.0	0.7	0.3	2.3	1.1	3.6	5.3	10.5	11.5	0.0	0.3	2.8	0.0	1.0	1.1	0.6	0.0	0.7	3.0	0.0	5.6	0.3	0.4	0.7	3.0	2.4	1.9	1.2	0.2	0.8	2.5	2.9	1.5	3.3	0.1	0.0	0.2	0.6	0.0	2.0	0.2	0.1	0.0	0.0	0.1	1.4	0.2	0.3	0.0	0.0	0.0	0.7	2.9	0.0	0.0	0.0	0.5	2.1	0.7	1.6	1.2	0.6	0.9	1.0	1.4	1.9	0.6	0.8	0.6
AL132671.2		ENSG00000282218			6	117318211-117573571	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"epididymis: 3.7;lung: 2.6"	"Cell line enriched"	"Detected in single"	37	"U-138 MG: 14.2"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA019477	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA019477: AB_1849890"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	3.7	0.0	0.0	0.0	0.0			0.0	0.0	2.6	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.7	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AP1S3		ENSG00000152056	"Adaptor related protein complex 1 sigma 3 subunit"	Q96PC3	2	223751686-223838027	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 50.0;epididymis: 64.5;seminal vesicle: 39.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 55.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA066782	Approved		Supported	Vesicles				Vesicles	Vesicles	"HPA066782: AB_2685720"	"unprognostic (9.45e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.89e-1)"	"unprognostic (1.65e-3)"	"prognostic unfavourable (3.36e-5)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (2.08e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.61e-2)"	1.9	1.4	1.6	5.4	3.0	1.8	1.6	2.2	1.9	1.6	1.8	0.2	50.0	3.1	0.8	64.5	5.8	1.7	7.6	1.0	2.3	1.7	7.0	1.9	5.2	3.8	1.1	1.0	0.8	5.1	3.3	6.8	4.6	0.9	2.5	2.0	1.9	4.1	39.6	0.5	1.6	4.1	0.9	1.0	3.1	6.2	1.1	0.4	0.8	10.5	3.1	5.7	8.1	2.9	8.8	5.3	4.9	0.5	0.7	1.6	0.7	8.9	8.5	1.0	3.2	0.5	0.2	4.6	3.7	0.9	1.9	1.7	55.0	7.0	3.5	3.1	0.5	14.8	2.7	10.2	2.8	5.1	4.3	0.3	13.5	5.6	0.2	1.1	0.4	0.1	11.1	3.4	11.7	1.3	0.5	0.8	1.1	3.8	0.1	0.2	1.2	6.0	1.3	0.0	1.5	17.4	17.6	2.5	0.7	2.0	3.6	1.2	1.7	1.6	0.6	0.3	1.9	1.0	2.9	3.5	3.0	9.6	1.3	0.4	2.0	4.9	0.5	0.4	1.1	0.3	0.8	8.8	0.5	0.4	2.2	3.5	0.4	0.7	1.9	0.7	0.2	5.3	1.6	0.7	1.6	3.0	2.2	1.9	2.3	1.7	1.1	1.0	0.9	0.4
BMX	"ETK, PSCTK3"	ENSG00000102010	"BMX non-receptor tyrosine kinase"	P51813	X	15464246-15556529	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 57.1"	"Cell line enriched"	"Detected in single"	121	"HUVEC TERT2: 88.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	105	"granulocytes: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001048, CAB032495"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB032495: AB_2290760, HPA001048: AB_1078289"	"unprognostic (7.80e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.81e-2)"	8.2	0.3	0.1	1.0	0.7	3.6	5.4	0.1	0.3	2.2	5.5	0.1	4.6	2.4	2.6	57.1	1.5	2.5	2.6	10.5	0.5	0.0	0.2	0.9	3.7	6.5	0.4	0.0	1.4	0.9	0.2	0.6	2.6	0.7	2.2	1.4	0.5	1.5	0.6	4.2	1.6	5.5	2.2	0.4	2.4	1.5	1.9	0.1	0.2	2.2	1.1	0.8	2.8	2.4	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.3	0.5	0.0	0.4	0.0	0.7	0.1
CAPN6	"CalpM, CANPX, CAPNX"	ENSG00000077274	"Calpain 6"	Q9Y6Q1	X	111245103-111270523	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 62.9;placenta: 173.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;HDLM-2: 11.0;NTERA-2: 17.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 25.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 1.2;plasmacytoid DC: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA040259			Approved	Vesicles				Vesicles	Vesicles	"HPA040259: "	"unprognostic (1.27e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.12e-1)"	"unprognostic (6.25e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (5.02e-3)"	"unprognostic (2.66e-1)"	"unprognostic (6.30e-2)"	1.7	0.0	0.2	1.7	0.2	0.0	6.0	0.3	0.3	3.9	4.2	0.2	23.4	0.2	18.2	62.9	2.4	2.9	2.6	0.4	0.2	0.0	5.1	0.4	0.3	1.1	0.2	0.4	1.9	4.1	0.0	0.2	173.5	0.3	3.6	2.2	2.1	5.6	21.7	1.7	1.0	1.3	2.0	0.3	1.0	7.2	2.8	0.2	0.5	1.7	4.7	2.9	1.4	2.6	0.1	2.0	0.8	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	17.3	0.0	0.0	0.0	0.1	1.5	0.0	0.1	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.2	0.2	0.3	0.3	0.2	0.0	0.2	0.4	0.3	0.2
CFAP157	C9orf117	ENSG00000160401	"Cilia and flagella associated protein 157"	Q5JU67	9	127706989-127716002	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 30.2;epididymis: 24.0;fallopian tube: 44.8;testis: 11.5"	"Cell line enhanced"	"Detected in many"		"A549: 9.1;HeLa: 7.4;MCF7: 6.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 19.8;pons and medulla: 30.2"	"Cell type enriched"	"Detected in single"	11	"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA021474, HPA021786"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA021474: AB_1845801, HPA021786: AB_1845802"	"unprognostic (1.69e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.41e-2)"	"prognostic favourable (1.45e-4)"	"unprognostic (3.02e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.14e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.93e-4)"	"unprognostic (9.32e-3)"	"unprognostic (4.95e-3)"	"unprognostic (5.71e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	0.4	0.4	3.1	0.3	19.8	0.3	0.3	0.1	0.4	5.3	0.3	7.0	1.6	0.2	1.0	24.0	0.8	44.8	0.6	0.4	4.6	5.8	0.4	0.3	6.1	0.4	0.0	0.0	4.4	0.9	0.2	4.4	0.3	30.2	0.4	0.2	0.0	0.5	1.3	0.4	0.6	0.3	0.2	0.5	0.4	0.4	11.5	3.5	0.0	0.4	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.5	9.1	0.9	1.2	0.0	0.0	1.2	1.1	0.0	0.0	0.0	0.9	1.3	1.4	1.4	0.0	4.5	0.0	0.0	0.0	3.4	1.0	0.9	7.4	2.2	0.0	0.7	2.0	0.0	0.0	0.0	0.0	0.0	3.0	0.7	0.0	6.5	1.3	0.5	0.8	4.9	2.0	0.9	1.5	0.0	0.4	6.3	1.1	1.9	3.6	0.7	3.2	0.3	1.7	1.9	1.5	4.9	0.8	1.0	2.5	1.1	0.7	0.7	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	19.8	0.1	0.3	4.6	5.8	0.0	0.0	30.2	3.5
CITED1	MSG1	ENSG00000125931	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1"	Q99966	X	72301638-72307187	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 247.1;pituitary gland: 62.8;testis: 89.9"	"Group enriched"	"Detected in some"	5	"AN3-CA: 17.5;SK-MEL-30: 69.6"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 134.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 18.9"	"Cell type enhanced"	"Detected in some"		"eosinophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049051	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA049051: AB_2680612"	"unprognostic (7.04e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (8.81e-2)"	"unprognostic (5.67e-4)"	"unprognostic (3.40e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.60e-3)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.62e-1)"	"prognostic favourable (6.10e-4)"	"prognostic favourable (3.95e-4)"	"unprognostic (2.99e-2)"	0.5	0.6	3.5	0.5	2.2	0.4	6.0	0.9	2.8	1.3	0.5	0.3	5.3	0.5	1.0	247.1	0.4	0.5	0.4	0.4	2.4	18.9	0.6	0.4	0.5	0.4	1.1	0.9	0.5	0.6	0.4	62.8	0.4	2.7	2.1	0.4	27.8	0.4	1.2	0.4	0.4	0.5	1.7	0.5	0.4	0.4	89.9	0.0	0.0	1.7	0.0	0.4	0.4	0.0	0.0	0.8	2.2	0.5	0.0	1.1	1.1	0.1	0.1	0.7	17.5	0.8	0.0	0.6	0.0	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	6.3	0.4	0.0	1.8	2.5	0.3	0.1	0.0	0.0	0.1	3.4	0.3	0.2	0.2	0.3	0.0	0.7	0.1	0.1	0.2	0.0	1.3	1.0	1.2	0.0	1.2	0.9	0.0	0.2	7.9	4.1	0.1	1.5	69.6	0.5	0.4	0.0	0.1	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.2	1.6	0.0	0.5	2.2	0.4	0.0	1.1	0.0	0.2	0.6	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	3.5	2.2	0.9	2.8	2.4	18.9	1.1	0.9	2.7	0.0
COL2A1	"AOM, SEDC, STL1"	ENSG00000139219	"Collagen type II alpha 1 chain"	P02458	12	47972965-48004554	"Cancer-related genes, Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 22.7;pituitary gland: 11.0;retina: 8.1;stomach 1: 11.3"	"Cell line enhanced"	"Detected in some"		"AF22: 54.0;HAP1: 33.8;HEK 293: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002214, HPA055753"	Supported		Approved	Nucleoplasm	"Secreted to extracellular matrix"			Nucleoplasm	Nucleoplasm	"CAB002214: AB_563666, HPA055753: AB_2682908"	"unprognostic (7.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.31e-4)"	"unprognostic (2.64e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.02e-1)"	0.0	0.0	0.1	2.2	0.3	0.0	0.7	0.9	0.9	0.0	0.2	0.3	0.0	0.0	0.3	22.7	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	1.4	0.0	0.0	0.7	1.3	0.0	0.0	11.0	0.4	1.9	2.6	0.4	8.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	11.3	2.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	33.8	0.0	0.0	0.0	12.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.9	0.9	0.5	1.3	0.0	0.7	1.9	0.0
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593998-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 11.6;heart muscle: 39.5"	"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 31.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.7"	"Low region specificity"	"Detected in single"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"HPA070941: AB_2686324"	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.3	0.1	0.3	0.0	0.1	0.0	0.8	0.1	0.1	3.1	0.1	0.1	2.6	0.0	3.4	11.6	0.7	1.2	4.5	39.5	0.0	0.2	2.0	0.0	1.3	0.0	0.2	0.0	0.6	0.1	0.0	1.5	0.6	1.6	1.7	0.0	0.4	0.3	4.6	0.2	5.3	0.4	0.5	0.0	3.5	0.3	3.7	0.0	0.2	0.1	1.7	0.4	0.8	3.2	0.2	0.0	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	7.3	31.8	0.0	1.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.2	0.0	1.6	0.0
DCAF12L2	WDR40C	ENSG00000198354	"DDB1 and CUL4 associated factor 12 like 2"	Q5VW00	X	126163499-126166097	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 15.7;epididymis: 53.6;testis: 15.8"	"Group enriched"	"Detected in some"	6	"HAP1: 5.7;NTERA-2: 4.8;U-2 OS: 7.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044737, HPA048981, HPA053138"	Approved		Uncertain	Cytosol				Cytosol	Cytosol	"HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054"	"unprognostic (1.16e-4)"			"unprognostic (8.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.52e-2)"		"unprognostic (2.72e-1)"		"unprognostic (3.02e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.47e-4)"	"unprognostic (1.56e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.51e-1)"	1.1	1.2	1.1	0.1	1.9	0.1	2.3	0.5	2.1	1.9	0.9	0.0	15.7	0.1	2.4	53.6	0.5	3.0	0.2	0.4	1.0	3.9	0.4	0.1	0.2	0.2	1.0	1.7	1.9	0.2	2.4	1.3	0.1	1.3	2.0	0.2	0.2	0.6	5.6	0.4	0.5	0.5	2.0	0.8	0.2	0.7	15.8	0.1	0.0	0.4	0.0	0.3	2.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	0.5	2.1	1.0	3.9	1.0	1.7	1.3	0.1
DEFB125	DEFB-25	ENSG00000178591	"Defensin beta 125"	Q8N687	20	87250-97094	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 74.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																							0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	13.6	0.0	0.0	74.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0
DEFB132	"DEFB32, RP5-1103G7.6"	ENSG00000186458	"Defensin beta 132"	Q7Z7B7	20	257736-261096	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ductus deferens: 37.1;epididymis: 119.7"	"Group enriched"	"Detected in some"	7	"BEWO: 1.1;NB-4: 3.2;RPMI-8226: 1.8;SH-SY5Y: 1.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.8;prostate cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046399	Approved				"Secreted in male reproductive system"					"HPA046399: AB_10960992"	"unprognostic (9.27e-3)"						"unprognostic (1.61e-2)"					"unprognostic (2.54e-2)"						17.2	0.1	0.1	0.0	0.1	0.0	4.4	0.1	0.1	0.1	0.1	0.0	37.1	0.0	0.1	119.7	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.9	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.1	6.4	0.1	0.1	0.2	0.0	0.1	0.1	0.1	1.3	0.0	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFB136	DEFB137	ENSG00000205884	"Defensin beta 136"	Q30KP8	8	11973937-11974599	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"epididymis: 5.8;prostate: 1.5"	"Group enriched"	"Detected in some"	16	"HAP1: 2.7;WM-115: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA068255	Enhanced				"Secreted in male reproductive system"					"HPA068255: AB_2732780"																		0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.0			0.0	0.3	5.8	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.3	0.0		1.5	0.0		0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3			0.0		0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
EMILIN3	"C20orf130, dJ620E11.4, EMILIN5"	ENSG00000183798	"Elastin microfibril interfacer 3"	Q9NT22	20	41359966-41366827	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 49.9"	"Group enriched"	"Detected in some"	7	"AF22: 6.8;HAP1: 11.8;NTERA-2: 7.5;SCLC-21H: 14.1"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	29	"cerebellum: 3.7"	"Low region specificity"	"Detected in single"			"HPA059912, HPA078559"	Enhanced				"Secreted to extracellular matrix"	650000	650000			"HPA059912: AB_2684158, HPA078559: "	"unprognostic (1.66e-4)"	"unprognostic (1.85e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.54e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.13e-7)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.62e-2)"	0.9	1.9	2.9	1.6	2.0	0.5	3.5	0.7	8.2	7.1	4.1	1.9	8.5	1.1	2.7	49.9	1.1	3.2	0.9	6.0	3.0	2.9	0.8	0.6	0.7	0.6	3.8	0.7	9.2	0.6	0.5	1.6	0.6	2.7	8.1	0.8	5.8	1.5	10.0	1.3	3.4	1.4	1.6	2.2	0.6	1.9	4.3	2.3	0.3	0.7	2.9	0.8	2.4	5.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	11.8	0.0	0.2	0.0	1.3	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.1	0.0	0.0	14.1	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.9	2.0	0.7	8.2	3.0	2.9	3.8	0.7	2.7	2.3
FAM43B	FLJ44952	ENSG00000183114	"Family with sequence similarity 43 member B"	Q6ZT52	1	20552439-20555010	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"adrenal gland: 21.9;brain: 14.9;epididymis: 8.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.5;BJ hTERT+: 3.3;fHDF/TERT166: 6.5;Hep G2: 4.8;SCLC-21H: 5.9;SiHa: 11.0"	"Cancer enhanced"	"Detected in some"		"glioma: 4.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA050813	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA050813: AB_2681244"	"unprognostic (1.51e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.74e-1)"	"unprognostic (8.33e-2)"	"unprognostic (5.87e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.46e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.78e-4)"	"unprognostic (1.06e-2)"	"unprognostic (6.05e-3)"	"unprognostic (6.48e-2)"	"unprognostic (2.12e-2)"	3.2	21.9	5.6	1.5	14.9	0.9	1.5	8.8	14.4	1.6	1.3	2.4	0.0	1.1	1.4	8.7	1.3	1.6	1.5	3.3	5.3	12.1	2.6	1.4	1.2	1.0	10.1	6.0	1.0	1.2	0.9	0.7	2.5	11.2	1.4	1.1	0.5	1.2	1.3	2.8	1.0	1.2	2.9	4.0	1.4	0.9	1.3	2.8	0.0	1.3	1.7	0.9	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	4.5	0.2	0.1	0.0	0.5	3.3	0.6	0.0	0.1	0.0	0.0	0.2	6.5	0.0	0.7	0.0	0.1	0.0	0.9	0.1	0.3	4.8	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.4	0.0	0.0	0.0	0.0	0.0	5.9	0.7	11.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	14.9	8.8	14.4	5.3	12.1	10.1	6.0	11.2	2.8
GOLGA7B	"bA451M19.3, bA459F3.4, C10orf132, C10orf133"	ENSG00000155265	"Golgin A7 family member B"	Q2TAP0	10	97850239-97871580	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 39.6;epididymis: 35.9;skin 1: 21.4"	"Cell line enhanced"	"Detected in some"		"A-431: 5.0;HDLM-2: 5.4;SK-MEL-30: 21.4;U-87 MG: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046878	Uncertain									"HPA046878: AB_2679854"	"unprognostic (7.90e-2)"	"unprognostic (1.70e-3)"	"unprognostic (7.10e-3)"	"unprognostic (1.06e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.20e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.89e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.15e-7)"	"unprognostic (2.12e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.90e-3)"	2.5	4.5	16.4	2.1	12.0	1.3	2.5	39.6	24.1	1.3	1.5	4.4	1.3	3.2	1.3	35.9	2.3	1.1	1.5	3.4	19.8	12.8	1.0	1.1	1.7	2.8	11.1	20.4	1.0	6.6	1.0	6.7	1.3	10.7	1.3	1.8	0.6	1.4	1.7	4.9	21.4	3.8	1.2	5.4	1.5	2.3	1.7	6.2	0.0	1.4	0.5	2.5	1.2	1.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	5.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	2.0	0.0	0.1	0.0	1.9	0.0	0.4	0.0	5.4	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.3	0.0	1.8	0.1	0.1	0.3	0.8	1.5	0.0	1.0	21.4	2.1	0.1	0.1	0.1	0.0	0.0	0.2	1.7	0.7	0.0	3.9	2.2	2.4	0.0	0.0	0.0	0.7	0.0	0.3	0.0	2.3	1.9	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.0	1.2	0.3	16.4	12.0	39.6	24.1	19.8	12.8	11.1	20.4	10.7	6.2
GPX5		ENSG00000224586	"Glutathione peroxidase 5"	O75715	6	28525925-28534952	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 27.7"	"Group enriched"	"Detected in some"	7	"BEWO: 1.0;NB-4: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in male reproductive system"																	"unprognostic (3.34e-2)"			"unprognostic (3.74e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPX6	GPXP3	ENSG00000198704	"Glutathione peroxidase 6"	P59796	6	28503296-28528215	"Enzymes, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 9.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.0;HEL: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"basal ganglia: 21.3"	"Low region specificity"	"Detected in single"								"Secreted in male reproductive system"																				"unprognostic (2.99e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.0	0.4	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9			0.0		0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0										
HOXB8	"HOX2, HOX2D"	ENSG00000120068	"Homeobox B8"	P17481	17	48611377-48614939	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 49.3;ductus deferens: 45.4;epididymis: 39.2;kidney: 16.1;seminal vesicle: 34.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.6;HDLM-2: 9.2;HEK 293: 21.2;LHCN-M2: 10.8;RPTEC TERT1: 22.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 33.3"	"Region enriched"	"Detected in single"	82	"pons and medulla: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	48	"pons and medulla: 6.8"	"Low region specificity"	"Detected in many"			HPA075905			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA075905: AB_2686767"	"unprognostic (4.44e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.07e-5)"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.00e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.14e-2)"	"prognostic favourable (1.30e-7)"	"unprognostic (1.77e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.88e-3)"	3.5	4.3	0.0	1.6	0.0	0.0	2.5	0.0	0.0	7.7	2.1	0.0	45.4	0.0	2.1	39.2	0.0	0.9	0.0	0.0	0.0	0.0	16.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.4	0.2	0.2	8.2	1.9	0.8	0.0	0.1	34.6	0.2	0.4	4.0	1.1	49.3	0.0	4.3	2.8	0.0	0.1	0.1	0.0	0.0	5.0	6.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	1.1	3.2	0.0	0.4	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	20.6	3.2	0.0	0.0	0.0	0.0	9.2	21.2	0.5	0.0	0.0	0.2	0.0	3.1	0.6	0.0	0.0	0.0	1.3	6.1	0.0	10.8	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	22.5	0.5	0.0	0.0	0.3	0.0	3.0	0.2	0.0	5.1	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0
HOXB9	"HOX2, HOX2E"	ENSG00000170689	"Homeobox B9"	P17482	17	48621159-48626356	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 27.3;epididymis: 42.8;intestine: 16.6;kidney: 15.3;seminal vesicle: 23.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 77.4;HEK 293: 29.8;HMC-1: 30.6;K-562: 32.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031463			Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA031463: "	"unprognostic (2.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (4.47e-4)"	"unprognostic (1.38e-4)"	"prognostic unfavourable (6.64e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.60e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.00e-2)"	0.5	0.8	0.1	1.9	0.2	0.0	0.4	0.1	0.3	5.3	16.6	0.1	27.3	0.0	1.4	42.8	0.1	0.4	0.1	0.1	0.1	0.1	15.3	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.4	0.3	0.5	0.2	1.1	10.4	0.1	0.1	23.5	0.2	0.2	11.3	1.0	3.5	0.2	0.2	2.0	0.1	0.1	0.1	0.1	0.1	2.0	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	4.0	1.3	0.0	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	1.6	0.0	8.3	0.2	0.0	1.3	0.0	0.0	77.4	29.8	13.5	0.5	0.0	0.5	0.2	30.6	0.0	0.0	0.0	0.8	0.0	32.8	0.0	1.3	0.0	0.0	0.1	0.0	1.2	0.0	5.2	0.4	13.5	0.0	0.0	0.0	1.0	0.0	8.5	0.1	0.0	0.1	0.0	7.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1
LCN12	MGC48935	ENSG00000184925	"Lipocalin 12"	Q6JVE5	9	136949551-136955497	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 131.5"	"Cell line enhanced"	"Detected in some"		"A549: 2.8;BEWO: 1.3;Daudi: 1.0;EFO-21: 1.7;HEL: 1.5;SH-SY5Y: 1.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 44.8"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	21	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 2.0"	"Not detected"	"Not detected"												"Secreted in male reproductive system"						"unprognostic (7.27e-3)"	"unprognostic (5.72e-3)"	"unprognostic (2.45e-2)"	"unprognostic (7.14e-2)"	"unprognostic (4.53e-4)"	"unprognostic (9.33e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.03e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.73e-2)"	"unprognostic (5.21e-3)"	"unprognostic (3.06e-1)"	"unprognostic (5.00e-2)"	"unprognostic (7.91e-4)"	0.3	0.4	0.9	0.3	1.8	0.3	0.3	0.2	0.9	0.9	0.3	0.4	24.4	0.4	0.5	131.5	0.3	2.4	0.3	0.3	0.8	0.8	2.3	1.2	0.3	0.3	1.0	0.7	0.6	0.7	0.3	1.9	0.3	1.2	0.3	0.3	1.6	0.3	10.9	0.3	0.3	0.4	0.3	0.9	0.6	0.4	1.1	0.9	0.0	8.6	0.0	0.3	0.3	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.9	1.8	0.2	0.9	0.8	0.8	1.0	0.7	1.2	0.9
LCN9		ENSG00000148386	"Lipocalin 9"	Q8WX39	9	135663322-135666422	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"ductus deferens: 17.2;epididymis: 5.0;seminal vesicle: 7.7"	"Cell line enriched"	"Detected in some"	15	"BEWO: 19.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA060941	Enhanced				"Secreted in male reproductive system"					"HPA060941: AB_2732654"					"unprognostic (7.64e-4)"													0.3	0.0	0.5	0.0	0.5	0.0	0.0	0.2	2.1	0.2	0.0	0.1	17.2	0.0	0.0	5.0	0.0	0.5	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	7.7	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	0.4	0.5	0.3	0.9	0.0	0.1	0.0
LEMD1	"CT50, LEMP-1"	ENSG00000186007	"LEM domain containing 1"	Q68G75	1	205381378-205457091	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 13.1;testis: 34.8"	"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 29.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.6"	"Group enriched"	"Detected in some"	13	"cerebellum: 2.6;pons and medulla: 5.3"	"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045425			Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"	"Nucleoli, Cytosol"	"HPA045425: "	"unprognostic (1.78e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.20e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.48e-1)"		"unprognostic (2.72e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.26e-4)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (3.31e-1)"	"unprognostic (5.66e-6)"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-2)"	0.2	0.2	0.2	0.0	0.3	0.0	0.3	2.6	0.2	0.4	1.4	0.0	3.8	0.6	1.0	13.1	1.0	1.5	0.7	0.2	0.2	0.3	0.9	0.2	0.4	0.0	0.3	0.0	0.6	0.6	0.0	0.6	4.7	5.3	0.3	0.0	0.3	3.2	0.4	0.2	0.3	1.4	0.1	0.2	0.2	0.3	34.8	0.0	0.0	4.8	2.2	2.6	0.2	0.3	0.0	0.0	0.0	0.0	1.5	0.7	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	29.2	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.2	0.3	2.6	0.2	0.2	0.3	0.3	0.0	5.3	0.0
PKHD1	"ARPKD, FCYT, FPC, TIGM1"	ENSG00000170927	"PKHD1, fibrocystin/polyductin"	P08F94	6	51615300-52087625	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 19.8;kidney: 49.4;pancreas: 32.9"	"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 15.4"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 1.4;renal cancer: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031227	Enhanced									"HPA031227: AB_10602068"	"unprognostic (6.34e-3)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.42e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.62e-2)"	"prognostic favourable (9.74e-8)"	"unprognostic (2.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-2)"	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.0	5.6	0.0	0.1	19.8	0.1	0.1	6.3	0.1	0.1	0.1	49.4	2.5	0.1	0.0	0.1	0.0	0.1	32.9	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	1.2	0.1	0.4	0.1	0.1	0.1	0.1	0.5	1.4	0.0	0.0	0.1	0.0	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	15.4	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
PLA1A	ps-PLA1	ENSG00000144837	"Phospholipase A1 member A"	Q53H76	3	119597842-119629811	"Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 47.8;epididymis: 63.1;seminal vesicle: 123.8"	"Cell line enriched"	"Detected in some"	18	"SK-MEL-30: 23.4"	"Group enriched"	"Detected in many"	5	"liver cancer: 14.8;melanoma: 55.4;prostate cancer: 24.2;renal cancer: 21.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"T-reg: 1.9"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059740			Approved	"Nucleoplasm,Nuclear speckles,Cytoplasmic bodies"	"Secreted in other tissues"			"Nuclear speckles, Cytoplasmic bodies"	"Nuclear speckles, Cytoplasmic bodies"	"HPA059740: AB_2684118"	"unprognostic (1.35e-1)"	"prognostic favourable (2.81e-7)"	"unprognostic (2.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.53e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.67e-1)"	2.5	0.4	3.8	1.5	4.7	0.2	1.8	1.4	2.5	2.5	1.3	1.7	47.8	0.6	3.2	63.1	0.8	2.7	1.3	5.0	3.6	4.3	9.3	17.2	13.7	6.1	6.0	1.0	0.5	1.8	11.4	1.0	4.4	7.0	6.0	1.2	10.7	1.5	123.8	10.3	0.3	1.9	4.2	7.4	0.5	2.2	2.0	2.5	0.4	5.0	0.4	3.7	2.1	1.3	0.0	0.0	0.0	0.4	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.7	0.2	0.5	0.1	0.0	0.2	0.0	0.0	23.4	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	0.0	3.8	4.7	1.4	2.5	3.6	4.3	6.0	1.0	7.0	2.5
PMFBP1		ENSG00000118557	"Polyamine modulated factor 1 binding protein 1"	Q8TBY8	16	72112157-72176878	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 13.6;testis: 30.8"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 20.6;SH-SY5Y: 10.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA056716, HPA075825"	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA056716: AB_2683215, HPA075825: "	"unprognostic (1.46e-1)"	"unprognostic (3.62e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.06e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.68e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.67e-2)"	1.1	0.9	1.1	1.1	1.1	3.9	1.1	2.1	1.1	1.1	2.1	1.1	1.1	2.6	1.1	13.6	1.6	0.9	1.1	1.1	1.1	0.7	1.3	1.6	1.1	1.5	1.1	1.1	1.5	4.2	2.9	1.5	1.1	1.1	2.1	3.3	1.1	1.1	1.1	1.1	4.1	2.9	1.1	1.1	2.9	1.1	30.8	1.1	1.1	1.1	1.1	1.1	1.1	1.1	0.5	1.9	0.9	2.0	0.0	0.3	0.2	0.2	0.4	2.7	2.5	0.0	0.6	1.8	0.5	0.2	0.5	2.0	1.0	2.6	1.8	0.4	0.1	1.7	1.0	0.1	1.3	0.2	4.1	1.8	2.9	2.9	0.0	4.0	3.1	0.0	0.8	0.1	2.1	0.7	0.3	1.5	0.1	2.3	1.0	5.9	0.8	1.1	2.7	0.2	1.4	0.3	0.7	20.6	10.3	0.0	0.0	0.2	0.5	2.5	1.7	1.3	2.1	0.6	1.3	3.8	1.4	1.1	0.6	2.6	0.7	0.0	1.6	0.9	0.1	0.5	0.0	0.0	0.1	0.2	1.6	0.5	0.1	0.1	0.2	0.0	2.0	1.9	0.3	0.2	1.1	1.1	2.1	1.1	1.1	0.7	1.1	1.1	1.1	1.1
RNF186	FLJ20225	ENSG00000178828	"Ring finger protein 186"	Q9NXI6	1	19814029-19815278	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"epididymis: 25.8;intestine: 59.0;kidney: 44.0;pancreas: 30.5"	"Cell line enriched"	"Detected in some"	5	"RPMI-8226: 6.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 18.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034547, HPA035558"	Enhanced									"HPA034547: AB_10670975, HPA035558: AB_2674678"	"unprognostic (1.66e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.93e-3)"			"unprognostic (1.77e-3)"	"unprognostic (3.23e-1)"			"unprognostic (3.05e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.40e-1)"		"unprognostic (8.60e-3)"	0.2	0.1	0.1	7.8	0.1	0.0	0.8	0.1	0.1	0.2	38.2	0.0	0.5	47.1	0.2	25.8	0.2	0.2	0.1	0.1	0.1	0.1	44.0	0.7	0.1	0.0	0.1	0.0	0.3	30.5	0.0	0.2	0.0	0.0	0.6	5.4	0.0	0.2	0.0	0.1	0.2	59.0	0.0	0.1	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	6.1	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SPACA9	"C9orf9, Mast"	ENSG00000165698	"Sperm acrosome associated 9"	Q96E40	9	132878027-132890201	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"epididymis: 55.8;fallopian tube: 29.1;testis: 53.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA022243, HPA051600"	Enhanced		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA022243: AB_1845844, HPA051600: AB_2681546"	"unprognostic (2.69e-1)"	"unprognostic (2.14e-3)"	"unprognostic (8.00e-3)"	"prognostic favourable (8.61e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-2)"	"unprognostic (9.51e-2)"	"prognostic favourable (8.31e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-2)"	2.7	6.0	7.8	1.6	8.4	1.7	3.9	4.3	9.3	5.1	4.8	8.5	7.9	1.7	5.3	55.8	5.3	29.1	4.5	7.0	7.0	8.9	7.0	1.8	4.6	2.1	7.2	7.3	9.2	2.8	2.7	5.8	3.0	6.9	4.1	2.1	5.7	7.7	6.2	1.5	8.0	1.7	4.3	7.7	2.3	3.1	53.8	5.1	6.2	10.2	3.6	3.0	2.9	3.8	6.0	3.0	5.6	3.3	7.8	3.5	1.6	2.7	3.0	4.6	3.7	6.4	8.3	5.5	1.7	3.3	2.5	2.7	0.8	8.6	0.7	4.1	8.0	3.9	1.9	5.0	2.3	3.2	3.6	0.7	2.1	0.9	9.4	2.0	0.3	9.4	10.8	6.1	6.7	2.8	0.8	2.3	6.7	5.9	6.8	7.8	1.0	2.8	3.3	1.0	1.9	10.0	1.1	1.2	4.5	7.4	1.3	5.9	9.8	0.7	2.7	5.4	3.6	5.1	0.7	0.9	1.5	2.4	9.9	0.8	2.6	5.6	2.2	3.6	2.2	2.0	2.5	6.0	2.4	1.3	3.0	4.7	2.9	2.6	3.1	7.8	3.3	1.0	3.5	1.6	7.8	8.4	4.3	9.3	7.0	8.9	7.2	7.3	6.9	5.1
SPINT3	HKIB9	ENSG00000101446	"Serine peptidase inhibitor, Kunitz type 3"	P49223	20	45512461-45515624	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"epididymis: 113.9"	"Group enriched"	"Detected in some"	14	"Karpas-707: 1.4;NTERA-2: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA026852	Enhanced				"Secreted in male reproductive system"					"HPA026852: AB_2732434"																		0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	113.9	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	16.7	0.0	4.8	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFAP2B	AP2-B	ENSG00000008196	"Transcription factor AP-2 beta"	Q92481	6	50818723-50847613	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"epididymis: 65.5"	"Group enriched"	"Detected in some"	4	"AF22: 31.7;SH-SY5Y: 59.0"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 12.1"	"Group enriched"	"Detected in some"	41	"cerebellum: 4.7;pons and medulla: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 11.2"	"Low region specificity"	"Detected in many"			"HPA034683, HPA062942"	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA034683: AB_10670966, HPA062942: AB_2684909"	"unprognostic (2.02e-1)"	"unprognostic (2.29e-2)"		"unprognostic (4.27e-2)"	"unprognostic (5.88e-4)"	"unprognostic (9.76e-2)"		"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"			"unprognostic (4.57e-1)"	"unprognostic (6.58e-6)"	"unprognostic (1.13e-2)"	"unprognostic (1.88e-1)"		"unprognostic (7.17e-3)"	0.2	3.0	0.0	0.0	0.0	0.0	9.4	4.7	0.0	0.2	0.2	0.0	8.8	0.0	0.0	65.5	5.8	0.0	0.0	0.1	0.0	0.1	6.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	6.3	0.1	0.0	12.2	7.0	0.6	0.0	6.3	0.0	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	59.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.1	0.0	6.3	0.0
UQCRHL		ENSG00000233954	"Ubiquinol-cytochrome c reductase hinge protein like"	A0A096LP55	1	15807169-15809348	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"blood: 5.5;bone marrow: 2.2;epididymis: 1.6;skeletal muscle: 4.4;skin 1: 2.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in all"											HPA042574	Approved									"HPA042574: AB_10960998"	"unprognostic (8.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (7.10e-2)"	"unprognostic (4.01e-3)"	"unprognostic (4.83e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.60e-1)"	"unprognostic (9.67e-3)"	"unprognostic (9.76e-3)"	"unprognostic (2.71e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.02e-1)"	0.0	0.1		0.2		2.2	0.4		0.4	0.0	0.0			0.2	0.4	1.6	0.1	0.4	0.4	0.1			0.0	0.4	0.2	0.2			0.5	0.0	0.0		0.0		0.1	0.1		0.5	0.0	4.4	2.1	0.4	0.1		0.6	0.0	0.5			0.2		0.0	0.0		1.5	1.2	5.5	1.0	1.3	1.0	0.5	0.7	0.5	3.1	3.2	0.7	0.8	1.2	0.6	0.3	0.1	0.3	0.7	2.5	1.2	0.9	0.5	1.3	0.6	0.5	0.7	2.2	0.3	1.1	1.9	0.5	0.7	0.9	1.4	0.5	1.0	0.3	0.3	0.0	1.1	2.3	0.2	1.9	0.4	1.4	1.5	1.2	1.1	0.7	1.0	0.0	1.7	2.7	1.7	1.0	2.1	0.8	0.9	2.7	0.5	2.0	1.1	1.2	0.8	2.2	0.9	1.3	0.9	2.1	0.9	3.6	1.0	0.9	0.8	0.7	0.6	1.1	0.6	0.8	0.6	1.5	1.0	1.0	5.5	1.3	0.7	1.2	0.5	0.5										
WFDC11	WAP11	ENSG00000180083	"WAP four-disulfide core domain 11"	Q8NEX6	20	45648563-45670270	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"epididymis: 46.2"	"Group enriched"	"Detected in some"	5	"HeLa: 12.7;RPMI-8226: 7.7"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"basophil: 4.7"	"Low lineage specificity"	"Detected in many"																"Secreted in male reproductive system"																							0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0			0.0	0.1	46.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	8.6			0.0		0.0	0.4	0.0	0.8	0.7	4.7	0.4	1.3	0.8	0.1	0.2	1.1	0.0	0.2	0.6	0.8	1.2	1.1	0.1	0.0	0.0	0.7	0.3	0.6	0.4	0.0	0.6	0.0	0.2	0.0	0.0	0.8	1.1	12.7	0.8	0.0	0.6	0.8	0.3	0.0	0.0	0.2	0.0	0.6	0.2	0.0	0.2	0.5	1.1	1.1	0.6	0.2	0.5	7.7	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.1	1.1	0.0	0.2	0.7	0.3	0.1	0.5	0.5	0.0	0.1	2.1	0.3	4.7	0.4	0.2	0.4	0.2	0.4	0.3	0.3	0.3	0.1	0.8	0.4	0.8	1.2	1.3	0.2	0.7	0.0	0.1										
AC096582.3		ENSG00000283247			7	45859994-45873082	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"breast: 2.8;epididymis: 1.2;placenta: 3.3"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.2"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.1	0.0	0.1	0.1	0.1	0.0	2.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	0.1	0.1	0.1	0.1		0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	3.3	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.3	0.3	0.1	0.3	0.6	0.0	0.1	0.1	0.1	0.7	0.7	0.1	0.8	0.4	0.4	0.5	0.0	0.3	0.4	0.4	0.4	0.1	0.5	0.0	0.1	0.5	0.1	0.1	0.3	1.2	0.6	0.0	0.3	0.2	0.0	0.5	0.2	0.5	0.0	0.4	0.3	0.4	0.1	0.8	1.0	0.3	1.0	0.4	0.2	0.7	0.5	0.0	2.2	0.4	0.2	0.5	0.1	0.1	0.1	0.3	0.1	1.3	1.3	0.2	0.6	1.2	0.2	1.2	0.2	0.3	0.0	0.1	0.2	0.3	0.0	0.3	0.5	0.3	0.6	0.0	0.4	0.3	0.4	0.3	0.3	0.0	0.3	0.2	0.0										
AC117457.1		ENSG00000275163			3	178419123-178843300	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"brain: 11.1;epididymis: 11.8;fallopian tube: 12.2;kidney: 5.2;pituitary gland: 19.9"	"Cell line enriched"	"Detected in single"	14	"HSkMC: 5.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.1	0.0	0.1	2.9	0.0	0.0	0.0	11.8	0.0	12.2	0.3	0.2	0.3		5.2	0.2	1.5	0.0	0.0	0.0	2.6	2.9	0.0	19.9	0.0	11.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6"	"Group enriched"	"Detected in some"	5	"A-431: 33.8;CAPAN-2: 52.0;HaCaT: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA032148: AB_2674180, HPA057356: AB_2732610"	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favourable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	6.9	0.4	1.1	2.1	1.1	0.0	17.2	1.6	1.4	9.7	5.3	1.1	142.4	0.2	14.2	38.5	3.6	11.7	10.6	6.9	1.1	0.2	2.6	24.4	4.4	1.5	1.0	1.0	3.9	4.5	0.5	2.0	6.2	1.5	7.2	1.7	1.7	122.9	93.6	3.4	19.1	1.8	5.7	1.0	1.1	9.5	7.6	0.9	1.1	8.9	8.1	3.8	4.5	5.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	33.8	1.3	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.6	0.0	63.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	4.9	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	10.8	0.2	4.1	0.1	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	1.6	1.4	1.1	0.2	1.0	1.0	1.5	0.9
C1orf189		ENSG00000163263	"Chromosome 1 open reading frame 189"	Q5VU69	1	154199372-154206333	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 11.9;fallopian tube: 41.8;testis: 21.0"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.2"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA045779	Uncertain									"HPA045779: AB_2679448"	"unprognostic (8.23e-3)"	"unprognostic (5.55e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.01e-3)"	"unprognostic (2.50e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.78e-3)"	"unprognostic (1.36e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.79e-2)"	"unprognostic (3.05e-2)"	0.1	0.0	0.4	0.1	0.6	0.5	0.1	0.1	0.2	2.2	0.1	0.8	0.1	0.0	0.7	11.9	0.1	41.8	0.1	0.1	0.8	1.1	0.1	0.3	5.6	0.1	0.1	0.1	4.2	0.1	0.0	0.1	0.1	0.9	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	21.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.3	3.2	1.0	0.0	1.6	0.3	0.1	0.0	1.8	0.0	1.4	0.0	0.9	0.6	0.8	2.1	0.0	3.3	0.9	1.2	0.4	0.0	0.5	1.4	2.2	0.0	1.3	2.1	0.8	2.7	2.3	2.1	0.6	0.8	2.6	1.8	0.8	0.0	0.0	1.1	0.4	1.0	3.7	0.8	0.3	3.2	3.7	0.4	1.5	0.9	0.0	0.0	0.9	0.0	0.0	0.0	2.7	2.5	0.0	1.8	0.0	1.9	1.3	1.2	2.3	2.2	0.5	0.4	0.5	0.0	0.0	0.1	1.5	0.2	1.0	0.0	0.2	0.1	0.4	0.3	0.8	0.2	1.6	3.2	0.0	0.5	0.0	0.4	0.3	0.4	0.6	0.1	0.2	0.8	1.1	0.1	0.1	0.9	0.3
CCDC78	"C16orf25, FLJ34512"	ENSG00000162004	"Coiled-coil domain containing 78"	A2IDD5	16	722582-726954	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.1;epididymis: 21.3;fallopian tube: 47.9;lung: 13.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.6;RPMI-8226: 10.1;SCLC-21H: 12.1;U-266/70: 10.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.2"	"Low lineage specificity"	"Detected in many"																						"unprognostic (1.10e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.62e-4)"	"unprognostic (1.02e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.82e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.45e-3)"	"unprognostic (5.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.22e-3)"	0.3	1.1	3.6	1.1	11.3	1.2	0.5	2.0	1.2	2.5	0.4	6.4	1.3	0.3	1.1	21.3	0.3	47.9	0.6	0.4	4.3	4.7	0.4	0.4	13.3	1.1	1.9	0.1	5.7	0.3	0.7	2.3	0.6	20.1	0.6	0.5	0.3	0.7	1.0	0.4	0.4	0.6	0.4	2.6	0.9	0.9	1.1	1.7	0.2	0.5	0.1	1.6	1.0	0.1	0.4	1.2	1.3	0.0	1.2	3.2	0.1	0.5	1.0	1.2	2.8	1.3	1.1	1.3	1.0	2.4	0.6	0.4	0.4	4.7	1.0	1.0	0.6	0.8	2.7	1.5	0.1	8.6	0.0	2.4	1.4	0.0	1.5	0.8	1.5	3.7	0.8	0.3	4.3	0.4	0.3	3.3	0.8	6.0	0.0	2.0	1.8	0.3	2.1	0.9	10.1	4.1	1.8	12.1	1.2	1.1	7.1	0.6	4.6	1.6	1.0	0.9	0.4	0.0	0.1	10.0	0.2	2.6	0.9	1.1	2.8	0.0	0.0	1.3	0.2	0.0	3.2	0.4	0.1	1.9	0.0	0.1	0.0	0.0	0.0	1.2	0.0	1.2	0.1	0.1	3.6	11.3	2.0	1.2	4.3	4.7	1.9	0.1	20.1	1.7
CCNB3		ENSG00000147082	"Cyclin B3"	Q8WWL7	X	50202713-50351910	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 6.1;epididymis: 11.6;pituitary gland: 3.7;testis: 14.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.8;Karpas-707: 3.9;U-2 OS: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdTCR: 2.2"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA000496			Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA000496: AB_1078605"	"unprognostic (1.57e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.48e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.63e-2)"	0.7	0.7	0.9	0.3	3.5	0.2	0.8	0.4	1.7	0.4	0.4	5.8	0.0	0.4	0.3	11.6	0.4	0.7	0.6	0.6	1.3	1.5	0.7	1.1	0.7	0.4	2.4	2.0	0.4	0.9	0.7	3.7	0.9	4.3	0.5	0.4	0.0	0.5	0.8	1.4	1.0	0.3	0.3	6.1	0.6	1.0	14.8	1.3	0.1	0.9	1.1	0.5	0.4	0.2	0.3	0.3	0.0	0.5	0.0	2.2	0.1	0.4	1.5	0.8	0.5	0.2	0.2	0.0	0.1	0.3	0.3	0.4	1.2	4.8	1.4	1.0	0.3	0.2	0.7	0.5	0.3	1.2	1.6	1.0	0.0	0.0	1.3	1.1	1.0	0.8	0.2	0.3	0.9	0.5	0.2	3.9	1.2	0.0	0.6	0.2	0.7	0.1	0.0	1.7	0.1	0.2	0.5	0.1	0.9	0.4	0.2	1.0	3.4	0.3	0.4	2.0	3.5	0.9	0.6	1.0	0.7	2.1	0.6	0.4	0.3	0.0	0.0	0.0	2.2	0.5	0.3	0.3	0.5	0.0	0.3	0.3	0.4	1.0	0.0	0.0	0.3	0.0	0.1	0.1	0.9	3.5	0.4	1.7	1.3	1.5	2.4	2.0	4.3	1.3
CRISP1	"AEGL1, ARP, CRISP-1, HSCRISP1D, HSCRISP1G, HUMARP"	ENSG00000124812	"Cysteine rich secretory protein 1"	P54107	6	49834257-49877096	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"epididymis: 203.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;NB-4: 7.1;RPMI-8226: 2.0;SH-SY5Y: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028445, HPA030534"	Enhanced				"Secreted in male reproductive system"					"HPA028445: AB_10670428, HPA030534: AB_2732459"																		0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.0	48.8	0.0	0.2	203.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.4	8.8	0.2	0.2	0.6	0.0	0.2	0.2	0.2	7.4	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
CRYBA4		ENSG00000196431	"Crystallin beta A4"	P53673	22	26621964-26630672	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 2.2;epididymis: 6.0;retina: 2.0;testis: 4.1"	"Cell line enriched"	"Detected in some"	4	"HEL: 12.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.2"	"Not detected"	"Not detected"							HPA071178	Supported									"HPA071178: AB_2686354"	"unprognostic (6.69e-2)"	"unprognostic (3.94e-3)"	"unprognostic (5.61e-5)"	"unprognostic (1.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.05e-6)"	"unprognostic (2.86e-1)"	"unprognostic (1.20e-6)"	"unprognostic (1.87e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.70e-1)"	0.1	0.0	0.5	0.3	0.5	0.4	0.1	0.1	0.5	0.2	0.5	0.1	0.1	0.8	0.1	6.0	0.1	0.0	0.1	0.1	0.2	0.4	0.1	0.3	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	2.0	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.8	0.1	4.1	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.5	0.1	0.5	0.2	0.4	0.3	0.1	0.1	0.1
DCAF12L1	"KIAA1892L, WDR40B"	ENSG00000198889	"DDB1 and CUL4 associated factor 12 like 1"	Q5VU92	X	126549383-126552851	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 22.6;testis: 30.9"	"Group enriched"	"Detected in some"	15	"EFO-21: 17.2;U-2 OS: 9.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA044737, HPA048981, HPA053138"	Approved		Uncertain	Cytosol				Cytosol	Cytosol	"HPA044737: AB_2679067, HPA048981: AB_2680586, HPA053138: AB_2682054"				"unprognostic (2.62e-5)"						"unprognostic (2.88e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.74e-1)"		0.2	0.1	0.2	0.0	0.1	0.0	0.7	0.1	0.1	0.5	0.1	0.0	6.2	0.0	0.6	22.6	0.1	4.3	4.3	0.1	0.1	0.4	3.3	0.1	0.1	0.0	0.1	0.0	1.5	0.1	0.0	0.6	0.0	0.3	1.0	0.0	0.5	0.1	3.9	0.1	0.1	0.1	2.5	0.1	1.5	1.6	30.9	0.0	0.3	0.9	0.2	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.3	0.0
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171756-24358052	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 37.0;kidney: 46.4;pancreas: 22.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 19.7;EFO-21: 13.8;Hep G2: 22.3;RPTEC TERT1: 72.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Enhanced	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"				"Mitotic spindle, Cytosol"	"Mitotic spindle, Cytosol"	"HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: "	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.1	0.9	1.1	0.2	1.5	0.0	3.5	0.3	0.9	1.6	0.3	0.2	1.0	0.3	3.4	37.0	0.2	5.8	7.7	0.2	1.3	1.7	46.4	1.8	3.9	0.0	0.6	0.5	2.1	22.7	7.6	4.3	1.7	1.8	1.5	0.3	2.8	0.9	3.7	0.5	0.2	0.2	0.4	0.5	0.1	1.1	3.7	0.2	0.2	8.4	0.0	0.2	1.0	0.1	1.2	0.5	1.3	0.4	1.0	0.5	0.2	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.5	0.0	1.5	0.1	0.0	0.3	0.0	3.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.4	0.3	0.5	0.2	0.2	0.5	0.5	0.3	0.3	1.2	0.4	0.4	1.3	1.0	0.2	0.5	0.2	0.2	1.1	1.5	0.3	0.9	1.3	1.7	0.6	0.5	1.8	0.2
DEFB131A	"DEFB-31, DEFB131"	ENSG00000186146	"Defensin beta 131A"	P59861	4	9444534-9450514	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"ductus deferens: 31.3;epididymis: 65.5"	"Cell line enriched"	"Detected in some"	6	"TIME: 6.7"	"Cancer enriched"	"Detected in single"	18	"thyroid cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																					"unprognostic (2.11e-1)"		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	9.0	0.0	31.3	5.5	0.1	65.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	10.9	0.1	0.1	10.3	0.0	0.1	0.1	0.2	0.3	0.0	0.0	8.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFB134		ENSG00000205882	"Defensin beta 134"	Q4QY38	8	11993174-11996312	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"epididymis: 24.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.5;NTERA-2: 1.2;U-87 MG: 1.1;WM-115: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"																				"unprognostic (3.80e-2)"	"unprognostic (2.20e-1)"		0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.0	0.2	0.0	0.0	0.0	1.6	0.3	0.0	24.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0
ECT2L	"ARHGEF32, C6orf91, FBXO49, LFDH"	ENSG00000203734	"Epithelial cell transforming 2 like"	Q008S8	6	138795926-138904070	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 8.1;epididymis: 7.7;fallopian tube: 18.5;lung: 12.2;ovary: 9.4"	"Cell line enhanced"	"Detected in some"		"HEL: 2.7;SCLC-21H: 2.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"pons and medulla: 8.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA035488	Uncertain									"HPA035488: AB_10672865"	"unprognostic (2.88e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.53e-3)"	"unprognostic (3.48e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.03e-2)"	"unprognostic (5.90e-4)"	"unprognostic (2.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.65e-3)"	0.5	0.3	0.7	0.2	1.1	0.5	0.4	0.8	0.7	1.1	0.3	4.2	0.0	0.2	0.6	7.7	1.0	18.5	1.7	2.7	1.1	1.1	0.1	0.2	12.2	0.2	0.3	0.0	9.4	0.1	0.3	1.8	0.2	8.1	0.3	0.1	0.8	0.6	0.2	0.5	0.7	0.6	1.6	0.3	0.3	0.3	1.2	0.8	0.0	0.4	0.0	0.1	0.8	0.3	0.6	0.3	1.7	0.6	0.7	0.8	0.0	0.2	0.1	0.2	0.8	0.0	0.4	1.2	0.0	0.0	0.1	0.1	0.8	0.8	0.8	0.3	0.0	0.3	0.0	0.0	0.8	0.2	0.5	2.7	0.2	0.0	0.1	0.9	0.4	1.3	0.9	0.0	0.0	0.0	0.2	0.9	0.0	0.3	0.6	1.0	0.6	0.6	0.5	0.3	0.2	0.0	0.6	2.8	0.6	0.2	0.7	0.4	0.3	1.1	0.0	0.6	0.3	0.8	0.3	0.4	0.2	0.3	0.4	0.7	0.2	1.7	0.3	0.6	0.3	0.3	0.4	0.3	0.2	0.7	0.1	0.6	0.7	0.8	0.6	0.7	0.6	0.3	0.2	0.0	0.7	1.1	0.8	0.7	1.1	1.1	0.3	0.0	8.1	0.8
ENPP5		ENSG00000112796	"Ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)"	Q9UJA9	6	46159187-46170971	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"epididymis: 116.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.8;HSkMC: 7.9;T-47d: 9.3;U-266/70: 5.8;U-266/84: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdTCR: 13.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016902	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	300000	300000	Cytosol	Cytosol	"HPA016902: AB_1848172"	"unprognostic (1.12e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.01e-2)"	"prognostic favourable (4.57e-4)"	"unprognostic (1.96e-1)"	"unprognostic (9.89e-2)"	"prognostic favourable (4.04e-4)"	"unprognostic (7.00e-2)"	"prognostic favourable (4.44e-13)"	"unprognostic (4.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-1)"	1.5	4.8	6.5	1.3	10.3	0.8	7.1	9.2	16.1	6.9	2.0	3.3	28.7	1.5	1.6	116.5	1.6	7.9	3.9	3.9	6.6	9.4	12.1	1.0	4.7	1.2	14.2	10.5	5.4	6.2	21.8	23.3	1.5	14.4	14.6	2.3	11.8	6.9	27.5	6.9	1.3	1.6	5.1	5.5	3.2	3.5	16.2	3.5	1.0	24.3	0.9	1.4	5.7	1.7	0.4	0.0	1.0	0.1	2.2	13.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.6	0.1	0.3	11.8	1.9	3.9	0.3	0.0	0.6	1.6	0.1	0.0	2.6	0.8	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.5	2.5	0.0	0.0	0.3	0.2	4.9	0.6	5.1	0.2	0.0	4.9	0.0	9.3	0.0	0.0	0.0	1.4	0.0	0.1	5.8	8.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	13.4	0.1	7.2	0.4	2.7	8.6	0.0	0.4	0.8	8.2	1.0	2.2	0.0	0.0	0.0	2.6	6.5	10.3	9.2	16.1	6.6	9.4	14.2	10.5	14.4	3.5
FRMPD2	"MGC35285, PDZD5C, PDZK5C"	ENSG00000170324	"FERM and PDZ domain containing 2"	Q68DX3	10	48153088-48274870	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.2;epididymis: 7.9;fallopian tube: 11.1;heart muscle: 6.3;retina: 11.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.6;HBEC3-KT: 2.8;Hep G2: 1.5;SCLC-21H: 2.8;SK-BR-3: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 7.6"												"unprognostic (1.53e-1)"	"unprognostic (3.08e-1)"		"unprognostic (7.88e-4)"	"unprognostic (7.59e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.54e-3)"		"unprognostic (1.85e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.25e-12)"	"unprognostic (3.48e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.43e-5)"	0.4	0.4	5.6	0.4	12.0	0.4	2.1	7.3	4.1	1.4	0.6	12.7	0.0	0.4	0.9	7.9	0.4	11.1	0.4	6.3	6.4	4.0	1.1	0.4	1.5	0.4	3.1	1.3	0.8	0.7	0.4	0.5	0.7	14.2	1.8	1.0	11.4	0.5	0.6	0.4	0.4	0.5	0.4	2.4	0.4	0.4	1.5	6.5	0.0	2.3	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	2.8	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	12.0	7.3	1.7	6.4	4.0	3.1	1.3	14.2	6.5
GDF9		ENSG00000164404	"Growth differentiation factor 9"	O60383	5	132861181-132866884	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 6.6;testis: 11.1"	"Cell line enhanced"	"Detected in many"		"U-266/84: 4.5"	"Cancer enriched"	"Detected in some"	5	"breast cancer: 2.9"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069146	Supported				"Secreted in female reproductive system"					"HPA069146: AB_2686094"	"unprognostic (4.64e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.75e-3)"	"unprognostic (3.10e-2)"	0.1	0.7	1.3	0.1	1.9	0.1	1.1	0.4	1.1	0.4	0.2			0.4	0.3	6.6	0.1	1.1	0.1	0.1	1.0	1.4	1.5	0.7	0.1	0.5	1.1		0.6	1.0	1.4	2.0	0.1		0.7	0.3		1.0	0.6	0.6	1.4	0.3	0.1	0.8	0.4	0.8	11.1			1.4		0.4	0.7	0.1	0.1	0.8	1.2	0.6	0.0	1.1	0.3	0.5	0.5	1.4	2.9	2.1	0.9	0.5	0.1	0.2	0.5	0.4	1.1	2.3	0.8	1.9	0.2	0.6	1.2	1.2	0.5	1.0	2.2	1.4	1.2	0.3	0.5	0.3	0.2	1.0	1.7	0.2	1.0	0.0	0.2	3.6	0.7	0.7	1.9	2.1	0.6	0.2	1.8	0.2	0.5	0.9	0.6	2.7	2.5	0.5	0.4	1.4	1.4	0.4	0.3	2.6	1.1	0.6	0.4	3.8	4.5	0.3	0.6	0.5	0.2	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.2	1.1	0.8	0.1	0.8	0.1	1.2	0.0	0.6	0.0	0.0	0.3										
H3.Y		ENSG00000269466	"Histone cluster 2, H3c pseudogene"		5	17654870-17655847	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"brain: 1.4;epididymis: 1.3;testis: 1.0"	"Cell line enriched"	"Detected in single"	14	"U-2 OS: 6.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042570	Uncertain									"HPA042570: AB_2678056"															"unprognostic (1.50e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0										
IFNA13		ENSG00000233816	"Interferon alpha 13"	P01562	9	21367424-21368962	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 2.1;epididymis: 3.7"	"Cell line enhanced"	"Detected in some"		"A549: 2.7;HeLa: 1.6;NB-4: 3.5;TIME: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: AB_2680087"																		0.0	0.0	1.1	0.0	2.1	0.0	0.0	0.4	0.6	0.0	0.0			0.0	0.1	3.7	0.0	0.1	0.0	0.0	1.5	0.6	0.4	0.0	0.2	0.2	0.8		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.3			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4										
LHFPL5	"DFNB67, dJ510O8.8, MGC33835, Tmhs"	ENSG00000197753	"LHFPL tetraspan subfamily member 5"	Q8TAF8	6	35805293-35833874	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"bone marrow: 7.4;brain: 6.7;epididymis: 12.0;pancreas: 12.3"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055110	Uncertain									"HPA055110: AB_2682697"	"unprognostic (2.35e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"		"unprognostic (4.89e-3)"		"unprognostic (2.96e-3)"	"unprognostic (2.46e-2)"		"unprognostic (1.47e-8)"	"unprognostic (5.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.41e-1)"	0.5	0.5	3.9	1.2	4.1	7.4	0.5	0.4	5.8	0.4	0.4	0.2	0.0	0.9	0.9	12.0	0.3	0.3	0.7	0.3	3.5	2.8	0.4	0.4	0.3	1.5	1.2	6.7	0.6	12.3	0.0	2.2	0.6	2.0	0.6	0.3	0.2	1.1	0.1	0.6	2.3	0.8	0.1	0.6	1.0	0.5	0.8	0.0	0.0	0.8	0.0	0.4	0.3	0.4	1.0	0.3	1.0	0.8	0.5	0.9	0.0	1.5	1.9	3.5	2.1	0.6	1.7	3.2	2.5	0.9	0.4	1.1	2.1	2.2	3.5	1.9	1.3	1.9	0.6	1.4	0.9	1.8	2.9	3.8	5.5	1.9	0.1	1.6	2.6	1.4	0.7	0.7	1.0	0.5	2.0	7.1	2.0	1.2	2.3	1.8	2.3	1.5	2.0	1.5	1.0	1.1	3.3	3.3	2.2	1.6	1.8	1.1	2.9	1.3	3.6	2.4	2.1	3.2	1.0	4.0	3.3	2.8	1.1	2.4	1.5	1.0	0.3	0.2	0.9	0.6	0.5	0.5	0.5	0.3	0.0	1.0	0.6	0.8	0.9	0.5	0.8	0.3	0.4	0.0	3.9	4.1	0.4	5.8	3.5	2.8	1.2	6.7	2.0	0.0
METTL7B	"ALDI, MGC17301"	ENSG00000170439	"Methyltransferase like 7B"	Q6UX53	12	55681546-55684611	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 35.7;heart muscle: 46.1;intestine: 44.7;liver: 82.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 11.8;CAPAN-2: 23.9;EFO-21: 17.9;Hep G2: 11.6;LHCN-M2: 19.8;THP-1: 17.5;U-87 MG: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 5.4;myeloid DC: 8.6;naive B-cell: 2.5;non-classical monocyte: 4.0"	"Group enriched"	"Detected in many"	56	"B-cells: 2.5;dendritic cells: 8.6;monocytes: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038644	Enhanced		Supported	Vesicles,Microtubules				Microtubules	Microtubules	"HPA038644: AB_2676130"	"unprognostic (7.54e-2)"	"unprognostic (7.15e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.07e-3)"	"unprognostic (6.30e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (2.00e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.76e-2)"	"unprognostic (7.10e-2)"	"prognostic favourable (2.37e-4)"	"unprognostic (2.43e-1)"	1.3	0.9	1.2	2.1	0.9	0.1	0.5	0.5	2.2	0.4	15.2	3.0	0.0	15.2	0.4	35.7	0.3	0.7	8.1	46.1	4.6	0.6	12.6	82.4	0.8	0.8	1.8	1.5	0.3	1.2	0.0	1.3	4.3	3.2	0.3	6.0	1.4	0.4	0.1	2.7	0.5	44.7	0.4	1.0	3.1	1.0	0.4	0.6	0.0	1.0	0.1	0.0	0.3	0.3	2.5	8.6	0.0	5.4	0.0	0.0	0.4	0.2	9.1	0.0	0.2	1.9	6.7	0.1	0.3	1.3	0.1	0.6	11.8	23.9	4.8	17.9	0.5	0.0	1.7	0.1	0.3	0.0	2.3	0.4	1.5	11.6	0.0	0.2	0.0	1.7	0.0	0.4	0.0	0.0	0.1	0.0	19.8	8.2	0.0	0.1	2.4	1.1	0.0	0.6	1.1	0.2	0.0	0.0	0.1	0.9	0.0	1.6	1.6	17.5	0.0	1.3	1.6	0.2	1.2	0.0	0.2	1.4	18.2	4.1	0.1	0.0	1.0	0.0	0.0	5.4	0.0	0.7	0.0	0.0	8.6	2.5	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.4	1.2	0.9	0.5	2.2	4.6	0.6	1.8	1.5	3.2	0.6
MGAT4C	HGNT-IV-H	ENSG00000182050	"MGAT4 family member C"	Q9UBM8	12	85955666-86838904	"Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 12.8;epididymis: 10.9;pituitary gland: 25.9;testis: 7.8;thyroid gland: 18.0"	"Group enriched"	"Detected in some"	13	"NTERA-2: 10.9;SCLC-21H: 4.8"	"Cancer enriched"	"Detected in single"	19	"thyroid cancer: 2.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA016418	Approved									"HPA016418: AB_2732416"	"unprognostic (5.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.64e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.32e-3)"	"unprognostic (3.51e-2)"	"unprognostic (6.85e-10)"	"unprognostic (3.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.74e-3)"	1.0	3.0	5.5	1.0	12.3	1.1	0.9	4.9	12.8	1.3	1.2	2.5	0.4	0.9	1.0	10.9	1.1	1.1	1.2	3.6	9.4	3.9	1.0	0.9	1.0	0.9	3.0	9.3	0.9	0.9	0.9	25.9	0.8	10.6	1.1	1.2	0.0	0.9	2.4	0.8	1.0	1.0	1.0	4.3	0.9	1.0	7.8	5.1	0.0	18.0	0.0	0.8	0.9	0.6	0.5	0.3	0.8	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	0.0	10.9	0.1	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.1	0.8	0.2	0.1	0.3	0.2	0.0	5.5	12.3	4.9	12.8	9.4	3.9	3.0	9.3	10.6	5.1
MMP3	"STMY, STMY1"	ENSG00000149968	"Matrix metallopeptidase 3"	P08254	11	102835801-102843803	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 177.5;salivary gland: 73.4"	"Group enriched"	"Detected in some"	17	"BJ: 98.9;BJ hTERT+: 269.1;fHDF/TERT166: 116.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 59.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA007875	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	170000	170000	Vesicles	Vesicles	"HPA007875: AB_1079396"	"unprognostic (2.27e-1)"	"prognostic unfavourable (9.73e-4)"	"unprognostic (1.63e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.11e-2)"	"unprognostic (5.26e-6)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavourable (4.09e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-15)"	"unprognostic (3.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.34e-1)"	19.1	0.0	0.2	14.4	0.3	0.0	6.9	0.2	0.5	0.2	1.5	0.3	0.2	1.8	28.3	177.5	0.2	0.0	1.4	0.2	0.2	0.0	0.3	0.5	0.4	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	1.2	1.7	0.2	73.4	1.5	7.3	12.6	0.7	5.9	0.2	0.2	2.8	1.4	0.2	0.2	0.6	1.5	0.9	7.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.9	269.1	1.7	0.5	0.0	0.0	0.0	0.0	116.5	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.9	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.2	0.8	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.5	0.2	0.0	0.2	0.2	0.2	0.2
NXPE2	"FAM55B, FLJ25224"	ENSG00000204361	"Neurexophilin and PC-esterase domain family member 2"	Q96DL1	11	114678386-114706933	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"epididymis: 22.9;salivary gland: 44.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.9;U-87 MG: 2.6"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							"HPA039744, HPA039876"	Enhanced									"HPA039744: AB_2676660, HPA039876: AB_2676721"	"unprognostic (2.85e-1)"		"prognostic favourable (9.29e-5)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.46e-2)"		"unprognostic (9.35e-2)"		"unprognostic (1.27e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.96e-4)"	"unprognostic (9.00e-2)"		"unprognostic (9.22e-2)"		0.2	0.1	0.2	3.0	0.2	0.0	0.2	0.1	0.2	0.3	7.4	0.0	0.8	0.3	0.5	22.9	0.4	0.2	0.0	0.3	0.2	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.5	7.1	0.0	44.1	0.0	0.2	0.2	1.8	0.5	0.2	0.1	0.2	0.5	0.0	0.0	0.2	0.7	4.8	0.2	0.4	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	2.9	0.1	0.8	0.4	0.0	0.0	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.7	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.2	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0
OR1Q1	"HSTPCR106, OR1Q2, OR1Q3, OR9-A, OST226, OST226OR9-A, TPCR106"	ENSG00000165202	"Olfactory receptor family 1 subfamily Q member 1"	Q15612	9	122614738-122615682	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"epididymis: 4.4;urinary bladder: 1.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.2;CAPAN-2: 1.4;fHDF/TERT166: 2.3;HSkMC: 1.4;Karpas-707: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA044828	Uncertain									"HPA044828: AB_10960565"										"unprognostic (5.41e-2)"				"unprognostic (2.00e-1)"			"unprognostic (1.98e-1)"	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.1	0.2			0.0	0.7	4.4	0.2	0.5	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.4	0.2		0.2	0.2		0.3	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.4	0.3			0.0		0.1	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	1.2	0.2	1.0	3.2	0.0	0.0	0.0	1.4	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR2H2	hs6M1-12	ENSG00000204657	"Olfactory receptor family 2 subfamily H member 2"	O95918	6	29585121-29590500	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"brain: 3.3;epididymis: 11.7;testis: 4.8"	"Cell line enhanced"	"Detected in some"		"AF22: 2.3;NTERA-2: 3.5;TIME: 1.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (2.95e-1)"	"unprognostic (3.76e-1)"			"unprognostic (2.33e-2)"			"unprognostic (2.42e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.20e-1)"		"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"			0.2	0.1	1.5	0.3	3.3	1.5	0.1	2.2	0.9	0.1	0.1			0.0	0.2	11.7	0.1	0.1	0.1	0.3	1.2	0.9	0.1	0.1	0.2	0.4	0.6		0.2	0.0	0.0	0.7	0.1		0.2	0.1		0.1	0.9	0.1	0.4	0.1	0.1	0.2	0.4	0.2	4.8			0.2		0.2	0.1	0.1	0.4	0.2	0.8	0.1	0.1	0.3	0.0	0.4	0.0	2.3	0.3	0.0	0.0	0.4	0.2	0.1	0.0	0.2	0.0	0.2	0.5	0.1	0.4	0.3	0.2	0.0	0.0	0.2	0.7	0.9	0.7	0.6	0.1	0.6	1.0	0.1	0.1	0.0	0.2	0.3	0.4	0.7	0.2	0.1	0.0	0.2	3.5	0.2	0.4	0.3	0.0	0.0	0.2	0.7	0.2	0.3	0.2	0.0	0.2	0.2	1.9	0.4	0.9	0.3	0.2	1.0	0.2	0.4	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0.0										
PNMA3	"MA3, MA5, MGC132756, MGC132758"	ENSG00000183837	"PNMA family member 3"	Q9UL41	X	153056409-153060467	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 17.4;epididymis: 35.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.8;NTERA-2: 8.0;SCLC-21H: 2.6;SH-SY5Y: 2.0;THP-1: 2.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA047920	Approved									"HPA047920: AB_2680210"	"unprognostic (1.66e-2)"	"unprognostic (8.97e-3)"	"unprognostic (8.70e-2)"	"prognostic unfavourable (4.14e-5)"	"unprognostic (9.43e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.77e-4)"	"unprognostic (2.84e-2)"	"unprognostic (6.20e-2)"	"unprognostic (7.62e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.92e-3)"	"unprognostic (2.93e-3)"	"unprognostic (7.25e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.07e-2)"	0.4	1.4	4.8	0.8	6.8	0.4	0.3	3.0	17.4	0.5	0.3	0.2	0.0	0.4	0.5	35.5	0.3	1.2	0.4	1.4	4.9		1.0	0.3	0.3	1.4	0.0	13.7	0.6	0.5	0.4	0.7	0.3	11.2	0.5	0.3	0.7	0.4	0.6	0.3	0.6	0.5	0.3	1.3	0.8	0.3	5.9	0.0	0.0	0.9	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.0	0.0	8.0	0.0	0.1	0.0	0.3	0.0	0.0	2.6	2.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.2	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0										
RFPL4A	"RFPL4, RNF210"	ENSG00000223638	"Ret finger protein like 4A"	A6NLU0	19	55759014-55763175	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 12.7;epididymis: 5.2;liver: 7.1;testis: 3.8"	"Cell line enriched"	"Detected in some"	17	"U-2 OS: 43.7"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.9"					"Cell type enhanced"	"Detected in some"		"classical monocyte: 12.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;monocytes: 12.7"									HPA046368	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"	"Centrosome, Cytosol"	"HPA046368: AB_2679640"							"unprognostic (3.74e-1)"						"unprognostic (2.96e-2)"		"unprognostic (9.20e-2)"			0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0	0.0	5.2	0.0	0.1	0.2	0.0	0.0	0.0	0.4	7.1	0.0	0.8	0.0		0.1	0.4	0.0	0.1	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.6	0.4	3.8			0.0		0.1	0.0	0.0	0.0	3.8	1.7	12.7	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	43.7	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	12.7	0.0	0.0	2.7	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	1.7	0.0	0.8	0.0	0.0	2.8										
RFPL4AL1	RNF210B	ENSG00000229292	"Ret finger protein like 4A like 1"	F8VTS6	19	55769141-55773179	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 5.4;epididymis: 1.7;liver: 3.0;lymphoid tissue: 2.3;testis: 1.5"	"Cell line enriched"	"Detected in some"	24	"U-2 OS: 24.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"classical monocyte: 5.4;myeloid DC: 2.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.5;monocytes: 5.4"									HPA046368	Uncertain		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"	"Centrosome, Cytosol"	"HPA046368: AB_2679640"															"unprognostic (8.87e-2)"			0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1			0.0	0.0	1.7	0.0	0.1	0.3	0.0	0.0	0.0	0.3	3.0	0.0	0.4	0.0		0.6	0.7	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.3	0.0	0.1	2.3	0.2	1.5			0.3		0.0	0.3	0.0	0.0	2.5	0.4	5.4	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	2.2										
SARDH	"DMGDHL1, SDH"	ENSG00000123453	"Sarcosine dehydrogenase"	Q9UL12	9	133663560-133739955	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 25.3;liver: 52.8;pancreas: 39.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.9;Hep G2: 18.4;MOLT-4: 13.3;RH-30: 11.4;RPMI-8226: 23.0;SH-SY5Y: 9.2"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 18.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 4.1;naive CD4 T-cell: 8.4;T-reg: 9.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057267, HPA058086"	Approved		Approved	Mitochondria		190000	190000	Mitochondria	Mitochondria	"HPA057267: AB_2683388, HPA058086: AB_2683601"	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (4.62e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.48e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.30e-2)"	0.5	1.1	1.7	1.0	1.8	0.3	0.4	0.8	1.9	0.9	0.5	1.1	2.9	0.8	1.4	25.3	0.3	0.9	1.2	1.1	1.1	1.4	5.8	52.8	1.3	1.7	1.2	2.1	3.4	39.4	2.0	1.9	0.3	1.2	1.4	0.1	3.7	8.2	0.9	0.3	0.2	0.6	0.6	0.6	0.7	1.2	1.1	0.8	2.2	0.8	0.2	1.2	0.6	0.6	0.4	0.3	0.6	0.1	0.1	9.7	1.6	0.0	0.1	0.8	10.9	0.0	0.3	1.4	0.1	0.4	0.5	0.7	0.2	0.1	0.0	1.5	0.1	0.0	0.0	0.2	0.4	0.0	0.2	1.5	0.0	18.4	1.2	0.0	0.2	2.6	0.0	1.3	0.0	0.1	0.0	0.2	6.9	1.9	13.3	1.4	1.7	0.1	0.9	11.4	23.0	0.0	0.1	1.0	9.2	0.0	0.3	2.3	1.5	0.1	0.0	2.1	1.9	0.2	0.0	0.1	0.0	0.7	1.3	0.8	0.0	0.1	0.1	0.1	0.4	0.0	1.0	0.0	4.1	1.0	0.0	0.4	8.4	1.5	0.6	0.1	0.0	0.3	9.7	1.6	1.7	1.8	0.8	1.9	1.1	1.4	1.2	2.1	1.2	0.8
SCD5	"ACOD4, FADS4, FLJ21032, HSCD5, SCD4"	ENSG00000145284	"Stearoyl-CoA desaturase 5"	Q86SK9	4	82629539-82798857	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 69.1;brain: 137.3;epididymis: 44.5;ovary: 42.7"	"Cell line enhanced"	"Detected in many"		"BJ: 27.1;RPTEC TERT1: 35.8"	"Group enriched"	"Detected in all"	6	"glioma: 152.4;thyroid cancer: 38.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA042380	Uncertain									"HPA042380: AB_10794797"	"unprognostic (3.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.82e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-2)"	"prognostic favourable (2.32e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.92e-2)"	3.0	69.1	61.2	2.7	48.6	2.5	3.0	33.5	137.3	5.9	3.0	50.4	1.8	3.0	6.7	44.5	3.7	9.3	5.1	3.5	49.6	43.4	15.4	2.3	7.5	2.3	58.2	36.3	42.7	18.1	2.2	6.9	4.4	42.0	6.9	3.0	6.3	5.6	12.4	1.7	4.8	3.7	6.2	57.1	3.0	4.3	14.8	43.4	1.2	16.4	0.0	3.0	3.8	2.0	0.9	1.3	3.0	1.2	2.0	7.2	1.8	4.4	2.8	14.5	7.4	8.0	5.2	0.3	27.1	13.4	11.9	9.2	0.3	0.7	8.8	9.5	5.6	7.9	4.2	3.0	15.0	1.7	1.9	0.4	3.5	0.4	1.2	3.9	2.9	4.1	12.2	2.4	2.1	19.0	0.6	1.1	6.2	1.7	16.0	0.9	1.1	1.9	13.7	8.6	6.9	35.8	4.4	8.1	4.6	4.5	0.4	2.6	0.6	2.0	23.3	12.8	7.5	4.8	7.3	2.5	1.0	0.9	6.2	4.1	3.6	3.0	1.2	0.4	7.2	0.5	4.6	0.5	1.7	4.3	0.5	0.9	1.5	5.1	2.0	2.0	0.9	1.3	0.4	1.8	61.2	48.6	33.5	41.2	49.6	43.4	58.2	36.3	42.0	43.4
SCGB1D4	IIS	ENSG00000197745	"Secretoglobin family 1D member 4"	Q6XE38	11	62296277-62299064	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"cervix, uterine: 27.5;ductus deferens: 9.9;endometrium 1: 9.5;epididymis: 27.9;fallopian tube: 36.8"	"Group enriched"	"Detected in some"	20	"HL-60: 3.1;Karpas-707: 1.0;RPMI-8226: 1.8"	"Cancer enriched"	"Detected in some"	57	"endometrial cancer: 100.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in female reproductive system"									"unprognostic (2.26e-3)"						"unprognostic (3.20e-1)"								0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	27.5	0.1	0.1	9.9	0.0	9.5	27.9	0.1	36.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	5.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SCGB2A1	"LPHC, MGB2, MGC71973, UGB3"	ENSG00000124939	"Secretoglobin family 2A member 1"	O75556	11	62208668-62213939	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix, uterine: 191.8;epididymis: 135.9"	"Cell line enriched"	"Detected in some"	4	"EFO-21: 13.7"	"Group enriched"	"Detected in many"	10	"endometrial cancer: 971.9;ovarian cancer: 208.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA034584	Enhanced		Approved	Vesicles	"Secreted in other tissues"			Vesicles	Vesicles	"HPA034584: AB_10602221"	"unprognostic (7.73e-2)"	"unprognostic (3.77e-1)"	"prognostic favourable (1.22e-4)"	"prognostic favourable (1.54e-8)"		"unprognostic (2.98e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.39e-1)"		"unprognostic (1.95e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.87e-3)"	"prognostic favourable (6.36e-4)"	"unprognostic (5.67e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.35e-1)"	0.2	0.0	0.2	0.5	0.2	0.0	6.8	0.2	0.3	191.8	1.0	0.3	20.8	0.0	40.8	135.9	1.0	28.7	2.5	0.4	0.2	0.3	1.2	0.4	0.9	0.2	0.2	0.3	5.6	2.2	0.0	1.5	0.7	0.5	1.2	1.3	0.2	18.8	1.4	0.2	2.3	0.3	0.2	0.2	0.2	4.3	4.5	0.2	0.3	0.8	1.1	3.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	1.0	0.2	0.0	2.5	0.6	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.5	0.2
SPINK2	HUSI-II	ENSG00000128040	"Serine peptidase inhibitor, Kazal type 2"	P20155	4	56809860-56821742	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"epididymis: 376.2"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 43.8"	"Group enriched"	"Detected in some"	5	"lung cancer: 1.3;testis cancer: 4.6;thyroid cancer: 2.4"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in many"	6	"NK-cell: 43.3"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 43.3"									"CAB020824, HPA026813"	Enhanced				"Secreted to blood"					"CAB020824: , HPA026813: AB_1857446"	"unprognostic (5.56e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.60e-1)"		"prognostic favourable (2.82e-4)"	"unprognostic (9.83e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.40e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.87e-2)"	0.2	0.1	0.2	0.5	0.2	0.7	0.3	0.1	0.3	0.4	0.4	0.0	85.2	0.0	0.2	376.2	0.1	0.2	0.0	2.2	0.3	0.3	0.2	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.0	1.4	0.0	1.1	1.1	0.1	0.0	0.6	49.9	0.5	0.2	0.5	0.0	0.2	0.6	0.2	85.5	0.0	0.3	0.2	0.0	0.2	1.3	1.3	3.9	0.4	1.3	0.0	43.3	7.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	8.4	0.2	0.0	0.0	0.0	2.0	0.0	2.8	0.1	1.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	43.8	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.2	0.0	0.2	2.3	1.7	1.8	0.4	3.9	3.9	7.3	0.3	43.3	0.0	0.2	0.1	2.0	0.2	0.2	0.1	0.3	0.3	0.3	0.2	0.0	1.1	0.0
TAS1R3	T1R3	ENSG00000169962	"Taste 1 receptor member 3"	Q7RTX0	1	1331314-1335306	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 35.2;salivary gland: 17.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.9"	"Cell type enriched"	"Detected in single"	37	"memory B-cell: 5.2"	"Lineage enriched"	"Detected in single"	37	"B-cells: 5.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA053439	Uncertain									"HPA053439: AB_2682150"	"unprognostic (1.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.22e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.05e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.22e-1)"	"unprognostic (8.44e-3)"	"unprognostic (7.59e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.04e-1)"	0.4	0.4	0.4	1.5	0.4	0.5	0.4	1.9	0.4	0.6	1.4	0.4	1.0	2.0	0.5	35.2	1.9	0.6	0.7	1.4	0.4	0.1	0.5	1.6	0.9	1.6	0.4	0.4	0.4	0.4	0.1	2.6	1.9	0.4	0.4	0.1	0.4	17.9	0.4	1.4	0.2	3.2	0.4	0.4	6.4	0.9	1.6	0.4	0.4	0.8	1.5	2.5	1.0	0.9	5.2	0.1	0.0	0.0	0.0	0.1	0.2	1.4	1.3	0.3	0.5	0.0	0.0	0.7	0.7	0.2	0.2	0.1	0.9	2.9	1.7	0.3	0.0	0.6	0.0	0.0	0.0	3.6	1.0	0.2	2.5	0.9	0.3	0.0	0.5	0.1	0.2	0.1	0.0	0.0	0.4	5.9	0.0	0.8	0.3	0.6	0.8	3.4	0.9	0.7	0.8	0.0	0.2	2.2	0.4	0.4	2.3	1.9	2.0	0.4	0.3	0.5	0.2	1.8	0.8	3.7	3.4	0.8	0.2	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	1.9	0.4	0.4	0.1	0.4	0.4	0.4	0.4
TCHHL1	"S100A17, THHL1"	ENSG00000182898	"Trichohyalin like 1"	Q5QJ38	1	152084144-152089064	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 1.7;skin 1: 3.8;tongue: 7.0"	"Cell line enriched"	"Detected in single"	59	"SK-BR-3: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"HPA042579, HPA063483"	Enhanced		Approved	"Nuclear membrane,Nucleoli"				"Nuclear membrane, Nucleoli"	"Nuclear membrane, Nucleoli"	"HPA042579: AB_10794283, HPA063483: AB_2685021"						"unprognostic (8.21e-2)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TCTEX1D4		ENSG00000188396	"Tctex1 domain containing 4"	Q5JR98	1	44805913-44806675	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 7.9;epididymis: 3.1;fallopian tube: 12.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;EFO-21: 2.4;HDLM-2: 2.7;TIME: 3.4"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 7.9"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062652	Enhanced									"HPA062652: AB_2684818"	"unprognostic (3.12e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.81e-1)"	"prognostic favourable (1.58e-4)"	"unprognostic (5.28e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.83e-3)"	0.0	1.1	0.2	0.4	0.2	0.8	0.2	0.0	0.1	1.0	0.2			0.5	0.8	3.1	0.2	12.4	0.7	0.2	0.3	0.4	0.3	0.5	1.8	0.0	0.0		0.0	0.7	0.0	0.3	0.0		0.1	0.0		0.6	0.3	0.1	0.2	0.5	0.0	0.1	0.0	1.2	0.1			0.5		0.0	0.2	0.0	0.0	0.0	7.9	0.6	0.0	0.2	0.3	1.4	1.1	0.3	0.0	0.0	0.0	3.3	1.5	0.0	0.0	0.2	0.0	1.2	0.0	2.4	0.0	1.8	0.0	0.0	0.0	2.7	0.0	0.3	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.5	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.2	2.1	0.0	0.0	3.4	0.2	1.9	0.2	0.7	1.4	1.2	0.0	0.2	0.4	0.6	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.3										
TMEM64	DKFZp762C1112	ENSG00000180694	"Transmembrane protein 64"	Q6YI46	8	90621995-90791632	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"epididymis: 84.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB034221	Enhanced									"CAB034221: AB_1567653"	"unprognostic (3.61e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.55e-3)"	"unprognostic (4.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.97e-1)"	9.2	12.6	4.3	5.2	5.3	2.1	6.1	2.7	6.1	10.6	10.8	16.2	14.5	5.7	11.9	84.0	7.3	5.7	6.3	5.8	6.2	5.5	11.6	11.7	7.2	6.7	11.2	3.3	10.1	11.3	4.1	5.9	6.1	10.0	10.7	3.7	15.1	12.4	11.0	8.2	6.8	11.3	9.6	12.1	7.2	5.4	9.7	7.5	2.3	20.0	5.2	7.2	11.9	10.9	5.7	0.6	3.2	0.8	5.9	3.7	1.6	12.6	9.9	5.0	2.6	23.3	17.0	2.7	9.4	9.0	7.4	8.2	2.7	8.7	8.2	3.8	5.7	4.4	13.2	6.3	9.8	16.6	4.8	15.4	3.9	6.2	8.2	0.9	2.6	22.1	7.0	3.0	6.9	7.4	6.9	18.3	12.4	16.9	0.0	2.2	0.7	5.2	1.8	11.0	4.2	14.6	24.6	3.5	10.0	6.1	5.4	11.3	5.4	0.7	7.3	7.5	6.6	5.4	7.6	12.1	0.2	9.0	6.8	1.9	9.8	3.2	0.2	0.3	3.0	0.6	3.7	5.7	3.2	3.4	0.6	2.9	1.5	2.1	0.1	5.9	0.8	0.4	1.4	1.6	4.3	5.3	2.7	6.1	6.2	5.5	11.2	3.3	10.0	7.5
WFDC2	"dJ461P17.6, EDDM4, HE4, WAP5"	ENSG00000101443	"WAP four-disulfide core domain 2"	Q14508	20	45469706-45481532	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix, uterine: 352.3;ductus deferens: 143.4;epididymis: 385.4;kidney: 135.1;salivary gland: 343.7"	"Group enriched"	"Detected in some"	9	"A-431: 26.2;CAPAN-2: 49.1;EFO-21: 41.0;HaCaT: 35.8;RPTEC TERT1: 38.1"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 1815.6"	"Region enriched"	"Detected in single"	5	"basal ganglia: 3.0"	"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.2"					"Group enriched"	"Detected in many"	13	"basal ganglia: 10.7;hypothalamus: 32.7;midbrain: 14.3;pons and medulla: 12.8;thalamus: 8.5"	HPA042302	Enhanced				"Secreted in other tissues"	1300000	1300000			"HPA042302: AB_2677939"	"unprognostic (5.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavourable (3.04e-5)"	"unprognostic (7.19e-3)"	"unprognostic (1.94e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.71e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.40e-1)"	"prognostic favourable (4.44e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.20e-2)"	1.2	0.1	0.3	1.5	3.0	0.0	10.6	0.2	0.6	352.3	11.0	0.4	143.4	0.7	19.4	385.4	4.5	44.6	10.4	0.4	0.3	0.3	135.1	9.9	31.6	0.2	0.3	0.3	20.4	5.0	5.0	14.9	1.3	0.5	27.2	14.7	2.2	343.7	60.9	0.2	2.8	5.0	10.9	0.2	0.1	3.8	15.6	0.5	0.7	45.5	15.3	29.1	21.9	6.9	0.0	1.2	0.0	0.0	0.0	0.0	0.1	26.2	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.1	49.1	0.0	41.0	0.0	35.8	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.6	4.3	0.0	0.0	0.0	0.0	38.1	0.3	1.2	0.2	2.4	0.0	0.2	0.7	0.1	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.3	3.0	0.2	0.6	0.3	0.3	0.3	0.3	0.5	0.5
ZNF705D		ENSG00000215343	"Zinc finger protein 705D"	P0CH99	8	12104389-12115516	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"epididymis: 9.7"	"Cell line enhanced"	"Detected in single"		"HaCaT: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																				"unprognostic (2.04e-1)"			0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AADACL4		ENSG00000204518	"Arylacetamide deacetylase like 4"	Q5VUY2	1	12644547-12667086	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.8;epididymis: 3.5;vagina: 3.3"	"Cell line enhanced"	"Detected in single"		"REH: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"																	"unprognostic (3.20e-1)"								"unprognostic (1.89e-2)"						2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8			0.0	0.4	3.5	0.0	0.7	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.7	0.0		0.1	0.2	0.0	0.0	0.7		1.1	0.0		0.0	1.4	0.2	0.0	0.0	0.5	0.0	0.6	0.4	1.4			0.0		0.0	0.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ABCB5	"ABCB5alpha, ABCB5beta, EST422562"	ENSG00000004846	"ATP binding cassette subfamily B member 5"	Q2M3G0	7	20615207-20777038	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 33.4;retina: 43.3"	"Cell line enriched"	"Detected in some"	6	"SK-MEL-30: 31.8"	"Cancer enriched"	"Detected in some"	9	"melanoma: 5.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"olfactory region: 1.3"												"unprognostic (3.82e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.26e-3)"	"unprognostic (3.56e-3)"	"unprognostic (9.30e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.70e-2)"	10.6	0.1	0.0	0.4	0.0	0.3	8.6	0.0	0.1	4.4	3.8	0.0	5.3	0.1	1.8	33.4	0.3	0.4	2.8	0.9	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.4	0.1	2.9	0.6	43.3	0.3	0.4	1.0	2.1	0.9	1.5	0.3	0.1	0.7	2.6	0.0	0.0	0.1	0.2	0.1	1.8	1.6	0.7	0.5	2.3	0.5	0.5	0.3	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	4.3	5.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	31.8	0.0	0.1	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.5	0.4	0.2	0.2	0.1	0.4	0.3	0.2	0.1	0.7	0.2	0.3	0.8	0.5	0.2	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
AC010646.1		ENSG00000269095			19	17235940-17255448	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"epididymis: 3.0"	"Group enriched"	"Detected in some"	5	"BEWO: 11.4;EFO-21: 3.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.3	0.4	0.7	0.0	0.3	0.0	0.3	0.3	0.3	0.2	0.9			2.0	0.2	3.0	0.5	0.4	0.0	0.3	0.2	0.5	0.3	1.2	1.1	0.0	0.6		0.2	1.3	0.7	0.3	0.9		0.3	1.0		0.2	0.2	0.3	2.5	0.6	0.8	0.2	0.3	1.9	0.3			0.5		0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.6	1.1	1.0	0.6	0.0	11.4	0.4	0.6	0.2	0.0	0.5	1.5	0.2	3.3	0.5	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.3	1.1	0.0	0.3	0.6	0.4	1.0	0.1	0.0	0.0	0.4	0.2	0.1	0.2	0.0	0.1	0.7	0.3	0.0	0.8	0.3	1.5	0.5	1.5	0.0	1.1	1.0	1.5	0.5	0.4	0.5	0.2	0.4	0.0	0.0	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0										
AC011530.1		ENSG00000268434			19	45779437-45785973	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"epididymis: 4.2;lymphoid tissue: 3.1;skeletal muscle: 3.4"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.6;HBEC3-KT: 4.1;HBF TERT88: 1.7;T-47d: 2.1;U-87 MG: 1.7;U-937: 2.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"																										"unprognostic (3.77e-2)"					"unprognostic (2.87e-1)"		"unprognostic (2.00e-1)"		"unprognostic (1.29e-1)"				0.1	0.8	0.0	3.1	0.1	0.0	0.0	0.1	0.5	0.3	0.9			0.0	0.8	4.2	0.0	0.4	0.0	2.4	0.0	0.0	0.2	0.2	0.9	0.3	0.0		0.2	0.1	0.0	0.0	0.9		0.4	0.0		0.0	0.0	3.4	0.0	0.2	0.0	0.1	0.0	0.4	0.8			0.0		0.7	0.3	0.2	0.1	0.3	0.0	0.0	0.0	1.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.8	0.4	4.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	1.0	0.0	1.1	0.0	1.4	0.3	1.7	2.8	1.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.5	0.0	0.3	0.1	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.3										
AC013470.2		ENSG00000226690			7	12469621-12542222	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 7.7;epididymis: 6.3;fallopian tube: 10.6"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.7;hTCEpi: 2.9;Karpas-707: 2.0;U-266/70: 2.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"																						"unprognostic (3.89e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.53e-4)"		"unprognostic (1.14e-3)"	"unprognostic (3.62e-3)"	"unprognostic (7.82e-3)"	"unprognostic (3.61e-1)"	"unprognostic (8.04e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.88e-2)"		"unprognostic (2.67e-1)"	0.1	0.1	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.7	6.3	0.0	10.6	0.0	0.0	0.0		0.1	0.0	2.5	0.0	0.0	0.0	2.8	0.4	0.0	1.1	0.1	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.3	0.7	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.7	2.3	0.5	0.8	0.4	0.0	0.1	0.2	1.0	0.4	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.1	1.1	0.1	0.2	0.1	0.2	4.7	0.0	0.0	0.1	0.1	0.0	0.8	0.5	0.0	1.1	0.2	0.1	2.9	0.0	0.0	0.0	0.1	2.0	0.0	0.1	0.0	0.2	1.6	0.0	0.3	0.1	0.4	0.0	0.5	1.2	0.1	0.0	0.3	0.2	0.2	0.3	0.0	0.5	0.6	0.0	0.0	2.4	0.1	0.0	0.2	0.0	0.0	2.3	0.5	0.3	0.3	0.2	0.4	0.8	0.3	0.3	0.2	0.9	0.4	0.3	1.8	0.8	0.4	0.7	0.3	0.0										
AC064853.3		ENSG00000284631			2	227616998-227618655	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 2.9;epididymis: 4.4;placenta: 8.4"	"Cell line enriched"	"Detected in single"	18	"U-2197: 15.4"									"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																																							0.0	0.0		0.9		1.4	0.0		0.5	0.0	0.0			0.0	0.1	4.4	0.0	0.0	0.0	0.0			0.0	1.1	0.0	0.0			0.0	0.3	0.0		8.4		0.0	0.0		0.0	0.3	0.0	0.8	0.0	0.0		0.0	0.0	0.4			0.1		0.0	0.0		1.2	1.3	2.9	0.8	0.6	0.8	0.4	0.1	0.4	0.3	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.6	0.6	0.0	0.1	0.2	0.4	0.0	0.0	0.2	0.0	0.1	0.2	0.7	0.1	0.0	0.1	0.3	0.2	0.3	0.1	0.0	0.1	0.2	0.3	0.1	0.1	0.2	0.0	0.0	0.2	0.3	0.7	0.3	0.1	15.4	0.3	0.2	0.1	0.4	0.1	0.1	0.4	2.9	0.8	0.4	0.6	0.4	0.2	0.7	0.4	0.4	0.2	1.2	0.7	0.8	2.1	0.6	0.4	1.3	0.4	0.4										
AC244517.10		ENSG00000279983			5	141223372-141245861	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 8.6"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 2.4;U-87 MG: 1.7;WM-115: 2.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							2.0	0.7	2.5	1.7	3.9	0.7	0.8	3.9	6.2	3.6	1.1	2.5	0.0	0.7	4.8	8.6	1.9	2.0	1.5	1.2	2.6		0.9	1.4	1.1	1.0	1.0	2.5	2.3	0.7	1.7	6.4	1.3	2.2	2.5	0.7	1.9	1.1	0.7	1.8	1.9	0.7	2.4	1.2	0.9	0.9	1.1	1.1	0.0	0.7	1.2	0.8	2.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.4	0.0	0.4	0.3	0.3	0.0	0.9	0.0	0.8	1.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.4	1.0	1.0	1.0	1.0	0.0	0.0	0.7	0.7	0.4	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.3	0.4	0.0	1.7	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ACOXL	FLJ11042	ENSG00000153093	"Acyl-CoA oxidase like"	Q9NUZ1	2	110732573-111118222	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 29.7;lung: 20.8;placenta: 23.8"	"Group enriched"	"Detected in some"	4	"A-431: 8.9;RPMI-8226: 16.2;RT4: 20.8;U-266/70: 14.1"	"Group enriched"	"Detected in some"	6	"lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035392, HPA035393"			Supported	Nucleoli,Cytosol				Cytosol	Cytosol	"HPA035392: AB_2674604, HPA035393: AB_2674605"	"unprognostic (1.62e-1)"	"unprognostic (7.30e-2)"	"unprognostic (6.77e-4)"	"unprognostic (2.93e-7)"	"unprognostic (1.32e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.72e-1)"	"prognostic favourable (6.48e-4)"	0.3	0.3	0.2	0.5	0.4	1.6	0.3	0.2	0.4	0.4	0.4	0.2	2.3	0.0	0.3	29.7	0.2	0.5	0.4	0.3	0.2	0.2	0.6	0.2	20.8	0.6	0.2	0.2	0.2	0.4	4.9	0.7	23.8	0.4	4.1	0.1	0.2	0.5	0.2	0.3	0.4	0.3	2.6	0.2	1.3	0.4	4.6	0.2	0.6	1.5	0.2	0.9	8.5	5.2	1.0	0.6	4.1	1.1	0.7	0.6	0.3	8.9	0.0	0.2	0.3	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.6	0.6	0.2	0.1	0.1	1.0	0.0	0.0	0.0	0.2	3.1	0.2	0.4	0.2	0.0	0.1	0.2	0.1	0.9	0.0	0.1	0.0	1.4	1.4	0.1	3.2	0.7	0.4	3.1	0.4	0.1	0.1	16.2	0.0	20.8	2.0	0.4	0.1	0.4	0.1	0.2	0.9	0.3	0.2	0.4	0.2	0.1	14.1	3.6	0.5	0.1	0.2	0.2	2.2	1.1	0.5	0.4	0.7	0.2	1.0	0.4	0.6	0.2	0.8	0.5	0.4	4.1	0.7	0.4	0.6	0.4	0.3	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2
ADAM28	"ADAM23, eMDCII, MDC-Lm, MDC-Ls"	ENSG00000042980	"ADAM metallopeptidase domain 28"	Q9UKQ2	8	24294040-24359018	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.1"	"Cell line enriched"	"Detected in some"	8	"CAPAN-2: 24.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 24.9;naive B-cell: 32.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074034	Enhanced		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"			"Plasma membrane"	"Plasma membrane"	"HPA074034: AB_2686654"	"unprognostic (4.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-2)"	"prognostic favourable (3.17e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.62e-1)"	2.0	1.7	7.7	17.4	8.8	3.5	2.1	0.9	5.8	6.7	5.8	12.7	2.0	3.7	3.1	133.1	2.7	5.1	16.7	1.1	8.9	5.0	3.1	1.1	3.1	10.1	12.4	3.7	1.8	2.7	1.0	22.5	1.9	10.8	3.3	5.0	1.9	12.6	5.1	0.7	1.8	17.9	1.7	26.0	15.5	38.7	0.9	12.1	0.8	1.8	0.4	19.9	7.4	1.6	32.2	7.5	12.5	0.9	0.9	0.0	0.9	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	1.0	24.7	0.2	0.7	0.0	0.1	0.0	0.8	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.2	0.6	0.1	0.1	0.0	0.3	0.6	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.1	1.1	2.1	0.1	1.9	0.9	0.2	12.5	0.9	6.4	0.0	0.2	0.0	24.9	0.0	0.0	7.5	32.2	0.0	0.0	1.6	0.9	0.0	0.4	0.0	0.9	7.7	8.8	0.9	5.8	8.9	5.0	12.4	3.7	10.8	12.1
ADCY8	"AC8, ADCY3, HBAC1"	ENSG00000155897	"Adenylate cyclase 8"	P40145	8	130780301-131042426	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.6;epididymis: 27.8"	"Group enriched"	"Detected in some"	5	"U-138 MG: 13.5;U-87 MG: 26.2"	"Group enriched"	"Detected in some"	5	"glioma: 6.0;ovarian cancer: 1.8;thyroid cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018652, HPA024291"	Supported									"CAB018652: AB_633654, HPA024291: AB_1844597"	"unprognostic (5.59e-3)"				"unprognostic (3.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.22e-3)"	"unprognostic (4.91e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.67e-2)"		0.2	0.2	8.2	0.2	5.1	0.2	0.9	5.3	9.6	0.8	0.2	1.2	1.4	0.2	0.3	27.8	0.2	4.8	0.2	0.3	6.4	6.2	0.5	0.2	1.6	0.2	7.8	0.6	0.3	0.2	0.2	0.0	0.2	5.7	0.2	0.2	0.0	2.8	2.0	0.2	1.5	0.2	0.9	5.0	0.2	0.3	0.7	1.1	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.3	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	5.1	5.3	5.0	6.4	6.2	7.8	0.6	5.7	1.1
ADGB	"C6orf103, CAPN16, dJ408K24.1, FLJ23121"	ENSG00000118492	Androglobin	Q8N7X0	6	146598965-146815462	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.9;epididymis: 13.1;testis: 30.6"	"Cell line enriched"	"Detected in single"	25	"HDLM-2: 17.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 6.6;pons and medulla: 20.9"	"Cell type enriched"	"Detected in single"	10	"myeloid DC: 2.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 2.6"					"Low region specificity"	"Detected in all"			"HPA036340, HPA036341"	Enhanced		Uncertain	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA036340: AB_2675071, HPA036341: "	"unprognostic (4.15e-3)"		"unprognostic (1.23e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-2)"		"unprognostic (3.11e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.68e-1)"		0.1	0.1	1.6	0.1	6.6	0.1	0.2	0.0	0.2	1.0	0.5	5.1	0.0	0.1	0.4	13.1	0.2	9.8	0.1	0.1	2.2	2.7	0.2	0.2	4.8	0.2	0.0	0.0	4.3	0.1	0.3	0.8	0.2	20.9	0.2	0.4	0.0	0.1	0.3	0.1	0.3	0.1	0.1	0.4	0.1	0.2	30.6	1.2	0.0	0.2	0.1	0.2	0.1	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	6.6	0.0	0.1	2.2	2.7	0.0	0.0	20.9	1.2
AFF2	"FMR2, FRAXE"	ENSG00000155966	"AF4/FMR2 family member 2"	P51816	X	148500619-149000663	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.6;brain: 13.6;epididymis: 15.1;pituitary gland: 17.4;placenta: 17.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 29.6;HL-60: 12.5;U-698: 43.2;U-937: 9.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"basophil: 1.7;eosinophil: 2.5;neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003139	Approved									"HPA003139: AB_1078107"	"unprognostic (5.68e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.00e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.80e-2)"	"unprognostic (9.78e-5)"	"unprognostic (2.54e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.34e-2)"	1.9	0.6	4.2	5.3	3.7	13.6	1.1	13.6	5.9	4.8	0.4	0.2	1.2	0.2	0.8	15.1	0.5	0.6	2.9	1.3	10.7	5.2	0.7	0.3	3.6	6.3	2.3	5.9	2.0	0.5	0.2	17.4	17.4	3.9	1.0	0.3	0.2	0.8	2.1	0.4	1.3	0.5	0.3	2.4	0.8	0.4	2.8	0.0	5.5	1.1	0.0	7.3	1.0	0.7	0.1	0.0	4.5	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6	0.0	1.7	0.0	4.6	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	12.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.6	3.8	1.1	0.0	3.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.5	0.0	1.3	0.1	0.1	43.2	0.0	9.2	0.0	1.7	0.1	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	4.5	0.0	0.0	0.0	0.0	0.0	4.2	3.7	13.6	5.9	10.7	5.2	2.3	5.9	3.9	0.0
AGRP	"Agrt, ART, ASIP2"	ENSG00000159723	"Agouti related neuropeptide"	O00253	16	67482571-67483813	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.4;epididymis: 49.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;CAPAN-2: 2.7;HeLa: 1.5;Hep G2: 2.1;HMC-1: 1.8"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	13	"hypothalamus: 19.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"hypothalamus: 18.9"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.9"	HPA041017	Enhanced	Supported			"Secreted in other tissues"					"HPA041017: AB_10795498"	"unprognostic (1.32e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.34e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-2)"	0.1	9.6	0.1	0.1	1.4	0.0	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.1	49.8	0.1	0.0	0.1	0.1	0.1	19.4	0.5	0.1	2.1	0.3	0.1	0.3	0.1	0.1	0.0	0.4	0.1	0.2	0.1	0.0	0.3	0.5	0.1	0.1	0.4	0.1	0.1	0.3	0.3	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.2	2.1	1.4	3.8	0.3	3.2	1.0	0.1	0.0	0.4	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	2.7	0.8	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	1.5	2.1	0.0	0.0	1.8	0.6	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.2	0.0	0.1	1.0	0.5	0.9	0.0	0.4	0.3	0.0	3.8	1.4	3.2	2.3	1.6	2.2	0.8	1.1	1.5	1.9	2.1	2.2	0.6	0.3	1.2	2.1	1.3	1.0	0.1	1.4	0.1	0.2	0.1	19.4	0.1	0.3	0.2	0.1
AK8	"C9orf98, FLJ32704"	ENSG00000165695	"Adenylate kinase 8"	Q96MA6	9	132725578-132878777	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 12.8;fallopian tube: 17.7;testis: 15.6"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.1;MCF7: 5.2;RPTEC TERT1: 6.0;T-47d: 4.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"NK-cell: 3.9"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 3.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021443, HPA023894"	Enhanced									"HPA021443: AB_1845852, HPA023894: AB_1845854"	"unprognostic (4.14e-2)"	"unprognostic (1.20e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (1.61e-4)"	"unprognostic (9.89e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.43e-1)"	0.5	0.7	1.3	0.5	2.2	0.0	0.5	1.6	1.3	1.6	0.5	0.5	0.5	0.0	1.1	12.8	0.5	17.7	0.7	0.5	1.3	2.0	1.4	0.5	1.1	0.5	1.2	0.5	0.9	0.5	2.5	1.7	1.5	2.3	0.5	0.0	0.9	1.0	1.8	0.5	1.1	0.5	0.5	1.7	0.5	0.3	15.6	0.5	0.5	3.1	0.5	0.5	0.5	0.5	0.1	0.0	0.0	0.0	3.9	0.5	0.0	2.0	1.0	0.6	3.1	0.4	0.8	0.6	0.3	0.2	0.2	0.0	0.4	2.1	0.0	0.7	0.3	0.5	0.2	0.0	0.1	0.1	0.7	0.0	0.2	0.0	1.3	0.0	0.0	1.8	0.9	0.3	0.6	0.2	0.1	0.0	0.5	5.2	1.5	0.4	0.2	0.6	0.0	0.0	0.0	6.0	0.0	1.1	1.2	2.6	0.0	0.4	4.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.3	2.2	1.6	1.0	1.3	2.0	1.2	0.5	2.3	0.5
AL109811.4		ENSG00000277726			1	11012662-11030528	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 4.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 7.0;MCF7: 3.4;RT4: 4.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (1.86e-2)"	"unprognostic (1.32e-1)"			"unprognostic (5.30e-2)"			"unprognostic (6.34e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.33e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.80e-2)"		"unprognostic (2.77e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.48e-2)"	0.3	0.0		0.0		2.2	0.1		0.0	0.3	0.2			0.0	0.5	4.2	0.0	0.0	0.1	0.0			0.0	0.0	2.8	1.8			0.0	0.0	1.8		0.0		0.1	2.9		2.6	1.1	1.0	1.9	0.0	0.0		0.6	1.1	0.0			0.0		0.0	0.3		1.5	1.7	1.2	1.3	0.2	2.9	0.0	0.0	0.7	0.0	0.5	1.7	1.3	0.7	1.7	0.0	0.0	0.0	0.7	0.0	0.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.0	0.9	0.0	0.3	1.2	2.2	0.0	0.0	0.0	0.0	0.0	1.7	3.4	0.6	0.3	0.0	0.2	0.0	1.3	0.0	0.8	4.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.2	0.8	0.7	2.5	0.5	2.7	1.3	1.8	2.6	0.2	1.5	1.6	2.9	0.7	0.2	1.3	1.7	1.1	0.0										
ALG1L	ALG1L1	ENSG00000189366	"ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like"	Q6GMV1	3	125929275-125937039	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 11.4;urinary bladder: 12.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 11.1;CAPAN-2: 10.1;HaCaT: 10.8;MCF7: 20.9;T-47d: 14.1;U-266/70: 7.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA036108	Uncertain									"HPA036108: AB_10673344"	"unprognostic (7.06e-3)"	"unprognostic (1.50e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"prognostic favourable (3.00e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.50e-6)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.57e-2)"	"prognostic favourable (6.24e-4)"	0.0	0.5	2.3	0.8	1.6	0.0	1.1	0.3	1.8	0.8	0.9			0.0	0.9	11.4	1.3	2.0	0.4	0.1	1.6	2.0	1.0	1.0	0.7	0.0	2.2		1.7	0.7	0.0	1.2	1.2		1.2	0.6		1.6	0.6	5.9	5.5	0.1	0.2	1.0	0.0	1.1	0.5			1.0		2.3	12.5	0.9	3.1	2.4	4.8	0.2	5.3	5.0	2.1	0.7	0.6	0.3	0.0	0.0	0.2	1.3	0.0	0.0	0.1	0.3	11.1	10.1	3.0	4.9	0.0	10.8	0.3	0.0	0.6	0.4	2.6	0.5	1.7	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.8	1.0	0.0	20.9	0.6	0.2	4.5	2.7	0.1	0.0	5.0	0.0	0.6	1.7	0.7	0.4	0.1	0.5	14.1	0.2	0.2	0.1	1.7	0.1	0.0	7.9	1.1	4.1	0.1	0.0	0.7	4.8	0.1	0.2	3.9	0.2	2.1	3.1	2.1	4.2	0.0	1.9	2.3	1.6	0.8	5.3	0.0	2.4	5.0	2.1										
ALS2CR12		ENSG00000155749	"Amyotrophic lateral sclerosis 2 chromosome region 12"	Q96Q35	2	201288271-201357398	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.3;epididymis: 14.4;testis: 29.9"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 6.9;U-2197: 9.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 14.3"	"Cell type enhanced"	"Detected in many"		"neutrophil: 7.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA035793			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA035793: AB_10602429"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.40e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.25e-2)"	0.8	0.9	1.5	0.7	3.6	4.3	0.5	0.7	1.1	0.9	0.6	7.6	0.4	0.3	0.7	14.4	1.1	9.9	0.9	4.7	2.1	2.6	1.3	0.7	3.7	1.4	1.0	1.3	5.3	0.7	1.2	1.3	0.9	14.3	0.4	0.9	0.5	0.7	0.7	1.4	1.1	0.9	0.9	0.9	0.8	0.5	29.9	1.3	0.4	1.7	0.4	0.5	0.6	0.4	1.8	0.5	7.3	1.1	2.8	1.5	0.4	0.3	0.4	2.0	1.4	5.6	2.2	0.1	1.5	0.5	1.2	0.8	0.0	0.4	0.7	1.2	2.1	2.0	0.7	0.2	0.6	1.2	0.2	0.3	2.5	0.7	1.1	2.1	1.8	1.0	0.5	1.3	0.3	0.2	1.0	2.9	1.2	0.0	1.1	1.8	0.6	1.2	0.5	1.0	1.3	0.7	0.5	0.5	1.3	1.6	0.0	6.9	1.5	2.4	1.5	2.8	1.7	9.4	1.0	1.6	3.0	1.0	2.7	1.0	1.3	5.4	1.1	1.0	1.5	0.5	0.7	0.6	1.0	0.9	0.5	1.8	1.2	1.4	7.3	2.8	0.6	0.4	0.6	0.4	1.5	3.6	0.7	1.0	2.1	2.6	1.0	1.3	14.3	1.3
AMELX	"AIH1, AMG"	ENSG00000125363	"Amelogenin, X-linked"	Q99217	X	11293413-11300761	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ductus deferens: 3.5;epididymis: 3.0;seminal vesicle: 9.4"	"Cell line enhanced"	"Detected in single"		"K-562: 1.3"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 1.9"	"Region enhanced"	"Detected in single"		"amygdala: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"								"unprognostic (1.76e-1)"									"unprognostic (1.00e-1)"		"unprognostic (2.00e-1)"				0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.1	0.3	3.5	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	9.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.6	0.5	0.5	0.0	0.7	0.0	0.0
AMELY	AMGL	ENSG00000099721	"Amelogenin, Y-linked"	Q99218	Y	6865918-6874027	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 1.2;prostate: 1.2;thyroid gland: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"																	"unprognostic (1.62e-1)"						0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0		0.0	0.9	0.0	0.0	0.2		1.2	0.0		0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.8			2.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AMOT	KIAA1071	ENSG00000126016	Angiomotin	Q4VCS5	X	112774503-112840815	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 40.0;epididymis: 102.0"	"Cell line enhanced"	"Detected in many"		"AF22: 17.6;HAP1: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067290, HPA067853"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA067290: AB_2685819, HPA067853: AB_2732773"	"unprognostic (1.08e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.82e-2)"	"prognostic favourable (3.94e-4)"	"unprognostic (4.46e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.60e-2)"	"prognostic favourable (4.21e-9)"	"unprognostic (9.54e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.44e-2)"	3.7	2.3	18.4	2.0	17.9	1.3	5.5	3.0	14.0	8.1	3.5	13.9	40.0	3.1	4.7	102.0	3.8	9.7	3.1	3.7	15.4	10.9	8.2	2.5	3.0	1.6	14.4	10.3	5.4	2.7	8.4	7.0	14.9	18.0	5.6	4.3	1.2	6.9	27.6	25.2	2.7	3.6	3.5	15.7	2.1	3.3	2.7	13.5	0.1	3.8	9.3	1.8	3.2	4.3	0.5	0.2	0.0	0.6	1.9	1.5	0.2	3.0	0.0	17.6	0.7	0.3	0.3	6.5	0.6	0.0	0.0	0.0	7.4	0.6	0.4	3.6	2.7	6.4	19.0	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.1	0.0	0.8	0.2	0.0	3.9	0.5	0.1	0.0	0.0	0.4	0.3	4.8	0.2	7.8	0.1	6.1	5.4	0.1	8.2	8.1	0.0	6.0	0.1	0.0	6.8	0.6	0.1	0.1	2.2	5.2	0.0	7.0	0.5	0.0	0.0	0.8	0.1	4.5	0.0	0.0	0.0	1.1	0.4	1.5	0.5	0.7	1.0	0.2	0.2	0.7	0.6	0.0	1.9	0.6	0.2	1.0	0.2	18.4	17.9	3.0	14.0	15.4	10.9	14.4	10.3	18.0	13.5
ANKRD66		ENSG00000230062	"Ankyrin repeat domain 66"	B4E2M5	6	46746917-46759506	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 15.0;epididymis: 12.1;fallopian tube: 36.0;ovary: 11.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.0"	"Region enhanced"	"Detected in many"		"pons and medulla: 15.0"	"Cell type enriched"	"Detected in single"	6	"myeloid DC: 1.0"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"																	"unprognostic (1.67e-3)"	"unprognostic (2.52e-1)"			"unprognostic (2.44e-2)"		"unprognostic (2.03e-2)"		"unprognostic (9.36e-2)"		"unprognostic (4.30e-3)"	"unprognostic (2.19e-1)"			0.1	0.2	2.0	0.2	4.3	0.1	0.2	0.0	0.6	1.7	0.1	5.9	0.0	0.1	0.9	12.1	0.1	36.0	0.1	0.1	3.0	3.0	0.1	0.1	7.1	0.2	0.0	0.0	11.1	0.1	0.1	0.5	0.2	15.0	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.9	1.9	0.0	0.2	0.1	0.2	0.2	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.3	0.0	0.6	3.0	3.0	0.0	0.0	15.0	1.9
AP1S2	"MRX59, MRXS5, PGS, SIGMA1B"	ENSG00000182287	"Adaptor related protein complex 1 sigma 2 subunit"	P56377	X	15825806-15854931	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 218.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 66.0;SK-MEL-30: 87.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 49.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 55.2;monocytes: 74.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049894, HPA060945"	Enhanced		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA049894: AB_2680939, HPA060945: AB_2684393"	"prognostic favourable (9.86e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.47e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.03e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.43e-2)"	"prognostic favourable (5.53e-6)"	"unprognostic (1.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.47e-2)"	10.1	8.2	21.2	11.7	17.9	12.6	9.7	13.0	17.6	12.0	17.3	9.8	12.6	4.8	25.7	218.0	9.8	5.6	7.0	34.2	12.7	19.9	5.2	5.8	8.9	11.6	16.1	11.8	4.5	4.1	8.2	11.7	13.1	39.7	5.5	8.0	13.3	5.1	13.2	41.4	5.0	8.7	24.9	18.5	14.1	9.9	8.6	11.4	9.8	10.7	8.6	9.6	8.5	5.9	8.2	55.2	12.5	74.9	5.5	8.4	44.8	3.3	2.8	31.9	15.7	6.0	4.1	1.1	10.0	4.7	7.8	10.0	2.0	3.5	5.7	44.7	14.6	3.9	8.8	2.7	13.0	8.1	14.1	3.4	5.0	3.1	5.3	12.7	3.8	2.4	2.8	7.4	7.6	15.6	3.1	66.0	14.0	1.8	3.3	6.7	42.5	10.5	7.2	23.3	11.5	8.7	0.8	3.9	15.5	4.5	1.3	87.3	14.9	13.0	8.2	13.3	5.1	18.5	9.3	7.6	17.3	12.1	7.1	5.7	32.3	8.2	74.9	8.0	5.6	67.8	5.4	8.2	5.7	4.5	55.2	7.5	4.1	4.0	12.5	5.5	34.7	17.9	8.4	44.8	21.2	17.9	13.0	17.6	12.7	19.9	16.1	11.8	39.7	11.4
ARHGAP40	"C20orf95, dJ1100H13.4"	ENSG00000124143	"Rho GTPase activating protein 40"	Q5TG30	20	38601934-38651035	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"breast: 18.6;epididymis: 38.0;skin 1: 26.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.5;HBEC3-KT: 12.0;RPTEC TERT1: 10.5;SK-BR-3: 11.3;T-47d: 13.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA042636, HPA042840"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA042636: AB_10962149, HPA042840: AB_10963929"	"unprognostic (9.89e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.35e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (2.89e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.54e-1)"	0.3	0.0	0.3	0.3	0.3	0.0	18.6	0.3	0.5	1.6	0.3	0.4	5.2	0.8	0.6	38.0	15.8	0.0	0.9	0.3	0.3	0.1	4.1	0.3	1.8	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.4	0.3	3.0	0.0	0.3	1.9	5.1	0.3	26.7	0.3	0.7	0.3	0.3	2.6	1.2	0.6	0.3	0.3	5.2	6.6	3.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.1	0.1	0.8	0.0	3.3	0.0	0.0	0.0	12.0	0.2	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	11.3	0.0	13.7	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.3	0.3	0.6
ARMCX2	"ALEX2, GASP9, KIAA0512"	ENSG00000184867	"Armadillo repeat containing, X-linked 2"	Q7L311	X	101655281-101659891	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 92.7"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 48.4;NTERA-2: 34.8;RH-30: 26.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005761	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA005761: AB_10600782"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.59e-2)"	"unprognostic (6.96e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.41e-2)"	"prognostic favourable (3.45e-5)"	"unprognostic (9.06e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.69e-4)"	"unprognostic (1.12e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.25e-1)"	7.7	21.5	12.5	6.7	19.9	1.0	14.2	17.6	17.5	17.1	11.4	8.2	38.8	3.7	18.4	92.7	6.2	16.7	12.5	18.8	13.2	17.1	13.3	2.6	8.3	4.9	11.8	13.3	28.8	9.8	34.1	38.9	15.4	12.4	17.6	5.3	9.7	23.6	41.8	3.8	3.2	6.2	19.3	9.0	10.9	8.3	6.3	10.7	1.4	35.1	3.6	4.3	13.9	18.9	7.6	1.6	0.0	1.4	4.3	4.4	1.9	0.0	0.0	15.0	0.1	13.4	12.2	0.1	16.4	20.6	0.4	0.4	0.0	6.3	0.0	0.0	21.5	0.4	0.0	0.3	0.1	0.0	0.5	0.0	17.6	0.0	14.1	0.1	0.0	19.2	5.2	12.8	0.1	17.4	0.0	0.1	48.4	0.0	0.0	0.2	34.8	0.1	4.1	26.7	0.0	0.8	0.0	6.0	11.1	0.0	0.0	0.4	7.6	0.0	3.8	18.5	19.7	11.5	0.1	0.0	0.0	0.0	16.9	0.0	0.3	0.0	0.7	0.0	1.6	1.4	0.7	5.1	1.5	1.5	1.1	7.6	4.2	4.4	0.0	4.3	0.9	1.6	0.9	1.9	12.5	19.9	17.6	17.5	13.2	17.1	11.8	13.3	12.4	10.7
ARSG	KIAA1001	ENSG00000141337	"Arylsulfatase G"	Q96EG1	17	68259182-68422731	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 42.3"	"Cell line enhanced"	"Detected in many"		"T-47d: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023245, HPA023285"	Enhanced				"Intracellular and membrane"	1600000	1600000			"HPA023245: AB_1845056, HPA023285: AB_1845057"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.02e-2)"	"unprognostic (3.67e-3)"	"unprognostic (4.11e-1)"	"unprognostic (1.14e-3)"	"unprognostic (5.18e-2)"	"unprognostic (5.47e-2)"	"unprognostic (6.11e-7)"	"unprognostic (4.24e-3)"	"prognostic favourable (7.04e-4)"	"unprognostic (1.87e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.49e-1)"	3.5	8.5	3.0	3.8	7.4	3.8	7.4	11.8	12.6	5.3	2.2	4.2	16.7	1.6	5.6	42.3	6.1	8.8	3.8	5.4	6.0	4.6	4.0	3.2	3.4	13.5	4.4	4.3	7.8	3.0	3.6	7.9	3.3	5.5	2.6	1.9	17.8	4.9	18.9	11.7	5.4	2.6	3.7	2.6	6.1	3.2	5.0	1.5	3.2	11.9	3.5	12.7	2.9	3.1	5.5	9.4	16.3	10.8	4.8	8.5	6.3	2.1	2.3	1.9	2.5	7.1	5.0	6.5	1.9	5.6	4.0	1.7	0.6	2.9	4.7	4.9	2.6	0.2	3.6	0.9	1.5	5.2	2.9	2.3	2.3	5.5	6.3	5.3	3.8	2.0	1.3	1.2	3.5	4.1	2.0	10.2	1.7	6.1	4.8	3.5	2.5	2.7	0.5	1.7	10.7	5.7	1.2	7.6	0.7	2.3	6.9	11.1	18.3	6.7	3.6	4.6	0.8	1.7	1.2	10.4	7.5	7.4	3.5	6.1	1.7	7.1	10.8	6.5	8.5	8.0	5.5	5.5	5.4	8.0	9.4	2.3	5.7	8.2	16.3	4.8	7.1	1.8	5.4	6.3	3.0	7.4	11.8	12.6	6.0	4.6	4.4	4.3	5.5	1.5
ARSH		ENSG00000205667	"Arylsulfatase family member H"	Q5FYA8	X	3006613-3033571	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 3.1;epididymis: 3.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.2;RT4: 1.4;SK-BR-3: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (3.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.01e-2)"	"unprognostic (8.90e-2)"		"unprognostic (6.79e-2)"		"unprognostic (2.56e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.48e-2)"	"unprognostic (2.39e-1)"		"unprognostic (1.63e-1)"		"unprognostic (2.65e-2)"	"unprognostic (6.75e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.2	0.0			0.0	0.0	3.7	1.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.5	0.0	0.0	0.0		0.2	0.0		0.9	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.1			0.0		0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ASIP	"AGTIL, ASP"	ENSG00000101440	"Agouti signaling protein"	P42127	20	34194569-34269344	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.7;epididymis: 18.4;ovary: 24.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.5;HSkMC: 5.3;U-698: 3.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"hippocampal formation: 5.4"	"Cell type enriched"	"Detected in single"	321	"plasmacytoid DC: 43.7"	"Lineage enriched"	"Detected in single"	321	"dendritic cells: 43.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA048636	Uncertain		Supported	Vesicles	"Secreted to blood"			Vesicles	Vesicles	"HPA048636: AB_2680471"	"unprognostic (4.81e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.97e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.57e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.53e-6)"	"unprognostic (1.02e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-1)"	0.5	0.1	0.3	0.3	0.3	0.2	1.9	0.3	0.8	2.0	1.0	0.3	0.3	0.0	2.0	18.4	0.3	2.1	0.3	10.3	5.4	0.0	0.3	0.5	0.3	0.4	0.3	0.3	24.8	0.3	0.0	0.3	0.3	0.7	2.5	0.0	0.3	0.3	0.3	0.3	5.4	0.3	0.3	1.3	0.3	0.1	7.1	0.3	0.3	0.3	0.3	0.8	0.5	0.4	0.1	43.7	0.0	0.0	0.0	0.0	0.2	0.1	2.3	0.8	0.8	0.5	1.6	0.2	0.2	0.0	0.0	0.0	6.5	0.1	2.4	0.5	0.6	0.3	0.0	0.0	0.0	0.1	1.6	3.4	0.7	1.1	0.0	0.0	0.9	5.3	0.0	0.0	0.0	0.0	1.2	2.0	0.0	0.7	0.5	3.4	0.0	1.3	0.7	0.6	2.9	0.0	0.2	0.6	0.6	0.0	0.4	3.8	0.6	0.4	0.7	1.2	1.2	0.2	0.6	0.8	0.7	3.9	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.2	0.3	0.3	0.3	0.8	5.4	0.0	0.3	0.3	0.7	0.3
ASMT	"ASMTY, HIOMT, HIOMTY"	ENSG00000196433	"Acetylserotonin O-methyltransferase"	P46597	X	1615001-1643081	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 8.8;epididymis: 7.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;NTERA-2: 1.4;U-266/70: 2.1;U-266/84: 3.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"pons and medulla: 8.8"	"Group enriched"	"Detected in some"	4	"memory B-cell: 2.2;memory CD8 T-cell: 2.0;naive B-cell: 3.8;NK-cell: 1.0"	"Group enriched"	"Detected in many"	4	"B-cells: 3.8;NK-cells: 1.0;T-cells: 2.0"																				"unprognostic (1.84e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-1)"	"unprognostic (8.55e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.79e-3)"	0.6	2.3	0.6	1.2	0.7	2.4	0.8	1.2	0.6	1.3	0.8	0.6	0.6	0.3	1.4	7.0	0.6	0.9	0.7	0.6	0.8	0.7	0.6	0.6	0.8	0.8	1.8	0.6	0.7	1.3	0.7	3.8	0.6	8.8	1.0	0.2	0.6	1.2	1.0	0.8	1.6	0.7	0.9	4.1	1.4	0.6	0.6	0.6	0.6	1.1	0.6	0.6	0.6	0.9	3.8	0.0	0.5	0.0	1.0	2.0	0.1	0.1	0.0	0.1	0.1	0.3	0.0	2.9	0.2	0.0	0.6	0.0	0.0	0.1	0.4	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.1	1.4	0.0	0.8	0.1	0.2	0.8	0.1	0.1	0.0	0.0	0.4	0.1	0.1	0.4	0.0	0.0	0.0	1.2	0.0	2.1	3.7	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.5	2.0	0.0	3.8	0.2	0.1	0.5	1.0	0.0	0.0	0.0	0.1	0.6	0.7	1.2	0.6	0.8	0.7	1.8	0.6	8.8	0.6
ATP13A4	"DKFZp761I1011, FLJ37958"	ENSG00000127249	"ATPase 13A4"	Q4VNC1	3	193402077-193593111	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 46.4;parathyroid gland: 52.5;thyroid gland: 51.2"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 9.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 23.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051932			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA051932: "	"unprognostic (4.97e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.72e-2)"	"prognostic favourable (3.91e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.00e-1)"	0.6	0.7	11.2	0.6	11.1	0.6	17.8	2.6	10.1	1.8	2.2	8.4	9.0	0.9	0.6	46.4	11.8	2.7	4.3	0.6	11.1	5.1	0.8	0.7	22.0	0.8	7.5	7.7	0.8	3.9	52.5	3.5	0.6	9.0	0.6	3.2	0.5	4.5	16.7	0.6	11.2	0.6	0.7	6.1	0.7	7.6	0.8	7.5	0.0	51.2	7.8	9.5	0.6	3.7	0.4	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.2	0.2	0.1	1.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	1.9	0.9	1.4	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	11.2	11.1	2.6	10.1	11.1	5.1	7.5	7.7	9.0	7.5
BASP1	"CAP-23, CAP23, NAP-22, NAP22"	ENSG00000176788	"Brain abundant membrane attached signal protein 1"	P80723	5	17065598-17276843	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 107.3;epididymis: 126.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 113.7;SiHa: 109.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 42.4"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 42.4"	"Low region specificity"	"Detected in many"							"HPA045218, HPA050333"	Enhanced		Enhanced	"Plasma membrane"		85000000	85000000	"Plasma membrane"	"Plasma membrane"	"HPA045218: AB_2679263, HPA050333: AB_2681090"	"unprognostic (3.35e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (5.25e-11)"	"unprognostic (1.95e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.70e-1)"	9.2	6.7	64.3	28.4	37.4	31.1	4.8	37.2	107.3	16.2	5.2	4.0	15.1	3.8	15.5	126.9	4.0	3.6	12.7	4.4	65.0	55.8	4.2	7.7	9.1	30.2	30.1	56.6	11.7	2.5	3.6	6.4	36.4	21.9	32.2	5.5	7.9	3.8	11.5	1.6	6.0	5.7	14.2	11.0	21.9	9.2	2.2	4.3	3.7	3.6	1.3	35.4	17.6	13.0	2.5	1.6	42.4	1.1	0.6	0.1	0.2	0.0	17.0	21.2	0.0	10.2	10.9	30.4	21.2	7.0	17.9	19.0	0.8	0.0	6.6	3.0	15.2	1.4	13.5	14.8	23.3	2.7	7.6	0.0	113.7	0.0	22.7	13.1	0.1	18.7	18.5	20.2	17.0	19.3	0.0	0.0	19.0	24.4	0.0	12.0	15.6	5.2	0.0	0.0	3.6	6.4	4.2	13.6	2.8	109.2	10.0	0.0	0.0	13.6	24.6	23.7	0.0	1.9	3.4	0.2	0.0	3.5	23.9	16.3	3.1	6.2	1.1	7.8	0.0	0.4	0.0	1.8	0.0	0.0	1.6	2.5	0.0	0.0	42.4	0.6	0.6	0.1	0.1	0.2	64.3	37.4	37.2	107.3	65.0	55.8	30.1	56.6	21.9	4.3
BEX2	DJ79P11.1	ENSG00000133134	"Brain expressed X-linked 2"	Q9BXY8	X	103309346-103311046	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 79.2;epididymis: 67.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 30.7;NTERA-2: 29.6;SCLC-21H: 43.6;SH-SY5Y: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 18.0;NK-cells: 21.3;T-cells: 26.8"									"HPA045384, HPA078630"	Uncertain		Uncertain	Cytosol				Cytosol	Cytosol	"HPA045384: AB_2679305, HPA078630: "	"unprognostic (7.56e-2)"	"unprognostic (7.08e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavourable (8.54e-7)"	"unprognostic (3.21e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.27e-2)"	"prognostic favourable (1.52e-4)"	"unprognostic (7.36e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.22e-3)"	"unprognostic (6.63e-2)"	"prognostic favourable (3.05e-13)"	"unprognostic (4.14e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.38e-3)"	1.7	39.6	49.1	4.1	62.6	6.8	10.9	44.9	79.2	5.8	4.7	11.5	3.0	2.7	14.7	67.1	3.0	8.9	4.8	7.3	53.4	57.6	26.4	1.4	6.6	7.3	32.5	40.3	29.0	13.5	29.6	40.1	5.0	29.6	12.4	4.1	11.5	11.1	12.8	2.5	4.2	4.2	5.7	18.7	7.9	6.5	13.2	13.6	3.1	52.8	1.3	9.2	3.7	2.2	18.0	3.5	4.0	0.1	21.3	26.8	7.1	0.0	0.8	3.7	0.0	0.0	0.0	14.7	0.1	2.0	2.5	3.6	2.5	1.2	0.0	10.3	0.0	0.6	0.0	3.0	2.2	0.0	8.0	0.4	0.4	0.1	15.0	0.0	8.2	0.9	30.7	1.2	9.4	0.1	5.3	0.2	0.3	1.3	6.1	0.0	29.6	2.6	0.0	0.0	0.0	1.2	1.1	43.6	19.9	1.9	0.4	6.5	3.6	0.0	0.0	0.0	2.9	0.1	0.6	10.1	6.4	0.0	4.9	0.0	0.4	4.0	0.1	0.3	8.5	0.1	11.8	18.0	16.8	9.8	0.5	15.0	26.8	19.2	0.5	21.3	0.0	3.5	11.3	7.1	49.1	62.6	44.9	60.5	53.4	57.6	32.5	40.3	29.6	13.6
BIRC7	"KIAP, ML-IAP, mliap, RNF50"	ENSG00000101197	"Baculoviral IAP repeat containing 7"	Q96CA5	20	63235883-63240507	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 14.4;placenta: 13.6;retina: 21.1"	"Cell line enriched"	"Detected in some"	4	"SK-MEL-30: 62.2"	"Cancer enriched"	"Detected in many"	10	"melanoma: 73.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 2.0"	"Not detected"	"Not detected"							"HPA047850, HPA061283"			Enhanced	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	Nucleoplasm	"HPA047850: AB_2680181, HPA061283: "	"unprognostic (3.60e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.24e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.84e-2)"	1.6	1.3	1.0	0.7	1.0	0.3	0.7	0.1	2.2	3.0	1.3	0.5	0.1	0.4	0.8	14.4	0.3	0.3	0.5	2.8	0.9	1.1	2.6	0.8	2.3	2.2	4.9	1.0	0.2	0.1	0.1	0.6	13.6	1.5	0.4	0.3	21.1	0.8	0.1	0.1	4.9	0.3	0.2	4.3	1.6	0.3	0.4	0.3	0.3	0.3	1.0	0.5	0.4	1.8	0.0	0.0	0.0	0.2	0.0	2.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.1	0.4	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.2	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	62.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.0	0.1	2.2	0.9	1.1	4.9	1.0	1.5	0.3
C10orf95	FLJ14280	ENSG00000120055	"Chromosome 10 open reading frame 95"		10	102449837-102451543	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 12.7"	"Cell line enhanced"	"Detected in many"		"HEK 293: 11.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"												"Secreted - unknown location"						"unprognostic (2.31e-1)"	"unprognostic (7.76e-3)"	"unprognostic (3.19e-1)"	"unprognostic (5.62e-3)"	"unprognostic (4.02e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.80e-3)"	0.0	1.0	0.4	1.2	0.4	1.1	0.0	1.0	1.2	1.7	1.4	0.0	0.0	2.0	0.7	12.7	0.9	9.7	1.2	0.0	0.4		1.0	0.0	9.8	2.2	0.0	0.2	8.9	4.2	0.0	2.6	7.0	0.9	1.0	0.0	10.1	3.4	3.4	0.1	3.6	1.9	0.0	0.0	1.9	3.2	0.9	0.0	0.1	5.0	2.7	4.1	0.5	0.0	9.3	5.6	1.6	1.2	8.4	11.6	4.5	5.5	1.0	0.1	2.3	0.0	0.0	4.9	0.2	0.0	0.0	0.0	4.4	9.7	4.8	2.3	0.0	9.7	0.0	0.4	0.0	4.1	11.7	3.1	4.0	3.6	0.0	4.2	3.0	0.1	1.8	0.0	0.1	0.0	5.3	4.1	0.0	4.3	2.2	4.0	2.2	3.3	6.7	0.1	5.3	1.1	2.0	8.9	1.3	2.4	1.5	3.0	4.8	0.3	0.4	0.3	1.1	0.2	0.5	3.5	2.7	3.2	0.2	6.3	0.1	1.6	1.2	1.5	7.4	0.5	7.0	9.3	8.2	7.6	3.2	7.5	11.6	9.7	1.0	8.4	0.2	5.6	8.2	4.5										
C12orf74		ENSG00000214215	"Chromosome 12 open reading frame 74"	Q32Q52	12	92702843-92708549	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 6.9;lung: 6.6;lymphoid tissue: 12.3"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 2.7;RT4: 2.4;SK-BR-3: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"memory B-cell: 3.7;naive B-cell: 3.1"	"Lineage enriched"	"Detected in single"	21	"B-cells: 3.7"																				"unprognostic (2.75e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.28e-3)"	"unprognostic (4.55e-3)"		"unprognostic (7.95e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.57e-1)"		"unprognostic (1.63e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.84e-2)"	"unprognostic (5.83e-4)"	"unprognostic (3.03e-1)"	"unprognostic (5.89e-2)"		"unprognostic (1.42e-2)"	0.2	0.1	0.1	12.3	0.1	0.0	0.2	0.1	0.1	2.1	0.7	0.0	3.6	0.3	0.7	6.9	1.7	4.5	0.3	0.2	0.1	0.1	1.3	0.5	6.6	1.9	0.1	0.0	1.0	1.1	0.0	0.2	0.0	0.0	0.6	0.3	0.0	0.9	0.9	0.1	0.2	1.8	0.0	0.1	2.6	2.1	0.5	0.0	0.1	0.2	0.0	10.5	2.5	1.4	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.5	2.4	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
C1GALT1C1L		ENSG00000223658	"C1GALT1-specific chaperone 1 like"	P0DN25	2	43675151-43676322	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 9.2"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 15.7;U-2 OS: 9.9"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"														"unprognostic (2.18e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.71e-3)"	"unprognostic (2.19e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.73e-2)"	"unprognostic (3.81e-3)"	"unprognostic (8.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (8.86e-2)"	1.5	1.2	1.0	0.2	1.7	0.0	5.1	0.0	2.8	1.6	1.6	0.1	1.8	0.0	5.7	9.2	0.6	1.5	1.1	8.0	0.5		2.3	0.0	0.3	0.5	3.9	0.1	1.5	2.9	0.0	0.0	1.0	3.1	3.0	0.7	1.7	1.4	3.5	0.7	0.0	0.4	4.7	1.6	0.4	0.3	7.8	1.4	0.0	1.6	0.8	0.2	1.5	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	3.0	1.5	0.1	0.2	0.5	1.0	1.3	0.6	4.5	0.0	4.5	0.3	0.3	0.0	0.3	2.4	0.0	3.5	2.0	1.4	0.9	1.1	0.0	0.0	2.0	0.8	3.1	0.1	3.2	2.3	0.0	0.3	4.6	0.0	4.2	0.0	0.0	0.0	1.7	0.0	3.9	0.9	0.2	15.7	0.0	0.2	3.0	1.1	3.0	0.0	4.1	9.9	0.2	0.9	0.0	2.3	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0										
C5orf67		ENSG00000225940	"Chromosome 5 open reading frame 67"	F2Z3F1	5	56511567-56606232	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 17.9;kidney: 9.3;retina: 16.3"	"Group enriched"	"Detected in some"	7	"CACO-2: 3.1;EFO-21: 9.1;U-266/70: 10.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.9"	"Region enriched"	"Detected in some"	5	"pons and medulla: 6.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 3.3;monocytes: 1.9"																				"unprognostic (7.28e-2)"	"unprognostic (1.41e-1)"		"unprognostic (2.55e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-3)"	"unprognostic (6.58e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.69e-2)"		"unprognostic (1.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.62e-2)"		0.4	0.0	0.2	0.2	1.2	0.4	1.0	0.2	0.2	0.4	0.8	0.4	0.2	1.5	0.6	17.9	0.4	0.4	0.2	0.2	0.6	0.2	9.3	0.2	0.4	0.6	0.7	0.2	0.2	0.2	0.0	0.2	0.2	6.1	0.2	0.0	16.3	1.1	0.2	0.2	0.8	1.6	0.2	0.2	1.5	0.1	0.2	0.2	0.2	2.1	0.2	0.2	0.2	0.2	0.1	1.5	3.3	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.3	0.0	9.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.1	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.5	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	3.3	0.0	1.9	1.5	0.4	0.1	0.2	1.2	0.2	0.2	0.6	0.2	0.7	0.2	6.1	0.2
CAMP	"CAP18, FALL-39, FALL39, LL37"	ENSG00000164047	"Cathelicidin antimicrobial peptide"		3	48223347-48225491	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 63.7;bone marrow: 201.8;epididymis: 275.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 13.3;hTCEpi: 9.3;U-698: 38.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 10.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 63.7"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 63.7"	"Low region specificity"	"Detected in single"							"CAB015949, CAB016522, HPA029874"	Enhanced				"Secreted to blood"					"CAB015949: , CAB016522: , HPA029874: AB_10600859"	"unprognostic (2.14e-2)"	"prognostic favourable (5.73e-4)"	"unprognostic (4.59e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.41e-2)"	"unprognostic (4.57e-5)"	"unprognostic (3.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.08e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.03e-2)"	0.2	0.1	0.1	0.1	0.2	201.8	0.2	0.1	0.1	0.1	0.1	0.0	14.7	0.0	0.0	275.0	0.1	0.2	0.0	0.5	0.1	0.1	0.1	0.2	1.5	0.5	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.2	0.0	0.1	1.1	0.1	0.1	0.1	2.6	0.0	0.1	10.1	0.1	4.0	0.0	0.4	0.4	0.1	0.2	0.4	0.1	0.5	1.5	63.7	5.2	0.5	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	38.5	0.0	1.4	0.0	5.5	1.1	15.8	0.0	1.7	0.0	0.5	0.0	0.0	1.5	0.3	0.0	0.0	63.7	0.5	5.2	0.8	0.0	10.9	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CAPSL	MGC26610	ENSG00000152611	"Calcyphosine like"	Q8WWF8	5	35904295-35938779	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 34.9;epididymis: 18.3;fallopian tube: 59.4"	"Group enriched"	"Detected in some"	4	"BJ hTERT+ SV40 Large T+: 7.3;BJ hTERT+ SV40 Large T+ RasG12V: 6.2;HBF TERT88: 4.8;REH: 7.6;U-698: 18.6"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 14.1;ovarian cancer: 3.4"	"Region enriched"	"Detected in many"	7	"pons and medulla: 34.9"	"Cell type enriched"	"Detected in single"	13	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA046811, HPA058495"	Enhanced		Approved	Nucleoplasm,Microtubules				"Nucleoplasm, Microtubules"	"Nucleoplasm, Microtubules"	"HPA046811: AB_2679819, HPA058495: AB_2683735"	"unprognostic (1.16e-1)"	"unprognostic (3.40e-2)"		"unprognostic (2.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.20e-2)"		"unprognostic (7.35e-2)"		"unprognostic (1.29e-1)"	"unprognostic (1.92e-3)"	"unprognostic (4.42e-1)"	"unprognostic (3.62e-4)"		"unprognostic (1.46e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.52e-1)"	0.1	0.2	3.6	0.1	4.4	0.2	0.2	0.0	0.5	2.4	0.1	4.3	0.4	0.1	1.3	18.3	0.2	59.4	0.2	0.2	5.2	5.3	0.7	0.1	11.8	0.1	0.3	0.0	6.7	0.4	0.1	17.0	0.2	34.9	0.2	0.1	0.0	0.4	0.4	0.2	0.2	0.1	0.2	0.8	0.1	0.2	5.4	0.5	0.5	3.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.8	7.3	6.2	0.0	0.0	2.1	0.0	0.9	0.0	0.1	0.0	4.8	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	1.3	0.0	0.0	1.2	2.2	0.0	0.5	0.0	0.0	18.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.6	4.4	0.0	0.3	5.2	5.3	0.3	0.0	34.9	0.5
CATIP	"C2orf62, MGC50811"	ENSG00000158428	"Ciliogenesis associated TTC17 interacting protein"	Q7Z7H3	2	218356856-218368099	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 12.0;fallopian tube: 24.5"	"Cell line enriched"	"Detected in single"	11	"BEWO: 9.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.4;neutrophil: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA044818	Supported									"HPA044818: AB_10959301"	"unprognostic (7.11e-3)"	"unprognostic (2.37e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.19e-1)"	0.2	0.2	1.5	0.2	3.3	0.2	0.1	0.1	0.6	2.1	0.1	5.7	4.9	0.1	0.7	12.0	0.2	24.5	1.2	0.1	2.1	2.7	3.6	0.1	2.7	0.2	0.4	1.9	3.6	5.5	2.6	1.7	2.0	9.3	1.3	0.1	0.3	0.1	1.6	0.1	0.1	0.1	0.2	0.4	0.3	0.2	9.5	1.8	0.0	5.7	0.0	0.2	0.7	0.0	0.0	0.5	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	1.5	3.3	0.1	0.6	2.1	2.7	0.4	1.9	9.3	1.8
CBLN4	"CBLNL1, dJ885A10.1"	ENSG00000054803	"Cerebellin 4 precursor"	Q9NTU7	20	55997440-56005472	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.5;brain: 16.8;epididymis: 11.8"	"Cell line enriched"	"Detected in single"	49	"SH-SY5Y: 14.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074497		Supported			"Secreted in brain"	10000000	10000000			"HPA074497: "	"unprognostic (3.61e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.22e-4)"	"unprognostic (7.50e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-3)"	1.3	23.5	11.9	0.3	8.9	0.2	1.8	0.1	16.8	2.8	0.3	0.5	0.8	0.3	1.2	11.8	0.3	5.4	0.9	0.2	5.9	14.8	1.0	1.3	1.1	0.2	1.6	5.0	2.2	1.2	0.4	0.1	0.5	2.4	0.4	0.2	0.1	0.3	0.7	0.5	0.3	0.3	0.6	0.4	0.2	0.7	2.7	0.0	0.0	1.3	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	8.9	0.1	16.8	5.9	14.8	1.6	5.0	2.4	0.0
CCDC170	"bA282P11.1, C6orf97, FLJ23305"	ENSG00000120262	"Coiled-coil domain containing 170"	Q8IYT3	6	151494030-151621193	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 19.4;fallopian tube: 33.0"	"Group enriched"	"Detected in some"	5	"MCF7: 13.8;T-47d: 8.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.1"	"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027114, HPA027185"	Enhanced		Approved	"Golgi apparatus,Cell Junctions"				"Golgi apparatus"	"Golgi apparatus"	"HPA027114: AB_2732435, HPA027185: AB_2672151"	"unprognostic (7.46e-2)"	"unprognostic (3.54e-2)"	"unprognostic (6.93e-2)"	"prognostic favourable (3.64e-4)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.21e-2)"	3.0	6.2	2.1	1.4	6.7	0.3	4.0	0.4	2.4	3.9	0.9	6.5	0.3	2.6	5.2	19.4	0.6	33.0	1.5	3.3	3.7	3.6	1.6	1.5	9.7	3.6	1.3	1.4	14.4	0.5	0.3	1.5	1.6	16.1	1.2	0.7	3.9	0.5	0.6	0.8	0.6	1.2	1.5	1.2	2.9	1.8	5.9	1.5	0.7	5.7	0.6	0.8	1.7	1.2	0.1	1.8	8.6	4.1	0.1	0.1	0.9	0.0	0.2	0.5	0.0	0.5	0.4	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.1	0.1	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	8.1	0.1	0.8	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.5	3.1	8.6	0.1	4.1	0.1	0.1	0.0	0.0	1.8	0.1	0.1	0.1	2.9	0.1	3.7	0.1	0.1	0.9	2.1	6.7	0.4	2.4	3.7	3.6	1.3	1.4	16.1	1.5
CCDC198	"C14orf105, FLJ10650"	ENSG00000100557	"Coiled-coil domain containing 198"	Q9NVL8	14	57469301-57493867	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 25.8;kidney: 75.8;pancreas: 21.8"	"Group enriched"	"Detected in some"	7	"A549: 9.1;RPTEC TERT1: 27.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 25.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029202			Uncertain	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA029202: "		"unprognostic (1.45e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.67e-2)"		"prognostic unfavourable (5.61e-4)"	"unprognostic (1.21e-1)"		"unprognostic (5.45e-3)"	"unprognostic (1.51e-1)"		"prognostic favourable (1.92e-4)"	"unprognostic (6.07e-2)"	"unprognostic (2.77e-1)"		"unprognostic (1.61e-3)"	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.6	0.1	0.6	0.1	0.0	1.6	0.7	0.4	25.8	0.1	15.3	17.7	0.1	0.1	0.2	75.8	17.7	0.1	0.0	0.1	0.0	6.1	21.8	0.0	0.1	0.1	1.5	0.1	0.0	0.0	0.1	0.8	0.1	0.4	0.1	0.0	0.3	0.1	0.2	1.6	0.0	0.0	0.1	0.0	0.0	0.3	0.1	2.7	1.9	4.5	0.9	3.4	5.0	3.6	0.0	9.1	0.0	0.3	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.9	0.9	0.4	2.5	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.3	0.1	0.1	0.2	0.1	0.0	0.2	27.1	0.4	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.7	0.5	0.1	0.1	0.3	0.4	0.3	1.4	0.3	0.2	3.1	0.9	0.6	2.1	0.4	2.6	2.1	4.2	3.0	0.2	2.7	3.5	5.0	4.5	3.4	0.6	1.9	5.0	3.6	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.0	1.5	0.0
CCNO	"CCNU, FLJ22422, UDG2, UNG2"	ENSG00000152669	"Cyclin O"	P22674	5	55231152-55233680	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 28.1;epididymis: 18.2;seminal vesicle: 23.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 6.5;T-47d: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA050090	Uncertain									"HPA050090: AB_2681011"	"unprognostic (3.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.28e-2)"	"prognostic favourable (6.78e-4)"	"unprognostic (3.96e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.18e-3)"	"prognostic favourable (7.60e-4)"	"unprognostic (3.54e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.03e-2)"	"prognostic favourable (5.10e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.49e-2)"	"unprognostic (8.88e-3)"	0.7	0.8	1.3	0.8	7.2	0.6	0.7	1.7	4.5	1.9	1.2	1.3	28.1	1.4	1.1	18.2	0.9	4.0	3.5	0.6	1.3	2.0	2.2	0.7	1.3	0.8	0.1	1.6	1.4	9.5	3.0	5.4	0.8	4.3	1.8	0.5	1.6	6.5	23.2	0.5	3.1	2.1	0.6	0.1	0.6	5.3	12.2	0.1	0.0	7.4	0.8	0.9	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.3	3.8	0.0	1.4	0.3	0.0	6.5	0.0	0.0	0.5	0.6	0.0	3.9	0.0	2.7	0.0	3.0	0.1	0.0	0.0	0.0	5.0	0.1	2.8	0.4	0.0	0.4	1.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.1	0.5	5.4	1.9	0.4	0.1	1.3	0.9	2.9	0.0	4.6	1.2	1.0	8.8	0.5	0.3	0.0	3.1	3.6	1.6	3.4	1.8	0.0	2.3	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	7.2	1.7	4.5	1.3	2.0	0.1	1.6	4.3	0.1
CDHR4	"CDH29, VLLR9392"	ENSG00000187492	"Cadherin related family member 4"	A6H8M9	3	49790732-49799835	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 37.8;fallopian tube: 42.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.6;HeLa: 4.4"	"Cancer enriched"	"Detected in some"	6	"endometrial cancer: 6.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 5.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 17.7"	"Low region specificity"	"Detected in many"			HPA076277	Enhanced				"Intracellular and membrane"					"HPA076277: AB_2732306"	"unprognostic (1.50e-4)"	"unprognostic (4.87e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (6.35e-7)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.61e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.07e-11)"	"unprognostic (2.65e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.37e-1)"	0.2	0.1	0.4	0.1	1.6	0.3	0.1	0.0	0.0	4.9	0.2	1.9	0.0	0.1	1.3	37.8	0.1	42.7	0.1	0.1	0.7	0.9	0.1	0.1	11.4	0.1	0.0	0.0	8.0	0.0	0.0	0.8	0.6	5.7	0.1	0.1	0.0	0.1	0.2	0.1	0.9	0.1	0.3	0.2	0.0	0.1	3.9	0.0	0.0	0.0	0.5	0.2	0.2	0.1	1.1	1.5	3.0	4.1	1.3	0.4	5.8	0.5	1.7	0.5	0.3	0.5	4.6	0.3	0.4	0.1	0.9	1.0	0.0	2.6	0.0	0.2	1.1	0.5	0.1	0.0	0.3	0.3	0.3	0.8	4.4	1.0	0.0	0.3	0.5	0.7	1.5	0.8	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.8	0.3	0.2	0.8	0.2	0.0	0.0	0.3	0.1	0.1	1.5	1.1	0.0	0.2	0.1	0.0	0.6	0.2	0.7	0.1	0.6	2.3	0.1	2.1	1.2	0.0	3.0	4.1	0.4	0.4	1.6	0.3	0.4	0.3	0.3	1.5	1.1	0.3	0.4	2.5	1.3	0.2	0.5	0.2	5.8	0.4	1.6	0.0	0.0	0.7	0.9	0.0	0.0	5.7	0.0
CDK15	"ALS2CR7, PFTAIRE2, PFTK2"	ENSG00000138395	"Cyclin dependent kinase 15"	Q96Q40	2	201790461-201895550	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 20.2;ovary: 9.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 14.6;BJ hTERT+ SV40 Large T+ RasG12V: 11.9;HBF TERT88: 18.2;HMC-1: 34.4;LHCN-M2: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	52	"basophil: 3.5;eosinophil: 6.9"	"Lineage enriched"	"Detected in single"	69	"granulocytes: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA015786	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA015786: AB_1844780"	"unprognostic (2.51e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.38e-2)"	"unprognostic (9.99e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.05e-2)"	1.3	0.2	0.1	5.2	0.1	0.0	3.7	0.3	0.1	3.4	2.3	0.1	0.1	0.3	4.1	20.2	1.1	1.0	4.2	0.3	0.1	0.0	0.4	0.1	3.3	0.1	0.1	0.1	9.8	0.2	0.0	0.5	0.1	0.1	2.0	0.7	1.4	0.6	0.3	0.7	1.1	3.0	3.9	0.1	0.1	1.1	2.5	0.1	0.1	0.2	1.2	1.2	1.6	1.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	1.7	0.0	3.1	14.6	5.5	11.9	0.0	1.5	0.0	0.0	1.3	0.0	0.0	0.0	18.2	0.0	0.0	1.0	0.0	0.0	0.2	0.0	34.4	2.0	0.0	1.5	0.7	0.0	0.0	0.0	10.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.5	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CER1	DAND4	ENSG00000147869	"Cerberus 1, DAN family BMP antagonist"	O95813	9	14719724-14722717	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.5;epididymis: 5.5"	"Group enriched"	"Detected in some"	9	"HEL: 6.3;NTERA-2: 11.5;SCLC-21H: 4.4"	"Cancer enriched"	"Detected in single"	82	"testis cancer: 17.3"	"Group enriched"	"Detected in many"	8	"basal ganglia: 2.5;cerebellum: 2.2;cerebral cortex: 1.1;pons and medulla: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA019917	Uncertain				"Secreted - unknown location"					"HPA019917: AB_1846539"					"unprognostic (2.98e-2)"						"unprognostic (5.36e-2)"				"unprognostic (5.99e-2)"			0.1	0.0	0.1	0.1	2.5	0.1	0.2	2.2	1.1	0.1	0.2	0.1	0.1	0.7	0.7	5.5	0.1	0.0	0.4	0.2	0.1	0.2	1.2	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.2	0.1	0.1	1.5	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	2.2	1.1	0.1	0.2	0.1	0.1	1.5	0.1
CFAP43	"bA373N18.2, C10orf79, FLJ22944, FLJ36006, WDR96"	ENSG00000197748	"Cilia and flagella associated protein 43"	Q8NDM7	10	104129888-104232362	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.5;epididymis: 21.6;fallopian tube: 37.7;testis: 40.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.0;U-266/70: 6.4;U-266/84: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"																		"unprognostic (1.20e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.46e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.88e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.11e-4)"	"unprognostic (6.67e-2)"	0.5	0.9	5.3	0.6	15.3	0.5	2.4	0.9	4.4	4.6	0.6	7.1	3.2	0.7	2.7	21.6	0.5	37.7	1.1	0.5	6.0	7.5	2.5	0.8	9.1	0.6	1.1	1.9	5.2	1.3	4.3	10.9	0.7	25.5	1.3	0.6	1.8	1.2	1.5	0.5	1.1	0.8	0.6	1.7	0.6	0.9	40.3	2.9	0.0	4.1	0.1	0.6	0.7	0.3	0.0	0.0	0.5	0.4	0.0	1.1	0.0	3.1	1.2	1.1	2.0	0.0	0.6	0.2	0.0	0.9	0.7	0.5	0.2	8.0	0.0	0.1	0.0	1.1	0.2	1.2	1.5	0.4	1.3	0.0	0.5	0.4	0.2	0.0	0.3	0.7	1.1	0.9	0.6	0.3	2.2	0.2	0.0	2.0	0.2	0.4	0.3	0.5	0.2	0.0	0.0	2.8	0.0	1.8	1.8	0.8	0.1	1.6	1.1	0.0	0.1	0.3	0.7	1.0	0.4	6.4	5.2	0.7	0.4	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.0	0.0	1.1	0.0	5.3	15.3	0.9	4.4	6.0	7.5	1.1	1.9	25.5	2.9
CFAP44	"FLJ11142, WDR52"	ENSG00000206530	"Cilia and flagella associated protein 44"	Q96MT7	3	113286947-113441610	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.2;epididymis: 20.2;testis: 20.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"pons and medulla: 38.2"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							HPA067258	Uncertain									"HPA067258: AB_2685814"	"unprognostic (2.83e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.39e-3)"	"unprognostic (7.51e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.13e-6)"	"unprognostic (8.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.77e-2)"	"prognostic favourable (7.09e-6)"	1.5	1.2	2.8	1.5	10.1	1.4	3.6	3.9	2.3	2.8	2.3	15.4	0.7	1.1	3.2	20.2	1.6	11.1	1.6	1.7	6.1	1.3	2.6	1.9	7.0	2.1	1.2	1.0	8.8	4.0	6.0	5.8	1.1	38.2	3.9	3.9	0.8	5.7	1.9	1.3	3.7	2.9	1.2	2.0	1.8	3.5	20.3	5.9	0.9	3.4	0.7	1.9	2.6	2.6	1.3	0.3	0.8	0.2	0.1	0.7	0.0	3.9	2.6	4.2	4.5	2.8	4.0	5.6	1.8	0.9	1.2	2.3	1.3	2.3	4.4	0.6	1.1	4.8	2.8	1.4	2.4	1.9	3.0	2.9	7.9	1.5	0.1	4.9	3.0	0.9	3.3	1.0	1.1	0.9	1.2	2.7	1.5	2.5	2.7	4.9	2.6	6.1	3.3	1.1	0.7	2.1	6.2	4.3	4.7	2.6	0.6	2.6	3.3	3.5	2.8	3.3	3.7	1.3	1.7	3.9	2.2	0.4	2.1	3.0	2.7	0.0	0.2	0.8	0.4	0.1	0.4	0.4	0.5	0.0	0.0	1.3	0.7	0.4	0.6	0.1	0.0	0.3	0.2	0.0	2.8	10.1	3.9	2.3	6.1	1.3	1.2	1.0	38.2	5.9
CFAP73	"CCDC42B, MIA2"	ENSG00000186710	"Cilia and flagella associated protein 73"	A6NFT4	12	113149858-113159276	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2;epididymis: 17.8;fallopian tube: 35.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.3;REH: 3.2;T-47d: 3.8;U-698: 12.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Region enhanced"	"Detected in many"		"pons and medulla: 27.2"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.0;naive CD4 T-cell: 1.3"	"Group enriched"	"Detected in many"	9	"B-cells: 1.0;T-cells: 1.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA048539	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA048539: AB_2680434"	"unprognostic (2.42e-2)"	"prognostic favourable (1.29e-4)"	"unprognostic (1.90e-3)"	"prognostic favourable (5.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.14e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.62e-4)"	"unprognostic (2.03e-4)"	"unprognostic (1.60e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.55e-2)"	0.2	0.3	4.3	0.5	16.9	2.0	0.3	0.5	0.9	3.1	0.3	15.3	1.0	0.5	1.0	17.8	0.6	35.5	0.4	0.2	5.8	6.1	0.6	0.2	5.7	0.9	0.2	0.9	6.8	0.3	0.7	0.9	0.2	27.2	0.3	0.3	0.0	2.2	0.9	0.5	4.5	0.6	0.2	1.1	0.5	3.9	1.5	4.7	0.0	0.5	0.5	1.3	0.4	0.0	1.0	0.1	0.0	0.0	0.0	1.3	0.2	0.3	0.1	0.4	0.4	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.5	3.0	6.3	0.2	0.0	1.0	0.0	0.0	0.0	0.2	0.5	0.3	2.1	0.2	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.3	1.1	0.4	0.2	3.2	0.0	0.5	0.8	0.7	0.6	0.1	0.0	0.9	0.0	3.8	0.0	0.1	0.1	1.0	0.3	0.2	0.6	0.2	12.7	0.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	4.3	16.9	0.5	0.9	5.8	6.1	0.2	0.9	27.2	4.7
CLCN4	"ClC-4, CLC4"	ENSG00000073464	"Chloride voltage-gated channel 4"	P51793	X	10156945-10237660	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1;epididymis: 22.8;skeletal muscle: 34.6"	"Cell line enhanced"	"Detected in many"		"HEL: 16.7;SCLC-21H: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 2.3;memory B-cell: 1.7;naive B-cell: 6.8;neutrophil: 4.4"	"Group enriched"	"Detected in many"	9	"B-cells: 6.8;granulocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031313, HPA063637"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA031313: AB_10601358, HPA063637: AB_2685069"	"unprognostic (1.01e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.07e-2)"	"prognostic unfavourable (2.13e-5)"	"unprognostic (2.96e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.99e-2)"	"prognostic favourable (9.55e-4)"	"unprognostic (9.70e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	3.1	3.4	9.7	2.0	21.3	2.1	1.6	18.6	29.1	2.0	1.4	15.7	0.0	1.2	1.3	22.8	2.3	3.0	2.8	11.4	13.0	10.5	3.4	3.5	3.4	2.9	23.5	10.4	2.2	2.4	8.9	3.9	1.7	18.2	2.1	1.1	6.0	2.3	1.7	34.6	1.2	1.2	1.4	15.2	3.2	2.1	2.2	17.9	0.0	6.8	2.0	2.2	2.3	0.8	6.8	0.6	4.4	0.5	0.0	0.0	0.6	4.9	3.1	2.3	0.0	1.1	2.0	0.1	0.1	0.0	0.0	0.0	6.0	3.4	3.7	9.0	1.0	1.1	1.4	3.4	0.1	0.0	3.5	16.7	1.7	2.5	5.5	0.0	0.0	10.0	2.7	4.3	1.1	6.4	1.2	0.0	2.3	0.5	0.0	0.1	2.9	10.8	0.0	3.8	0.0	1.5	0.5	17.3	6.5	7.1	0.7	0.0	1.8	2.1	6.3	2.7	4.6	11.8	0.4	0.4	8.3	1.3	8.6	0.0	3.4	2.3	0.5	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.6	6.8	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.6	9.7	21.3	18.6	26.7	13.0	10.5	23.5	10.4	18.2	17.9
CLU	"APOJ, CLI, CLU1, CLU2, KUB1, SGP-2, SP-40, TRPM-2"	ENSG00000120885	Clusterin	P10909	8	27596917-27615031	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 580.4;liver: 590.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 233.1;SK-BR-3: 203.8;T-47d: 148.7;U-2 OS: 133.0"	"Cancer enhanced"	"Detected in all"		"glioma: 1485.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"basophil: 69.2"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000572, CAB016253"	Enhanced				"Secreted to blood"	36000000000	36000000000			"CAB016253: AB_673562, HPA000572: AB_1078539"	"unprognostic (1.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.74e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.72e-1)"	"prognostic favourable (7.66e-5)"	"unprognostic (5.29e-2)"	82.5	217.4	233.5	50.2	280.3	3.4	90.4	141.2	414.7	78.3	47.9	139.5	184.6	19.9	55.4	580.4	48.3	217.2	172.7	24.6	176.2	154.7	69.8	590.5	30.5	127.3	209.0	173.1	49.6	134.8	220.4	34.3	8.5	189.0	63.4	18.0	125.4	62.2	359.2	7.7	12.8	24.0	87.9	255.2	17.2	56.6	161.5	113.5	5.3	106.6	11.8	134.8	72.2	54.7	0.1	1.3	69.2	2.1	0.9	2.7	110.6	0.7	96.0	4.2	4.9	23.8	32.8	13.4	17.0	33.6	4.5	2.3	18.4	15.2	0.3	68.3	15.1	32.2	18.2	2.7	2.9	70.8	17.6	41.6	233.1	22.6	20.8	1.0	111.1	54.9	11.0	19.4	5.6	59.1	0.5	49.0	1.5	16.1	0.3	3.1	35.0	11.4	0.3	16.1	13.3	44.4	69.3	3.9	2.4	23.6	203.8	1.0	148.7	0.6	8.7	1.3	133.0	7.6	5.7	6.3	22.4	0.7	107.0	6.9	0.6	69.2	2.1	0.9	2.3	0.6	0.8	0.0	2.7	2.5	0.7	0.1	0.3	0.8	9.6	0.9	0.1	1.3	0.7	110.6	233.5	280.3	141.2	223.1	176.2	154.7	209.0	173.1	189.0	113.5
CNGA4	"CNCA2, CNG5, CNGB2, OCNC2, OCNCb"	ENSG00000132259	"Cyclic nucleotide gated channel alpha 4"	Q8IV77	11	6234765-6244429	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 8.0;fallopian tube: 22.5;ovary: 9.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.5;CAPAN-2: 2.6;HaCaT: 2.2;HMC-1: 3.3"	"Cancer enriched"	"Detected in single"	6	"endometrial cancer: 2.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	21	"eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"														"unprognostic (1.11e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.69e-3)"	"prognostic favourable (1.48e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.55e-3)"	0.2	0.3	1.5	0.3	2.0	0.6	0.2	0.6	1.1	1.0	0.4	1.9	0.1	0.5	1.2	8.0	0.4	22.5	0.3	0.1	1.7	1.4	0.3	0.2	6.6	0.4	1.0	0.1	9.1	0.3	0.3	2.3	0.2	3.3	0.3	0.2	0.3	0.2	0.8	0.1	0.4	0.3	0.3	1.3	0.3	0.3	7.4	1.4	0.1	0.3	0.1	0.3	0.2	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.7	2.5	0.1	0.1	0.1	0.0	0.1	0.0	0.0	2.6	0.7	0.3	0.0	2.2	0.1	0.5	0.0	1.6	0.3	0.0	0.4	0.1	0.1	0.2	3.3	1.6	1.2	0.2	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.3	0.2	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.2	0.6	0.0	1.1	0.6	0.0	0.7	0.3	1.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.0	0.6	1.1	1.7	1.4	1.0	0.1	3.3	1.4
COL13A1		ENSG00000197467	"Collagen type XIII alpha 1 chain"	Q5TAT6	10	69801867-69964275	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.6;epididymis: 22.3"	"Cell line enhanced"	"Detected in many"		"BJ: 19.7;BJ hTERT+: 18.3;HUVEC TERT2: 31.9;PC-3: 29.3;TIME: 45.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	18	"cerebellum: 54.6"	"Group enriched"	"Detected in some"	18	"gdTCR: 1.9;NK-cell: 1.9"	"Group enriched"	"Detected in many"	18	"NK-cells: 1.9;T-cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050392	Approved									"HPA050392: AB_2681110"	"unprognostic (2.79e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.67e-4)"	"unprognostic (3.13e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.36e-5)"	"unprognostic (2.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.93e-2)"	0.7	1.2	0.5	3.3	1.0	0.0	1.3	54.6	1.3	3.5	3.1	0.6	4.3	1.8	1.4	22.3	1.3	2.0	2.7	2.7	0.6	0.5	1.3	0.5	8.2	0.7	0.9	0.7	1.1	1.2	0.9	2.7	0.9	3.0	10.7	2.3	3.8	1.0	6.2	2.7	3.1	2.9	2.0	1.7	5.0	3.9	0.9	0.7	0.3	1.0	1.1	0.6	2.2	1.2	0.0	0.0	0.1	0.0	1.9	1.9	0.4	0.4	0.1	7.0	0.0	0.0	1.3	0.0	19.7	18.3	3.3	1.6	0.0	0.4	0.0	3.3	8.8	0.7	0.0	0.0	5.6	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	2.8	0.0	8.4	2.6	31.9	0.0	0.0	3.1	0.0	0.0	0.0	1.3	29.3	0.0	0.0	3.5	0.1	0.0	0.7	0.0	0.0	0.0	0.9	0.0	0.0	45.5	0.1	5.4	1.8	15.0	4.4	0.0	0.0	11.7	0.0	16.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.4	0.5	1.0	54.6	1.3	0.6	0.5	0.9	0.7	3.0	0.7
CPLX2	"CPX-2, DKFZp547D155"	ENSG00000145920	"Complexin 2"	Q6PUV4	5	175796310-175884020	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 95.3;epididymis: 80.1"	"Group enriched"	"Detected in some"	22	"A549: 103.7;Hep G2: 62.5;SCLC-21H: 44.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071191, HPA074390"	Supported		Uncertain	Vesicles				Vesicles	Vesicles	"HPA071191: , HPA074390: "	"unprognostic (1.36e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.49e-3)"		"unprognostic (6.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.90e-5)"	"unprognostic (6.88e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.87e-2)"	1.7	23.3	72.6	2.0	32.7	1.4	1.3	79.0	95.3	1.3	2.6	2.6	0.3	2.7	1.3	80.1	1.4	1.4	1.4	1.3	68.3	16.3	1.4	1.3	2.1	1.3	37.2	26.3	1.3	7.9	1.3	11.3	1.3	17.9	1.4	2.2	0.2	1.3	1.4	1.3	1.4	2.5	1.6	4.0	1.3	5.1	3.1	3.7	0.0	1.4	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	103.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	44.1	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	72.6	32.7	79.0	66.6	68.3	16.3	37.2	26.3	17.9	3.7
CPNE7		ENSG00000178773	"Copine 7"	Q9UBL6	16	89575768-89597246	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 34.5;epididymis: 26.2;seminal vesicle: 21.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 42.6;TIME: 23.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 8.5"	"Lineage enriched"	"Detected in many"	7	"T-cells: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043359	Uncertain									"HPA043359: AB_10794884"	"unprognostic (6.77e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-1)"	"unprognostic (6.47e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.93e-2)"	"prognostic unfavourable (9.52e-6)"	"unprognostic (1.87e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.08e-1)"	"prognostic favourable (7.22e-4)"	0.4	0.9	9.5	1.4	6.4	1.3	1.6	0.0	14.2	1.7	0.8	3.3	34.5	4.8	0.9	26.2	1.6	1.6	4.4	0.7	8.0	14.6	3.3	0.9	1.4	0.9	4.0	9.3	0.7	1.1	0.8	11.0	0.6	4.1	1.9	0.4	0.7	2.0	21.9	0.2	2.3	2.8	0.5	0.7	1.0	4.5	2.7	1.0	1.7	0.6	0.0	0.8	1.4	0.8	0.0	0.0	0.2	0.0	1.2	8.5	0.4	0.0	9.8	0.1	0.1	16.7	17.4	0.1	4.2	1.7	5.9	4.6	9.7	8.2	0.0	3.8	1.6	6.6	6.1	0.2	2.0	2.3	4.8	0.1	7.3	0.1	42.6	0.0	1.6	6.8	0.4	3.1	11.7	0.1	10.3	0.1	14.1	1.4	3.0	1.8	6.4	7.5	0.1	0.0	6.7	0.8	0.0	5.5	0.0	1.4	2.0	0.4	1.8	1.2	23.1	11.5	0.0	7.0	0.0	0.0	0.0	1.8	11.3	6.7	4.7	0.0	0.0	0.2	1.1	0.0	8.5	0.0	2.0	3.1	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.3	0.4	9.5	6.4	0.0	14.2	8.0	14.6	4.0	9.3	4.1	1.0
CROCC2		ENSG00000226321	"Ciliary rootlet coiled-coil, rootletin family member 2"	H7BZ55	2	240906330-240993311	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"brain: 9.5;epididymis: 19.4;fallopian tube: 14.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.2;Hep G2: 1.2;HSkMC: 2.8;RPMI-8226: 7.3"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.5"	"Group enriched"	"Detected in many"	4	"basal ganglia: 5.0;hippocampal formation: 4.2;pons and medulla: 9.5"	"Group enriched"	"Detected in some"	18	"intermediate monocyte: 1.1;non-classical monocyte: 3.1"	"Lineage enriched"	"Detected in single"	26	"monocytes: 3.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA048678	Enhanced									"HPA048678: AB_2680491"	"unprognostic (4.33e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.68e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.75e-4)"	"unprognostic (2.84e-3)"	"unprognostic (3.10e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-2)"	"unprognostic (9.90e-3)"	"unprognostic (7.19e-2)"	0.2	0.1	0.6	0.3	5.0	0.2	0.0	0.0	0.1	2.4	0.1	3.8	0.0	0.5	0.4	19.4	0.0	14.9	0.1	0.0	4.2	1.4	0.1	0.5	2.3	1.4	0.0	0.0	3.2	0.1	0.0	2.1	0.1	9.5	0.0	0.1	0.0	0.1	0.1	0.2	0.2	0.8	0.1	0.0	4.7	0.3	0.4	0.5	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.6	5.0	0.0	0.1	4.2	1.4	0.0	0.0	9.5	0.5
CRYBB1		ENSG00000100122	"Crystallin beta B1"	P53674	22	26599278-26618088	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 10.6;epididymis: 17.4"	"Group enriched"	"Detected in some"	5	"Karpas-707: 21.0;RPMI-8226: 37.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 10.6;non-classical monocyte: 7.5"	"Lineage enriched"	"Detected in many"	6	"monocytes: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003448, CAB010058"	Supported					93000	93000			"CAB010058: AB_668166, HPA003448: AB_2732396"	"unprognostic (1.31e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.89e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-4)"	"unprognostic (2.62e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.76e-2)"	3.0	3.0	2.5	2.1	2.2	1.1	2.0	0.3	4.4	1.2	1.1	5.6	0.0	1.1	1.1	17.4	1.4	1.5	2.3	2.8	2.4	1.9	1.1	1.0	2.9	3.1	3.8	0.3	1.2	2.6	0.7	1.7	8.3	1.9	2.7	0.8	1.7	1.3	1.1	1.1	0.4	0.9	1.6	3.6	5.7	1.0	1.0	1.0	0.8	0.6	0.0	1.0	2.3	0.7	0.3	1.7	0.5	10.6	0.4	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.7	5.8	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.1	0.9	0.0	0.4	0.0	37.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.8	0.0	1.0	0.0	0.0	1.0	0.0	0.0	10.6	0.0	0.3	0.0	0.0	1.7	0.0	0.0	0.0	0.5	0.4	7.5	0.0	0.0	0.6	2.5	2.2	0.3	4.4	2.4	1.9	3.8	0.3	1.9	1.0
CTNNA2	"CAP-R, CT114"	ENSG00000066032	"Catenin alpha 2"	P26232	2	79185231-80648861	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.1;brain: 58.4;epididymis: 58.1"	"Cell line enhanced"	"Detected in some"		"AF22: 8.2;Karpas-707: 9.4;NTERA-2: 7.7;SCLC-21H: 4.4;SH-SY5Y: 12.4"	"Group enriched"	"Detected in some"	7	"endometrial cancer: 3.9;glioma: 11.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	66	"basophil: 25.1"	"Lineage enriched"	"Detected in single"	252	"granulocytes: 25.1"	"Low region specificity"	"Detected in all"							CAB037175	Enhanced									"CAB037175: AB_476883"	"unprognostic (9.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.31e-2)"	"unprognostic (4.04e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.62e-2)"	"unprognostic (7.96e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.27e-4)"	"unprognostic (7.80e-2)"	"unprognostic (8.44e-4)"	"unprognostic (1.73e-4)"	"unprognostic (2.83e-1)"	1.2	5.1	34.7	1.6	24.1	1.2	1.2	10.1	58.4	1.2	1.9	8.7	0.0	1.4	3.8	58.1	1.3	2.7	1.3	1.1	23.6	16.1	1.2	1.2	1.1	1.1	12.5	28.3	1.1	1.7	1.1	9.3	1.1	12.7	1.9	1.8	5.1	1.3	1.8	1.3	1.2	1.7	1.5	4.3	1.1	2.1	14.4	10.4	0.0	1.1	0.0	1.1	1.1	0.3	0.0	0.0	25.1	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.4	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.0	0.0	0.8	0.0	4.4	12.4	0.0	0.0	0.5	0.1	0.7	0.0	0.5	0.8	0.2	0.0	2.7	0.0	0.0	3.2	0.0	2.2	25.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	34.7	24.1	10.1	35.8	23.6	16.1	12.5	28.3	12.7	10.4
CTXND1	LINC01314	ENSG00000259417	"Cortexin domain containing 1"		15	80195484-80252213	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enhanced"	"Detected in some"		"brain: 20.8;epididymis: 9.1;liver: 14.7"	"Group enriched"	"Detected in some"	6	"SK-MEL-30: 3.3;WM-115: 10.0"	"Group enriched"	"Detected in many"	7	"glioma: 3.4;liver cancer: 2.7;melanoma: 9.1;thyroid cancer: 5.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 38.5"																"unprognostic (4.15e-5)"	"unprognostic (8.42e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.86e-3)"	"unprognostic (5.59e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.14e-3)"	"unprognostic (1.34e-1)"	0.3	4.2	12.8	0.3	5.7	0.1	0.2	4.4	8.2	0.2	0.5	2.2	0.0	0.7	0.2	9.1	0.2	0.4	0.2	6.6	20.8		3.5	14.7	2.6	0.4	1.9	1.9	0.4	0.7	0.0	0.0	0.1	4.5	0.2	0.5	1.1	0.2	0.3	0.6	1.3	0.8	0.2	3.3	2.0	3.3	0.3	7.1	0.0	0.8	0.0	0.5	0.2	0.0	0.4	0.1	0.5	0.1	0.3	0.6	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.2	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	3.3	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.1	0.2	0.2	10.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.4	0.6	0.1	0.5	0.3	0.0	0.1	0.1	0.0										
DAPL1		ENSG00000163331	"Death associated protein like 1"	A0PJW8	2	158795317-158862781	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 53.5;esophagus: 75.6;retina: 63.9;skin 1: 61.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;hTCEpi: 21.6;SCLC-21H: 5.5;U-87 MG: 7.9"	"Group enriched"	"Detected in all"	7	"cervical cancer: 16.2;head and neck cancer: 14.5;lung cancer: 19.7;ovarian cancer: 62.5;thyroid cancer: 30.1"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA046937, HPA058635"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Microtubules"				"Nucleoplasm, Nuclear bodies, Microtubules"	"Nucleoplasm, Nuclear bodies, Microtubules"	"HPA046937: AB_2679870, HPA058635: AB_2732625"	"unprognostic (3.95e-5)"	"prognostic favourable (8.43e-4)"	"unprognostic (2.05e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.63e-2)"		"unprognostic (8.59e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.30e-3)"	0.3	14.7	1.4	0.4	1.3	0.0	7.4	0.4	1.0	11.7	1.0	0.8	1.6	0.0	2.1	53.5	75.6	21.1	0.6	0.2	1.5	3.6	1.3	0.2	0.8	0.4	2.8	0.3	3.8	5.7	0.0	5.6	0.2	1.5	2.3	0.0	63.9	6.8	0.4	0.2	61.3	0.5	1.1	0.4	0.2	0.2	2.1	0.8	0.8	21.5	37.3	16.9	2.0	21.1	1.4	4.0	2.9	2.6	2.8	1.3	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.1	2.2	0.0	0.0	0.0	0.0	0.2	21.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.8	0.0	0.0	0.3	5.5	0.0	0.0	0.0	0.6	0.6	1.1	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	7.9	0.0	0.0	2.9	2.6	1.6	0.5	1.9	1.0	1.2	0.8	0.4	1.0	1.4	0.4	0.5	2.2	2.8	0.6	4.0	1.3	0.5	1.4	1.3	0.4	1.0	1.5	3.6	2.8	0.3	1.5	0.8
DCDC2B		ENSG00000222046	"Doublecortin domain containing 2B"	A2VCK2	1	32209094-32216196	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 11.1;fallopian tube: 26.6;lung: 10.1"	"Cell line enhanced"	"Detected in some"		"AF22: 1.6;TIME: 3.8;U-266/70: 1.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045832	Uncertain									"HPA045832: AB_10962048"	"unprognostic (6.45e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.87e-3)"	"unprognostic (7.66e-3)"	"unprognostic (6.35e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.71e-3)"	"unprognostic (8.73e-2)"	"unprognostic (6.18e-4)"	"unprognostic (8.53e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.39e-3)"	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	11.1	0.0	26.6	0.2	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	5.5	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	1.0	0.6	0.1	0.2	0.3	0.0	0.1	0.9	1.6	0.4	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	1.0	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.5	0.9	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.6	0.1	0.0	1.3	0.4	0.0	0.0	0.6	0.2	0.8	0.1	3.8	0.1	0.8	1.1	0.7	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.1	0.0	1.0	0.1	0.0	0.0	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0
DDX24		ENSG00000089737	"DEAD-box helicase 24"	Q9GZR7	14	94048291-94081245	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 103.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002554	Uncertain		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"	"Nucleoli, Cytosol"	"HPA002554: AB_1078631"	"unprognostic (7.48e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.13e-2)"	"prognostic favourable (3.06e-9)"	"prognostic unfavourable (2.89e-4)"	"unprognostic (6.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.66e-2)"	18.0	45.5	19.7	13.7	41.3	53.3	18.5	31.4	40.8	17.4	20.9	21.9	14.3	13.6	23.2	103.0	20.1	18.9	21.3	28.6	25.0	31.3	36.3	30.1	16.4	27.4	22.0	29.0	21.4	12.5	8.3	32.0	11.2	38.7	16.0	14.6	17.4	15.9	17.7	28.5	23.4	12.6	17.9	21.8	18.1	15.0	38.5	17.4	14.3	25.3	11.8	25.8	21.7	14.9	4.1	3.1	10.6	3.3	6.2	5.3	5.0	3.8	1.0	7.1	4.6	4.3	5.6	1.7	10.7	8.9	13.9	12.5	1.3	2.4	17.7	4.0	2.3	2.5	7.3	0.6	15.2	7.7	0.4	9.4	2.0	5.7	3.5	13.5	4.2	0.9	4.0	2.5	2.4	2.3	4.9	5.2	5.9	10.6	4.0	11.5	4.7	0.1	5.4	16.5	2.0	10.1	1.4	5.6	5.2	10.5	2.6	4.9	4.1	4.8	6.8	4.0	2.6	5.1	3.2	2.1	13.6	19.0	5.7	7.4	3.1	10.6	3.3	2.5	5.0	2.6	1.4	2.9	2.9	3.0	2.0	4.1	5.3	5.3	2.6	6.2	2.5	3.1	3.3	5.0	19.7	41.3	31.4	40.8	25.0	31.3	22.0	29.0	38.7	17.4
DEFB116	DEFB-16	ENSG00000215545	"Defensin beta 116"	Q30KQ4	20	31303212-31308585	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"epididymis: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA047430	Uncertain				"Secreted in male reproductive system"					"HPA047430: AB_10964749"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0			0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DLEC1	"CFAP81, DLC1"	ENSG00000008226	"Deleted in lung and esophageal cancer 1"	Q9Y238	3	38039205-38124025	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 21.1;fallopian tube: 23.2;testis: 28.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.4;RT4: 2.8;SK-BR-3: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA019077	Enhanced		Supported	Cytosol				Cytosol	Cytosol	"HPA019077: AB_1847724"	"unprognostic (1.24e-4)"	"unprognostic (3.60e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.50e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.62e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.94e-4)"	0.8	0.3	1.3	0.7	8.3	1.1	0.5	0.0	0.6	3.3	0.6	6.1	3.5	0.7	1.1	21.1	0.3	23.2	1.3	0.3	1.7	2.5	0.3	0.3	10.0	1.7	0.5	0.2	6.3	0.2	0.6	14.2	0.3	9.8	0.8	0.6	0.8	0.6	1.8	0.2	0.7	0.7	0.3	0.6	0.7	0.6	28.9	1.7	0.0	0.8	0.0	0.6	0.4	0.1	0.2	0.1	0.9	0.4	0.1	1.1	0.1	0.1	0.0	1.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.7	0.0	0.0	0.2	0.2	0.5	0.0	0.2	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.2	0.1	3.4	0.0	0.0	0.0	0.2	0.1	2.8	0.5	0.2	0.3	1.7	0.5	0.1	0.3	0.0	0.0	0.4	0.3	0.0	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.4	0.4	0.8	0.2	0.4	0.2	1.1	0.0	0.1	0.1	0.2	0.0	0.9	0.1	0.1	0.1	0.2	0.1	1.3	8.3	0.0	0.6	1.7	2.5	0.5	0.2	9.8	1.7
DNAH10	FLJ43808	ENSG00000197653	"Dynein axonemal heavy chain 10"	Q8IVF4	12	123762188-123936206	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.0;epididymis: 10.1;fallopian tube: 9.5;lung: 11.8;testis: 16.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.3;ASC diff: 4.0;ASC TERT1: 1.7;U-87 MG: 1.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.8;pons and medulla: 10.0"	"Cell type enhanced"	"Detected in some"		"gdTCR: 1.6;naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.6"									HPA039066	Enhanced									"HPA039066: AB_10673237"	"unprognostic (1.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.08e-3)"	"unprognostic (9.90e-3)"	"unprognostic (2.16e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.28e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.11e-3)"	0.4	0.2	0.7	0.2	4.8	3.1	0.3	1.2	0.6	1.9	0.7	3.9	0.5	0.5	0.6	10.1	0.2	9.5	0.2	0.2	1.4	1.7	0.4	0.2	11.8	0.2	0.5	0.0	6.2	0.2	0.1	0.2	0.4	10.0	1.1	0.2	0.0	0.2	0.2	0.1	0.2	1.1	0.2	1.5	0.3	0.2	16.4	0.3	0.0	0.5	0.0	0.2	0.4	0.9	0.1	0.0	0.1	0.0	0.0	1.6	0.2	0.0	0.0	0.1	2.3	4.0	1.7	0.6	1.0	0.3	0.0	0.2	0.0	0.5	0.1	0.2	1.2	0.5	0.0	0.0	0.0	0.4	0.8	0.6	0.0	0.0	0.4	0.0	1.1	1.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.8	0.0	0.2	0.3	1.2	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	4.8	1.2	0.5	1.4	1.7	0.5	0.0	10.0	0.3
DNAH11	"CILD7, DNAHBL, Dnahc11, DNHBL, DPL11"	ENSG00000105877	"Dynein axonemal heavy chain 11"	Q96DT5	7	21543215-21901839	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 22.2;parathyroid gland: 62.2"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 3.0;U-2 OS: 3.4;U-2197: 4.2"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"basal ganglia: 5.5;pons and medulla: 15.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA045880, HPA056474"	Approved									"HPA045880: AB_10962003, HPA056474: AB_2683145"	"unprognostic (2.24e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.10e-1)"	"prognostic unfavourable (1.49e-7)"	"unprognostic (9.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.86e-3)"	"unprognostic (4.79e-3)"	3.2	4.6	0.8	0.5	5.5	0.4	0.4	0.2	1.0	1.6	0.9	6.7	3.0	0.4	0.8	22.2	2.5	9.3	0.5	1.1	2.5	1.2	0.5	0.8	7.7	0.4	0.2	0.6	7.2	0.5	62.2	0.8	2.9	15.5	1.1	0.5	0.0	0.4	1.0	1.5	0.9	0.6	0.4	0.3	0.4	0.5	0.9	2.1	0.7	5.2	0.3	0.5	0.4	3.4	0.6	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.9	0.0	0.7	1.1	0.0	0.2	0.2	0.0	0.5	0.1	0.2	0.1	0.0	0.9	1.9	0.0	2.2	0.0	0.7	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.2	0.1	1.1	0.5	0.9	0.3	0.4	0.0	0.0	0.8	0.0	0.2	0.9	0.0	0.0	0.0	2.1	0.9	3.4	4.2	0.5	0.3	0.1	0.4	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	5.5	0.2	1.0	2.5	1.2	0.2	0.6	15.5	2.1
DNAJC10	"ERdj5, PDIA19"	ENSG00000077232	"DnaJ heat shock protein family (Hsp40) member C10"	Q8IXB1	2	182716041-182794464	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 74.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031111	Approved									"HPA031111: AB_10601211"	"unprognostic (3.29e-2)"	"unprognostic (5.20e-3)"	"unprognostic (3.10e-3)"	"prognostic favourable (6.42e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.76e-2)"	"prognostic unfavourable (2.19e-7)"	"unprognostic (2.91e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavourable (7.27e-4)"	"unprognostic (2.87e-2)"	10.4	8.6	10.2	21.2	12.1	2.8	14.8	11.2	14.5	17.2	10.9	7.4	28.9	8.3	18.5	74.8	8.1	18.8	17.0	17.7	10.8	12.8	14.5	14.0	12.2	17.3	10.7	8.9	14.4	21.9	16.1	17.7	11.5	10.5	12.4	11.8	9.0	19.7	31.5	7.6	6.6	11.7	11.8	11.4	16.3	15.1	14.5	7.7	13.5	17.8	8.2	15.0	10.9	10.3	22.0	13.1	2.1	12.2	6.6	7.3	6.9	10.4	8.1	13.9	7.1	22.8	30.2	14.3	23.0	29.9	14.6	16.3	14.7	19.9	31.8	22.5	21.4	11.5	12.0	18.2	26.5	15.4	10.8	11.1	12.1	11.9	19.6	25.0	21.6	15.8	20.2	17.9	29.8	32.3	10.7	16.5	15.3	4.5	8.8	6.9	22.4	20.0	9.9	14.0	38.1	24.1	12.0	12.4	11.8	14.5	13.6	13.8	6.5	8.4	29.7	25.6	18.6	14.4	16.7	11.5	23.8	17.8	35.5	16.7	22.0	2.1	12.2	0.9	5.8	10.8	7.3	22.0	6.3	6.3	13.1	20.2	6.1	6.3	1.2	6.6	7.7	7.7	5.9	6.9	10.2	12.1	11.2	14.5	10.8	12.8	10.7	8.9	10.5	7.7
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 76.4;BJ hTERT+: 53.2;fHDF/TERT166: 50.1;hTEC/SVTERT24-B: 36.0;LHCN-M2: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.2;myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA027241	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	12000000000	12000000000	Cytosol	Cytosol	"HPA027241: AB_1847976"	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavourable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (1.20e-5)"	16.1	2.5	0.9	1.8	1.3	0.1	11.0	0.9	4.2	37.9	2.8	0.1	7.4	1.5	10.5	133.2	257.1	3.3	30.7	11.6	0.9	1.0	2.5	16.7	3.8	0.2	1.0	1.7	3.0	0.8	0.3	2.0	20.2	4.2	2.6	3.1	1.6	28.7	2.9	3.5	11.5	2.0	5.3	0.8	3.6	2.1	5.9	0.0	0.0	1.8	45.5	107.2	6.0	46.6	0.0	1.8	0.0	1.2	0.0	0.4	1.3	6.1	0.6	2.3	0.0	13.8	76.4	2.1	22.4	53.2	14.0	18.3	0.3	3.4	0.1	0.2	50.1	12.9	0.0	2.6	14.7	0.1	0.1	0.9	0.7	0.1	3.8	0.0	23.2	6.7	0.1	36.0	1.3	3.9	4.8	0.1	39.0	0.0	0.0	0.7	0.2	0.7	0.3	16.8	0.1	0.5	0.0	0.1	0.0	5.2	0.1	19.1	0.0	5.9	1.0	29.7	4.4	3.3	4.8	0.1	0.1	0.2	15.6	2.0	4.0	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	1.3	0.9	4.2	0.9	1.0	1.0	1.7	4.2	0.0
ELOA3C		ENSG00000275553	"Elongin A3 family member C"		18	46968695-46969912	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"epididymis: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049178, HPA050086"	Uncertain									"HPA049178: AB_2680664, HPA050086: AB_2681009"																		0.0	0.0		0.0		0.0	0.0		0.1	0.0	0.0			0.5	0.0	1.3	0.0	0.0	0.0	0.1			0.2	0.2	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.5	0.0	0.0	0.0		0.0	0.0	0.0			0.1		0.0	0.0		0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0										
EME1	"FLJ31364, MMS4L, SLX2A"	ENSG00000154920	"Essential meiotic structure-specific endonuclease 1"	Q96AY2	17	50373220-50381483	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 15.3;epididymis: 10.6;testis: 21.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	29	"basophil: 15.3"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016127, HPA052188"	Supported		Approved	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"	"Nuclear bodies, Cytosol"	"CAB016127: AB_2278026, HPA052188: "	"unprognostic (3.81e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.94e-5)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.83e-3)"	"unprognostic (0.00e+0)"	"unprognostic (9.82e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.41e-1)"	1.0	0.9	1.6	2.5	2.0	6.0	0.8	0.8	1.8	1.3	1.9	3.0	0.0	1.1	0.9	10.6	2.6	0.7	1.6	0.7	0.9	0.6	0.7	0.8	1.1	3.3	1.4	0.9	1.3	0.6	0.2	0.5	2.4	1.5	0.7	2.0	1.0	1.6	0.1	1.4	1.5	2.1	0.8	1.9	2.2	1.1	21.9	2.8	5.7	0.5	0.9	3.9	1.0	1.2	0.1	0.5	15.3	0.0	0.0	0.1	0.2	7.4	11.0	14.7	7.6	0.7	1.5	10.6	7.8	3.0	10.9	10.1	17.3	6.1	5.9	10.4	3.1	5.9	13.6	6.2	15.6	11.6	10.7	14.3	12.7	8.0	0.0	5.8	4.7	0.3	0.4	12.5	5.2	2.5	8.6	14.4	6.4	8.1	13.3	7.5	8.5	7.6	13.8	28.5	8.3	2.4	3.0	5.7	11.4	4.8	2.6	4.5	9.4	6.7	1.7	14.2	8.5	9.3	10.7	9.0	9.1	5.8	4.5	6.6	8.7	15.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.2	1.6	2.0	0.8	1.8	0.9	0.6	1.4	0.9	1.5	2.8
EMX2		ENSG00000170370	"Empty spiracles homeobox 2"	Q04743	10	117542444-117549546	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 46.8;epididymis: 53.9;seminal vesicle: 76.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 16.8;fHDF/TERT166: 18.6;RPTEC TERT1: 18.7;RT4: 5.9"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 40.8;ovarian cancer: 52.8;renal cancer: 18.6"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003497, HPA065294"	Enhanced	Supported	Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA003497: , HPA065294: AB_2685455"	"unprognostic (1.53e-1)"	"prognostic favourable (2.80e-4)"	"unprognostic (7.21e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"		"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-1)"	"prognostic favourable (2.28e-13)"	"unprognostic (3.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.88e-2)"	4.6	0.5	11.5	0.6	10.3	0.5	1.4	0.5	12.5	23.5	0.7	7.3	46.8	0.5	40.5	53.9	0.7	25.4	1.2	0.6	14.7	2.1	25.5	0.5	0.5	0.7	1.8	10.4	5.7	0.5	0.6	1.1	0.6	2.5	1.9	0.5	3.4	1.3	76.3	5.1	4.7	0.5	22.6	0.6	0.5	0.5	3.6	6.2	0.0	0.5	1.2	0.7	4.2	2.4	0.7	0.5	2.4	0.9	1.0	0.7	0.1	0.0	0.0	0.0	1.8	0.0	0.2	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	16.8	18.6	0.1	0.4	0.0	0.0	0.0	1.8	0.5	0.1	0.1	0.0	0.1	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.1	18.7	5.9	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.5	0.6	0.5	0.6	0.7	0.4	0.4	0.4	0.4	0.7	0.6	0.5	1.1	1.0	0.9	0.5	0.6	0.1	11.5	10.3	0.5	12.5	14.7	2.1	1.8	10.4	2.5	6.2
ENAM	AIH2	ENSG00000132464	Enamelin	Q9NRM1	4	70628744-70686816	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 10.1;heart muscle: 5.0;kidney: 7.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.3;RPTEC TERT1: 1.5;U-266/70: 2.4;U-266/84: 3.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.7"					"Group enriched"	"Detected in some"	18	"memory B-cell: 1.2;naive B-cell: 1.7;plasmacytoid DC: 2.2"	"Group enriched"	"Detected in many"	20	"B-cells: 1.7;dendritic cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted to extracellular matrix"						"unprognostic (1.52e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.94e-3)"	"unprognostic (4.73e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.06e-4)"	"unprognostic (1.01e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.81e-14)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.2	10.1	0.0	0.1	1.5	5.0	0.0	0.0	7.9	0.5	0.0	0.0	0.0		0.0	2.5	0.8	0.5	0.0		0.0	0.0		0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	1.3	1.2			0.0		0.0	0.0	0.0	1.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.4	3.3	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0										
ENO4	"AC023283.3, C10orf134"	ENSG00000188316	"Enolase family member 4"	A6NNW6	10	116849512-116911788	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.1;epididymis: 12.6;fallopian tube: 13.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.6;MCF7: 8.2;T-47d: 5.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037937, HPA037938"	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA037937: , HPA037938: AB_2675746"	"unprognostic (2.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.55e-4)"	"unprognostic (8.38e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.74e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.18e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.87e-5)"	"unprognostic (1.08e-2)"	0.7	2.1	4.3	0.6	4.3	0.2	2.2	2.6	3.6	1.7	1.0	8.0	0.9	0.3	4.3	12.6	1.4	13.6	1.3	0.5	6.4	4.7	2.3	2.7	3.9	1.2	4.1	4.8	4.2	3.2	3.7	3.4	0.5	12.1	2.1	0.8	3.0	1.6	1.2	0.2	1.1	0.5	0.9	4.4	0.5	0.8	8.8	1.9	0.2	4.2	0.0	0.6	1.8	0.5	1.8	1.0	0.0	0.6	0.0	1.2	0.1	1.4	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.3	1.1	0.0	0.9	2.0	2.6	0.0	0.7	0.8	0.0	1.5	0.0	1.0	0.3	0.0	0.0	0.0	0.1	0.6	0.6	0.0	0.1	0.1	0.0	0.7	8.2	0.0	0.0	1.4	0.2	0.0	0.0	0.0	1.1	0.6	0.9	0.0	2.1	0.1	0.0	5.1	0.0	0.5	0.0	0.7	0.4	1.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.4	0.0	1.6	0.2	0.0	0.3	1.8	0.2	0.0	0.0	0.0	0.2	1.0	1.2	0.1	4.3	4.3	2.6	3.6	6.4	4.7	4.1	4.8	12.1	1.9
EPGN	"ALGV3072, EPG, epigen, PRO9904"	ENSG00000182585	"Epithelial mitogen"	Q6UW88	4	74308473-74315307	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 14.3;esophagus: 39.6;tongue: 25.7"	"Group enriched"	"Detected in some"	6	"hTCEpi: 61.2;U-2197: 27.4"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014420			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted in other tissues"			"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA014420: "	"unprognostic (7.51e-2)"	"unprognostic (8.08e-3)"	"unprognostic (1.09e-1)"		"unprognostic (1.07e-1)"	"unprognostic (1.77e-1)"		"unprognostic (2.38e-4)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-4)"	"unprognostic (3.84e-1)"		"unprognostic (7.89e-2)"	"prognostic unfavourable (2.40e-4)"	1.1	0.0	0.0	1.3	0.0	0.1	1.0	0.0	0.0	7.9	0.3	0.0	1.0	0.0	0.0	14.3	39.6	1.2	0.3	0.6	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.5	0.0	1.0	0.0	1.7	0.0	0.3	0.0	0.0	2.5	2.8	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.4	0.0	25.7	5.4	0.6	6.5	0.4	0.1	0.0	0.6	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	1.1	0.0	1.0	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.1	0.0	61.2	1.0	4.5	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	3.2	1.1	0.0	0.1	0.0	0.0	0.1	0.0	27.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.4	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FADS6		ENSG00000172782	"Fatty acid desaturase 6"		17	74877299-74893781	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 13.2;epididymis: 22.6;intestine: 20.0"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"liver cancer: 2.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016802	Uncertain									"HPA016802: AB_2669448"	"unprognostic (2.41e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.41e-2)"	"unprognostic (6.98e-4)"	"unprognostic (3.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.79e-1)"	0.4	6.3	1.7	0.7	3.3	1.7	0.7	13.2	5.9	0.5	9.7	0.4	1.2	9.2	0.4	22.6	2.7	0.3	0.2	0.4	1.7	3.4	1.4	5.2	0.3	0.7	4.5	1.9	0.4	0.6	0.6	0.1	0.4	12.5	0.6	1.0	0.6	2.3	0.5	0.7	6.5	20.0	0.3	0.8	4.7	0.4	1.0	0.4	0.3	0.6	2.2	1.1	1.7	0.9	1.1	0.8	5.3	2.9	1.3	0.5	0.0	0.6	0.7	1.8	1.6	0.0	2.7	2.9	3.2	0.2	0.4	0.8	2.3	1.3	1.1	0.5	1.5	1.0	2.4	0.0	0.4	0.4	0.1	1.3	3.8	1.6	0.9	1.3	1.5	1.0	0.2	3.3	1.2	0.0	1.5	4.2	2.0	2.1	0.9	3.0	1.1	1.5	0.7	1.0	1.5	0.9	0.7	1.6	1.2	2.5	1.0	0.5	1.0	2.0	1.0	1.7	2.4	1.9	1.6	1.6	0.7	1.3	3.3	1.1	2.1	2.1	1.3	1.0	0.4	1.2	0.2	0.4	0.3	0.4	0.2	1.1	0.4	0.5	5.3	1.3	2.9	0.8	0.3	0.0	1.7	3.3	13.2	5.9	1.7	3.4	4.5	1.9	12.5	0.4
FAHD2B	DKFZp434N062	ENSG00000144199	"Fumarylacetoacetate hydrolase domain containing 2B"	Q6P2I3	2	97083583-97094882	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 21.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 6.9;NK-cells: 11.5;T-cells: 12.2"									"HPA042145, HPA044987"	Approved									"HPA042145: AB_2677873, HPA044987: AB_2679170"	"unprognostic (6.55e-3)"	"unprognostic (5.56e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavourable (4.04e-4)"	"unprognostic (9.03e-3)"	"unprognostic (4.13e-3)"	"unprognostic (8.84e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.65e-3)"	"unprognostic (1.94e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.26e-3)"	"unprognostic (2.04e-1)"	3.6	2.6	5.5	0.9	7.4	0.9	5.9	7.6	6.8	3.8	2.9			0.7	5.9	21.1	2.8	5.0	1.6	8.9	5.7	6.2	3.0	1.1	2.2	2.1	7.1		10.3	4.0	6.8	2.1	0.3		3.5	2.4		4.1	3.3	10.2	4.3	1.3	5.5	7.6	1.6	10.1	11.4			0.1		3.3	3.9	2.7	6.9	2.1	0.1	0.2	11.5	12.2	3.6	2.8	3.5	4.9	10.0	4.8	5.8	7.9	2.5	2.9	4.4	4.1	3.3	4.5	5.6	2.2	0.9	3.0	7.1	5.6	2.6	7.1	12.9	6.1	4.7	2.5	15.7	6.8	3.9	7.7	6.0	0.5	9.4	4.7	10.4	13.8	0.3	0.0	8.1	20.1	4.7	9.6	8.0	1.4	19.7	4.8	4.8	1.1	4.2	8.6	2.3	12.0	9.5	5.4	0.8	0.5	8.3	0.5	2.4	9.0	11.8	14.6	0.7	17.7	6.0	0.0	0.1	0.1	9.0	0.2	12.2	6.9	8.7	8.8	1.3	2.9	6.1	7.8	0.1	11.5	0.1	2.1	10.8	3.6										
FAM169A	"KIAA0888, SLAP75"	ENSG00000198780	"Family with sequence similarity 169 member A"	Q9Y6X4	5	74777574-74866951	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.8;epididymis: 23.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.1;Hep G2: 15.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041574	Enhanced		Supported	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"	"Nuclear membrane, Cytosol"	"HPA041574: AB_10794382"	"unprognostic (3.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.75e-4)"	"unprognostic (5.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.02e-2)"	"unprognostic (3.51e-3)"	"unprognostic (4.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	0.7	4.2	9.9	1.4	13.5	1.5	1.1	11.0	21.8	1.7	1.9	5.2	2.9	0.7	3.8	23.6	0.9	3.8	3.0	2.2	9.4	14.2	6.7	3.1	0.8	2.5	9.6	10.3	3.4	2.0	10.7	8.3	1.2	10.4	6.4	3.0	11.3	1.9	7.0	0.8	0.7	1.0	1.0	11.1	2.5	2.1	15.5	4.6	3.7	9.6	0.0	2.5	4.1	1.1	1.4	0.5	0.0	0.0	0.8	4.0	1.2	5.2	4.7	3.3	4.5	0.0	0.0	23.1	0.7	1.7	3.5	3.6	2.1	3.5	0.0	2.4	0.0	3.7	6.9	10.4	3.7	3.9	7.9	1.4	0.8	15.7	0.1	0.0	0.0	0.1	11.0	0.8	5.2	0.0	0.0	0.0	2.1	1.5	4.9	0.0	8.4	2.6	7.2	2.1	0.3	3.3	8.3	2.0	2.7	8.7	3.9	0.6	3.7	1.0	0.0	0.2	3.4	0.0	3.8	12.8	11.9	0.0	0.4	0.0	0.4	0.0	0.0	0.0	2.7	0.0	4.0	0.8	1.6	2.5	0.0	1.4	3.5	3.4	0.0	0.8	0.0	0.5	0.9	1.2	9.9	13.5	11.0	17.1	9.4	14.2	9.6	10.3	10.4	4.6
FAM216B	"C13orf30, FLJ40919"	ENSG00000179813	"Family with sequence similarity 216 member B"	Q8N7L0	13	42781550-42791549	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 21.0;epididymis: 18.2;fallopian tube: 51.3;lung: 28.5;ovary: 18.3"	"Cell line enriched"	"Detected in single"	12	"U-87 MG: 6.3"	"Group enriched"	"Detected in some"	10	"endometrial cancer: 4.4;lung cancer: 1.4;ovarian cancer: 0.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 9.5;pons and medulla: 21.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040118	Uncertain									"HPA040118: AB_10674429"	"unprognostic (1.03e-2)"		"unprognostic (2.24e-1)"	"prognostic favourable (9.77e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.19e-1)"	"unprognostic (2.54e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.27e-1)"		"unprognostic (8.14e-3)"	"unprognostic (1.37e-1)"		"unprognostic (1.30e-2)"	0.3	0.2	1.7	0.9	9.5	0.2	0.2	0.1	0.6	3.0	0.3	8.0	0.0	0.3	1.3	18.2	0.2	51.3	0.4	10.0	3.1	3.2	0.2	0.2	28.5	2.2	0.1	0.0	18.3	0.3	0.2	2.0	0.2	21.0	0.2	0.5	0.0	0.7	0.2	0.2	0.2	1.5	0.2	0.5	0.3	0.3	1.0	1.7	0.0	0.2	0.0	3.9	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	9.5	0.1	0.6	3.1	3.2	0.1	0.0	21.0	1.7
FBXO16	FBX16	ENSG00000214050	"F-box protein 16"	Q8IX29	8	28348287-28490318	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 22.9;pituitary gland: 42.3"	"Cell line enhanced"	"Detected in many"		"AF22: 15.4;Karpas-707: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058676, HPA076472"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Nucleoplasm, Vesicles, Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles, Plasma membrane, Cytosol"	"HPA058676: AB_2683795, HPA076472: "	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.56e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.95e-3)"	"unprognostic (6.49e-2)"	"prognostic favourable (6.70e-5)"	"unprognostic (3.41e-3)"	"unprognostic (4.90e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.07e-1)"	0.9	2.3	7.3	1.3	17.6	2.6	3.4	15.8	9.9	5.4	2.0	1.1	7.6	2.6	1.8	22.9	1.1	5.7	2.1	2.0	4.2	6.8	4.0	7.2	1.9	1.5	4.4	7.5	1.2	6.3	7.2	42.3	1.0	6.3	4.3	2.6	4.6	5.9	7.3	1.1	0.8	3.8	1.2	2.1	1.7	2.7	4.8	1.4	0.0	8.7	0.2	3.3	1.9	1.1	0.6	11.5	1.4	0.3	0.1	0.5	0.2	12.0	2.5	15.4	6.0	0.4	0.0	0.4	0.1	0.6	2.4	4.5	2.4	3.6	4.6	5.6	0.1	4.1	1.7	2.5	2.3	1.8	2.9	2.2	0.2	1.3	0.3	2.6	1.6	0.2	8.3	0.6	2.5	0.0	0.8	17.8	1.0	4.1	0.3	3.6	3.3	3.5	0.1	3.6	7.1	3.2	2.1	10.0	4.2	0.3	2.5	6.7	10.7	4.5	0.5	1.3	4.7	2.7	2.2	3.9	3.4	3.9	5.2	0.6	2.7	0.5	0.3	0.1	0.2	0.2	0.5	0.4	0.4	0.3	0.9	0.6	0.2	0.3	1.4	0.1	0.2	11.5	0.3	0.2	7.3	17.6	15.8	9.9	4.2	6.8	4.4	7.5	6.3	1.4
FCGR1A	"CD64, CD64A"	ENSG00000150337	"Fc fragment of IgG receptor Ia"	P12314	1	149782671-149792518	"CD markers, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.6;epididymis: 33.2"	"Cell line enriched"	"Detected in some"	5	"THP-1: 59.6"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"					"Group enriched"	"Detected in some"	7	"classical monocyte: 35.6;intermediate monocyte: 14.0;myeloid DC: 9.5;neutrophil: 25.5"	"Group enriched"	"Detected in many"	80	"dendritic cells: 9.5;granulocytes: 25.5;monocytes: 35.6"																				"unprognostic (5.27e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.18e-2)"	"prognostic unfavourable (4.83e-8)"	"unprognostic (1.28e-1)"	"unprognostic (4.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (9.03e-2)"	3.9	2.4	6.7	14.1	4.4	5.0	0.7	0.3	3.5	1.1	0.3			0.0	0.1	33.2	0.3	0.7	2.4	0.7	5.3	4.9	1.0	1.1	8.9	3.4	10.1		0.3	1.0	0.5	1.2	10.8		0.4	0.3		0.7	0.2	0.0	0.0	0.1	5.5	14.3	7.0	0.3	0.9			0.3		0.0	3.3	0.0	0.2	9.5	25.5	35.6	0.0	0.2	11.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	12.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	59.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.5	35.6	0.4	0.0	14.0	0.2	0.2	0.0	0.1	9.5	0.0	0.0	0.0	25.5	0.0	2.8	0.2	0.1	11.2										
FCGR1B	CD64b	ENSG00000198019	"Fc fragment of IgG receptor Ib"	Q92637	1	121087345-121096310	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.8;epididymis: 36.9"	"Group enriched"	"Detected in some"	6	"NB-4: 10.4;THP-1: 40.0"	"Cancer enhanced"	"Detected in single"		"glioma: 1.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 19.2;neutrophil: 21.8"	"Low lineage specificity"	"Detected in many"																"Intracellular and membrane"						"unprognostic (3.21e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.24e-10)"	"unprognostic (8.99e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.86e-3)"	"unprognostic (8.93e-2)"	4.2	2.3	6.6	13.2	6.2	3.9	1.3	0.8	3.2	0.8	0.5	3.0	0.2	0.5	0.9	36.9	0.5	0.8	1.5	7.4	5.0	4.2	1.0	1.1	4.8	7.9	8.9	0.2	1.1	1.9	0.4	1.5	8.1	6.4	0.6	0.6	0.4	1.3	0.5	0.2	0.0	0.4	4.2	11.3	6.8	0.5	0.5	6.2	0.4	1.8	0.2	0.4	1.5	0.2	0.0	5.2	21.8	19.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.0	4.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	10.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	40.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	19.2	0.2	0.0	11.3	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	21.8	0.0	6.2	0.1	0.0	5.3	6.6	6.2	0.8	3.0	5.0	4.2	8.9	0.2	6.4	6.2
FHAD1	KIAA1937	ENSG00000142621	"Forkhead associated phosphopeptide binding domain 1"	B1AJZ9	1	15247272-15400283	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.8;epididymis: 16.0;fallopian tube: 17.9;testis: 28.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.5;HMC-1: 38.9;K-562: 8.3;U-87 MG: 20.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	4	"pons and medulla: 13.8"	"Cell type enhanced"	"Detected in many"		"gdTCR: 3.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054284	Enhanced									"HPA054284: AB_2682436"	"unprognostic (3.18e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.36e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-3)"	0.4	0.4	1.4	0.8	2.0	0.0	1.1	0.2	0.9	2.6	0.4	6.7	0.8	1.0	1.0	16.0	0.2	17.9	0.6	0.2	3.0	2.6	0.6	0.3	7.6	0.2	0.5	0.2	8.2	0.9	1.8	1.1	0.5	13.8	1.0	0.3	0.5	0.6	1.3	0.1	0.3	1.1	0.3	0.6	0.2	2.5	28.5	2.8	0.0	1.4	0.1	0.3	0.9	0.3	0.8	0.4	0.0	1.6	1.2	3.6	0.8	0.9	0.2	0.8	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.5	2.6	0.3	0.1	0.2	0.1	0.0	0.1	13.5	0.1	0.0	0.0	0.0	0.2	1.1	38.9	0.4	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.2	0.0	3.4	0.1	4.0	0.0	0.0	4.4	0.0	20.9	0.0	0.1	0.0	1.6	0.0	3.6	0.6	0.1	0.8	0.4	1.2	0.4	0.0	0.0	1.5	0.0	1.2	1.2	0.0	0.0	0.8	1.4	2.0	0.2	0.9	3.0	2.6	0.5	0.2	13.8	2.8
FOXJ1	"FKHL13, HFH-4, HFH4"	ENSG00000129654	"Forkhead box J1"	Q92949	17	76136333-76141299	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.9;epididymis: 20.4;fallopian tube: 45.9"	"Group enriched"	"Detected in some"	9	"BEWO: 22.4;CAPAN-2: 18.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 73.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.6"	"Lineage enriched"	"Detected in single"	9	"T-cells: 2.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 55.6"	HPA005714	Enhanced									"HPA005714: AB_1078902"	"prognostic favourable (9.39e-4)"	"unprognostic (4.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.71e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (2.03e-5)"	"unprognostic (7.49e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-1)"	0.4	0.4	4.1	0.5	8.9	0.6	0.4	0.1	2.2	5.1	0.9	19.9	0.4	0.6	2.4	20.4	0.4	45.9	0.4	0.4	6.5	6.6	1.5	0.4	17.0	0.4	2.0	1.2	14.7	1.2	0.4	1.2	0.4	19.6	0.6	0.6	0.1	0.4	2.8	0.4	0.8	0.6	0.5	1.8	0.4	0.9	15.2	3.4	0.0	2.9	0.0	0.4	1.1	0.2	0.0	0.0	0.0	0.0	0.2	2.6	0.1	0.0	0.4	1.3	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	2.3	18.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.4	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.6	2.6	0.0	0.2	0.0	0.0	0.0	0.1	4.1	8.9	0.1	2.2	6.5	6.6	2.0	1.2	19.6	3.4
FREM1	"C9orf143, C9orf145, C9orf154, DKFZp686M16108, FLJ25461, TILRR"	ENSG00000164946	"FRAS1 related extracellular matrix 1"	Q5H8C1	9	14734666-14910995	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 33.3;epididymis: 30.8"	"Cell line enriched"	"Detected in some"	8	"HEL: 62.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 22.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA054897, HPA073351"	Enhanced				"Secreted to extracellular matrix"					"HPA054897: , HPA073351: "	"unprognostic (1.13e-5)"	"unprognostic (2.59e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.27e-3)"	"unprognostic (2.50e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.95e-13)"	"unprognostic (2.28e-3)"	"unprognostic (8.53e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.86e-1)"	4.4	2.5	1.5	3.2	1.4	0.2	4.0	22.2	2.5	10.9	7.5	5.0	22.9	1.8	33.3	30.8	0.9	4.5	3.1	7.3	1.8	2.0	10.4	0.8	2.6	0.1	1.1	1.0	2.3	14.2	6.0	1.2	4.6	4.0	3.1	1.5	5.0	1.0	11.4	0.7	2.6	9.3	12.8	2.7	0.4	1.3	3.5	0.6	1.7	0.8	3.4	1.1	2.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	22.2	2.5	1.8	2.0	1.1	1.0	4.0	0.6
GALNT12	GalNAc-T12	ENSG00000119514	"Polypeptide N-acetylgalactosaminyltransferase 12"	Q8IXK2	9	98807699-98850081	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 34.7"	"Cell line enriched"	"Detected in many"	4	"U-2197: 58.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 17.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048292	Enhanced				"Intracellular and membrane"	15000	15000			"HPA048292: AB_2680343"	"unprognostic (7.85e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.97e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.71e-2)"	"prognostic favourable (3.24e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-3)"	"unprognostic (6.87e-2)"	7.5	1.7	1.0	9.5	2.3	0.6	3.7	17.7	1.6	4.0	29.6	1.7	7.4	14.6	1.8	34.7	15.2	3.2	20.5	1.1	1.4	1.6	2.9	0.4	13.8	1.1	3.3	1.0	1.0	9.2	4.0	3.1	1.0	2.7	4.2	24.8	4.0	15.2	6.6	1.1	2.6	22.4	15.4	1.3	1.5	23.5	3.4	1.1	2.8	9.3	8.1	23.9	9.0	3.4	0.8	0.4	1.6	0.0	2.2	2.5	0.4	1.8	1.4	1.2	4.8	3.7	2.9	0.0	0.5	0.7	0.7	1.7	0.3	7.7	0.0	1.8	0.3	13.5	1.0	0.4	0.6	9.1	0.6	0.8	0.1	0.0	0.1	0.5	0.2	1.4	0.3	2.3	0.0	0.8	10.3	0.0	0.2	4.8	0.9	1.6	6.0	2.0	2.2	0.1	0.0	0.8	2.7	4.5	0.4	0.2	11.0	1.0	1.6	1.6	1.5	0.0	0.1	58.4	0.0	0.7	1.6	0.8	13.6	0.0	0.3	0.0	0.0	1.6	1.4	0.0	2.5	0.1	1.9	0.8	0.2	0.8	2.3	1.5	0.1	2.2	0.0	0.4	0.1	0.4	1.0	2.3	17.7	1.6	1.4	1.6	3.3	1.0	2.7	1.1
GAS2L2	GAR17	ENSG00000270765	"Growth arrest specific 2 like 2"	Q8NHY3	17	35744511-35752878	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 8.4;fallopian tube: 20.1"	"Cell line enriched"	"Detected in some"	5	"HaCaT: 5.9"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA044370	Enhanced									"HPA044370: AB_2678915"	"unprognostic (3.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.54e-3)"	"prognostic favourable (7.00e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.07e-1)"		"unprognostic (6.67e-2)"		"unprognostic (4.42e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.01e-4)"	"unprognostic (3.96e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.92e-2)"	0.6	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.2	0.1	0.1	4.0	3.4	0.0	1.2	8.4	0.1	20.1	0.0	0.0	0.5		0.0	0.0	6.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	3.1	0.7	0.0	0.0	0.0	1.5	2.7	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.9	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.0	0.0	0.4	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0										
GDPD2	"FLJ20207, GDE3, OBDPF"	ENSG00000130055	"Glycerophosphodiester phosphodiesterase domain containing 2"	Q9HCC8	X	70423031-70433390	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 22.5;intestine: 19.5;lymphoid tissue: 37.5;skin 1: 33.2"	"Group enriched"	"Detected in some"	7	"AF22: 9.2;NTERA-2: 19.7"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.53e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.00e-7)"	"unprognostic (3.15e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.91e-2)"	0.4	0.4	6.8	0.6	5.7	0.4	1.0	1.1	4.0	0.3	13.0	8.2	8.3	8.0	0.4	22.5	0.4	0.5	0.5	0.8	7.6	4.0	0.6	0.3	0.4	0.4	4.3	5.6	0.4	0.4	0.3	2.6	0.4	8.4	0.3	3.0	0.2	1.1	0.6	0.6	33.2	19.5	0.4	1.5	37.5	1.6	0.3	4.9	0.0	0.4	0.6	0.3	1.0	0.3	0.4	0.1	1.4	0.2	0.1	0.2	0.0	0.0	0.0	9.2	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.2	19.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.4	0.1	0.1	1.4	0.1	0.1	0.1	0.0	0.0	6.8	5.7	1.1	4.0	7.6	4.0	4.3	5.6	8.4	4.9
GJB4	CX30.3	ENSG00000189433	"Gap junction protein beta 4"	Q9NTQ9	1	34759741-34763724	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 11.1;skin 1: 26.2"	"Cell line enhanced"	"Detected in some"		"A-431: 6.6;HaCaT: 9.8;HBEC3-KT: 6.4;hTCEpi: 4.2;RPTEC TERT1: 3.8;RT4: 4.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055112, HPA073904"	Enhanced		Supported	"Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA055112: AB_2682699, HPA073904: "	"unprognostic (3.30e-2)"	"prognostic favourable (5.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.65e-1)"	"prognostic unfavourable (3.24e-5)"	"unprognostic (3.73e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.52e-4)"	"unprognostic (5.42e-2)"	0.1	0.1	0.1	1.2	0.1	0.0	1.5	0.1	0.1	1.7	0.3	0.0	2.9	0.0	0.1	11.1	2.9	0.1	8.3	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	3.4	0.0	2.0	0.2	0.0	0.8	2.0	0.1	26.2	0.3	1.2	0.1	0.1	0.2	0.7	0.0	0.1	0.1	1.6	2.4	3.2	6.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	6.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	1.0	0.0	9.8	0.0	6.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
GNRH2		ENSG00000125787	"Gonadotropin releasing hormone 2"	O43555	20	3043622-3045747	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 10.2"	"Cell line enhanced"	"Detected in many"		"U-266/84: 7.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA004338	Uncertain				"Secreted to blood"					"HPA004338: AB_1079012"	"unprognostic (1.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.04e-3)"	"unprognostic (7.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.47e-4)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	0.8	0.9	0.6	1.2	0.9	0.4	0.5	5.1	1.7	1.6	0.5	0.5	0.5	0.3	1.3	10.2	0.5	2.4	2.0	1.1	0.7	1.2	1.7	3.3	0.5	0.6	1.5	0.5	5.6	0.5	0.5	1.8	0.5	1.2	4.2	0.1	1.0	1.6	2.0	0.5	0.1	0.5	0.5	0.5	0.5	2.2	3.9	0.5	0.5	2.8	0.5	0.5	0.5	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	3.2	3.9	1.9	0.5	0.6	0.8	0.0	0.5	0.8	1.9	0.8	1.5	0.1	0.2	3.2	1.2	1.0	0.9	1.2	3.6	1.3	1.1	2.5	0.0	0.2	2.1	2.5	2.5	2.4	0.0	0.8	1.4	0.5	1.3	1.0	0.7	2.5	1.4	0.0	0.9	0.4	0.8	0.5	2.7	4.5	2.1	0.2	2.7	1.5	2.9	1.4	0.0	1.9	0.8	1.6	1.8	1.1	7.4	1.0	1.7	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	5.1	1.7	0.7	1.2	1.5	0.5	1.2	0.5
GPR137C	"DKFZp762F0713, TM7SF1L2"	ENSG00000180998	"G protein-coupled receptor 137C"	Q8N3F9	14	52553148-52637713	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 31.1;epididymis: 16.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 2.4;NK-cells: 3.9;T-cells: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003640, HPA030763"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA003640: AB_2667025, HPA030763: AB_10602352"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.84e-2)"	"unprognostic (8.50e-3)"	"unprognostic (7.34e-3)"	"unprognostic (5.95e-3)"	"unprognostic (2.32e-2)"	"unprognostic (4.41e-2)"	"unprognostic (8.42e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.88e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.60e-1)"	1.4	2.2	7.1	1.0	11.0	3.3	1.9	31.1	20.2	1.4	1.2	7.5	0.2	2.0	2.5	16.6	1.7	1.2	2.8	2.4	5.9	10.6	1.2	1.3	1.7	2.1	6.3	7.5	1.6	0.7	2.3	1.8	1.8	13.3	1.6	1.5	3.2	1.7	1.5	1.3	1.8	1.2	1.5	7.0	2.5	1.4	6.5	8.3	0.0	2.1	0.0	1.2	2.1	0.7	0.7	0.5	2.4	0.5	3.9	4.1	0.8	0.8	0.3	8.1	7.4	2.3	0.7	3.2	3.4	2.3	3.5	8.6	1.5	1.6	0.8	2.5	2.8	1.9	2.7	0.5	5.3	1.2	1.8	0.9	2.3	0.9	0.3	0.5	1.9	0.4	0.0	3.3	0.2	1.8	1.2	3.5	5.1	3.9	0.3	1.1	2.0	4.7	1.8	5.1	0.3	1.0	5.7	8.3	10.4	1.7	0.5	0.2	5.1	0.0	0.3	8.1	8.7	5.9	2.8	0.8	2.0	1.8	2.0	0.4	2.4	1.2	0.5	0.5	3.1	0.1	4.1	0.3	2.0	3.9	0.2	0.7	1.5	1.8	2.4	3.9	0.4	0.5	1.4	0.8	7.1	11.0	31.1	14.1	5.9	10.6	6.3	7.5	13.3	8.3
GPR31	"12-HETER, HETER1"	ENSG00000120436	"G protein-coupled receptor 31"	O00270	6	167156271-167158329	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.7;epididymis: 2.5;lymphoid tissue: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	28	"myeloid DC: 2.7"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 2.7"	"Not detected"	"Not detected"							"HPA014014, HPA027108"	Uncertain									"HPA014014: AB_1849292, HPA027108: AB_10601474"	"unprognostic (9.92e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-3)"		"unprognostic (2.20e-3)"	"unprognostic (5.95e-3)"	"unprognostic (4.03e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.10e-4)"	"unprognostic (2.45e-1)"	"unprognostic (6.01e-2)"	0.0	0.0	0.1	0.9	0.1	0.2	0.1	0.0	0.1	0.1	0.1			0.5	0.0	2.5	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.1	4.5	0.2		0.0	0.0	0.0	0.1	0.0		0.0	0.1		0.1	0.0	0.0	0.0	0.9	0.0	0.2	2.1	0.3	1.1			0.1		1.4	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GRAMD2A	GRAMD2	ENSG00000175318	"GRAM domain containing 2A"	Q8IUY3	15	72159807-72197785	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 24.6;placenta: 49.2"	"Group enriched"	"Detected in some"	12	"BEWO: 58.1;SK-BR-3: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"myeloid DC: 2.3"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 2.3"	"Low region specificity"	"Detected in many"							HPA029435	Uncertain		Approved	"Nucleoli,Nuclear speckles,Cytosol"				"Nucleoli, Nuclear speckles"	"Nucleoli, Nuclear speckles"	"HPA029435: AB_10601811"	"unprognostic (5.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.95e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (7.01e-4)"	"unprognostic (7.29e-2)"	0.1	0.0	2.0	0.2	4.5	0.0	6.8	1.1	1.0	3.1	0.7	1.2	9.8	0.6	0.4	24.6	1.0	8.2	0.8	0.1	2.9	6.5	1.9	0.1	9.7	0.2	1.1	0.1	1.1	1.0	0.2	0.9	49.2	3.9	1.2	0.5	1.0	1.8	4.0	0.3	1.5	3.6	0.1	1.0	0.1	0.4	0.7	0.9	0.2	7.7	1.3	1.1	0.3	0.6	0.0	2.3	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	26.5	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.5	1.1	1.0	2.9	6.5	1.1	0.1	3.9	0.9
HOXB3	"HOX2, HOX2G"	ENSG00000120093	"Homeobox B3"	P14651	17	48548870-48604912	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 56.7;epididymis: 44.9;seminal vesicle: 68.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.2;EFO-21: 17.7;HEK 293: 21.4;RPTEC TERT1: 16.6;U-251 MG: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	40	"pons and medulla: 9.3"	"Region enriched"	"Detected in single"	29	"pons and medulla: 12.9"	"CAB009860, HPA064990"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB009860: AB_2119262, HPA064990: AB_2685398"	"unprognostic (5.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.14e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.60e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.32e-1)"	"prognostic favourable (8.45e-6)"	8.3	4.5	1.0	7.3	1.1	0.2	8.0	1.0	1.0	11.3	16.4	1.0	56.7	2.3	10.1	44.9	5.5	17.7	3.6	1.7	1.0	0.0	16.3	1.6	4.8	1.6	1.0	1.0	2.8	1.7	6.7	1.0	3.8	2.6	4.1	4.9	1.0	1.0	68.4	4.0	2.9	11.3	3.5	4.8	6.5	7.8	3.7	1.0	1.0	1.8	1.0	1.1	6.4	5.2	0.1	2.8	1.7	0.9	1.4	1.1	0.4	3.2	6.8	4.6	2.1	3.8	5.4	1.2	0.1	0.0	0.1	0.1	3.2	20.2	1.6	17.7	14.5	0.1	0.9	0.3	0.0	5.2	21.4	5.0	3.0	0.0	6.3	0.0	13.3	6.2	0.0	6.0	0.4	6.3	6.8	0.1	3.7	0.1	0.3	0.1	0.1	0.7	0.0	3.3	0.6	16.6	3.0	0.0	0.0	0.7	0.0	3.3	6.5	1.4	7.0	2.2	7.0	1.2	19.1	1.7	2.0	0.1	4.5	0.0	3.7	1.7	0.1	0.0	0.9	0.1	0.4	0.0	0.5	1.1	0.3	0.1	0.8	1.0	0.0	1.4	0.9	2.8	1.1	0.4	1.0	1.1	1.0	1.0	1.0	0.0	1.0	1.0	2.6	1.0
HOXB4	"HOX2, HOX2F"	ENSG00000182742	"Homeobox B4"	P17483	17	48575513-48580111	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 13.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 23.0;HEK 293: 11.1;HMC-1: 14.1;K-562: 11.2"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.4"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	36	"pons and medulla: 3.7"	"Region enriched"	"Detected in single"	61	"pons and medulla: 7.5"	HPA057432	Uncertain		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"	"Nucleoplasm, Centrosome"	"HPA057432: AB_2683437"	"unprognostic (2.71e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.97e-3)"	"unprognostic (5.39e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.41e-3)"	4.4	2.4	0.0	1.5	0.0	0.0	2.9	0.0	0.0	4.2	8.1			1.2	2.3	13.3	2.7	8.5	1.5	0.4	0.0	0.0	5.7	0.7	3.6	0.6	0.0		0.0	0.7	1.8	0.0	1.0		0.6	1.1		0.0	4.8	0.8	0.9	4.3	2.0	2.4	3.0	3.9	0.5			0.6		0.2	1.3	1.7	0.3	2.4	0.0	0.1	0.6	0.7	0.1	0.1	0.3	0.0	0.1	4.8	3.8	1.8	0.0	0.0	0.2	0.1	2.1	1.9	3.1	23.0	1.4	0.1	4.0	0.0	0.0	7.9	11.1	7.5	0.6	0.0	4.9	0.0	14.1	3.7	0.0	5.6	0.0	6.4	11.2	0.2	5.5	0.0	1.8	0.0	0.0	0.0	0.0	4.3	1.5	4.5	1.9	0.0	0.0	0.6	0.0	2.8	0.4	1.4	2.5	0.3	0.2	0.8	0.2	1.9	3.9	0.7	1.5	0.0	2.1	0.0	0.1	0.0	0.7	0.0	0.1	0.3	0.2	0.5	0.0	0.1	0.2	0.1	0.0	0.6	0.0	2.4	0.0	0.1										
HOXB7	"HOX2, HOX2C"	ENSG00000260027	"Homeobox B7"	P09629	17	48607227-48633572	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 62.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 30.8;RPTEC TERT1: 24.5;SK-MEL-30: 29.2;WM-115: 21.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"pons and medulla: 4.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	45	"pons and medulla: 6.0"	"Region enriched"	"Detected in single"	13	"pons and medulla: 1.5"	HPA049940	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA049940: AB_2616461"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.05e-3)"	"unprognostic (9.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (7.01e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	"prognostic favourable (2.39e-4)"	8.3	8.3	0.0	7.3	0.3	0.1	17.2	0.1	0.6	10.0	8.1	0.1	24.1	0.5	4.1	62.3	0.8	4.2	0.3	1.1	0.0	0.0	23.7	0.8	1.7	2.4	0.1	0.3	2.3	0.6	0.4	0.5	4.1	4.1	5.2	7.0	0.1	0.1	22.1	2.4	2.2	12.4	3.5	20.1	2.2	4.6	3.0	0.2	0.1	0.5	0.1	0.6	5.8	15.1	2.2	1.8	0.0	0.0	2.0	4.7	0.5	17.1	7.5	0.0	0.2	5.4	8.1	0.0	0.0	0.0	0.1	0.3	11.4	0.3	0.3	30.8	7.2	2.5	0.0	0.0	0.0	7.9	5.5	2.6	5.9	0.0	4.5	0.0	5.5	5.3	2.3	5.3	0.0	16.2	2.8	0.1	17.0	4.4	0.3	0.1	0.0	0.0	0.0	14.6	2.0	24.5	5.7	0.0	0.0	5.8	0.0	29.2	1.4	1.7	13.9	0.0	9.4	7.6	13.2	0.9	2.2	0.0	0.1	0.0	21.5	0.0	0.0	0.0	3.8	0.0	1.9	1.9	0.7	2.1	0.0	2.2	0.0	1.4	0.0	2.0	0.0	1.8	4.7	0.5	0.0	0.3	0.1	0.6	0.0	0.0	0.1	0.3	4.1	0.2
HOXC8	"HOX3, HOX3A"	ENSG00000037965	"Homeobox C8"	P31273	12	54009106-54012362	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 16.7;ovary: 25.2;skeletal muscle: 12.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 23.7;ASC TERT1: 15.5;fHDF/TERT166: 27.6;HSkMC: 18.9;LHCN-M2: 20.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028911, CAB037020"	Uncertain		Supported	Nucleoplasm,Microtubules				Nucleoplasm	Nucleoplasm	"CAB037020: AB_1840935, HPA028911: AB_10602236"	"unprognostic (1.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.26e-6)"	"unprognostic (4.89e-2)"	"unprognostic (5.20e-4)"	"unprognostic (5.34e-3)"		"unprognostic (2.43e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (1.47e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.14e-2)"	5.2	5.4	0.4	0.7	0.2	0.0	7.1	0.2	0.3	0.5	0.5	0.2	0.2	0.0	0.3	16.7	0.4	6.3	0.6	0.6	0.2	0.0	7.0	0.2	0.2	2.2	0.2	0.5	25.2	0.2	0.0	0.2	1.9	0.4	0.3	0.0	0.2	0.2	0.2	12.8	2.6	4.8	7.9	2.5	0.2	0.0	2.6	0.2	0.3	0.7	0.2	0.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	8.3	23.7	15.5	0.1	1.5	0.0	2.8	1.8	2.5	1.2	0.0	0.2	27.6	1.0	2.2	0.7	3.2	2.8	3.0	0.4	1.0	0.0	2.9	0.0	3.2	18.9	2.1	8.9	5.2	0.2	0.3	0.0	20.6	0.7	0.0	0.2	0.0	0.4	0.0	0.0	0.0	3.1	0.0	0.0	1.1	2.8	0.5	7.2	0.8	0.0	0.0	0.5	4.4	3.8	0.9	0.0	0.0	0.0	0.5	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.0	0.2	0.5	0.4	0.2
HOXD1	"HOX4, HOX4G"	ENSG00000128645	"Homeobox D1"	Q9GZZ0	2	176188579-176190907	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9;epididymis: 14.1;seminal vesicle: 20.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.7;Hep G2: 5.9;RPTEC TERT1: 18.3;RT4: 14.1;SCLC-21H: 4.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.2"	"Low region specificity"	"Detected in many"			"HPA040062, HPA056900"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA040062: AB_2676826, HPA056900: AB_2683270"	"unprognostic (8.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.64e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.54e-5)"	"unprognostic (4.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	2.4	0.6	1.5	1.1	3.5	0.3	2.0	0.6	3.9	0.5	5.2	18.8	11.8	0.7	0.8	14.1	0.9	8.8	1.4	0.3	4.1	2.2	6.8	0.2	5.7	0.9	9.8	1.3	1.2	0.5	0.2	0.2	0.3	15.5	1.7	3.7	0.3	1.0	20.4	0.3	1.2	4.4	0.9	18.9	1.5	0.7	2.2	6.3	0.0	0.4	0.0	0.5	4.6	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	5.7	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	18.3	14.1	4.9	0.8	0.0	0.0	0.9	0.0	0.0	3.3	0.0	0.2	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.5	0.6	3.2	4.1	2.2	9.8	1.3	15.5	6.3
HOXD3	"HOX1D, HOX4, HOX4A"	ENSG00000128652	"Homeobox D3"	P31249	2	176136612-176173102	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 25.9;epididymis: 36.4;seminal vesicle: 22.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 7.9;HSkMC: 9.3;RPTEC TERT1: 9.7;SCLC-21H: 13.8;SH-SY5Y: 9.3"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	36	"pons and medulla: 3.8"	"Region enriched"	"Detected in single"	30	"pons and medulla: 6.7"	"HPA051831, HPA063671"			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA051831: , HPA063671: AB_2685083"	"unprognostic (1.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.52e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.56e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.57e-4)"	"unprognostic (1.47e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.44e-2)"	6.2	1.1	0.4	3.2	0.4	0.2	19.6	0.2	0.2	8.7	3.6	0.0	22.5	0.3	25.9	36.4	1.1	4.8	2.0	0.4	0.8	0.5	8.5	0.2	0.3	0.8	1.5	0.0	7.0	0.3	0.2	0.2	0.2	0.5	2.1	0.4	0.0	0.6	22.6	0.7	0.7	0.4	4.0	7.2	1.9	0.3	3.6	0.0	0.0	0.4	0.2	0.3	1.7	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.9	0.0	0.1	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	9.3	0.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	9.7	0.5	13.8	9.3	0.1	0.1	3.9	0.0	0.0	0.6	0.0	0.2	0.7	0.4	0.0	0.1	0.0	0.3	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.8	0.5	1.5	0.0	0.5	0.0
HOXD4	"HOX4, HOX4B"	ENSG00000170166	"Homeobox D4"	P09016	2	176151222-176153226	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 21.0;seminal vesicle: 26.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 9.1;HEK 293: 21.6;RPTEC TERT1: 16.0;SK-MEL-30: 6.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.3"	"Region enriched"	"Detected in some"	7	"pons and medulla: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enriched"	"Detected in single"	31	"pons and medulla: 8.2"	"HPA054383, HPA070349"	Approved		Supported	"Nucleoplasm,Cell Junctions"				Nucleoplasm	Nucleoplasm	"HPA054383: AB_2682470, HPA070349: AB_2686258"	"unprognostic (9.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.10e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.19e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.61e-1)"	3.4	4.9	0.5	0.5	0.5	0.0	4.0	0.5	0.7	2.8	3.4	0.5	13.8	0.2	15.6	21.0	0.5	7.9	0.5	0.5	0.5	0.0	10.2	0.5	0.5	0.6	1.1	0.5	9.7	0.5	0.0	0.5	0.5	7.6	1.5	0.8	0.5	0.5	26.2	1.3	1.0	3.5	5.3	3.7	4.4	0.4	1.5	0.5	0.5	0.8	0.5	0.5	2.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.1	1.7	0.0	0.1	0.4	0.0	0.6	0.5	0.0	0.0	9.1	1.6	0.1	1.5	0.0	0.2	0.0	21.6	0.2	0.0	0.0	0.3	0.0	0.0	4.9	1.4	0.0	0.2	3.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	16.0	2.5	1.3	2.1	0.3	0.0	6.0	0.0	0.0	2.7	0.2	0.1	1.4	1.1	0.0	0.0	0.0	1.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.7	0.5	0.0	1.1	0.5	7.6	0.5
HOXD8	"HOX4, HOX4E"	ENSG00000175879	"Homeobox D8"	P13378	2	176129694-176132695	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 37.6;epididymis: 42.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 21.2;RPTEC TERT1: 34.6;TIME: 15.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"pons and medulla: 0.6"	"Not detected"	"Not detected"														"unprognostic (1.22e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.56e-3)"	"prognostic unfavourable (3.78e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.05e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.80e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.80e-2)"	11.1	9.1	0.3	2.4	0.3	0.0	9.8	0.2	0.4	10.3	5.9	0.4	37.6	0.3	12.6	42.6	2.0	7.7	2.5	2.6	0.3	0.0	32.8	0.2	0.7	1.9	0.2	0.2	16.9	1.7	0.2	0.2	1.4	1.2	5.6	1.8	0.3	0.8	27.5	6.9	2.4	4.2	5.3	11.5	9.1	0.8	21.0	0.2	0.3	2.9	2.3	0.9	5.3	10.8	0.2	0.0	0.0	0.0	0.0	0.2	0.0	6.3	1.0	0.0	0.0	4.3	6.7	0.1	0.8	3.3	1.0	0.1	0.0	0.0	0.0	8.1	4.8	0.0	2.1	0.2	2.5	0.0	3.1	1.0	0.3	0.0	1.4	0.6	0.4	11.7	21.2	0.1	3.2	10.5	0.1	0.0	1.6	0.0	0.0	0.1	0.1	1.2	0.0	2.2	0.0	34.6	4.3	6.8	12.7	1.9	0.0	12.6	0.0	0.0	15.1	0.5	4.4	7.2	4.3	0.0	0.0	0.0	10.1	0.0	12.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.3	0.0	0.2	0.2	1.2	0.2
IFNA14	"IFN-alphaH, LEIF2H"	ENSG00000228083	"Interferon alpha 14"	P01570	9	21239002-21239991	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.1;kidney: 1.2"	"Cell line enriched"	"Detected in single"	10	"HMC-1: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA5	IFN-alphaG	ENSG00000147873	"Interferon alpha 5"	P01569	9	21304326-21305312	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 2.3"	"Cell line enhanced"	"Detected in single"		"BJ: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: AB_2680087"																		0.3	0.3	0.0	0.0	0.2	0.2	0.2	1.0	0.2	0.2	0.5			0.6	0.4	2.3	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.4	0.3	0.0		0.0	0.1	0.0	0.3	0.2		0.2	0.1		0.0	0.0	0.2	0.3	0.3	0.0	0.0	0.3	0.1	0.0			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IFNE	IFNE1	ENSG00000184995	"Interferon epsilon"	Q86WN2	9	21480839-21482313	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 3.9;urinary bladder: 4.1"	"Cell line enhanced"	"Detected in some"		"BJ: 4.7;HeLa: 12.3"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	10	"intermediate monocyte: 1.0"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"						"unprognostic (1.52e-3)"	"unprognostic (8.36e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.56e-5)"	"unprognostic (2.70e-1)"	"unprognostic (2.25e-1)"		"unprognostic (5.14e-3)"	"unprognostic (6.32e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-2)"	"unprognostic (6.58e-3)"	"unprognostic (3.34e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.6	2.6	0.2	1.3	0.0			1.4	0.3	3.9	3.3	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.2	0.0		1.4	0.0		0.1	0.8	0.0	0.0	2.4	0.0	0.0	0.1	1.5	0.0			0.6		0.7	4.1	1.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.6	2.8	0.0	0.0	1.4	1.4	0.2	4.7	0.3	0.2	0.3	0.1	3.1	0.0	1.0	0.9	1.7	0.0	3.0	0.5	0.0	0.0	0.0	12.3	0.0	0.8	0.0	0.0	1.3	0.6	1.9	2.7	0.9	0.0	0.0	1.9	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	3.5	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IQANK1		ENSG00000203499	"IQ motif and ankyrin repeat containing 1"		8	143734140-143790644	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 12.2;skin 1: 15.5;testis: 31.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.6;HaCaT: 13.0;hTCEpi: 15.9;MCF7: 30.9;RT4: 13.2;SK-BR-3: 13.4;T-47d: 28.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (1.45e-3)"	"unprognostic (3.38e-1)"	"unprognostic (7.46e-2)"	"unprognostic (4.94e-3)"	"unprognostic (4.31e-3)"	"unprognostic (1.98e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.22e-3)"	"unprognostic (3.29e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.40e-2)"	0.2	0.0	0.2	0.2	0.9	0.0	2.9	0.2	0.7	1.0	0.3	0.9	1.6	0.1	0.4	12.2	6.1	3.7	0.2	0.2	0.8		0.6	0.5	1.5	0.2	0.2	0.4	0.7	1.0	1.7	1.0	1.3	0.8	1.8	0.8	2.4	1.5	3.2	0.2	15.5	0.7	0.6	0.7	0.2	1.7	31.2	0.3	0.2	2.0	0.2	1.4	2.1	0.2	1.6	0.9	5.1	1.0	0.9	0.7	0.2	7.5	0.4	0.1	0.4	0.0	0.1	8.8	0.1	0.0	0.0	0.1	4.0	11.6	0.0	0.9	0.0	13.0	0.4	1.5	0.1	0.1	0.3	0.0	1.1	0.9	0.2	0.1	0.1	0.1	15.9	0.1	0.3	0.0	0.5	0.1	0.0	30.9	0.0	0.1	0.7	0.5	0.1	0.0	0.2	0.8	13.2	4.4	0.1	1.1	13.4	0.4	28.5	0.1	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.2	2.1	1.0	0.7	0.7	0.9	0.4	1.0	0.6	0.5	0.2	1.6	0.5	0.6	5.1	0.9	0.9	0.9	0.3	0.2										
ITGA2B	"CD41, CD41B, GP2B, PPP1R93"	ENSG00000005961	"Integrin subunit alpha 2b"	P08514	17	44372180-44389505	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.5;epididymis: 25.2;lymphoid tissue: 22.8"	"Group enriched"	"Detected in some"	13	"HEL: 69.4;HMC-1: 118.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"basophil: 28.5"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 28.5"	"Low region specificity"	"Detected in single"							"CAB018611, HPA031168, HPA031169, HPA031170, HPA031171"	Enhanced		Approved	"Plasma membrane"		1100000000	1100000000	"Plasma membrane"	"Plasma membrane"	"CAB018611: AB_2265153, HPA031168: AB_10664706, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773"	"unprognostic (6.11e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.23e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.83e-9)"	"unprognostic (7.82e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-1)"	0.7	0.2	1.4	0.4	1.0	15.2	0.6	3.8	2.4	1.2	0.9	0.4	0.4	0.1	1.1	25.2	0.7	1.9	1.4	10.6	0.9	1.6	1.0	0.4	6.5	0.5	0.7	0.8	2.1	2.5	0.1	2.5	1.9	1.1	0.6	0.3	0.6	0.4	1.6	0.8	0.1	0.6	0.4	0.8	22.8	0.2	3.0	0.4	0.4	5.2	1.0	0.6	0.7	1.9	0.0	0.5	28.5	0.2	0.0	0.2	11.1	0.0	0.1	0.7	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	69.4	0.0	0.6	0.0	0.0	118.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	7.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	28.5	0.2	2.1	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.5	0.0	11.1	1.4	1.0	3.8	2.4	0.9	1.6	0.7	0.8	1.1	0.4
ITM2B	"BRI, BRI2, BRICD2B, E25B, E3-16"	ENSG00000136156	"Integral membrane protein 2B"	Q9Y287	13	48233158-48270357	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 346.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 108.7;RPTEC TERT1: 154.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 236.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 236.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029292, HPA071992"	Approved		Enhanced	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	2600000	2600000	"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA029292: AB_10601917, HPA071992: AB_2686480"	"unprognostic (4.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.87e-2)"	"prognostic favourable (3.73e-5)"	"unprognostic (4.38e-2)"	"unprognostic (4.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.22e-1)"	89.3	79.6	60.6	41.3	61.6	25.0	79.6	87.2	65.8	72.6	58.3	64.9	93.4	83.4	61.2	346.2	71.5	53.2	59.4	86.9	75.9	61.4	198.7	65.1	80.2	75.9	71.7	49.8	100.7	48.5	27.0	63.1	132.0	50.2	66.5	36.0	80.8	75.1	99.8	30.9	73.5	81.0	53.1	90.0	78.5	64.5	44.7	48.3	35.0	73.1	63.0	47.7	63.3	74.5	13.3	23.3	236.4	46.6	17.2	31.7	73.7	8.6	7.5	12.7	23.8	48.5	29.4	18.9	22.9	29.0	11.5	14.6	5.3	41.5	2.3	19.5	16.7	35.3	6.8	16.5	9.7	6.7	16.1	16.4	6.1	14.6	20.9	16.1	108.7	17.6	14.8	6.7	7.5	14.8	4.2	19.9	14.0	5.8	25.9	35.6	34.8	10.2	11.7	12.6	11.7	154.6	40.9	4.3	17.1	20.3	16.7	11.8	10.9	17.1	23.8	9.6	9.6	12.5	11.1	7.8	7.2	0.3	14.0	9.4	21.4	136.9	46.6	141.3	21.3	35.7	28.1	12.0	29.8	26.5	23.3	13.3	31.7	26.5	236.4	17.2	35.5	10.3	28.7	73.7	60.6	61.6	87.2	58.0	75.9	61.4	71.7	49.8	50.2	48.3
KCNIP1	KCHIP1	ENSG00000182132	"Potassium voltage-gated channel interacting protein 1"	Q9NZI2	5	170353487-170736632	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.2;epididymis: 27.8"	"Cell line enriched"	"Detected in some"	23	"RPTEC TERT1: 35.9"	"Cancer enriched"	"Detected in some"	18	"glioma: 22.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022864, HPA066717"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA022864: AB_1858712, HPA066717: "	"unprognostic (7.75e-5)"	"unprognostic (2.66e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.22e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.46e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.05e-2)"	1.1	5.9	20.6	1.2	27.9	0.6	1.9	6.4	31.2	4.0	1.0	6.0	5.2	0.9	2.7	27.8	1.0	2.8	2.9	1.2	11.7	20.5	4.9	0.8	1.9	1.2	12.9	7.3	0.9	2.4	5.1	0.7	2.1	11.1	2.3	1.3	0.8	1.3	7.9	0.8	0.7	1.1	2.1	6.9	2.2	1.1	5.2	5.3	0.0	1.2	0.0	1.2	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	35.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	27.9	6.4	14.6	11.7	20.5	12.9	7.3	11.1	5.3
KCNMB2		ENSG00000197584	"Potassium calcium-activated channel subfamily M regulatory beta subunit 2"	Q9Y691	3	178272932-178844429	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 36.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.3;fHDF/TERT166: 2.5;SCLC-21H: 8.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB022649	Uncertain									"CAB022649: "	"unprognostic (9.52e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.58e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.89e-4)"	"unprognostic (7.85e-2)"	0.7	6.3	7.8	0.5	6.2	0.4	1.3	1.8	11.2	2.5	1.9	2.2	4.4	1.0	7.2	36.8	0.9	14.3	0.9	7.4	13.2	4.5	4.1	0.6	1.6	0.4	4.7	4.9	16.3	4.5	0.4	10.2	0.5	6.2	1.1	0.9	0.5	0.6	1.9	0.6	0.7	0.9	3.0	3.2	1.9	3.6	0.6	3.2	0.0	1.1	0.0	0.4	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	6.3	0.0	0.0	0.4	0.0	0.0	1.4	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	1.7	0.0	1.0	8.3	0.0	0.0	0.5	0.0	1.4	0.0	0.3	0.0	0.1	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	6.2	1.8	11.2	13.2	4.5	4.7	4.9	6.2	3.2
KIAA1211L	"C2orf55, MGC42367"	ENSG00000196872	"KIAA1211 like"	Q6NV74	2	98793846-98936259	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.4;epididymis: 27.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 21.9;HDLM-2: 31.3;Karpas-707: 9.2;SiHa: 8.9;SK-BR-3: 11.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"amygdala: 19.0;basal ganglia: 23.7;cerebral cortex: 27.4;hippocampal formation: 12.9;olfactory region: 18.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"							"Group enriched"	"Detected in many"	15	"amygdala: 29.7;basal ganglia: 59.8;cerebral cortex: 52.5;hippocampal formation: 81.9;olfactory region: 36.3"	"HPA051082, HPA061678"	Enhanced		Approved	"Microtubules,Cytokinetic bridge,Centrosome"				"Microtubules, Centrosome"	"Microtubules, Centrosome"	"HPA051082: AB_2681337, HPA061678: AB_2684584"	"unprognostic (3.56e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.67e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.61e-2)"	"prognostic favourable (1.13e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.34e-1)"	"prognostic favourable (1.33e-5)"	"unprognostic (2.22e-2)"	2.7	0.8	19.0	1.3	23.7	0.5	3.5	2.4	27.4	4.6	5.0	0.8	3.5	6.7	1.5	27.7	9.1	19.3	2.5	1.4	12.9	1.9	2.5	0.4	3.9	0.6	2.7	18.3	1.4	3.7	9.6	4.3	4.0	0.1	1.6	4.0	0.0	9.0	4.3	1.3	4.3	6.1	2.1	1.2	1.0	6.8	3.6	3.6	0.0	4.3	3.3	2.5	2.4	3.2	0.0	0.7	1.4	0.3	0.2	0.9	0.0	4.2	0.2	0.1	1.7	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.2	2.5	0.0	5.5	0.0	3.8	0.1	0.2	0.0	31.3	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.1	1.2	0.0	0.6	1.3	0.0	9.2	0.0	8.4	0.1	0.6	0.0	0.4	0.0	0.0	0.4	1.7	3.4	3.1	0.5	8.9	11.9	0.0	4.6	0.7	5.4	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.1	0.0	1.4	0.2	0.0	0.7	0.0	0.0	19.0	23.7	2.4	27.4	12.9	1.9	2.7	18.3	0.1	3.6
KLHL8	KIAA1378	ENSG00000145332	"Kelch like family member 8"	Q9P2G9	4	87160103-87240314	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 56.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013856, HPA017762"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA013856: AB_1852594, HPA017762: AB_2669660"	"unprognostic (2.93e-2)"	"unprognostic (4.91e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.46e-1)"	"prognostic favourable (1.53e-5)"	"unprognostic (4.24e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.57e-3)"	6.8	7.3	6.9	5.6	8.1	3.0	12.0	10.0	10.7	9.2	7.5	5.3	3.8	7.3	8.3	56.2	5.3	5.4	5.0	7.4	7.7	7.2	11.4	10.3	9.0	8.1	6.3	5.6	6.1	6.3	7.1	14.2	6.6	7.3	5.7	8.5	4.6	6.5	7.7	23.4	4.8	8.2	6.6	8.0	6.9	5.5	4.2	6.5	7.0	17.3	2.9	4.7	6.8	10.9	3.8	10.3	8.6	12.1	8.7	4.9	5.0	6.5	5.7	10.4	4.6	9.5	7.0	5.6	8.4	4.5	5.6	6.6	9.2	5.0	9.5	6.8	6.1	2.8	11.0	8.3	12.2	9.0	6.9	11.5	4.3	5.4	8.1	18.9	7.3	8.7	6.0	8.6	8.6	6.6	14.9	8.7	5.8	7.2	22.6	9.6	2.6	2.3	8.5	8.9	5.8	9.5	6.8	21.9	7.6	5.5	13.5	6.2	4.6	14.0	6.2	7.1	8.8	7.5	6.9	13.0	8.5	16.9	5.4	9.0	7.8	1.9	12.1	7.3	3.0	9.2	4.9	3.3	2.4	2.5	10.3	3.8	4.4	4.3	8.6	8.7	9.0	2.7	0.9	5.0	6.9	8.1	10.0	10.7	7.7	7.2	6.3	5.6	7.3	6.5
KRTAP5-10	KRTAP5.10	ENSG00000204572	"Keratin associated protein 5-10"	Q6L8G5	11	71565563-71566738	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 5.6;skin 1: 8.3"	"Cell line enriched"	"Detected in single"	10	"RT4: 8.7"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (4.05e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.39e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.81e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.53e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.39e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.27e-4)"	0.3	0.0	0.2	0.0	0.7	0.1	0.6	0.4	0.1	0.1	0.1			0.0	0.0	5.6	0.1	0.9	0.2	0.0	0.2	0.1	0.4	0.4	0.1	0.0	0.1		0.1	1.8	0.0	0.2	0.0		0.4	0.3		0.1	1.1	0.7	8.3	0.3	0.0	0.2	0.2	0.1	0.8			0.2		0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP5-9	"KRN1, KRTAP5-1, KRTAP5.9"	ENSG00000254997	"Keratin associated protein 5-9"	P26371	11	71548418-71549553	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 5.1;testis: 4.6;urinary bladder: 4.6"	"Cell line enriched"	"Detected in single"	20	"RT4: 14.1"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.0"					"Cell type enriched"	"Detected in single"	11	"myeloid DC: 1.0"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.0"																				"unprognostic (1.72e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.13e-1)"	"unprognostic (6.53e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.82e-4)"	"prognostic favourable (9.25e-4)"	0.4	0.4	1.1	0.1	2.8	0.5	0.5	1.3	1.3	0.1	0.9			0.3	0.1	5.1	0.5	0.8	0.9	0.1	1.0	2.0	0.4	0.8	0.3	0.3	0.8		0.2	0.0	1.5	1.1	0.2		0.9	0.7		0.8	1.4	0.4	1.4	0.7	0.1	1.0	0.7	0.4	4.6			0.4		0.4	4.6	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	14.1	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
LCN10		ENSG00000187922	"Lipocalin 10"	Q6JVE6	9	136738167-136743356	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 21.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.7;Hep G2: 1.3;REH: 2.0;RPMI-8226: 2.5"	"Cancer enriched"	"Detected in single"	8	"thyroid cancer: 1.2"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	21	"memory B-cell: 5.5;naive B-cell: 6.2"	"Lineage enriched"	"Detected in single"	22	"B-cells: 6.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA055919	Approved				"Secreted in male reproductive system"					"HPA055919: AB_2682969"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.85e-2)"	"unprognostic (6.54e-3)"	"unprognostic (2.22e-4)"	"unprognostic (4.54e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.96e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.86e-1)"	2.8	0.0	0.5	1.4	0.5	0.2	2.2	0.5	1.0	6.2	0.9	0.7	3.2	0.2	7.2	21.8	0.8	7.8	1.2	4.5	0.5	0.0	0.5	0.5	0.5	0.8	0.5	0.5	1.8	1.5	0.0	0.5	0.5	0.5	2.1	0.6	0.5	1.2	0.8	0.6	0.2	2.0	2.5	0.5	1.4	1.5	2.1	0.5	0.5	4.3	0.5	0.9	2.1	2.6	6.2	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.7	0.5	0.0	2.0	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	6.2	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.5	0.5	0.5	1.0	0.5	0.0	0.5	0.5	0.5	0.5
LONRF2	"FLJ45273, RNF192"	ENSG00000170500	"LON peptidase N-terminal domain and ring finger 2"	Q1L5Z9	2	100273291-100322733	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.9;epididymis: 32.6"	"Cell line enhanced"	"Detected in some"		"A549: 6.5;HAP1: 6.4;HEK 293: 6.9;HMC-1: 5.7;PC-3: 5.9;SCLC-21H: 14.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 15.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057366	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA057366: AB_2683420"	"unprognostic (9.81e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.20e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.72e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.86e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.32e-1)"	"prognostic favourable (6.42e-5)"	"unprognostic (1.14e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.66e-3)"	"unprognostic (6.34e-2)"	1.6	23.0	8.4	0.6	32.9	0.2	2.2	21.1	15.4	5.1	1.7	1.3	2.3	0.5	19.0	32.6	2.0	17.8	1.7	4.3	5.6	9.9	1.3	0.7	1.5	0.5	3.9	7.0	10.5	4.4	9.6	7.8	0.6	6.4	3.2	0.7	1.6	1.5	3.2	4.6	0.4	0.5	19.8	4.5	0.5	1.5	1.8	4.3	0.4	3.5	0.8	0.4	1.4	1.3	0.7	0.5	1.7	0.4	0.7	0.5	0.1	0.0	6.5	2.0	2.4	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	1.2	0.0	1.1	0.0	0.0	6.4	0.0	0.0	0.5	6.9	0.0	0.4	0.0	0.2	0.1	5.7	0.0	0.0	0.3	0.0	0.0	3.7	0.1	0.0	4.2	0.0	0.3	0.4	5.9	0.0	0.0	0.0	1.6	0.2	14.1	3.8	0.0	0.0	1.0	3.5	0.1	0.1	0.1	0.8	0.0	0.4	0.0	0.0	0.0	2.8	0.0	0.3	1.1	0.4	0.4	0.3	0.3	0.3	0.4	0.3	0.3	0.2	0.7	0.4	0.5	1.7	0.7	0.3	0.5	0.2	0.1	8.4	32.9	21.1	9.7	5.6	9.9	3.9	7.0	6.4	4.3
LOXHD1	"DFNB77, FLJ32670, LH2D1"	ENSG00000167210	"Lipoxygenase homology domains 1"	Q8IVV2	18	46476972-46657220	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ductus deferens: 15.5;epididymis: 9.7;testis: 22.0"	"Cell line enhanced"	"Detected in some"		"THP-1: 3.4;WM-115: 1.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in some"	5	"basal ganglia: 2.4;cerebral cortex: 1.9;thalamus: 1.1"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"olfactory region: 1.0"												"unprognostic (6.95e-2)"	"unprognostic (1.88e-2)"	"unprognostic (4.81e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.75e-4)"	"unprognostic (9.53e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.61e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.43e-3)"	"unprognostic (6.48e-5)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.66e-3)"	1.7	0.0	0.4	0.0	2.4	2.7	0.4	0.1	1.9	0.0	0.1	0.2	15.5	0.0	0.0	9.7	0.1	1.7	0.1	0.5	0.2	0.1	0.5	0.0	0.8	0.0	0.0	0.0	0.1	0.1	0.4	4.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.2	0.1	0.0	0.0	0.7	0.1	22.0	1.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.4	2.4	0.1	1.9	0.2	0.1	0.0	0.0	0.0	1.1
LRRC63	RP11-139H14.4	ENSG00000173988	"Leucine rich repeat containing 63"		13	46211943-46277366	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 16.3;epididymis: 7.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.6;MOLT-4: 2.1;THP-1: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.7"	"Low lineage specificity"	"Detected in single"											"HPA039318, HPA039763"	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA039318: AB_10796224, HPA039763: AB_10795408"	"unprognostic (3.40e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.33e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.18e-6)"	"unprognostic (1.27e-1)"	"unprognostic (2.98e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.31e-2)"	0.6	1.3	1.5	1.0	9.9	1.0	0.7	0.7	5.0	1.2	0.7	11.9	0.0	0.6	0.5	7.2	0.5	1.3	0.4	0.5	3.0	1.8	0.8	0.7	1.1	1.3	16.3	2.3	0.5	0.5	0.7	0.5	0.7	10.0	1.1	0.7	0.7	0.7	0.8	0.5	0.6	0.6	0.4	15.9	0.8	0.8	6.2	10.0	3.6	0.6	0.0	0.4	0.8	0.5	0.0	0.9	0.2	0.1	0.0	1.8	0.5	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.4	4.6	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.2	0.0	2.4	0.0	0.1	0.0	0.0	0.5	1.0	0.4	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.0	0.4	0.4	0.1	0.0	1.8	1.7	0.2	0.0	0.0	0.9	0.0	0.5	1.5	9.9	0.7	5.0	3.0	1.8	16.3	2.3	10.0	10.0
LRRC74B		ENSG00000187905	"Leucine rich repeat containing 74B"	Q6ZQY2	22	21045960-21064168	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 17.1;epididymis: 5.6;fallopian tube: 11.4"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 1.6;U-87 MG: 3.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"pons and medulla: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049947	Uncertain									"HPA049947: AB_2680966"	"unprognostic (3.43e-2)"	"unprognostic (1.76e-1)"		"unprognostic (3.28e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.44e-3)"		"unprognostic (2.23e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.57e-9)"	"unprognostic (4.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.10e-2)"	"unprognostic (4.92e-2)"	0.2	0.2	2.1	0.2	2.3	0.2	0.2	0.4	1.6	1.5	0.2	3.7	0.0	0.4	0.3	5.6	0.2	11.4	0.2	0.2	1.5	1.2	0.2	0.2	1.9	0.2	0.1	0.7	1.9	0.2	0.2	0.9	0.2	17.1	0.2	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.5	0.2	0.2	3.6	0.3	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.3	0.4	1.6	1.5	1.2	0.1	0.7	17.1	0.3
MAGEA11	"CT1.11, MAGE-11, MAGE11, MAGEA-11, MGC10511"	ENSG00000185247	"MAGE family member A11"	P43364	X	149688228-149717266	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 36.5;testis: 9.3"	"Cell line enriched"	"Detected in some"	4	"U-2 OS: 22.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052687			Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA052687: AB_2681915"	"unprognostic (4.06e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.09e-2)"		"unprognostic (9.64e-2)"		"unprognostic (1.32e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.16e-1)"				"unprognostic (6.67e-4)"	"unprognostic (1.14e-1)"		"unprognostic (1.33e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	36.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	22.9	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MAGEC3	"CT7.2, HCA2, MAGE-C3"	ENSG00000165509	"MAGE family member C3"	Q8TD91	X	141838316-141897832	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.9;epididymis: 3.0;testis: 3.1"	"Group enriched"	"Detected in some"	4	"U-2197: 1.9;U-266/70: 2.9;U-266/84: 6.3"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052067	Approved									"HPA052067: AB_2681717"	"unprognostic (3.45e-1)"				"unprognostic (2.39e-1)"			"unprognostic (4.01e-1)"		"unprognostic (2.95e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.35e-11)"		"unprognostic (3.21e-2)"	"unprognostic (4.29e-2)"		0.1	0.1	1.6	0.0	2.5	0.1	0.5	0.5	2.5	0.2	0.0			0.0	0.2	3.0	0.1	0.4	0.2	0.0	3.3	2.0	0.1	0.1	0.2	0.0	2.8		0.4	0.0	0.0	0.7	0.0		0.3	0.0		0.5	0.3	0.0	0.1	0.2	0.3	4.9	1.1	0.1	3.1			0.5		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.9	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	1.9	0.3	2.9	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MAP7D2	FLJ14503	ENSG00000184368	"MAP7 domain containing 2"	Q96T17	X	20006713-20116917	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.8;epididymis: 38.7"	"Cell line enhanced"	"Detected in some"		"A549: 8.6;CACO-2: 12.4;HEK 293: 17.0;HeLa: 14.7;Hep G2: 7.3;SCLC-21H: 19.6;SiHa: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"basophil: 5.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051508, HPA059537"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA051508: AB_2681513, HPA059537: AB_2684054"	"unprognostic (1.51e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.45e-5)"	"unprognostic (5.65e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (7.77e-3)"	"unprognostic (3.58e-4)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (7.27e-5)"	"unprognostic (9.12e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.19e-1)"	0.7	3.6	11.1	0.9	18.5	1.3	1.0	12.9	30.8	0.7	1.3	0.8	0.7	1.3	1.2	38.7	0.9	3.0	1.1	0.9	16.5	10.3	4.1	0.7	0.9	0.8	10.4	15.0	0.8	1.7	0.7	3.0	8.1	24.2	1.5	1.5	0.8	0.8	2.8	1.0	1.5	1.8	1.0	7.1	0.7	8.9	9.7	2.1	0.0	0.6	0.0	0.9	0.7	0.5	0.0	0.8	5.5	0.1	0.0	0.3	0.0	0.0	8.6	0.8	0.0	0.0	0.2	0.0	0.9	0.0	0.1	0.1	12.4	0.3	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.6	17.0	0.0	14.7	7.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.0	0.2	0.0	0.0	1.0	0.0	19.6	3.3	8.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.9	0.0	0.9	5.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	11.1	18.5	12.9	21.7	16.5	10.3	10.4	15.0	24.2	2.1
MAPK15	"ERK7, ERK8"	ENSG00000181085	"Mitogen-activated protein kinase 15"	Q8TD08	8	143716259-143722458	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.9;epididymis: 27.6;fallopian tube: 29.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.1;HeLa: 14.0;MCF7: 13.6;T-47d: 12.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA002704			Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA002704: "	"unprognostic (9.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.78e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	0.6	0.1	3.6	0.3	8.1	0.1	1.1	0.2	2.1	4.5	0.4	8.7	5.2	0.5	2.2	27.6	1.3	29.5	0.4	1.1	5.4	4.6	3.9	0.2	7.4	0.5	0.2	1.5	4.7	2.0	9.1	4.2	0.6	26.9	0.9	0.4	1.6	3.0	2.4	0.2	4.9	0.7	0.5	0.4	0.5	0.9	7.3	2.4	0.1	8.4	0.5	0.4	0.5	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.7	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.2	7.1	0.0	1.3	0.0	5.3	0.0	0.2	0.0	1.1	1.6	0.0	14.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	13.6	0.0	0.0	2.0	1.1	0.0	2.9	0.3	0.9	1.3	3.9	3.9	0.0	2.8	0.0	12.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	8.1	0.2	2.1	5.4	4.6	0.2	1.5	26.9	2.4
MARCOL		ENSG00000248109	"MARCO like"		5	148221650-148243580	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"ductus deferens: 3.8;epididymis: 5.7;seminal vesicle: 3.1;skeletal muscle: 2.9"	"Cell line enriched"	"Detected in some"	8	"HeLa: 124.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.8	0.3	0.0	3.8	0.0	0.7	5.7	0.0	0.0	0.0	0.9	0.0		1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.1	2.9	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	124.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0										
MAS1L	"dJ994E9.2, MAS-L, MRG"	ENSG00000204687	"MAS1 proto-oncogene like, G protein-coupled receptor"	P35410	6	29486697-29487956	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 7.5;epididymis: 4.0"	"Cell line enriched"	"Detected in single"	39	"HEL: 3.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA017983	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA017983: AB_1849332"	"unprognostic (3.66e-2)"										"unprognostic (2.51e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.65e-1)"				2.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	7.5	1.3			0.4	1.2	4.0	2.1	0.2	1.2	0.4	0.0	0.0	0.1	0.1	0.3	0.1	0.0		0.0	0.1	0.0	0.0	0.0		0.8	1.1		1.5	0.3	0.2	1.7	1.5	1.1	0.0	0.0	0.5	0.3			0.0		0.5	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MC5R		ENSG00000176136	"Melanocortin 5 receptor"	P33032	18	13824149-13827323	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 7.9;esophagus: 2.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.1;SiHa: 1.7;U-138 MG: 6.1;U-2 OS: 1.4;U-2197: 1.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA042365	Approved									"HPA042365: AB_2677961"	"unprognostic (1.57e-2)"				"unprognostic (1.37e-1)"			"unprognostic (8.77e-2)"	"unprognostic (7.10e-2)"		"unprognostic (2.64e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.04e-3)"	"unprognostic (1.54e-1)"			0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0			0.0	0.0	7.9	2.7	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.1		0.0	0.0	0.0	0.2	0.0		0.0	0.0		0.2	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.1	1.6			0.0		0.2	0.0	0.4	0.1	1.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.5	0.0	0.0	6.1	1.4	1.1	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0										
MCOLN2	"FLJ36691, TRP-ML2, TRPML2"	ENSG00000153898	"Mucolipin 2"	Q8IZK6	1	84925583-84997113	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 18.9;epididymis: 18.4;lymphoid tissue: 31.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 13.8;HAP1: 9.9;HDLM-2: 16.4;THP-1: 19.7;U-698: 12.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 18.9"	"Group enriched"	"Detected in many"	12	"B-cells: 6.6;dendritic cells: 18.9;T-cells: 5.9"	"Region enriched"	"Detected in single"	5	"amygdala: 0.4"	"Low region specificity"	"Detected in all"			"HPA019114, HPA048999"	Uncertain		Supported	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA019114: AB_1853645, HPA048999: AB_2680592"	"unprognostic (3.02e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.38e-1)"	"prognostic favourable (2.56e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.12e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-2)"	1.3	12.5	0.4	31.9	0.4	2.2	1.1	0.2	0.4	1.7	8.5	0.5	1.6	1.2	1.4	18.4	1.3	2.9	3.8	2.0	0.6	0.4	1.4	0.6	7.5	18.4	0.6	0.0	1.0	1.8	0.0	1.2	2.1	1.5	1.5	14.0	1.6	3.2	0.9	0.6	1.8	7.5	0.5	1.7	9.7	1.7	2.7	0.4	4.1	1.0	2.8	27.5	2.3	1.3	6.6	18.9	0.2	0.8	0.4	5.9	1.4	1.0	1.1	0.1	2.9	0.6	0.2	0.4	0.7	3.8	0.9	1.2	0.0	0.1	13.8	0.4	0.0	0.1	9.9	1.2	1.1	16.4	7.3	1.4	0.4	0.0	0.8	0.3	1.3	0.2	0.0	0.9	0.8	0.1	0.0	0.3	0.2	0.4	0.2	0.1	1.1	1.9	0.1	2.3	0.0	0.1	0.3	0.7	0.0	0.1	0.2	6.1	1.7	19.7	0.1	0.9	1.5	0.1	2.6	0.1	0.0	12.3	0.8	0.1	2.4	0.1	0.2	0.0	4.1	0.8	1.3	6.6	3.3	5.9	4.5	1.9	0.5	3.4	0.2	0.4	0.1	18.9	0.2	1.4	0.4	0.4	0.2	0.4	0.6	0.4	0.6	0.0	1.5	0.4
MFAP3L	"KIAA0626, NYD-sp9"	ENSG00000198948	"Microfibril associated protein 3 like"	O75121	4	169986597-170033031	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 14.3;RT4: 23.4;SK-BR-3: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 7.9;eosinophil: 2.1;neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017986, HPA062306"	Approved		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA017986: AB_1853842, HPA062306: "	"unprognostic (8.04e-3)"	"unprognostic (8.67e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-1)"	"unprognostic (7.58e-2)"	"prognostic favourable (1.42e-8)"	"unprognostic (6.59e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-4)"	"unprognostic (2.40e-3)"	2.1	3.4	15.0	1.3	19.6	2.7	10.2	4.9	19.4	11.4	2.1	21.1	4.2	1.0	4.9	32.9	1.2	4.0	2.6	1.9	15.4	11.1	25.6	29.5	2.7	1.2	21.8	10.0	1.1	1.6	5.7	3.3	5.5	21.1	2.9	2.2	17.5	2.0	11.7	4.2	19.7	1.1	3.9	16.4	1.7	1.3	30.6	20.8	0.0	2.8	0.2	1.0	11.9	1.5	0.0	0.7	7.9	0.8	0.0	0.8	6.9	0.2	3.5	1.9	1.9	1.6	0.8	0.7	3.8	0.5	1.8	1.6	1.2	0.2	0.0	0.1	5.9	1.8	6.8	0.8	0.8	0.0	2.6	0.0	3.7	1.4	0.9	0.0	14.3	1.1	2.1	0.2	0.6	0.2	0.5	0.7	3.6	2.0	0.6	0.5	2.0	3.0	0.0	1.1	0.0	5.1	23.4	1.6	3.5	3.2	21.6	6.9	1.2	0.0	0.1	1.8	7.1	3.5	7.3	0.3	0.0	0.0	4.8	0.7	7.1	7.9	0.2	2.1	0.8	0.8	0.4	0.0	0.7	0.2	0.3	0.0	0.3	0.1	4.9	0.0	0.0	0.7	0.1	6.9	15.0	19.6	4.9	15.4	15.4	11.1	21.8	10.0	21.1	20.8
MKRN2OS	"C3orf83, MKRN2-AS1"	ENSG00000225526	"MKRN2 opposite strand"	H3BPM6	3	12514934-12561059	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 10.1;epididymis: 8.8"	"Cell line enhanced"	"Detected in some"		"A-431: 3.4;CAPAN-2: 16.4;HBEC3-KT: 4.2;MCF7: 3.7;RT4: 6.8;T-47d: 3.9"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA065586, HPA065753"	Uncertain		Approved	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA065586: AB_2685514, HPA065753: AB_2685553"	"unprognostic (2.53e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.03e-3)"	"unprognostic (3.81e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.29e-3)"	"unprognostic (2.53e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.48e-1)"	"unprognostic (8.50e-3)"	"unprognostic (3.17e-3)"	0.0	0.0	0.0	0.0	0.6	0.0	0.9	10.1	0.5	1.4	3.7			7.0	0.2	8.8	5.5	1.5	1.7	1.4	0.0	0.3	0.5	0.0	0.1	0.0	0.0		0.1	5.1	1.1	1.9	0.0		0.6	4.3		5.8	1.5	0.3	2.0	6.6	0.0	0.0	0.0	4.5	0.0			0.1		0.3	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	16.4	0.0	0.4	0.0	0.7	0.0	4.2	0.0	0.0	1.1	0.0	0.3	0.3	0.0	0.2	0.3	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	3.7	0.1	0.1	0.1	0.0	0.0	0.0	0.2	2.6	6.8	0.3	0.0	0.0	1.0	0.0	3.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MPP2	"DKFZp761D0712, DLG2"	ENSG00000108852	"Membrane palmitoylated protein 2"	Q14168	17	43875357-43909711	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.3;epididymis: 31.0;parathyroid gland: 31.1"	"Cell line enhanced"	"Detected in many"		"T-47d: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026486	Approved		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"	"Mitochondria, Cytosol"	"HPA026486: AB_1854085"	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.30e-5)"	"prognostic unfavourable (1.87e-4)"	"unprognostic (4.37e-2)"	"unprognostic (2.86e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.23e-2)"	"unprognostic (6.89e-4)"	2.1	5.0	12.1	2.1	11.8	1.1	3.1	19.5	26.3	3.5	5.1	19.8	2.7	1.9	4.6	31.0	4.1	3.3	3.0	9.0	13.8	14.2	2.0	0.9	2.0	1.2	15.3	14.4	2.8	4.4	31.1	8.4	3.4	11.5	7.1	2.0	6.5	2.3	10.7	1.7	2.0	2.0	6.5	20.3	1.3	2.5	13.8	12.3	0.0	4.5	0.0	1.4	3.6	2.8	0.1	0.0	0.0	0.1	0.0	1.9	0.7	4.9	7.3	7.8	11.3	1.1	0.7	4.3	1.7	0.2	6.8	6.5	2.5	3.3	7.1	4.0	1.7	2.0	10.5	4.1	5.3	0.0	8.1	0.6	6.7	0.1	0.2	0.0	2.1	1.1	0.3	4.9	0.0	0.4	2.7	0.0	2.0	1.9	1.0	0.5	14.0	4.5	5.0	11.2	0.5	0.1	0.1	8.4	7.8	2.1	0.7	2.9	17.2	3.4	0.1	7.6	9.6	2.9	3.1	2.4	4.9	0.0	11.4	4.8	1.4	0.0	0.1	0.0	1.4	0.0	0.2	0.0	0.5	1.2	0.0	0.1	1.6	1.9	0.0	0.0	0.0	0.0	0.1	0.7	12.1	11.8	19.5	22.5	13.8	14.2	15.3	14.4	11.5	12.3
MSLNL	"C16orf37, MPFL"	ENSG00000162006	Mesothelin-like	Q96KJ4	16	769428-783370	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 2.4;epididymis: 4.1"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 14.5;HeLa: 8.5"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"														"unprognostic (1.93e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (5.26e-4)"	"unprognostic (3.50e-2)"	"unprognostic (4.49e-2)"		"unprognostic (2.38e-2)"		"unprognostic (1.54e-1)"	"unprognostic (3.73e-3)"	"unprognostic (6.50e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.16e-1)"			0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.1	2.4	0.0	0.0			0.2	0.3	4.1	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0		0.0	0.2	0.0	0.4	0.0		0.0	0.0		0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	14.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MUC15		ENSG00000169550	"Mucin 15, cell surface associated"	Q8N387	11	26559033-26572233	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 265.1;placenta: 56.8;thyroid gland: 77.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;K-562: 9.8;SK-BR-3: 16.7;U-266/70: 6.6;U-266/84: 17.6"	"Cancer enriched"	"Detected in many"	11	"thyroid cancer: 56.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebellum: 1.3;thalamus: 1.5"	"Low region specificity"	"Detected in all"			"HPA026110, HPA073304"	Enhanced				"Intracellular and membrane"					"HPA026110: AB_1854200, HPA073304: "	"unprognostic (1.49e-1)"	"unprognostic (2.08e-3)"		"unprognostic (7.71e-5)"		"unprognostic (5.09e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.98e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.54e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	3.9	0.0	0.0	9.3	0.0	0.1	265.1	11.0	1.0	0.1	0.1	0.0	0.0	5.2	0.1	4.8	0.1	0.0	0.0	0.1	1.8	0.0	2.1	56.8	0.0	0.8	0.0	0.0	14.4	1.0	0.0	12.0	0.0	0.0	0.0	0.0	0.2	4.1	0.0	1.1	77.8	8.1	1.7	3.0	6.5	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	9.8	0.1	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.1	0.6	0.0	16.7	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	6.6	17.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYMK	"TMEM226, TMEM8C"	ENSG00000187616	"Myomaker, myoblast fusion factor"	A6NI61	9	133514586-133528612	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.3;epididymis: 3.1;skeletal muscle: 8.0"	"Group enriched"	"Detected in some"	34	"HSkMC: 18.0;RH-30: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051846, HPA055785"	Uncertain									"HPA051846: AB_2681636, HPA055785: AB_2682920"						"unprognostic (9.17e-3)"	"unprognostic (8.63e-2)"	"unprognostic (3.76e-1)"		"unprognostic (1.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.37e-1)"	"unprognostic (9.32e-2)"			"unprognostic (1.91e-1)"		0.6	0.2	0.5	0.0	3.3	0.2	0.0	0.7	2.6	0.0	0.0	0.8	0.0	0.0	0.0	3.1	0.6	0.1	0.0	0.3	1.0	0.4	1.7	0.2	0.3	0.0	0.9	2.1	0.0	0.0	0.0	0.1	2.0	1.6	0.6	0.0	0.0	0.2	0.0	8.0	0.2	0.0	0.0	0.4	0.1	0.0	1.5	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.3	0.7	2.6	1.0	0.4	0.9	2.1	1.6	0.4
MYO3B		ENSG00000071909	"Myosin IIIB"	Q8WXR4	2	170178145-170655171	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 20.0;parathyroid gland: 12.6;retina: 21.6"	"Group enriched"	"Detected in some"	10	"HDLM-2: 11.0;HEL: 10.1;RT4: 11.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdTCR: 1.4;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.4"	"Region enriched"	"Detected in single"	5	"basal ganglia: 4.7"	"Not detected"	"Not detected"			HPA045483	Approved									"HPA045483: AB_2679344"	"unprognostic (1.65e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.61e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.12e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.25e-5)"	"unprognostic (2.34e-1)"	"unprognostic (8.12e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.07e-1)"	0.2	0.2	0.3	0.0	0.3	0.0	0.2	0.2	0.3	0.6	0.2	0.0	4.6	0.0	0.3	20.0	0.3	0.5	0.0	0.3	0.3	0.5	8.5	0.2	0.3	0.5	0.3	0.3	0.4	2.2	12.6	1.0	0.0	0.3	0.3	0.0	21.6	1.4	1.1	0.2	0.5	0.2	0.5	0.2	0.3	0.2	4.2	0.0	0.0	2.2	0.0	0.8	4.4	0.3	0.1	0.3	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.2	0.3	0.3	0.5	0.3	0.3	0.3	0.0
MYOCOS		ENSG00000283683	"Myocilin opposite strand"	A0A1B0GUC4	1	171600621-171638799	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 8.1;epididymis: 4.8;fallopian tube: 3.9"	"Cell line enriched"	"Detected in some"	6	"HEL: 24.0"									"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																																							0.0	0.0		0.0		0.1	0.0		0.0	8.1	0.0			0.0	1.3	4.8	0.0	3.9	0.0	0.0			1.1	0.0	0.0	0.0			0.0	0.4	0.0		0.1		0.0	0.0		0.0	0.8	0.1	0.0	0.0	0.0		0.0	0.1	1.1			0.8		0.0	0.3		0.9	0.6	1.6	0.3	0.1	1.3	0.0	0.0	0.4	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.1	3.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	24.0	0.4	0.4	0.1	0.0	2.7	0.0	0.1	0.0	0.0	0.0	4.2	0.4	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.9	1.8	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.1	0.4	0.1	0.1	0.1	0.3	0.3	0.2	0.3	0.2	1.0	0.9	0.4	1.1	0.1	0.9	0.5	0.4	1.6	0.1	0.0	0.6	1.3	0.0										
NHLRC4		ENSG00000257108	"NHL repeat containing 4"	P0CG21	16	566996-569495	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 21.1;fallopian tube: 17.3"	"Cell line enhanced"	"Detected in some"		"HEL: 4.5;HMC-1: 13.6;RPMI-8226: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 5.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							HPA077301			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA077301: "	"unprognostic (7.95e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.28e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.60e-1)"	1.3	6.9	1.6	1.4	2.3	3.4	1.4	1.4	1.8	2.4	0.9	1.7	9.5	1.4	2.5	21.1	0.7	17.3	1.5	1.8	2.4	2.4	7.0	0.3	4.8	3.8	0.5	0.9	5.1	0.2	5.9	1.4	1.5	2.0	2.2	0.3	2.1	3.1	10.9	2.3	0.3	1.7	0.5	0.8	4.8	0.8	2.8	0.7	7.8	0.4	0.4	1.2	1.3	0.7	1.1	4.4	5.0	0.5	0.7	1.5	0.7	0.0	0.0	0.6	0.1	0.1	0.3	0.1	0.0	0.8	0.2	0.2	0.1	0.2	0.8	0.6	0.1	0.1	0.0	0.1	0.0	2.3	0.2	4.5	0.0	1.0	1.0	0.3	13.6	2.8	0.0	0.1	0.3	0.3	1.4	1.6	0.0	0.0	0.4	3.3	0.3	0.0	3.5	0.0	5.7	0.3	0.2	0.0	1.3	0.0	0.0	0.5	0.6	0.7	0.7	0.0	0.1	0.0	0.0	2.1	1.9	0.9	0.0	0.1	0.3	0.0	0.5	5.0	0.4	0.2	0.7	1.1	1.3	0.6	0.6	0.7	1.5	0.8	0.0	0.7	0.2	4.4	1.4	0.7	1.6	2.3	1.4	1.8	2.4	2.4	0.5	0.9	2.0	0.7
NLRP11	"CLR19.6, NALP11, NOD17, PAN10, PYPAF6"	ENSG00000179873	"NLR family pyrin domain containing 11"	P59045	19	55785397-55836800	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 4.0;liver: 3.3;lymphoid tissue: 4.5;testis: 3.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 38.2;RPMI-8226: 21.5;U-266/70: 38.0;U-266/84: 16.4;U-698: 27.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.4"	"Low lineage specificity"	"Detected in single"							"Not detected"	"Not detected"			"HPA046402, HPA078027"	Uncertain		Supported	Cytosol				Cytosol	Cytosol	"HPA046402: AB_10962951, HPA078027: AB_2732369"	"unprognostic (2.36e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.36e-3)"	"unprognostic (3.31e-2)"	"unprognostic (7.88e-2)"	"unprognostic (9.95e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.76e-2)"	"unprognostic (7.61e-2)"	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	4.0	0.1	0.3	0.2	0.1	0.1	0.0	0.7	3.3	0.1	0.6	0.1	0.1	0.9	0.4	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	1.2	0.1	0.1	0.3	0.5	3.6	0.1	0.1	0.1	0.1	4.5	0.1	0.1	1.4	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	38.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.7	21.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.0	0.0	38.0	16.4	27.6	0.6	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NPPC	CNP	ENSG00000163273	"Natriuretic peptide C"	P23582	2	231921820-231926403	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 34.2;retina: 24.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 7.7;NTERA-2: 3.6;SCLC-21H: 5.1;SK-MEL-30: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 33.4"	HPA035362	Uncertain				"Secreted to blood"					"HPA035362: AB_10671103"	"unprognostic (9.70e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.22e-3)"	"unprognostic (9.81e-3)"	"unprognostic (9.16e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.91e-1)"	1.4	0.9	4.1	6.3	4.4	4.5	1.4	5.4	12.0	3.0	5.0	2.9	0.7	0.9	1.6	34.2	7.3	1.8	0.6	3.9	6.9	6.3	0.9	0.5	0.8	4.5	2.8	2.2	1.8	0.5	0.5	3.8	1.1	12.4	13.1	1.3	24.7	4.4	2.0	2.4	0.8	1.6	2.2	13.3	1.7	4.3	1.0	0.9	13.7	2.1	9.3	6.0	0.5	0.6	0.0	1.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	3.6	0.0	0.9	0.0	0.0	0.0	0.0	5.1	0.3	0.2	0.2	22.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.1	4.4	5.4	12.0	6.9	6.3	2.8	2.2	12.4	0.9
NUP62CL	FLJ20130	ENSG00000198088	"Nucleoporin 62 C-terminal like"	Q9H1M0	X	107123427-107206433	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 40.6"	"Cell line enhanced"	"Detected in many"		"A549: 13.9;CAPAN-2: 15.0;HEK 293: 11.3;HeLa: 20.0;K-562: 14.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"pons and medulla: 18.3"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 4.3;NK-cells: 1.7;T-cells: 2.6"									HPA001884	Approved									"HPA001884: AB_1079512"	"unprognostic (1.62e-2)"	"prognostic favourable (5.66e-5)"	"unprognostic (8.80e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (1.56e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.82e-3)"	"unprognostic (4.52e-3)"	0.5	12.4	1.2	2.9	2.6	1.4	2.6	0.3	0.6	1.7	3.1	3.2	8.7	2.4	2.0	40.6	2.3	15.0	2.3	1.6	1.7	2.2	5.5	2.0	2.4	1.4	1.1	1.2	4.4	12.6	2.5	9.0	0.7	18.3	1.0	2.7	1.1	2.5	10.9	0.5	1.5	3.3	0.2	1.3	0.6	1.3	11.0	1.7	3.3	8.6	1.0	3.4	1.4	1.4	4.3	0.2	0.6	0.5	1.7	2.6	0.6	8.3	13.9	1.2	0.0	0.0	0.0	6.1	0.0	0.5	0.3	0.3	1.3	15.0	4.8	1.6	0.0	7.6	8.9	3.0	0.0	0.0	11.3	0.5	20.0	2.4	0.0	0.0	0.0	0.1	4.1	0.0	2.1	0.0	14.0	1.2	0.0	4.1	1.8	0.0	1.8	5.0	0.0	0.0	0.4	4.5	2.2	3.6	4.2	5.0	1.5	0.0	0.0	0.2	0.0	0.0	4.6	0.1	0.0	1.6	5.6	2.6	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.4	0.7	4.3	2.6	0.2	0.1	3.3	1.3	1.5	0.0	1.7	0.5	0.2	1.1	0.6	1.2	2.6	0.3	0.6	1.7	2.2	1.1	1.2	18.3	1.7
NXF5		ENSG00000126952	"Nuclear RNA export factor 5"	Q9H1B4	X	101832112-101857577	"Disease related genes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"epididymis: 1.5"	"Cell line enhanced"	"Detected in single"		"PC-3: 1.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA002079	Uncertain									"HPA002079: AB_1079515"	"unprognostic (1.23e-1)"				"unprognostic (2.85e-1)"		"unprognostic (2.73e-1)"				"unprognostic (1.44e-3)"	"unprognostic (9.58e-2)"	"unprognostic (5.65e-2)"		"unprognostic (2.24e-1)"	"unprognostic (2.91e-2)"		0.7	0.2	0.3	0.0	0.4	0.7	0.2	0.8	0.7	0.0	0.0			0.0	0.0	1.5	0.1	0.3	0.4	0.1	0.6	0.5	0.8	0.5	0.2	0.4	0.7		0.2	0.1	0.0	0.1	0.0		0.2	0.0		0.0	0.4	0.6	0.0	0.1	0.2	0.9	0.8	0.0	0.1			0.3		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NYNRIN	"CGIN1, FLJ11811, KIAA1305"	ENSG00000205978	"NYN domain and retroviral integrase containing"	Q9P2P1	14	24398786-24419288	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 45.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 9.0;HEL: 9.0;HUVEC TERT2: 22.3;RT4: 18.4;TIME: 10.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 26.6"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018945	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus"	"Golgi apparatus"	"HPA018945: AB_1859538"	"unprognostic (9.41e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.49e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.43e-1)"	8.1	2.8	2.1	4.3	2.2	0.2	6.8	26.6	2.6	16.7	7.6	2.5	29.6	2.9	14.6	45.9	11.6	13.4	14.5	5.1	2.2	4.2	6.1	3.6	7.5	2.0	1.8	1.8	28.0	2.9	4.5	4.9	10.5	2.4	9.8	4.1	9.1	5.5	20.2	2.5	9.1	4.5	8.0	1.5	5.2	4.5	7.3	1.4	3.5	7.5	8.5	6.5	8.6	10.2	0.0	1.7	0.0	0.1	0.5	0.1	0.0	0.1	0.0	2.9	0.0	4.1	8.5	0.2	1.3	1.4	0.9	1.0	2.0	9.0	0.2	0.4	5.3	0.0	4.7	0.1	1.0	0.0	0.5	9.0	1.2	0.2	3.0	0.0	0.0	8.6	0.3	0.6	0.0	22.3	1.4	0.0	0.1	0.4	0.0	0.4	1.7	0.0	1.1	0.0	0.0	0.0	18.4	0.4	6.4	0.0	0.8	0.1	1.6	1.3	10.8	0.1	5.4	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	0.0	2.1	2.2	26.6	2.6	2.2	4.2	1.8	1.8	2.4	1.4
OR1J2	"OR1J3, OR1J5, OST044"	ENSG00000197233	"Olfactory receptor family 1 subfamily J member 2"	Q8NGS2	9	122510802-122511743	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 1.3;testis: 1.2;urinary bladder: 1.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.3;HSkMC: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1			0.0	0.4	1.3	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	1.2			0.0		0.0	1.7	0.0	0.5	0.6	0.6	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0										
OR1J4	"HSHTPCRX01, HTPCRX01"	ENSG00000239590	"Olfactory receptor family 1 subfamily J member 4"	Q8NGS1	9	122519141-122520082	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"epididymis: 2.0"	"Cell line enhanced"	"Detected in some"		"BJ: 1.4;BJ hTERT+: 3.0;fHDF/TERT166: 2.6;HMC-1: 1.3;HSkMC: 1.0;U-266/70: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																							"unprognostic (7.83e-2)"		"unprognostic (2.53e-1)"		"unprognostic (4.13e-2)"				"unprognostic (1.82e-1)"			"unprognostic (4.45e-1)"	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.2			0.0	0.3	2.0	0.2	0.5	0.2	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.4		0.3	0.0	0.0	0.4	0.3	0.0	0.0	0.6	0.2	0.8			0.0		0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	1.4	3.0	0.0	0.0	0.0	0.4	0.0	0.4	2.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR1L3	OR9-D	ENSG00000171481	"Olfactory receptor family 1 subfamily L member 3"	Q8NH93	9	122675036-122676153	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"epididymis: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA058878	Uncertain									"HPA058878: AB_2683843"																		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.2	0.0			0.0	0.1	1.3	0.7	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.1		0.0	0.0		0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.8			0.0		0.0	0.5	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR2T12		ENSG00000177201	"Olfactory receptor family 2 subfamily T member 12"	Q8NG77	1	248290139-248303424	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 2.4;epididymis: 2.9;liver: 4.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 4.6;U-2197: 3.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																																							0.1	0.1	0.1	0.2	0.3	0.9	0.2	0.1	0.4	0.4	0.2			0.1	0.3	2.9	0.1	0.3	0.0	0.1	0.4	0.4	0.1	4.7	0.2	0.2	0.4		0.2	0.1	0.0	0.2	0.0		0.1	0.4		0.1	0.0	0.2	0.7	0.3	0.0	0.2	0.2	0.2	0.7			0.6		0.2	0.2	0.2	1.3	0.6	2.4	0.4	1.0	0.8	0.1	1.0	0.3	0.4	0.8	0.1	0.2	0.8	0.1	0.1	0.1	0.2	0.7	0.5	1.1	0.5	0.1	0.3	0.2	0.3	0.2	0.8	0.3	0.9	4.6	0.7	0.1	0.9	1.2	0.2	0.2	0.3	0.0	0.1	0.4	2.0	0.1	0.8	1.3	0.8	1.2	0.3	0.5	0.6	0.7	0.2	1.1	0.7	0.8	0.6	0.9	0.3	0.7	0.9	1.2	1.0	0.9	3.5	0.6	0.9	0.9	0.4	0.6	0.5	0.8	2.4	0.4	0.3	0.8	0.3	0.6	0.8	0.6	0.6	0.2	1.3	0.8	0.8	1.1	1.0	0.4	0.6	0.3	0.1										
OR4C3		ENSG00000176547	"Olfactory receptor family 4 subfamily C member 3"	Q8NH37	11	48324920-48328471	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"epididymis: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA049116	Uncertain									"HPA049116: AB_2680638"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0			0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR51B5		ENSG00000167355	"Olfactory receptor family 51 subfamily B member 5"	Q9H339	11	5303444-5505652	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.0;epididymis: 1.7"	"Group enriched"	"Detected in some"	6	"K-562: 9.1;U-2197: 2.7"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.1"					"Cell type enriched"	"Detected in single"	4	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.0"					"Region enhanced"	"Detected in single"		"olfactory region: 0.3"	HPA063124	Uncertain									"HPA063124: AB_2684943"	"unprognostic (9.22e-3)"				"unprognostic (1.80e-1)"		"unprognostic (2.01e-1)"	"unprognostic (3.76e-2)"		"unprognostic (4.75e-1)"		"unprognostic (1.36e-1)"	"unprognostic (7.37e-5)"	"unprognostic (2.94e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.71e-2)"	0.0	0.0		0.0		0.0	0.2		0.0	0.0	0.0			0.0	0.5	1.7	0.0	0.3	0.0	0.1			0.5	0.3	0.0	0.0			0.6	0.0	0.0		0.4		0.1	0.0		0.2	0.0	0.0	0.3	0.0	0.0		0.0	0.0	0.7			0.0		0.0	0.0		0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.9	2.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR51I1		ENSG00000167359	"Olfactory receptor family 51 subfamily I member 1"	Q9H343	11	5440570-5441514	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 1.8;testis: 1.2"	"Cell line enhanced"	"Detected in some"		"PC-3: 1.0;U-2197: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"olfactory region: 6.3"																										"unprognostic (2.36e-1)"			0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1			0.0	0.2	1.8	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0		0.5	0.1	0.0	0.1	0.0		0.2	0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.2			0.1		0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1										
OR51Q1		ENSG00000167360	"Olfactory receptor family 51 subfamily Q member 1 (gene/pseudogene)"	Q8NH59	11	5422111-5423206	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.0;epididymis: 2.0"	"Cell line enriched"	"Detected in single"	30	"RT4: 7.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enriched"	"Detected in single"	11	"olfactory region: 4.5"	HPA044998	Uncertain									"HPA044998: AB_10794780"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.2	0.0			0.0	0.0	2.0	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR52B2		ENSG00000255307	"Olfactory receptor family 52 subfamily B member 2"	Q96RD2	11	6169330-6170408	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"epididymis: 1.0"	"Cell line enriched"	"Detected in single"	16	"MCF7: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																											"unprognostic (6.53e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.3			0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0		0.7	0.2	0.0	0.0	0.1		0.0	0.1		0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.2			0.1		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR52I2		ENSG00000226288	"Olfactory receptor family 52 subfamily I member 2"	Q8NH67	11	4581743-4593340	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"epididymis: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049343	Uncertain									"HPA049343: AB_2680721"																		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0			0.0	0.1	2.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0		0.1	0.0	0.0	0.0	0.0		0.1	0.0		0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR5P3	JCG1	ENSG00000182334	"Olfactory receptor family 5 subfamily P member 3"	Q8WZ94	11	7824818-7830840	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 1.7;skin 1: 2.1;urinary bladder: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA060787	Uncertain									"HPA060787: AB_2684364"																	"unprognostic (1.54e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0			0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.5			0.0		0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR6C2	OR6C67	ENSG00000179695	"Olfactory receptor family 6 subfamily C member 2"	Q9NZP2	12	55444069-55453347	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"epididymis: 1.5;testis: 1.2"	"Cell line enriched"	"Detected in single"	15	"Karpas-707: 3.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"																												"unprognostic (2.37e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0			0.0	0.1	1.5	0.1	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2			0.0		0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR6C76		ENSG00000185821	"Olfactory receptor family 6 subfamily C member 76"	A6NM76	12	55426254-55427192	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"epididymis: 1.2;fallopian tube: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0			0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.5		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR6X1		ENSG00000221931	"Olfactory receptor family 6 subfamily X member 1"	Q8NH79	11	123753488-123754545	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"epididymis: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"																															0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0			0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR9A4		ENSG00000258083	"Olfactory receptor family 9 subfamily A member 4"	Q8NGU2	7	141916399-141920625	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 1.9;epididymis: 1.0;testis: 1.0"	"Cell line enriched"	"Detected in single"	6	"U-937: 5.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																												"unprognostic (2.77e-1)"			0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.1	0.2	0.0			0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.1	0.0	0.0	0.6	0.0	0.0	0.4	0.1	0.0	1.0			0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1										
P2RX2	"DFNA41, P2X2"	ENSG00000187848	"Purinergic receptor P2X 2"	Q9UBL9	12	132618776-132622386	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 23.1;prostate: 11.1;seminal vesicle: 16.1"	"Group enriched"	"Detected in some"	4	"MCF7: 6.6;T-47d: 15.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"amygdala: 6.1;hippocampal formation: 8.6"	"Cell type enriched"	"Detected in single"	13	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (1.12e-1)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.94e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.12e-1)"	"unprognostic (5.79e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.05e-1)"		"unprognostic (9.12e-2)"	0.4	0.1	6.1	0.5	0.6	0.0	0.3	0.3	1.6	0.7	1.5	0.3	3.0	1.1	0.3	23.1	5.3	2.5	0.3	0.3	8.6	0.9	1.1	0.3	3.6	1.8	0.3	0.3	0.3	0.3	0.0	0.9	0.7	0.3	11.1	0.3	0.6	0.3	16.1	0.3	0.0	3.4	0.3	0.3	2.4	1.3	1.3	0.3	0.3	0.3	0.3	0.8	0.7	1.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	6.6	0.1	0.4	0.7	0.0	0.1	0.2	0.1	0.0	0.4	0.1	0.0	0.0	2.6	0.0	15.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.2	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	6.1	0.6	0.3	1.6	8.6	0.9	0.3	0.3	0.3	0.3
P4HA3	C-P4Halpha(III)	ENSG00000149380	"Prolyl 4-hydroxylase subunit alpha 3"	Q7Z4N8	11	74235801-74311657	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 22.6"	"Cell line enhanced"	"Detected in some"		"BJ: 12.6;fHDF/TERT166: 6.1;HSkMC: 6.1;HUVEC TERT2: 24.8;TIME: 17.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA007897	Approved				"Intracellular and membrane"					"HPA007897: AB_2156427"	"unprognostic (2.74e-2)"	"unprognostic (1.37e-4)"	"unprognostic (1.31e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.54e-4)"	"unprognostic (9.65e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.38e-2)"	"unprognostic (8.31e-2)"	"prognostic unfavourable (3.34e-9)"	"unprognostic (1.96e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (7.83e-4)"	3.0	1.2	0.1	4.7	0.5	0.0	1.3	2.1	0.4	2.5	2.3	0.4	2.8	0.3	7.1	22.6	0.7	1.9	7.5	1.1	0.4	0.2	0.9	1.7	2.2	0.9	0.1	0.0	3.8	0.3	0.0	5.7	7.4	1.1	9.8	0.9	6.4	2.0	6.1	1.1	0.5	1.0	13.7	0.4	0.2	0.7	2.3	0.0	0.0	4.1	1.6	0.4	9.7	2.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.0	4.2	0.4	0.0	12.6	0.9	0.6	1.4	0.0	0.0	0.0	1.2	6.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.7	0.0	5.4	0.0	0.0	6.1	0.0	4.3	0.5	24.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	17.6	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	2.1	0.4	0.4	0.2	0.1	0.0	1.1	0.0
PAX2		ENSG00000075891	"Paired box 2"	Q02962	10	100735603-100829941	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 30.5;epididymis: 93.7;kidney: 43.1"	"Group enriched"	"Detected in some"	9	"AN3-CA: 14.2;EFO-21: 19.8;RPTEC TERT1: 14.1"	"Group enriched"	"Detected in some"	19	"endometrial cancer: 6.7;ovarian cancer: 7.0;renal cancer: 14.5"	"Group enriched"	"Detected in some"	6	"cerebellum: 1.0;pons and medulla: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebellum: 1.5;pons and medulla: 3.5"	"Group enriched"	"Detected in some"	6	"cerebellum: 7.9;pons and medulla: 8.1"	"CAB013024, HPA047704, HPA070751"	Enhanced		Supported	"Nucleoli,Golgi apparatus"	"Intracellular and membrane"			Nucleoli	Nucleoli	"CAB013024: AB_2533990, HPA047704: AB_2636861, HPA070751: "	"unprognostic (3.98e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (4.85e-2)"	"unprognostic (5.54e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"		"unprognostic (1.24e-2)"	"unprognostic (6.59e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.34e-2)"	"unprognostic (8.26e-2)"	0.1	0.1	0.2	0.0	0.1	0.0	0.1	1.0	0.1	3.1	0.1	0.0	30.5	0.0	1.5	93.7	0.1	9.1	0.0	0.1	0.1	0.1	43.1	0.1	0.1	0.0	0.2	0.0	1.5	0.3	0.6	0.7	0.0	1.8	0.8	0.0	0.5	0.1	19.4	0.1	0.1	0.1	0.0	1.7	0.1	0.1	2.4	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	19.8	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	14.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.0	0.1	0.1	0.1	0.2	0.0	1.8	0.1
PCCA		ENSG00000175198	"Propionyl-CoA carboxylase alpha subunit"	P05165	13	100089015-100530437	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 106.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 53.2;SCLC-21H: 29.5;U-937: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041716, HPA047792"	Enhanced		Supported	Mitochondria		120000	120000	Mitochondria	Mitochondria	"HPA041716: AB_2677635, HPA047792: AB_2680156"	"unprognostic (1.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (0.00e+0)"	"unprognostic (7.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.32e-2)"	15.6	26.2	9.7	11.3	11.1	3.2	12.0	24.0	10.7	12.0	17.5	12.0	14.3	6.7	16.4	106.7	8.8	8.4	7.6	12.4	9.5	7.5	51.3	44.3	8.1	4.0	11.2	8.2	9.7	12.7	5.5	12.4	10.5	12.6	13.1	13.7	11.7	12.2	10.4	10.7	7.7	7.8	17.0	12.0	8.2	16.1	4.7	10.9	4.2	11.9	5.0	6.9	10.8	8.8	3.7	13.0	1.6	10.8	7.3	6.1	4.7	3.2	5.8	9.6	3.1	9.2	8.0	5.4	3.2	4.8	3.0	2.8	7.2	4.4	0.2	4.9	3.2	3.7	2.8	4.5	5.0	5.3	3.2	7.5	4.1	15.4	5.1	0.3	3.7	7.4	4.8	2.8	4.7	6.2	3.0	4.3	5.5	3.5	0.8	16.9	5.9	2.6	6.6	4.1	5.2	53.2	6.4	29.5	3.5	2.2	12.3	5.4	8.9	13.4	4.5	3.1	2.6	2.1	2.2	4.2	3.8	0.1	6.0	41.0	2.2	1.5	8.5	1.6	4.6	10.3	6.1	3.7	3.0	4.3	13.0	2.6	4.1	5.1	1.3	7.3	10.8	1.1	6.0	4.7	9.7	11.1	24.0	10.7	9.5	7.5	11.2	8.2	12.6	10.9
PDZRN4	"DKFZp434B0417, FLJ33777, IMAGE5767589, LNX4"	ENSG00000165966	"PDZ domain containing ring finger 4"	Q6ZMN7	12	41188448-41574590	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 18.3;seminal vesicle: 20.8"	"Cell line enriched"	"Detected in some"	9	"U-266/70: 8.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA042101	Enhanced									"HPA042101: AB_2732496"	"unprognostic (6.74e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.80e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.41e-3)"	1.6	1.3	2.4	5.0	1.8	0.1	2.6	2.7	3.7	3.1	13.9	1.0	13.8	1.3	1.1	18.3	4.1	3.4	3.0	0.5	2.1	2.1	0.8	0.9	0.5	0.1	1.8	2.4	3.3	0.8	0.3	0.7	4.5	2.5	8.3	4.0	4.8	0.6	20.8	0.6	0.8	4.2	17.2	5.0	0.4	5.9	4.1	2.0	0.0	0.5	0.5	0.5	7.3	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.8	2.7	3.3	2.1	2.1	1.8	2.4	2.5	2.0
PEBP4	"CORK1, hPEBP4, MGC22776"	ENSG00000134020	"Phosphatidylethanolamine binding protein 4"	Q96S96	8	22713251-23000000	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 85.8;skeletal muscle: 124.6"	"Cell line enriched"	"Detected in some"	6	"U-266/70: 9.3"	"Group enriched"	"Detected in many"	13	"lung cancer: 11.4;prostate cancer: 23.7;thyroid cancer: 35.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.7;neutrophil: 2.7;NK-cell: 2.6"	"Group enriched"	"Detected in many"	19	"B-cells: 2.7;granulocytes: 2.7;NK-cells: 2.6"									HPA025064	Uncertain				"Secreted in other tissues"	200000000	200000000			"HPA025064: AB_1855174"	"unprognostic (1.34e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.11e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.76e-3)"	"unprognostic (9.70e-8)"	"unprognostic (1.13e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.59e-1)"	2.7	0.9	2.2	0.2	4.9	0.2	0.9	1.0	1.9	0.3	0.2	2.4	0.8	0.1	0.3	85.8	1.6	0.5	0.6	43.8	2.2	5.1	0.6	0.7	31.8	0.3	10.8	0.8	0.4	7.4	0.4	4.7	0.2	7.8	10.4	0.2	18.9	12.3	0.8	124.6	0.3	0.2	0.2	1.0	0.2	1.7	1.4	2.5	0.0	22.3	16.6	2.3	0.2	0.0	2.7	0.1	2.7	0.0	2.6	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.7	0.1	0.0	0.7	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.1	0.2	0.0	0.0	1.4	0.1	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.3	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.4	0.0	0.0	2.7	2.6	0.0	0.1	0.0	0.0	2.2	4.9	1.0	1.9	2.2	5.1	10.8	0.8	7.8	2.5
PEMT	"PEMPT, PEMT2"	ENSG00000133027	"Phosphatidylethanolamine N-methyltransferase"	Q9UBM1	17	17505563-17591708	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 95.7;liver: 103.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042375	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA042375: AB_10796905"	"unprognostic (1.39e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.43e-2)"	"prognostic favourable (6.77e-6)"	"unprognostic (2.85e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.63e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.60e-2)"	21.8	7.5	5.6	2.8	6.2	4.2	26.5	2.9	8.1	16.1	6.1	6.4	13.2	7.4	8.7	95.7	5.6	10.5	4.7	5.3	5.3	6.1	8.5	103.5	5.5	6.7	6.3	4.8	7.7	11.4	4.4	5.7	7.1	6.2	7.3	2.2	7.3	12.7	12.9	7.4	7.3	5.8	4.0	6.4	2.8	4.6	19.1	3.2	3.8	9.9	6.3	5.4	3.9	5.2	12.8	17.0	1.6	23.4	15.1	14.4	11.6	14.3	27.5	7.2	19.0	15.5	10.9	10.9	9.2	8.2	12.6	10.0	16.0	9.8	12.6	16.8	9.4	17.1	10.7	5.5	3.2	9.3	37.3	6.2	15.1	23.0	17.1	5.6	9.4	11.1	11.6	8.4	12.8	6.7	6.0	5.3	5.6	27.5	9.9	10.0	10.2	22.6	9.3	11.7	11.5	10.4	5.3	7.3	17.3	6.5	4.4	16.4	6.8	2.1	5.9	12.4	12.5	20.7	8.0	7.4	4.9	2.3	11.5	7.8	10.2	1.0	23.4	1.1	10.1	20.8	14.4	12.6	13.2	12.7	17.0	12.8	10.6	11.9	1.6	15.1	14.2	15.5	12.0	11.6	5.6	6.2	2.9	8.1	5.3	6.1	6.3	4.8	6.2	3.2
PGAP2	"CWH43-N, FRAG1, MRT21"	ENSG00000148985	"Post-GPI attachment to proteins 2"	Q9UHJ9	11	3797724-3826371	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 117.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063099	Approved		Approved	Microtubules				Microtubules	Microtubules	"HPA063099: AB_2684940"	"unprognostic (1.94e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavourable (7.49e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.67e-2)"	4.9	9.5	7.6	7.3	8.2	5.2	6.9	5.0	10.6	7.3	12.3	12.4	18.3	10.2	7.4	117.3	20.0	11.1	8.1	9.3	8.0	6.3	8.6	17.1	9.5	8.6	6.9	8.8	7.1	30.8	12.6	9.1	10.7	5.6	10.1	7.9	12.5	14.5	19.6	6.4	25.0	16.7	4.9	8.9	6.6	7.5	17.7	8.4	15.0	14.1	14.6	15.3	7.7	10.4	11.2	8.7	15.9	8.0	8.7	17.0	7.5	12.7	17.5	8.5	7.8	7.7	14.8	13.5	5.3	4.6	7.9	7.1	14.9	22.7	13.9	6.2	3.8	21.6	13.5	14.8	7.8	16.9	14.8	8.5	7.6	18.2	5.4	10.8	11.1	11.7	20.8	5.7	19.7	8.9	17.9	20.7	8.2	19.2	13.2	9.2	16.1	10.6	20.6	1.0	13.3	14.9	15.5	11.3	11.3	9.6	25.7	5.7	21.4	4.7	8.3	4.9	4.7	11.6	3.2	13.0	14.2	10.3	6.5	7.3	9.3	1.9	5.8	5.0	8.8	8.0	10.8	11.0	12.6	10.7	8.7	11.2	17.0	11.3	15.9	8.7	8.0	5.9	11.5	7.5	7.6	8.2	5.0	10.6	8.0	6.3	6.9	8.8	5.6	8.4
PIK3C2G		ENSG00000139144	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma"	O75747	12	18247614-18648416	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 54.2;epididymis: 30.7;seminal vesicle: 46.0"	"Group enriched"	"Detected in some"	5	"BEWO: 2.9;HaCaT: 4.6;hTERT-HME1: 8.5"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"														"unprognostic (1.29e-1)"	"unprognostic (1.61e-1)"		"unprognostic (6.21e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.46e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.81e-3)"	"prognostic unfavourable (3.50e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.98e-1)"		"unprognostic (2.37e-2)"	0.3	0.6	0.2	0.1	0.2	0.0	6.7	0.2	0.3	0.6	0.3	0.1	54.2	0.0	0.3	30.7	4.2	0.6	6.0	0.2	0.3	0.2	9.6	8.8	0.3	0.1	0.3	0.1	0.3	1.2	8.1	0.4	1.2	0.1	2.4	0.0	0.1	13.1	46.0	0.2	7.0	2.2	0.2	0.3	0.2	15.1	2.1	0.1	0.1	0.5	1.6	0.5	0.9	0.9	0.1	0.1	0.4	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	8.5	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.3	0.3	0.2	0.3	0.1	0.1	0.1
PJA1	"FLJ11830, RNF70"	ENSG00000181191	"Praja ring finger ubiquitin ligase 1"	Q8NG27	X	69160851-69165793	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 98.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000595	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA000595: AB_1079826"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.58e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (7.44e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-1)"	12.6	9.9	21.6	5.5	35.7	2.6	7.9	13.4	23.7	12.2	5.8	8.9	19.3	4.7	9.2	98.7	5.7	10.2	7.1	7.5	18.4	23.4	7.5	4.4	7.4	5.9	14.9	16.7	16.2	6.0	27.1	12.5	10.7	11.7	9.9	5.3	7.2	6.4	20.3	4.7	7.1	4.4	9.8	12.0	5.9	6.5	13.7	9.5	3.0	13.8	2.9	7.4	7.8	7.9	11.2	4.3	2.7	4.5	14.8	17.8	9.0	10.4	8.0	25.1	17.5	8.8	9.3	7.5	7.0	8.4	6.6	8.9	6.5	9.9	1.6	10.9	11.0	9.1	38.5	13.6	8.3	7.8	13.7	3.1	6.6	4.3	11.0	1.8	6.0	9.7	9.1	11.2	6.7	7.4	2.9	1.1	6.7	5.6	0.8	3.5	17.1	13.1	7.5	11.2	2.5	10.6	8.8	18.6	12.1	11.2	1.9	8.5	3.1	2.6	6.7	5.7	9.2	16.9	3.2	0.0	0.1	3.8	6.2	5.1	7.6	2.7	3.3	1.0	15.5	4.5	17.8	8.7	13.7	14.2	3.6	11.2	14.4	16.6	1.1	14.8	2.9	4.3	8.3	9.0	21.6	35.7	13.4	23.7	18.4	23.4	14.9	16.7	11.7	9.5
PLEKHG7	FLJ46688	ENSG00000187510	"Pleckstrin homology and RhoGEF domain containing G7"	Q6ZR37	12	92721462-92772455	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 5.6;fallopian tube: 7.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.8;HBF TERT88: 1.3;RPMI-8226: 5.0;RT4: 1.1;SK-BR-3: 4.1"	"Low cancer specificity"	"Detected in single"							"Group enriched"	"Detected in some"	31	"memory B-cell: 4.5;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	45	"B-cells: 4.5"									HPA060632	Uncertain									"HPA060632: AB_2684333"	"unprognostic (4.47e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.80e-2)"	"unprognostic (9.91e-5)"	"unprognostic (1.38e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.75e-1)"		"unprognostic (3.27e-5)"	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.3	0.6			0.1	0.4	5.6	0.1	7.9	0.3	0.0	0.0	0.0	0.7	0.5	2.2	2.0	0.0		0.0	1.4	0.0	0.0	0.0		0.8	0.4		0.1	0.6	0.0	0.0	2.6	0.0	0.0	1.6	2.7	0.1			0.0		2.9	2.9	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.2	1.8	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	5.0	0.1	1.1	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PLSCR2		ENSG00000163746	"Phospholipid scramblase 2"	Q9NRY7	3	146391421-146495991	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 8.1;testis: 16.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.0;EFO-21: 2.4;Karpas-707: 2.7;U-266/70: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (1.11e-1)"	"unprognostic (9.83e-2)"	"unprognostic (8.94e-3)"	"unprognostic (7.53e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.11e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.88e-4)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.23e-2)"	0.3	0.3	0.3	1.7	0.3	1.3	0.4	1.0	0.4	0.4	1.5	0.0	1.3	0.2	0.3	8.1	0.6	0.9	1.4	0.3	1.1	0.3	1.4	0.3	1.0	1.8	0.3	0.4	1.0	1.2	0.3	3.2	0.5	1.6	0.4	0.5	0.6	1.4	3.0	0.3	0.3	0.4	0.2	0.8	0.3	0.5	16.8	0.0	0.1	2.5	0.7	0.1	0.3	2.2	0.6	0.5	1.7	1.1	1.3	1.6	0.6	0.0	0.3	0.0	0.1	0.0	1.5	0.2	0.0	0.5	0.7	0.9	0.2	2.0	0.0	2.4	0.0	0.2	0.3	0.0	0.5	0.1	0.4	0.6	0.9	0.2	0.9	0.0	0.8	0.5	0.5	0.2	0.9	0.0	0.3	2.7	0.1	0.0	0.0	0.0	0.5	1.6	0.3	0.0	0.0	1.6	0.0	0.7	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.6	0.6	1.3	0.6	0.9	1.4	0.5	0.3	1.4	1.6	1.7	1.3	0.0	0.4	0.0	0.6	0.3	0.3	1.0	0.4	1.1	0.3	0.3	0.4	1.6	0.0
PNMA6E		ENSG00000214897	"PNMA family member 6E"	A0A0J9YXQ4	X	153395640-153401420	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 8.0;ovary: 6.5;testis: 26.2"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 2.7;THP-1: 1.1;U-937: 2.1"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																									"unprognostic (5.82e-2)"						"unprognostic (1.71e-1)"		"unprognostic (2.99e-2)"			"unprognostic (1.77e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PNP	"NP, PUNP"	ENSG00000198805	"Purine nucleoside phosphorylase"	P00491	14	20468954-20477094	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 153.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 81.4;U-937: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA001625	Enhanced		Supported	Cytosol		100000000	100000000	Cytosol	Cytosol	"HPA001625: AB_1854577"	"unprognostic (1.20e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (4.94e-3)"	"unprognostic (3.87e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"prognostic favourable (2.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	24.7	7.6	9.5	15.0	14.0	69.4	15.7	13.9	11.8	9.5	19.1	6.2	25.2	29.4	5.9	153.1	34.0	7.8	15.7	12.1	11.5	8.4	49.7	24.2	18.3	13.2	13.5	3.4	3.6	11.0	8.7	8.4	45.3	17.7	6.0	16.1	3.8	9.2	7.9	3.3	10.6	32.0	9.8	16.3	18.0	17.0	4.5	12.5	7.0	7.1	21.7	19.1	7.5	14.7	13.1	20.7	4.1	12.4	15.7	33.7	12.1	13.2	17.9	3.8	8.6	4.3	3.5	11.7	13.6	6.4	11.1	11.0	10.3	12.2	35.4	15.8	7.2	14.3	20.1	25.6	14.8	11.4	17.7	29.6	15.3	17.0	4.0	81.4	15.4	2.3	9.3	33.5	14.8	47.3	14.5	22.1	13.9	12.3	23.9	48.0	10.8	29.9	20.2	5.7	13.7	39.4	12.6	16.6	3.7	26.0	33.2	2.1	12.2	14.5	37.9	7.6	10.1	17.1	23.0	10.2	17.0	40.1	6.5	92.8	0.7	4.0	12.4	4.1	18.1	11.5	33.7	11.2	20.3	20.0	20.7	13.1	12.9	16.3	1.6	15.7	10.6	11.7	6.9	12.1	9.5	14.0	13.9	11.8	11.5	8.4	13.5	3.4	17.7	12.5
PNPLA5	"dJ388M5.4, GS2L"	ENSG00000100341	"Patatin like phospholipase domain containing 5"	Q7Z6Z6	22	43879678-43892013	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.6;epididymis: 6.2;skin 1: 4.6"	"Group enriched"	"Detected in some"	5	"NTERA-2: 3.9;RPMI-8226: 7.1;SCLC-21H: 2.4"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.9"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA050409, HPA054211"	Uncertain									"HPA050409: AB_2681118, HPA054211: AB_2682418"				"unprognostic (6.69e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.27e-2)"		"unprognostic (3.33e-3)"				"unprognostic (1.05e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.31e-2)"		0.0	0.1	0.5	0.2	5.6	1.0	0.9	0.1	2.4	0.1	0.0			0.1	0.3	6.2	0.0	0.6	0.5	0.0	0.8	0.9	0.0	1.7	0.1	0.1	0.4		0.0	0.0	0.0	1.3	0.1		0.2	0.0		0.1	0.1	0.0	4.6	0.0	0.1	0.1	0.2	0.1	0.4			0.5		0.0	0.0	0.0	0.7	1.0	2.2	0.5	0.2	0.7	0.0	0.2	0.0	0.1	0.3	0.1	0.4	0.2	0.1	0.3	0.1	0.8	0.3	0.4	0.1	0.4	0.2	0.4	0.2	0.5	0.1	0.7	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.2	0.3	0.4	0.3	0.1	0.3	3.9	0.1	0.2	0.2	7.1	0.1	0.0	2.4	0.2	0.5	0.1	0.0	0.3	0.1	0.2	0.6	0.2	0.3	0.1	0.3	0.1	0.2	0.4	0.2	0.1	2.2	0.5	0.1	0.7	0.3	0.5	0.4	0.6	0.6	0.1	0.7	0.4	0.6	1.6	0.2	0.5	1.0	0.6	0.0										
PPP1R11	"CFAP255, HCG-V, HCGV, TCTE5, Tctex5"	ENSG00000204619	"Protein phosphatase 1 regulatory inhibitor subunit 11"	O60927	6	30066709-30070333	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 93.3"	"Cell line enhanced"	"Detected in some"		"A-431: 19.8;AN3-CA: 26.4;fHDF/TERT166: 14.7;HBEC3-KT: 16.6;HEK 293: 13.6;HEL: 15.9;RPTEC TERT1: 18.4;U-266/84: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043266, HPA060174"	Approved		Approved	Vesicles				Vesicles	Vesicles	"HPA043266: AB_2678400, HPA060174: AB_2684216"	"unprognostic (2.00e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-3)"	36.0	18.2	18.5	8.3	21.6	4.4	12.9	9.8	31.7	11.0	27.0	17.3	7.9	33.2	16.0	93.3	26.8	33.7	23.9	16.8	16.6	17.6	18.2	22.6	12.9	13.2	15.5	14.5	26.2	33.1	5.9	8.8	21.1	14.6	13.6	4.6	14.0	20.4	8.8	39.0	37.0	28.6	9.4	13.4	16.0	27.2	18.1	11.4	16.9	20.6	10.9	29.6	15.8	12.4	2.6	2.7	4.4	3.5	0.8	3.2	1.8	19.8	0.0	0.0	26.4	11.7	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	16.6	0.0	0.0	13.6	15.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	18.4	8.6	0.0	0.0	0.0	9.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	17.6	7.7	0.0	0.0	0.0	2.9	2.6	4.4	1.7	3.5	2.0	2.1	1.9	3.1	1.3	2.6	2.7	2.1	2.9	0.8	2.9	2.7	3.2	1.8	18.5	21.6	9.8	31.7	16.6	17.6	15.5	14.5	14.6	11.4
PRAF2	"JM4, Yip6a"	ENSG00000243279	"PRA1 domain family member 2"	O60831	X	49071156-49074071	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 125.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA002859, HPA005504, CAB011655"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB011655: , HPA002859: AB_1079672, HPA005504: AB_2667340"	"unprognostic (1.50e-1)"	"prognostic favourable (7.42e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.67e-1)"	"prognostic unfavourable (1.66e-6)"	"prognostic favourable (2.81e-4)"	"unprognostic (6.10e-2)"	"unprognostic (3.77e-1)"	"prognostic favourable (4.88e-6)"	"unprognostic (8.39e-3)"	"prognostic unfavourable (5.83e-6)"	"unprognostic (4.96e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	13.5	17.5	25.0	12.3	26.9	6.7	9.0	18.0	39.7	28.1	11.8	26.3	12.6	6.0	22.1	125.1	7.3	15.6	12.3	12.9	25.3	29.9	12.4	6.9	11.5	11.3	26.1	18.9	20.1	6.2	19.7	31.0	9.8	25.5	12.2	10.0	13.0	7.5	29.4	6.8	7.6	6.6	33.2	23.1	10.9	9.2	17.7	17.0	14.4	13.3	3.8	11.9	12.6	10.7	14.6	6.7	16.4	6.4	16.8	29.4	11.1	4.5	9.5	11.1	14.1	40.0	24.3	1.4	16.1	16.9	11.0	12.1	0.5	1.4	0.4	3.9	34.9	4.2	0.4	8.7	12.2	8.3	12.6	3.6	12.3	0.4	41.0	2.3	7.0	30.9	7.5	20.8	15.2	16.8	0.5	1.2	19.1	8.3	14.9	2.8	6.2	0.6	8.2	6.1	0.9	16.3	1.3	7.4	18.5	13.5	7.0	9.2	6.8	1.6	10.1	8.5	11.3	18.2	4.7	20.1	5.1	3.6	20.4	4.1	13.1	16.4	5.9	7.9	18.3	6.4	20.7	14.6	20.1	16.1	6.7	13.6	18.1	19.4	15.4	16.8	4.8	2.6	29.4	11.1	25.0	26.9	18.0	39.7	25.3	29.9	26.1	18.9	25.5	17.0
PRDM9	"KMT8B, MSBP3, PFM6, ZNF899"	ENSG00000164256	"PR/SET domain 9"	Q9NQV7	5	23443586-23528597	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 4.1;epididymis: 3.3;testis: 8.3"	"Cell line enriched"	"Detected in some"	11	"U-266/70: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"							HPA059555	Uncertain									"HPA059555: AB_2684061"							"unprognostic (1.23e-4)"			"unprognostic (8.64e-2)"				"unprognostic (2.18e-2)"	"unprognostic (8.34e-2)"		"unprognostic (4.11e-1)"	0.1	0.0	0.1	0.1	0.1	1.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	3.3	0.1	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.0	8.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.5	4.1	0.7	2.3	1.0	0.1	0.0	0.5	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.7	0.2	0.0	0.5	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.9	0.0	0.0	12.1	0.2	0.1	0.1	0.2	0.1	2.9	0.7	0.3	0.7	0.3	0.8	0.9	0.8	0.6	0.3	1.5	0.8	1.0	4.1	2.3	0.5	0.5	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PROKR1	"GPR73, GPR73a, PKR1, ZAQ"	ENSG00000169618	"Prokineticin receptor 1"	Q8TCW9	2	68643589-68658247	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 3.3;epididymis: 8.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 2.2;NTERA-2: 6.5;SCLC-21H: 1.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.5"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA029396	Uncertain									"HPA029396: AB_10610285"	"unprognostic (5.46e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.75e-2)"	"unprognostic (4.99e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.72e-2)"	"unprognostic (8.96e-7)"	"unprognostic (4.07e-2)"	"unprognostic (2.53e-1)"	"unprognostic (4.19e-1)"	"unprognostic (7.22e-2)"	3.3	2.6	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.2			0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.3	0.0		0.0	0.1		0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0										
PRR29	"C17orf72, DKFZp761M2312, FLJ11724"	ENSG00000224383	"Proline rich 29"	P0C7W0	17	63998351-64004304	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 17.9;fallopian tube: 48.7;testis: 23.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.7;REH: 6.8;RPMI-8226: 2.8;TIME: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA051264			Uncertain	Nucleoli				Nucleoli	Nucleoli	"HPA051264: "	"unprognostic (2.05e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.22e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.30e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.98e-3)"	0.9	0.5	3.3	0.8	7.6	0.6	0.9	0.1	2.1	4.0	0.5	8.3	0.4	0.6	1.0	17.9	0.6	48.7	1.0	0.7	5.6	5.5	0.6	0.6	7.3	0.7	1.6	0.8	8.1	0.5	0.9	5.8	0.7	15.2	0.6	0.4	0.2	0.9	0.9	0.6	0.5	0.5	0.6	1.1	2.5	0.5	23.5	1.0	0.0	2.5	0.0	0.7	1.0	0.0	1.0	0.7	3.1	1.8	1.0	3.0	1.6	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.2	0.0	0.0	0.4	0.0	6.7	0.0	0.7	0.0	0.0	0.1	0.4	0.2	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	1.0	0.0	0.0	0.0	2.3	0.0	0.2	0.2	6.8	0.1	2.8	0.5	0.0	0.4	2.0	0.0	0.3	0.4	1.0	0.0	5.5	0.2	2.3	0.7	0.2	0.7	0.1	0.5	0.9	0.3	0.0	3.1	0.9	0.0	2.0	1.8	0.4	0.7	1.7	1.0	0.7	1.0	3.0	1.7	0.8	1.0	1.7	0.1	1.1	1.6	3.3	7.6	0.1	2.1	5.6	5.5	1.6	0.8	15.2	1.0
PRRG3	TMG3	ENSG00000130032	"Proline rich and Gla domain 3"	Q9BZD7	X	151695124-151705924	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 12.4;epididymis: 10.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.7;HMC-1: 2.2;NTERA-2: 4.1;U-2197: 2.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA060566	Uncertain									"HPA060566: AB_2684321"	"unprognostic (1.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.42e-4)"	"unprognostic (7.24e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.84e-2)"	3.1	0.2	5.6	1.2	12.4	0.4	2.0	1.0	10.2	9.2	1.1	1.0	0.1	0.3	3.0	10.3	4.0	1.0	3.3	1.6	5.3	11.6	0.4	0.1	2.0	0.2	3.2	5.3	3.9	0.1	0.4	1.3	1.3	5.3	1.1	1.0	1.4	1.3	0.4	3.3	2.5	0.5	2.4	1.2	2.6	0.6	0.6	0.7	0.1	0.7	0.6	0.4	1.4	2.4	1.2	1.4	3.8	1.8	2.4	1.4	1.0	0.2	0.2	0.3	0.3	0.2	0.0	0.3	0.2	0.0	0.0	0.0	1.2	0.4	0.3	0.2	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.1	2.7	0.4	0.2	0.3	2.2	0.3	0.0	0.1	0.2	0.0	0.1	0.5	0.2	0.3	0.1	0.5	4.1	0.1	0.2	0.0	0.1	0.1	0.5	1.0	0.4	0.0	0.3	0.1	0.2	0.2	0.1	0.5	0.5	2.3	0.1	0.1	1.4	0.1	0.3	0.2	0.1	3.8	1.3	1.3	1.2	1.2	1.4	1.1	0.9	0.9	1.0	1.2	1.3	1.1	3.1	2.4	1.8	1.4	1.1	1.0	5.6	12.4	1.0	10.2	5.3	11.6	3.2	5.3	5.3	0.7
PRSS45	TESSP5	ENSG00000188086	"Serine protease 45"	Q7RTY3	3	46742092-46744755	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 7.6;skeletal muscle: 6.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.2;HBF TERT88: 1.0;HHSteC: 2.6"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	19	"naive B-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"B-cells: 1.9"									HPA060284	Uncertain									"HPA060284: AB_2684242"	"unprognostic (4.55e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-4)"	"unprognostic (2.33e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.97e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.5	0.2			0.1	0.2	7.6	0.1	0.8	0.0	0.2	0.0	0.0	0.9	0.7	0.2	0.1	0.0		0.3	1.3	2.0	0.5	0.1		0.5	0.0		0.5	0.3	6.7	0.3	0.0	0.0	0.0	0.0	0.2	1.6			3.2		0.0	0.4	0.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PXYLP1	"ACPL2, FLJ23751"	ENSG00000155893	"2-phosphoxylose phosphatase 1"	Q8TE99	3	141228726-141367753	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 89.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017243	Uncertain				"Intracellular and membrane"					"HPA017243: AB_1844509"	"unprognostic (9.55e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.45e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.05e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.07e-3)"	"unprognostic (4.67e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.56e-2)"	"unprognostic (8.17e-3)"	4.1	4.4	9.1	3.8	11.8	3.2	5.5	3.8	13.2	6.5	3.7	5.9	23.7	3.8	8.6	89.2	2.2	5.8	5.4	8.9	6.6	6.6	5.1	3.5	4.9	9.0	4.5	7.4	6.5	8.6	8.6	6.5	10.8	5.2	6.7	4.0	5.2	5.1	20.7	3.3	4.2	4.7	4.8	5.4	3.8	5.5	13.7	4.6	28.0	4.3	1.9	6.1	6.0	4.5	0.5	3.8	7.2	4.1	13.0	16.8	6.3	3.3	3.6	15.5	12.2	6.1	5.3	3.7	2.3	5.9	6.1	8.5	5.9	1.1	0.2	3.3	5.3	0.8	16.3	1.5	5.8	11.0	10.7	1.2	4.9	4.7	13.1	3.0	0.6	5.0	7.0	1.8	0.6	0.4	0.5	1.4	2.7	2.9	16.2	3.8	6.4	2.0	2.2	9.0	2.1	4.3	14.8	6.8	12.0	6.1	1.9	5.0	6.4	1.8	0.7	7.8	4.7	5.3	2.2	3.3	0.2	0.5	7.2	4.2	6.8	7.2	4.1	6.2	9.9	2.8	6.4	0.5	5.7	6.6	3.8	0.4	16.8	13.5	2.8	13.0	1.3	1.3	3.0	6.3	9.1	11.8	3.8	13.2	6.6	6.6	4.5	7.4	5.2	4.6
RAB40A	"Rar-2, RAR2A"	ENSG00000172476	"RAB40A, member RAS oncogene family"	Q8WXH6	X	103499130-103519489	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 34.0"	"Cell line enhanced"	"Detected in many"		"AF22: 6.4;NTERA-2: 7.1"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 4.2"	"Cell type enriched"	"Detected in single"	5	"memory B-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.2"									HPA076172			Uncertain	Vesicles				Vesicles	Vesicles	"HPA076172: "	"unprognostic (3.49e-1)"	"unprognostic (6.01e-2)"	"unprognostic (4.33e-2)"	"unprognostic (4.49e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.43e-1)"	"unprognostic (7.36e-4)"	"unprognostic (7.85e-3)"	"unprognostic (9.39e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.11e-3)"	2.0	1.4	0.6	0.6	4.2	0.0	0.8	0.6	1.1	2.8	0.8	0.6	11.9	0.5	5.5	34.0	10.6	2.6	2.9	0.6	0.6	0.9	1.3	0.6	2.0	1.7	0.6	0.6	5.4	0.6	0.6	2.4	0.8	0.8	5.5	0.4	0.6	0.6	6.2	0.6	0.7	0.9	1.3	0.6	0.8	0.5	7.8	0.6	0.6	0.6	0.6	0.6	1.5	2.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.4	1.7	6.4	0.2	1.4	1.9	3.1	1.9	0.4	0.3	0.5	1.3	0.9	1.6	2.4	0.3	0.1	0.4	0.1	0.3	0.0	3.7	0.5	2.9	0.3	0.6	0.1	0.2	1.5	0.3	0.6	0.4	0.3	2.3	1.0	0.6	0.4	0.4	0.2	7.1	1.0	0.0	0.5	0.1	0.1	0.6	2.7	3.3	0.6	0.1	1.3	0.0	0.2	3.2	2.6	1.5	4.0	1.8	1.1	0.7	1.2	2.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.6	4.2	0.6	0.6	0.6	0.9	0.6	0.6	0.8	0.6
RAB40AL	"RAR2, RLGP"	ENSG00000102128	"RAB40A like"	P0C0E4	X	102937272-102938300	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 2.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;HEK 293: 1.9"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"											HPA076172			Uncertain	Vesicles				Vesicles	Vesicles	"HPA076172: "	"unprognostic (1.99e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (5.90e-10)"	"unprognostic (4.74e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.64e-2)"	0.3	1.0	0.2	0.2	0.3	0.7	0.4	2.1	0.4	0.3	0.4			1.0	0.8	2.9	0.2	0.3	0.7	0.3	0.3	0.3	0.2	0.5	0.5	0.0	0.2		1.0	0.2	0.0	0.9	0.6		0.8	0.1		0.2	0.5	0.0	0.2	0.1	0.6	0.4	0.2	0.1	0.3			0.8		0.2	0.0	0.5	0.0	1.2	0.0	0.3	0.0	0.7	0.0	0.5	0.6	0.8	0.2	0.0	0.0	2.3	0.0	0.2	0.0	0.5	0.0	0.5	0.0	0.6	0.0	0.0	1.2	0.0	0.6	0.2	1.9	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.3	0.3	0.4	0.3	0.3	0.0	0.0	1.4	0.6	0.9	0.6	1.6	0.0	0.3	0.0	0.2	1.0	0.0	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.3	1.4	0.5	0.4	0.3	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0										
RABL2B		ENSG00000079974	"RAB, member of RAS oncogene family like 2B"	Q9UNT1	22	50767501-50783663	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 59.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042642, HPA042700, HPA044007"	Approved		Approved	Vesicles,Centrosome				Centrosome	Centrosome	"HPA042642: , HPA042700: AB_2678120, HPA044007: "	"unprognostic (2.09e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.86e-3)"	"prognostic favourable (5.58e-4)"	"unprognostic (7.85e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavourable (4.58e-5)"	"unprognostic (3.14e-1)"	"unprognostic (6.97e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.71e-3)"	"unprognostic (7.43e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.37e-3)"	8.2	8.2	12.4	11.1	22.1	8.1	12.9	19.7	21.2	13.0	8.4	12.7	12.6	7.9	13.9	59.0	8.1	41.9	9.4	5.8	13.1	15.3	10.6	7.0	14.4	13.3	9.9	16.5	17.8	9.6	10.9	16.7	7.4	14.3	10.0	11.0	9.5	9.5	11.6	5.1	13.8	8.6	10.2	9.5	11.5	9.1	12.2	14.5	12.6	17.9	3.5	12.3	9.4	9.2	13.6	13.2	9.2	19.4	10.8	16.8	10.3	13.4	12.3	21.0	16.4	23.6	18.8	15.4	10.1	11.3	8.2	11.3	3.4	11.9	8.7	9.0	14.5	17.7	9.6	11.8	8.9	7.5	13.6	7.5	21.1	8.9	9.8	21.1	8.1	16.0	16.2	10.8	13.6	9.1	5.7	11.0	16.3	17.0	10.5	9.3	8.0	9.2	17.8	12.1	9.1	15.9	13.4	9.0	16.4	12.4	11.0	7.6	10.8	6.6	14.0	7.9	15.8	6.7	6.8	9.3	4.3	4.2	14.9	5.3	11.0	1.0	10.9	9.2	16.8	17.4	12.2	11.2	13.0	13.7	11.6	13.6	15.2	14.7	4.3	10.8	19.4	13.2	13.0	10.3	12.4	22.1	19.7	21.2	13.1	15.3	9.9	16.5	14.3	14.5
RCN1	"FLJ37041, PIG20, Rcal, RCN"	ENSG00000049449	"Reticulocalbin 1"	Q15293	11	32090904-32105755	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 123.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA038474, HPA062104"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	2300000	2300000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA038474: AB_10672595, HPA062104: AB_2684683"	"unprognostic (1.65e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.03e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.92e-3)"	"prognostic unfavourable (7.13e-6)"	"unprognostic (8.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.32e-2)"	"prognostic unfavourable (2.70e-13)"	"unprognostic (1.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.93e-3)"	25.0	19.8	9.6	14.3	38.8	1.6	38.2	7.6	11.4	22.3	13.6	5.8	17.0	10.8	23.3	123.1	12.2	18.2	15.3	19.4	9.2	9.8	12.4	33.7	17.9	20.2	7.0	5.9	35.2	16.4	17.9	34.9	32.6	9.7	22.6	12.6	11.4	37.0	24.2	12.8	9.1	10.5	19.2	10.9	11.5	11.8	11.4	6.9	5.4	16.8	10.0	6.9	25.3	32.3	4.3	11.0	0.5	11.8	7.5	12.4	6.5	13.2	14.3	33.1	22.0	81.4	62.1	38.1	45.6	55.7	32.2	58.1	12.5	17.0	0.0	31.6	74.3	16.3	11.9	13.6	48.4	6.4	26.0	2.9	10.3	4.5	60.2	2.1	4.4	86.5	16.9	20.4	23.0	70.4	1.7	2.4	36.8	11.0	6.0	4.0	14.2	16.2	4.7	41.5	3.9	27.4	30.9	8.9	4.6	12.1	2.8	34.9	17.5	8.4	36.7	41.7	23.7	36.1	38.5	0.1	0.0	0.1	57.9	2.7	23.6	0.2	10.0	0.3	12.4	11.8	9.7	4.3	5.7	9.9	11.0	3.5	4.2	8.0	0.5	7.5	7.2	6.4	2.0	6.5	9.6	38.8	7.6	11.4	9.2	9.8	7.0	5.9	9.7	6.9
RCN2	"E6BP, ERC-55, ERC55, TCBP49"	ENSG00000117906	"Reticulocalbin 2"	Q14257	15	76931619-76954392	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 147.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030694, HPA030695"	Enhanced	Supported	Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	41000	41000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA030694: AB_2673573, HPA030695: AB_2673574"	"unprognostic (1.69e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.71e-2)"	"prognostic unfavourable (7.36e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.67e-2)"	13.8	14.7	29.9	12.1	32.6	9.9	16.8	25.1	37.5	16.8	15.0	17.3	28.1	10.4	20.6	147.5	14.9	25.0	15.3	17.3	29.5	41.5	22.6	9.3	13.5	12.5	27.2	29.5	18.8	11.0	28.4	17.8	27.7	24.6	19.6	17.2	15.5	12.0	21.9	22.7	10.6	11.0	18.2	18.5	12.4	13.8	48.2	14.8	14.8	22.1	17.0	14.3	17.8	13.3	15.9	12.0	9.8	7.2	14.1	19.0	11.5	20.4	14.5	64.8	30.5	28.0	32.0	40.5	24.4	33.3	31.8	26.6	17.9	17.6	12.8	35.4	26.5	31.3	49.0	21.0	40.7	9.8	38.2	6.3	21.2	29.6	33.5	22.8	9.8	28.9	29.1	15.6	20.2	33.5	15.9	12.8	33.1	13.1	22.5	15.7	49.3	16.2	23.8	42.7	8.1	20.9	27.5	37.1	37.0	39.9	22.4	46.4	21.8	25.3	17.9	37.6	30.4	23.9	50.1	18.4	56.6	15.2	21.4	19.2	34.0	4.5	4.8	9.8	14.8	4.4	17.2	14.8	15.7	19.0	10.2	15.9	17.8	17.2	2.6	14.1	7.2	12.0	10.9	11.5	29.9	32.6	25.1	37.5	29.5	41.5	27.2	29.5	24.6	14.8
REELD1		ENSG00000250673	"Reeler domain containing 1"		4	146214515-146230878	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"breast: 1.3;epididymis: 1.5;skin 1: 1.7"	"Cell line enriched"	"Detected in single"	87	"HDLM-2: 14.3"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (6.26e-3)"	"unprognostic (1.40e-1)"		"unprognostic (3.81e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.55e-6)"	"unprognostic (2.19e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.90e-1)"	"unprognostic (3.13e-2)"	0.1	0.0		0.9		0.4	1.3		0.2	0.4	0.0			0.0	0.0	1.5	0.0	0.2	0.0	0.0			0.1	0.7	0.2	0.2			0.0	0.4	0.0		0.0		0.3	0.0		0.0	0.0	0.5	1.7	0.0	0.0		1.0	0.0	0.1			0.0		0.7	0.0		0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.2										
RIPPLY3	DSCR6	ENSG00000183145	"Ripply transcriptional repressor 3"	P57055	21	37006150-37019659	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 9.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.5;EFO-21: 1.8;PC-3: 2.3;RT4: 1.3;SCLC-21H: 6.9;T-47d: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"basal ganglia: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA055541	Uncertain									"HPA055541: AB_2682840"	"unprognostic (1.77e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.57e-4)"	"unprognostic (2.69e-1)"	0.1	0.3	0.0	0.1	3.4	0.1	0.1	0.9	0.6	0.7	0.2	0.0	3.7	0.1	0.7	9.6	0.9	0.1	0.1	0.1	0.0	0.0	0.7	0.4	1.9	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.8	0.0	2.0	0.1	2.8	1.9	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.1	0.5	1.8	0.0	0.2	0.0	1.6	2.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	2.3	0.0	0.0	0.0	1.2	1.3	6.9	0.1	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8
RNF183	MGC4734	ENSG00000165188	"Ring finger protein 183"	Q96D59	9	113297093-113303376	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 19.0;kidney: 9.5"	"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 20.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA057675	Uncertain									"HPA057675: AB_2683499"	"unprognostic (1.23e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (7.95e-6)"	"unprognostic (2.56e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.98e-1)"	"prognostic favourable (3.51e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.53e-3)"	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	1.9	0.2			0.2	1.2	19.0	5.1	1.2	6.2	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0		0.1	0.1	0.0	1.9	0.0		0.8	0.3		6.9	0.2	0.0	0.1	0.1	0.0	0.0	0.0	3.7	4.3			0.1		0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ROBO3	"FLJ21044, HGPPS, HGPS, RBIG1"	ENSG00000154134	"Roundabout guidance receptor 3"	Q96MS0	11	124865386-124881470	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 20.1"	"Cell line enriched"	"Detected in some"	11	"AF22: 20.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.0"	"Low region specificity"	"Detected in all"			HPA071053			Approved	"Vesicles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA071053: "	"unprognostic (1.30e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.95e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.84e-2)"	"unprognostic (6.25e-2)"	"unprognostic (6.95e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.15e-2)"	"unprognostic (3.75e-8)"	"unprognostic (7.27e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-3)"	2.4	1.5	1.5	0.5	1.4	1.3	1.7	0.5	3.1	0.8	0.9	0.5	0.5	1.9	1.8	20.1	0.5	2.1	0.5	1.5	1.5	0.6	0.7	0.5	1.7	0.8	1.1	1.1	7.4	0.5	0.2	0.5	1.5	1.0	1.0	0.2	1.0	1.7	0.5	2.6	0.2	2.2	4.5	0.7	3.0	0.8	1.0	0.5	0.8	1.1	0.5	0.5	0.5	1.0	0.0	1.3	1.4	0.3	0.0	0.8	0.0	0.0	0.0	20.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	1.2	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.7	1.0	0.0	1.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.0	0.3	0.4	0.0	0.6	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.2	1.3	0.8	0.0	1.5	1.4	0.5	2.7	1.5	0.6	1.1	1.1	1.0	0.5
ROS1	"c-ros-1, MCF3, ROS"	ENSG00000047936	"ROS proto-oncogene 1, receptor tyrosine kinase"	P08922	6	117288300-117425855	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 38.6;lung: 20.2"	"Group enriched"	"Detected in some"	5	"HSkMC: 9.3;hTCEpi: 19.3;LHCN-M2: 13.4"	"Cancer enriched"	"Detected in some"	13	"lung cancer: 6.9"	"Group enriched"	"Detected in some"	10	"cerebral cortex: 7.4;olfactory region: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049098, HPA072424"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA049098: AB_2680628, HPA072424: AB_2686519"	"unprognostic (8.18e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.56e-12)"	"unprognostic (1.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	0.3	0.2	0.2	0.0	0.4	0.0	0.2	0.2	7.4	0.2	0.4	0.0	7.9	0.0	0.2	38.6	0.2	0.2	0.0	0.2	0.2	0.2	0.4	0.2	20.2	0.0	0.2	2.5	0.2	0.2	0.0	0.3	0.7	0.0	0.2	0.3	0.0	0.2	2.3	0.2	0.7	0.3	0.0	0.2	0.2	0.3	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	9.3	19.3	0.2	1.7	0.0	0.0	0.0	13.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	1.8	0.0	2.3	1.5	0.1	1.8	0.0	0.0	0.0	1.7	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	7.4	0.2	0.2	0.2	2.5	0.0	0.0
RPRD1A	"FLJ10656, HsT3101, P15RS"	ENSG00000141425	"Regulation of nuclear pre-mRNA domain containing 1A"	Q96P16	18	35984387-36067576	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 88.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040602	Supported		Supported	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA040602: AB_10673137"	"unprognostic (2.06e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.92e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.50e-3)"	"unprognostic (7.95e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.30e-1)"	16.8	27.0	32.1	12.0	32.0	7.8	19.0	28.5	36.9	16.9	18.1	22.8	26.3	14.4	20.0	88.6	18.4	19.7	14.4	21.3	30.2	27.6	20.8	16.5	14.5	13.8	27.5	31.3	19.3	17.6	20.2	24.0	13.7	30.2	23.3	16.1	13.2	20.2	23.4	36.1	15.3	13.5	21.2	27.8	16.0	14.9	20.3	23.5	10.2	24.4	11.1	14.3	20.6	20.1	8.6	10.7	5.0	8.4	9.3	7.6	4.3	12.0	13.4	22.8	24.2	12.5	14.8	14.2	22.0	21.6	12.7	18.0	3.6	13.5	17.0	23.1	15.8	20.2	25.3	22.1	18.1	15.0	14.5	18.0	20.1	14.2	22.1	30.0	9.8	11.3	29.6	12.1	34.6	18.2	16.2	18.6	16.3	15.0	15.9	12.8	18.3	9.7	13.3	7.3	27.2	19.5	26.1	39.9	33.7	18.2	10.2	18.7	14.0	21.6	22.1	13.4	8.4	7.1	17.8	21.1	29.1	17.6	13.6	24.9	13.4	0.9	6.3	3.0	4.4	8.4	6.5	7.5	5.8	5.0	10.7	8.6	7.6	5.8	5.0	9.3	5.5	7.4	3.1	4.3	32.1	32.0	28.5	36.9	30.2	27.6	27.5	31.3	30.2	23.5
RXFP2	"GPR106, GREAT, INSL3R, LGR8, RXFPR2"	ENSG00000133105	"Relaxin/insulin like family peptide receptor 2"	Q8WXD0	13	31739542-31803388	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 8.3;epididymis: 28.4"	"Group enriched"	"Detected in some"	6	"U-2197: 2.1;U-87 MG: 4.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"basal ganglia: 8.3"	"Cell type enriched"	"Detected in single"	11	"classical monocyte: 5.0"	"Lineage enriched"	"Detected in single"	23	"monocytes: 5.0"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	7	"basal ganglia: 2.0"																											"unprognostic (1.77e-2)"		0.5	3.3	1.5	0.1	8.3	2.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.9	28.4	0.0	1.5	0.1	0.5	0.6	0.5	0.3	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.6	0.0	0.2	0.0	3.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	5.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	1.5	8.3	0.0	0.5	0.6	0.5	0.0	0.0	0.5	0.0
SEC14L2	"C22orf6, KIAA1186, KIAA1658, SPF, TAP, TAP1"	ENSG00000100003	"SEC14 like lipid binding 2"	O76054	22	30396857-30425317	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 43.0;liver: 112.3"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 38.3;hTCEpi: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 2.6;naive CD4 T-cell: 7.1;naive CD8 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	8	"T-cells: 7.1"									HPA064466	Approved		Supported	Nucleoplasm,Cytosol		190000	190000	Nucleoplasm	Nucleoplasm	"HPA064466: AB_2685270"	"prognostic favourable (3.05e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.59e-3)"	"unprognostic (6.51e-2)"	"prognostic unfavourable (7.63e-6)"	"unprognostic (1.25e-3)"	"unprognostic (3.76e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.01e-1)"	1.9	1.2	13.6	1.9	14.2	2.4	22.7	7.3	15.0	2.2	5.7	12.6	7.3	10.1	2.4	43.0	8.0	2.3	4.3	1.1	10.8	10.4	3.6	112.3	1.8	2.1	16.1	10.4	1.3	1.9	3.7	5.0	1.5	10.6	25.7	1.4	24.2	4.0	7.8	1.0	2.9	13.5	2.4	8.9	1.0	3.4	1.2	10.4	1.1	4.3	0.6	2.7	1.8	2.9	0.8	0.9	0.5	0.2	0.1	7.1	1.5	9.9	2.4	2.0	2.7	3.0	7.5	0.1	8.1	6.5	4.8	5.0	0.6	6.7	0.2	2.4	9.8	7.7	1.2	38.3	5.3	0.9	1.9	0.2	2.4	3.6	4.1	0.0	2.6	5.2	20.9	4.4	7.9	12.0	0.0	0.2	9.6	1.7	1.0	0.2	0.0	3.4	0.4	3.5	0.2	8.5	3.3	1.2	1.4	5.0	1.1	4.5	6.5	0.1	18.2	6.7	4.3	2.7	4.9	0.1	0.0	0.3	14.7	0.0	5.3	0.1	0.2	0.4	0.9	0.2	0.4	0.8	2.6	0.6	0.1	0.6	7.1	4.7	0.5	0.1	0.1	0.9	1.1	1.5	13.6	14.2	7.3	13.4	10.8	10.4	16.1	10.4	10.6	10.4
SEC14L6		ENSG00000214491	"SEC14 like lipid binding 6"	B5MCN3	22	30522799-30546682	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 15.4;parathyroid gland: 20.9"	"Group enriched"	"Detected in some"	4	"K-562: 11.0;RPTEC TERT1: 20.6;SiHa: 6.1"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 12.6"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA067695			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA067695: AB_2685889"	"unprognostic (3.49e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.25e-2)"	"unprognostic (8.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.02e-2)"	0.7	0.7	3.3	0.0	3.6	1.1	2.4	1.1	2.1	2.3	0.0			0.1	2.0	15.4	0.0	0.9	2.8	0.0	2.4	3.4	7.2	0.0	7.9	0.0	4.0		1.7	3.5	20.9	1.8	0.0		1.0	0.0		0.0	1.6	0.0	7.3	0.0	1.3	3.9	0.0	0.6	3.8			0.0		0.1	0.1	0.0	1.2	0.9	2.7	0.8	1.9	2.2	0.3	0.2	0.1	0.9	0.3	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.2	0.5	0.3	1.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	2.8	0.3	0.3	0.1	0.2	0.4	0.0	0.1	0.1	0.1	0.0	11.0	0.2	0.0	0.4	0.1	0.4	0.5	0.1	0.2	0.0	0.1	20.6	0.2	0.2	0.1	6.1	0.1	0.0	1.6	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.3	0.1	1.9	0.8	0.7	0.6	0.6	1.6	0.7	0.5	0.5	0.2	1.2	0.6	0.9	2.7	1.9	0.7	0.9	2.2	0.3										
SERTM2	LINC00890	ENSG00000260802	"Serine rich and transmembrane domain containing 2"		X	111511662-111522399	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enhanced"	"Detected in some"		"epididymis: 60.2;seminal vesicle: 38.7"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 19.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 3.0"																"unprognostic (9.56e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.65e-1)"		"unprognostic (3.79e-2)"	"unprognostic (5.74e-2)"		"unprognostic (1.93e-2)"	"unprognostic (4.03e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.77e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.26e-1)"	"unprognostic (9.57e-3)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	15.2	0.5	0.0	9.1	0.0	14.2	60.2	0.0	0.0	0.0	0.0	0.0		0.0	1.7	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.6	1.7	0.5	4.6	0.0	0.1	0.0	38.7	0.0	0.0	0.0	2.2	0.0	2.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	1.0	0.0	3.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SH2D4B		ENSG00000178217	"SH2 domain containing 4B"	Q5SQS7	10	80537902-80646560	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 1.8;bone marrow: 2.5;epididymis: 2.4"	"Cell line enriched"	"Detected in single"	87	"REH: 24.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA040022	Uncertain									"HPA040022: AB_10805601"	"unprognostic (1.19e-2)"	"unprognostic (4.51e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.65e-6)"	"unprognostic (9.37e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.81e-1)"	0.6	0.0	0.2	0.2	0.3	2.5	0.3	0.1	0.3	0.1	0.1	0.1	0.1	0.3	0.2	2.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.2	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.0	1.3	0.1	0.1	0.5	0.1	0.2	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1
SLC16A12	MCT12	ENSG00000152779	"Solute carrier family 16 member 12"		10	89430299-89556641	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 28.0;kidney: 55.6"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 22.3;HSkMC: 7.9"	"Cancer enriched"	"Detected in many"	10	"renal cancer: 18.0"	"Region enriched"	"Detected in many"	6	"pons and medulla: 11.7"	"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037587			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA037587: AB_2732475"	"unprognostic (5.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.51e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic favourable (4.50e-12)"	"unprognostic (3.84e-2)"	"unprognostic (7.91e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.84e-3)"	2.3	1.3	1.0	0.1	0.7	0.0	2.4	1.3	0.6	4.9	1.6	2.6	6.2	0.1	2.0	28.0	0.5	2.2	0.1	4.0	1.8	0.8	55.6	1.0	3.3	0.1	0.8	0.3	1.8	13.3	0.0	5.0	5.9	11.7	1.4	0.1	16.3	0.9	7.9	4.4	1.1	0.8	0.5	0.6	0.1	1.7	2.4	0.3	0.0	3.8	0.7	0.0	1.8	1.5	0.7	0.5	1.8	0.3	0.9	0.3	0.0	0.2	0.0	0.1	0.1	2.9	22.3	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.3	0.1	3.6	0.0	0.0	7.9	0.2	1.1	1.4	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.4	0.1	0.0	0.8	0.0	2.7	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.8	0.3	0.3	0.2	0.3	0.2	0.3	0.2	0.2	0.0	0.7	0.2	0.3	0.8	0.9	0.1	0.5	0.0	0.0	1.0	0.7	1.3	0.6	1.8	0.8	0.8	0.3	11.7	0.3
SLC16A6	"MCT6, MCT7"	ENSG00000108932	"Solute carrier family 16 member 6"	O15403	17	68267026-68291267	"Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.5"	"Cell line enriched"	"Detected in some"	13	"SK-MEL-30: 104.5"	"Group enriched"	"Detected in many"	6	"breast cancer: 10.9;melanoma: 11.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA054459, HPA066328"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA054459: AB_2682494, HPA066328: AB_2685660"	"unprognostic (2.53e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.41e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.26e-3)"	"unprognostic (5.08e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (9.46e-2)"	7.8	3.4	3.0	6.6	6.3	8.1	6.2	3.7	6.2	2.2	0.8	3.1	9.8	0.9	2.8	32.5	12.4	1.5	1.6	1.4	3.2	4.2	0.9	1.4	9.7	4.6	4.7	1.4	1.8	1.2	0.4	2.4	2.4	6.9	0.8	1.0	13.0	3.5	11.0	10.3	4.2	1.2	0.9	2.7	6.3	1.1	2.2	0.9	1.5	3.3	6.6	7.9	3.7	3.3	0.6	2.7	8.5	4.7	1.1	2.9	1.2	0.4	0.3	0.1	0.1	0.1	0.1	3.0	0.1	3.8	0.3	0.2	0.1	0.5	3.4	0.3	0.0	0.1	0.5	0.0	0.1	1.0	0.2	0.2	0.4	4.4	0.6	1.1	0.2	0.1	0.0	0.2	0.2	0.1	0.2	0.7	0.0	3.8	1.6	0.7	0.0	0.1	0.0	0.0	0.4	0.1	0.3	0.8	0.0	0.1	2.0	104.5	3.0	0.7	0.5	1.2	0.2	0.1	0.3	0.8	3.0	3.2	7.9	0.9	0.5	1.1	4.7	0.3	2.9	4.4	1.5	0.6	1.2	2.3	2.7	0.3	0.8	1.6	8.5	1.1	2.2	0.6	2.6	1.2	3.0	6.3	3.7	6.2	3.2	4.2	4.7	1.4	6.9	0.9
SLC38A11	"AVT2, FLJ39822"	ENSG00000169507	"Solute carrier family 38 member 11"	Q08AI6	2	164896186-164955525	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 35.6"	"Cell line enriched"	"Detected in some"	9	"BJ hTERT+: 73.8"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 7.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	54	"memory B-cell: 2.7;naive B-cell: 7.9"	"Lineage enriched"	"Detected in single"	79	"B-cells: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043432	Uncertain									"HPA043432: AB_10793948"	"unprognostic (1.52e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.28e-3)"	"unprognostic (3.53e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.99e-1)"	"prognostic favourable (2.00e-8)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.36e-2)"	1.8	3.9	5.1	1.4	8.0	0.4	1.1	1.4	9.7	2.7	1.5	2.7	6.5	5.4	2.1	35.6	1.3	1.2	19.1	1.1	5.6	4.0	7.2	2.5	0.6	2.8	5.8	2.6	0.6	2.7	2.1	11.7	0.5	22.1	9.9	2.7	15.6	1.0	15.9	1.8	0.8	2.6	2.1	2.4	11.2	10.2	1.1	3.2	0.0	2.1	2.9	1.4	2.1	1.5	7.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.5	73.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	8.0	1.4	9.7	5.6	4.0	5.8	2.6	22.1	3.2
SMIM10L2A	"LED, LINC00086, LINC0086, MGC39606, NCRNA00086"	ENSG00000178947	"Small integral membrane protein 10 like 2A"	P0DMW4	X	135421943-135428074	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 15.2;brain: 16.3;epididymis: 13.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.7;CACO-2: 3.3;HAP1: 13.5;hTCEpi: 7.2;PC-3: 3.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 15.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (4.22e-2)"	"unprognostic (4.72e-2)"	"unprognostic (4.50e-2)"	"prognostic unfavourable (6.78e-4)"	"unprognostic (8.62e-3)"	"unprognostic (5.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.36e-1)"	"prognostic favourable (8.28e-8)"	"unprognostic (5.29e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.28e-2)"	0.4	15.2	3.6	0.1	9.6	0.0	1.4	1.6	16.3	0.9	0.0	1.9	0.2	0.0	1.1	13.3	0.6	1.9	0.2	2.4	4.5		3.8	0.0	1.6	0.2	0.4	7.2	4.1	2.5	2.1	0.2	0.0	5.7	1.7	0.1	0.7	2.3	1.5	0.0	1.8	0.0	0.5	1.3	2.3	0.7	5.3	1.4	0.0	3.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.3	6.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	1.0	0.1	0.0	13.5	1.7	0.0	0.0	1.2	0.2	0.0	0.0	0.2	0.0	0.5	0.6	7.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.4	3.1	0.1	0.0	0.0	2.0	0.2	0.4	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0										
SMIM24	"C19orf77, HSPC323"	ENSG00000095932	"Small integral membrane protein 24"	O75264	19	3473986-3480542	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 160.8;intestine: 204.2;kidney: 76.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 45.8;HEL: 21.6;Hep G2: 34.2;MOLT-4: 32.6;REH: 17.9;U-937: 25.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 78.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA045046, HPA056027"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA045046: AB_10964444, HPA056027: AB_2683012"	"unprognostic (2.18e-4)"	"unprognostic (4.63e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (4.13e-10)"	"unprognostic (1.68e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.11e-2)"	0.2	0.1	0.7	0.6	0.9	7.0	0.3	0.2	2.2	0.2	137.0	0.4	2.4	71.4	0.2	160.8	0.3	0.3	46.7	0.3	0.4	0.5	76.9	7.2	0.3	0.3	0.4	0.6	0.3	1.6	0.0	0.9	0.2	0.3	0.3	2.0	0.2	0.3	0.4	0.2	0.3	204.2	0.2	0.6	0.4	24.8	1.2	0.3	8.8	0.2	0.2	0.2	0.2	0.2	3.2	2.4	3.0	0.0	8.6	2.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	45.8	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.2	34.2	0.0	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	32.6	4.6	0.0	0.0	17.9	0.0	1.2	0.4	0.0	0.4	0.7	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.8	0.0	25.7	0.0	3.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.1	0.6	0.7	1.7	0.0	8.6	0.0	2.4	2.1	1.1	0.7	0.9	0.2	2.2	0.4	0.5	0.4	0.6	0.3	0.3
SORT1	"Gp95, NT3"	ENSG00000134243	"Sortilin 1"	Q99523	1	109309568-109397951	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.1;epididymis: 75.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 9.0;non-classical monocyte: 10.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006889, CAB011498"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"CAB011498: AB_2192606, HPA006889: AB_1080056"	"unprognostic (2.10e-2)"	"unprognostic (7.46e-2)"	"prognostic favourable (7.74e-6)"	"unprognostic (4.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.23e-4)"	"unprognostic (3.34e-3)"	"unprognostic (4.27e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.95e-1)"	"unprognostic (4.46e-3)"	22.9	6.5	24.0	6.2	35.5	10.1	15.5	6.4	40.6	10.1	15.2	50.3	18.1	11.5	11.9	75.2	22.0	14.8	9.5	31.8	45.2	19.8	21.1	3.7	19.2	3.6	57.9	22.8	3.6	9.3	24.2	5.7	22.9	27.1	10.3	14.4	12.2	11.8	24.8	36.4	8.3	11.3	14.6	71.1	5.4	9.5	21.6	42.2	1.1	22.5	5.1	5.4	8.7	8.2	0.0	4.5	2.3	10.0	0.4	0.0	1.7	11.6	4.7	11.8	14.3	34.4	6.8	34.0	8.7	13.9	8.6	9.2	12.1	4.3	0.1	11.1	3.6	2.9	13.9	6.9	12.4	0.3	6.6	3.2	7.6	13.0	13.5	0.0	10.6	17.1	1.1	10.5	2.3	1.3	24.1	1.2	12.0	12.4	8.2	0.2	4.4	1.9	9.2	27.8	5.6	16.4	8.5	12.1	6.9	5.1	34.2	36.7	14.4	2.0	0.3	1.8	7.0	0.3	14.5	11.6	9.5	0.0	3.1	0.0	7.5	0.0	7.1	2.3	0.0	9.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.9	0.4	10.0	1.6	0.0	1.7	24.0	35.5	6.4	33.9	45.2	19.8	57.9	22.8	27.1	42.2
SPAG17	"CT143, FLJ34497, PF6, RP4-776P7.2"	ENSG00000155761	"Sperm associated antigen 17"	Q6Q759	1	117953861-118185223	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1;epididymis: 16.3;testis: 24.7"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.8;HMC-1: 1.6;RT4: 2.8;SCLC-21H: 3.3;U-2 OS: 1.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 24.1"	"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"midbrain: 12.2"	"HPA028597, HPA028666"	Enhanced									"HPA028597: AB_10600221, HPA028666: AB_10602281"	"unprognostic (3.67e-2)"	"unprognostic (4.86e-3)"	"unprognostic (3.42e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.35e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.76e-5)"	"unprognostic (4.81e-1)"	"unprognostic (9.90e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.67e-2)"	0.8	0.1	1.4	0.2	5.6	0.2	1.3	0.0	0.2	2.0	0.2	7.4	2.2	0.2	0.9	16.3	8.6	11.8	0.7	0.2	2.6	3.0	3.0	0.1	6.1	0.1	0.1	0.3	7.8	0.7	0.3	9.2	0.3	24.1	0.2	0.2	0.6	0.3	0.4	0.5	0.3	0.2	0.2	0.4	0.2	0.9	24.7	1.5	0.0	1.4	0.1	0.8	2.1	2.7	0.0	1.4	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	1.8	1.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.8	3.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.2	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.6	0.0	0.2	2.6	3.0	0.1	0.3	24.1	1.5
SRD5A2		ENSG00000277893	"Steroid 5 alpha-reductase 2"	P31213	2	31522480-31581067	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 17.9;liver: 30.9;prostate: 28.4"	"Group enriched"	"Detected in some"	7	"BJ hTERT+: 2.8;RT4: 5.4"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.1;liver cancer: 4.2;prostate cancer: 3.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (6.75e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.92e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-3)"	"unprognostic (6.61e-6)"	"unprognostic (4.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.48e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	10.1	0.0	0.2	17.9	0.0	10.4	0.0	0.0	0.0		0.0	30.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0										
SRMS	"C20orf148, dJ697K14.1, PTK70, SRM"	ENSG00000125508	"Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites"	Q9H3Y6	20	63540810-63547504	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 10.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.7;HaCaT: 2.6;MCF7: 4.9;RT4: 10.1;T-47d: 2.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"CAB044668, CAB044669, HPA073987"	Uncertain		Approved	"Intermediate filaments,Actin filaments,Cytosol"				"Intermediate filaments"	"Intermediate filaments"	"CAB044668: AB_10609403, CAB044669: AB_10608235, HPA073987: AB_2686650"	"unprognostic (2.26e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.63e-2)"	"unprognostic (6.48e-3)"	"unprognostic (7.28e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.58e-3)"	"unprognostic (4.75e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.54e-3)"	0.3	0.0	0.3	0.5	0.3	0.0	1.1	1.1	0.3	0.3	1.8	0.3	0.3	0.4	0.3	10.2	0.4	0.0	0.3	0.3	0.3	0.0	0.9	0.3	0.3	0.3	0.3	0.3	0.3	2.7	0.0	0.3	0.3	0.3	2.2	0.0	0.3	2.5	0.3	0.3	1.7	0.8	0.3	0.3	2.5	4.2	0.9	0.3	0.3	0.3	0.3	0.8	1.5	0.3	1.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	5.7	0.2	2.3	0.0	2.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.2	0.0	0.8	0.0	0.2	0.0	0.0	10.1	0.8	1.0	0.3	2.1	0.4	2.6	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	1.1	0.3	0.3	0.0	0.3	0.3	0.3	0.3
STOML3	"Epb7.2l, SRO"	ENSG00000133115	"Stomatin like 3"	Q8TAV4	13	38965925-38991066	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;epididymis: 8.1;fallopian tube: 31.7;lung: 9.2"	"Cell line enriched"	"Detected in single"	39	"AF22: 18.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"olfactory region: 29.0"	"Low region specificity"	"Detected in all"			"HPA012892, HPA071011"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA012892: AB_1857610, HPA071011: AB_2732169"		"unprognostic (2.64e-1)"	"unprognostic (1.91e-2)"	"prognostic favourable (1.49e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"		"unprognostic (4.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.74e-1)"		"unprognostic (1.22e-1)"	0.1	0.1	2.9	0.1	3.8	0.1	0.2	0.0	0.2	1.7	0.2	6.6	0.0	0.2	1.1	8.1	0.1	31.7	0.1	0.1	4.4	4.1	0.1	0.1	9.2	0.1	0.0	0.0	7.6	0.1	0.1	0.0	0.3	9.7	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.6	2.1	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.8	0.0	0.2	4.4	4.1	0.0	0.0	9.7	2.1
TAS2R13	"T2R13, TRB3"	ENSG00000212128	"Taste 2 receptor member 13"	Q9NYV9	12	10907926-10909562	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"epididymis: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (2.78e-1)"				"unprognostic (3.66e-2)"			"unprognostic (1.77e-1)"		"unprognostic (5.48e-2)"			"unprognostic (1.52e-3)"	"unprognostic (6.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (8.80e-2)"		0.1	0.3	0.0	0.1	0.1	0.3	0.3	0.7	0.1	0.1	0.1			0.1	0.4	1.4	0.2	0.1	0.1	0.4	0.1	0.0	0.1	0.2	0.1	0.1	0.0		0.8	0.4	0.1	0.6	0.2		0.3	0.1		0.6	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.2			0.4		0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
THSD7B	KIAA1679	ENSG00000144229	"Thrombospondin type 1 domain containing 7B"	Q9C0I4	2	136765545-137677717	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.2;epididymis: 11.6;retina: 14.9"	"Group enriched"	"Detected in some"	8	"Daudi: 10.1;SCLC-21H: 21.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	7	"pons and medulla: 24.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051416, HPA056745"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA051416: AB_2681477, HPA056745: AB_2683224"	"unprognostic (4.65e-3)"	"unprognostic (2.25e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.80e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.20e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.47e-6)"	"unprognostic (2.42e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.30e-2)"	4.7	0.3	1.7	0.3	1.6	0.1	2.6	0.7	3.2	0.9	0.5	1.1	0.8	0.3	0.9	11.6	1.6	2.8	0.8	1.4	1.8	3.3	2.7	0.6	0.5	0.2	1.8	1.5	0.4	0.3	1.3	3.0	0.7	24.2	2.1	0.3	14.9	1.2	0.7	0.3	0.2	1.5	2.2	3.2	0.2	0.3	1.1	0.3	0.1	2.1	0.0	0.3	0.8	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	10.1	0.0	0.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	0.7	3.2	1.8	3.3	1.8	1.5	24.2	0.3
TMEM150C	"FLJ12993, TTN3"	ENSG00000249242	"Transmembrane protein 150C"	B9EJG8	4	82483170-82562357	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"epididymis: 74.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.9;MCF7: 24.6;SCLC-21H: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052921	Enhanced									"HPA052921: AB_2681988"	"unprognostic (2.99e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.71e-3)"	"prognostic favourable (7.87e-4)"	"unprognostic (2.94e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-2)"	"prognostic favourable (5.68e-4)"	"unprognostic (4.57e-2)"	"prognostic favourable (4.59e-6)"	"unprognostic (4.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	7.0	30.0	10.8	3.2	12.8	1.5	12.4	0.6	16.0	8.4	4.4	8.3	12.9	4.4	3.2	74.9	2.5	4.6	3.9	7.4	12.7	7.9	9.7	7.7	3.6	8.1	7.5	10.3	18.0	2.2	1.7	10.5	5.5	7.3	7.1	2.6	12.4	10.3	4.7	3.5	3.1	4.4	4.0	5.4	7.6	3.0	4.2	6.8	2.7	7.0	1.6	6.9	3.2	3.3	5.5	1.4	5.0	0.9	1.3	0.7	0.3	0.3	0.9	6.8	8.9	0.0	0.1	0.7	1.5	3.7	0.9	1.1	0.0	0.4	0.2	0.7	0.2	0.1	4.2	0.0	1.1	0.4	2.1	0.5	0.8	0.0	0.0	0.0	1.0	4.1	0.4	0.0	0.0	2.2	0.0	0.1	0.1	24.6	0.4	0.6	3.1	0.4	0.9	0.1	0.8	0.3	3.4	17.3	2.7	0.5	0.2	2.4	0.4	0.1	0.5	0.4	0.2	0.1	0.8	0.1	0.3	0.3	0.5	0.3	1.9	5.0	0.9	1.0	0.7	0.4	0.4	3.5	0.7	0.6	0.2	5.5	0.5	0.6	3.7	1.3	0.6	1.4	0.2	0.3	10.8	12.8	0.6	16.0	12.7	7.9	7.5	10.3	7.3	6.8
TOGARAM2	"Crescerin-2, FAM179A, FLJ43249, LOC165186"	ENSG00000189350	"TOG array regulator of axonemal microtubules 2"	Q6ZUX3	2	28956611-29061373	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.3;epididymis: 14.4;fallopian tube: 15.7;lung: 14.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.8;NB-4: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 3.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA037561, HPA037562"	Uncertain									"HPA037561: AB_10670384, HPA037562: AB_2675545"	"unprognostic (8.35e-5)"	"unprognostic (2.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.93e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.92e-2)"	"unprognostic (3.94e-11)"	"unprognostic (3.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.81e-3)"	0.3	2.3	3.0	1.7	8.4	2.6	0.4	3.4	1.7	0.6	0.6	7.1	0.0	0.8	1.1	14.4	0.7	15.7	0.5	2.6	3.3	3.9	0.3	0.5	14.2	1.1	2.1	2.0	4.5	0.8	0.1	6.1	0.6	15.3	0.5	0.4	0.1	0.5	0.1	1.7	0.6	0.7	0.8	2.5	2.2	1.5	3.2	6.1	0.0	0.3	0.3	1.3	0.4	0.3	0.3	0.3	0.6	0.3	0.6	3.7	1.0	0.2	0.2	0.3	0.2	0.3	0.0	0.7	0.1	2.3	0.7	2.2	0.4	0.3	0.3	0.3	0.0	0.9	0.4	0.0	0.7	0.4	1.4	0.2	2.0	0.5	0.9	2.0	3.8	0.2	0.3	0.0	0.0	0.3	0.3	1.0	0.8	0.2	0.8	3.6	2.7	0.7	0.1	0.7	1.5	1.1	0.3	2.6	1.8	0.1	0.1	0.1	0.4	0.2	0.2	0.2	0.5	0.2	0.3	0.5	0.5	0.2	1.7	1.3	0.1	0.5	0.3	0.3	3.7	0.1	2.0	0.2	0.6	2.9	0.1	0.3	0.4	1.0	0.6	0.6	0.2	0.3	1.5	1.0	3.0	8.4	3.4	1.2	3.3	3.9	2.1	2.0	15.3	6.1
TP53TG3D		ENSG00000205456	"TP53 target 3D"	Q9ULZ0	16	32252719-32255922	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 8.7;testis: 5.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.4;HEL: 3.1;HMC-1: 3.9;RH-30: 3.0;SCLC-21H: 3.3;U-2 OS: 3.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.65e-2)"				"unprognostic (1.92e-1)"	"unprognostic (5.60e-2)"		"unprognostic (1.57e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.47e-2)"		"unprognostic (2.06e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-1)"		0.1	2.0	0.9	0.2	1.5	0.0	0.1	3.3	1.8	0.0	0.1			0.1	0.4	8.7	0.8	0.3	0.1	0.6	0.6	1.8	0.0	0.0	0.1	0.2	1.0		0.2	0.0	0.0	0.6	1.0		0.7	0.0		0.2	0.0	0.0	0.8	0.0	0.0	1.7	0.5	0.1	5.1			0.2		0.0	0.0	0.4	0.8	0.0	0.7	0.4	0.0	0.6	1.5	0.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	3.9	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.3	0.4	0.2	0.0	0.1	3.0	0.3	0.0	0.0	3.3	1.0	0.0	0.0	0.9	0.8	0.0	0.0	0.3	3.5	0.6	0.0	1.6	0.8	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.5	0.1	0.7	0.0	0.2	0.0	0.3	1.5										
TRIM46	"FLJ23229, TRIFIC"	ENSG00000163462	"Tripartite motif containing 46"	Q7Z4K8	1	155173787-155184971	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.4;epididymis: 11.0"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055583	Enhanced									"HPA055583: AB_2732599"	"unprognostic (1.06e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.86e-2)"	"prognostic unfavourable (2.61e-7)"	"unprognostic (1.75e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.65e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.29e-12)"	"unprognostic (8.58e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-2)"	1.3	1.7	6.0	2.4	12.6	1.7	1.7	21.4	15.5	1.7	1.2	6.5	0.0	1.6	3.4	11.0	1.1	2.9	2.0	1.0	7.8	7.4	1.1	0.9	1.7	2.3	5.1	7.3	1.0	2.1	0.8	4.5	1.1	7.4	1.7	1.4	0.5	0.9	3.6	1.0	1.2	1.8	3.9	5.8	1.8	1.6	2.5	3.5	6.7	0.9	0.0	1.7	1.3	0.8	0.4	0.5	1.5	0.4	0.8	3.0	0.6	2.0	2.8	2.1	0.2	0.4	1.8	0.1	2.1	2.2	2.5	3.1	0.0	1.2	0.9	1.5	2.5	2.4	0.0	1.0	0.7	5.0	0.9	1.7	3.0	0.1	1.1	0.5	6.2	1.9	0.5	2.6	0.9	3.8	0.0	4.4	1.3	1.4	3.3	0.3	7.6	3.1	5.1	0.2	1.0	0.6	0.0	5.7	13.1	0.9	0.7	1.5	4.1	4.1	4.5	4.9	1.9	0.3	1.0	4.1	1.6	0.8	5.2	0.8	1.4	1.5	0.1	0.1	1.2	0.4	1.1	0.3	2.1	2.0	0.2	0.4	0.8	1.0	0.8	0.8	0.3	0.5	3.0	0.6	6.0	12.6	21.4	14.2	7.8	7.4	5.1	7.3	7.4	3.5
TRPM5	"LTRPC5, MTR1"	ENSG00000070985	"Transient receptor potential cation channel subfamily M member 5"	Q9NZQ8	11	2404515-2423045	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 4.1;intestine: 6.3;pancreas: 4.5;seminal vesicle: 4.0"	"Cell line enhanced"	"Detected in some"		"MCF7: 3.2;RPMI-8226: 1.4"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043315	Uncertain									"HPA043315: AB_2678422"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.47e-5)"	"unprognostic (6.81e-4)"	"unprognostic (7.90e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.91e-2)"	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7			6.1	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0		0.0	4.5	0.0	0.5	0.0		0.2	0.5		0.0	4.0	0.0	0.0	6.3	0.0	0.0	0.0	0.5	0.9			3.1		0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0										
TTLL9	"C20orf125, dJ310O13.1"	ENSG00000131044	"Tubulin tyrosine ligase like 9"	Q3SXZ7	20	31870702-31944963	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 16.0;epididymis: 8.9;fallopian tube: 9.2;testis: 11.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.0;REH: 2.0"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA041772, HPA055676"	Uncertain		Uncertain	Nucleoplasm,Microtubules				"Nucleoplasm, Microtubules"	"Nucleoplasm, Microtubules"	"HPA041772: AB_10959904, HPA055676: AB_2682881"	"unprognostic (8.77e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.59e-1)"	"unprognostic (9.05e-3)"	"unprognostic (6.17e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.23e-2)"	0.4	0.6	3.4	0.5	8.9	0.4	1.3	1.0	2.8	0.6	0.5	10.9	1.8	0.6	1.1	8.9	0.6	9.2	0.8	0.5	4.8	3.7	0.8	0.5	1.7	0.7	5.2	0.6	1.8	0.4	2.8	2.8	0.7	16.0	0.6	0.5	0.0	0.5	1.8	0.4	0.6	0.4	0.6	4.5	0.5	0.6	11.0	4.0	0.0	2.1	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.3	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.9	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.4	0.8	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.6	0.3	0.0	0.1	0.5	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	8.9	1.0	2.7	4.8	3.7	5.2	0.6	16.0	4.0
USH1G	"ANKS4A, FLJ33924, Sans"	ENSG00000182040	"USH1 protein network component sans"	Q495M9	17	74916084-74923256	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.9;epididymis: 11.4;esophagus: 11.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 4.7;hTCEpi: 4.3;K-562: 3.2;MCF7: 5.0;U-2 OS: 2.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.6"	"Region enriched"	"Detected in single"	20	"cerebellum: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	12	"olfactory region: 12.1"	"Low region specificity"	"Detected in some"			HPA024360	Uncertain									"HPA024360: AB_1858660"	"unprognostic (2.95e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.34e-4)"	"unprognostic (2.92e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.59e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.10e-4)"	"unprognostic (1.57e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.35e-2)"	0.0	1.4	0.0	0.0	0.4	0.3	0.0	13.9	0.2	1.4	0.0	0.0	1.1	0.3	1.9	11.4	11.8	0.2	0.0	0.1	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	3.6	0.4	0.0	0.0	0.0	0.5	0.1	0.0	1.3	0.9	0.1	0.0	4.2	0.7	1.5	0.0	0.0	0.0	2.6	0.0	0.5	0.0	1.2	0.8	0.5	1.7	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.4	0.1	0.0	0.0	4.7	1.0	0.2	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.1	4.3	0.0	0.0	0.1	3.2	0.4	0.0	5.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.5	0.0	0.7	0.1	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	13.9	0.2	0.7	0.0	0.0	0.0	0.5	0.0
USP17L15		ENSG00000223569	"Ubiquitin specific peptidase 17-like family member 15"	C9J2P7	4	9234385-9236334	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"brain: 1.0;epididymis: 1.0"	"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045642	Uncertain									"HPA045642: AB_2679403"																		0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	1.0	0.1	0.0			0.0	0.2	1.0	0.0	0.3	0.0	0.1	0.3	0.4	0.0	0.4	0.2	0.0	0.2		0.0	0.0	0.4	0.4	0.0		0.0	0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0			0.1		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
VRTN	"C14orf115, FLJ10811, vertnin"	ENSG00000133980	"Vertebrae development associated"	Q9H8Y1	14	74303069-74360008	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 4.9;lymphoid tissue: 4.5;testis: 5.8"	"Cell line enriched"	"Detected in some"	9	"NTERA-2: 33.0"	"Cancer enriched"	"Detected in single"	40	"testis cancer: 15.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001460	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA001460: AB_1078318"			"unprognostic (1.20e-1)"	"unprognostic (4.31e-2)"				"unprognostic (1.37e-1)"		"unprognostic (5.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.78e-2)"		"unprognostic (1.66e-1)"	"unprognostic (1.77e-1)"			0.1	0.1	0.1	2.2	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.6	0.0	4.9	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	4.5	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.1	0.2	0.2	5.8	0.0	0.0	0.1	0.0	1.9	0.1	0.1	0.8	1.2	1.4	0.5	0.8	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.4	0.5	0.3	0.3	0.2	0.3	0.2	0.5	0.2	0.8	0.3	0.4	1.4	0.8	0.5	1.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
VTCN1	"B7-H4, B7H4, B7S1, B7X, FLJ22418"	ENSG00000134258	"V-set domain containing T cell activation inhibitor 1"	Q7Z7D3	1	117143587-117210960	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 46.4;epididymis: 29.9;kidney: 27.0;pancreas: 35.9"	"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 72.8"	"Group enriched"	"Detected in many"	6	"breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054200	Approved		Approved	"Plasma membrane,Cell Junctions,Focal adhesion sites"				"Plasma membrane"	"Plasma membrane"	"HPA054200: AB_2682415"	"unprognostic (4.13e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	46.4	0.1	0.1	6.7	0.1	0.1	7.0	0.0	2.6	29.9	0.4	14.2	1.9	0.2	0.1	0.1	27.0	0.9	0.3	0.1	0.1	0.1	4.5	35.9	0.0	1.4	3.0	0.1	1.5	0.0	0.1	17.5	3.6	0.2	2.2	0.1	0.8	0.1	0.1	1.5	2.5	0.1	0.2	0.1	0.5	1.5	2.1	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.0	72.8	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
VWA5B1	FLJ32784	ENSG00000158816	"Von Willebrand factor A domain containing 5B1"	Q5TIE3	1	20290919-20354894	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 17.6;epididymis: 6.4;testis: 6.9"	"Cell line enriched"	"Detected in single"	9	"SCLC-21H: 5.2"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"pons and medulla: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA027496, HPA028405, HPA064829"	Enhanced		Approved	"Plasma membrane,Mitochondria,Cytosol"	"Secreted in male reproductive system"			Mitochondria	Mitochondria	"HPA027496: , HPA028405: , HPA064829: AB_2685363"	"unprognostic (2.34e-1)"	"unprognostic (2.91e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.21e-2)"		"unprognostic (1.09e-1)"		"unprognostic (1.86e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.41e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.03e-1)"	0.0	1.2	0.7	0.2	3.3	0.0	0.0	0.0	0.5	0.0	0.0	6.1	0.0	0.0	0.0	6.4	0.1	0.7	0.5	0.1	2.8	3.3	2.0	0.0	0.1	0.2	0.2	0.4	0.0	0.1	2.2	5.6	0.2	17.6	0.2	0.0	0.0	4.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.9	0.5	0.0	0.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.3	0.0	0.5	2.8	3.3	0.2	0.4	17.6	0.5
WDR45	"JM5, NBIA5, WDRX1, WIPI4"	ENSG00000196998	"WD repeat domain 45"	Q9Y484	X	49071470-49101170	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 124.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA027562	Uncertain		Uncertain	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA027562: "	"unprognostic (1.39e-1)"	"prognostic favourable (1.21e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-1)"	"prognostic favourable (1.61e-4)"	"unprognostic (4.30e-2)"	"unprognostic (6.66e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.06e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.27e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.11e-3)"	21.2	30.3	16.7	13.5	22.6	21.4	20.3	16.1	29.8	19.4	20.7	16.6	30.6	16.2	21.1	124.8	16.5	18.1	21.9	28.6	16.4	15.1	24.6	34.4	17.1	18.4	19.1	12.7	20.7	23.7	26.3	17.6	28.4	17.0	18.6	12.3	20.0	28.2	26.6	40.7	17.9	16.8	15.1	12.2	18.2	21.5	7.6	13.6	18.8	32.4	24.5	17.1	20.5	16.4	19.8	27.1	44.0	36.0	32.4	25.5	26.4	12.4	14.6	8.4	8.5	18.4	23.8	16.3	13.7	28.5	10.8	15.3	7.6	18.3	8.7	7.9	27.3	10.9	12.7	11.1	7.9	9.7	21.5	5.3	26.7	11.6	42.1	4.1	12.5	21.1	19.7	17.8	19.1	10.9	11.3	15.7	14.2	13.9	8.6	10.6	8.5	12.7	7.1	12.4	28.8	19.2	11.5	11.2	16.5	17.6	13.5	41.6	8.6	15.3	14.9	11.8	10.7	23.5	5.7	24.2	16.2	6.2	22.0	6.8	8.6	44.0	36.0	31.5	23.1	32.1	22.8	19.8	17.6	21.8	26.7	18.6	14.0	15.9	36.5	32.4	35.4	27.1	25.5	26.4	16.7	22.6	16.1	29.8	16.4	15.1	19.1	12.7	17.0	13.6
WFDC10B	WAP12	ENSG00000182931	"WAP four-disulfide core domain 10B"	Q8IUB3	20	45684653-45705019	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 27.3;testis: 5.9;urinary bladder: 8.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.0;Daudi: 2.7;HHSteC: 2.2;hTEC/SVTERT24-B: 1.8;PC-3: 5.6;U-87 MG: 2.6"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"						"unprognostic (1.14e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.37e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.81e-2)"		"unprognostic (4.30e-3)"		"unprognostic (5.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.36e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.39e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.17e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.3	0.2	0.2	0.2	0.6	0.2	0.2	0.0	0.3	27.3	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.2	0.9	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.2	1.0	0.5	0.2	0.2	0.2	0.2	1.5	0.2	0.3	0.2	0.2	0.4	5.9	0.2	0.2	0.2	0.2	0.2	8.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	2.0	2.7	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.8	5.6	0.0	0.3	0.0	0.6	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
WISP3	CCN6	ENSG00000112761	"WNT1 inducible signaling pathway protein 3"	O95389	6	112054072-112070969	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 9.5"	"Cell line enhanced"	"Detected in some"		"RT4: 10.9;THP-1: 3.5;U-2197: 2.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basal ganglia: 2.3;cerebellum: 5.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA062438, HPA078340"			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"			"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA062438: AB_2684763, HPA078340: AB_2732381"	"unprognostic (2.13e-2)"	"unprognostic (7.90e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.07e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.93e-2)"	0.4	0.5	0.3	0.4	2.3	0.8	4.2	5.9	0.5	1.9	0.3	0.3	0.3	0.1	0.6	9.5	0.9	3.2	1.4	0.4	0.3	0.5	5.3	0.8	0.4	0.5	0.4	0.3	1.6	0.3	0.0	0.3	0.4	0.3	1.1	0.0	0.3	0.6	0.3	0.6	4.8	0.3	0.3	0.4	0.4	0.4	5.8	0.9	0.3	0.3	2.8	2.2	0.3	1.5	1.1	0.6	2.0	0.5	1.7	1.2	0.2	0.1	0.0	0.3	1.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.8	0.1	0.3	0.3	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.1	0.0	0.2	0.9	0.4	0.2	0.3	0.1	0.3	0.0	10.9	0.5	0.5	0.1	0.2	0.9	0.2	3.5	0.2	0.2	0.2	2.6	0.3	0.3	0.0	0.3	0.4	1.1	0.2	1.4	0.4	0.6	0.5	0.3	0.6	0.8	0.9	0.9	0.3	1.1	1.2	1.1	2.0	1.7	0.5	0.6	0.6	0.2	0.3	2.3	5.9	0.5	0.3	0.5	0.4	0.3	0.3	0.9
WNK3	PRKWNK3	ENSG00000196632	"WNK lysine deficient protein kinase 3"	Q9BYP7	X	54192823-54358642	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 31.6;testis: 26.7"	"Cell line enhanced"	"Detected in some"		"AF22: 5.8;AN3-CA: 4.4;HAP1: 6.7;NTERA-2: 11.9;SiHa: 5.8;U-2 OS: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.9"	"Group enriched"	"Detected in many"	10	"B-cells: 1.1;T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077678	Approved		Approved	Vesicles				Vesicles	Vesicles	"HPA077678: AB_2686850"	"unprognostic (1.86e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.44e-1)"	"unprognostic (7.87e-5)"	"unprognostic (4.82e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.85e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-4)"	"unprognostic (2.22e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.61e-2)"	"unprognostic (9.99e-2)"	"unprognostic (7.63e-2)"	"unprognostic (8.74e-2)"	0.9	5.0	3.9	0.9	4.3	0.8	1.7	3.0	3.6	1.5	0.7	1.7	13.9	1.0	1.3	31.6	1.1	1.8	1.1	1.5	3.9	3.4	2.8	8.7	0.9	1.0	2.3	3.0	5.7	0.9	2.2	14.0	1.2	3.9	2.2	0.7	1.3	1.2	4.8	0.7	0.9	0.7	1.5	3.3	1.0	1.2	26.7	3.5	0.0	1.7	0.0	0.8	1.3	1.9	1.1	0.0	0.1	0.0	0.1	1.9	0.1	0.0	0.0	5.8	4.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.7	0.1	0.2	0.0	1.2	0.0	0.0	0.1	0.2	0.0	0.2	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.9	0.0	2.8	0.8	0.0	1.1	0.2	1.9	1.8	5.8	0.0	0.7	0.5	0.0	0.3	0.0	5.2	0.0	1.2	0.0	4.0	0.0	1.6	0.0	2.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	1.1	1.9	0.4	0.1	0.1	0.0	0.0	0.0	0.1	3.9	4.3	3.0	3.6	3.9	3.4	2.3	3.0	3.9	3.5
WNT9B	"WNT14B, WNT15"	ENSG00000158955	"Wnt family member 9B"	O14905	17	46833201-46886730	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 31.6;epididymis: 13.0;seminal vesicle: 19.1"	"Cell line enhanced"	"Detected in some"		"AF22: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	7	"thalamus: 6.4"	"Low region specificity"	"Detected in all"			"HPA058361, HPA059572"	Approved				"Secreted to extracellular matrix"					"HPA058361: AB_2683691, HPA059572: AB_2684067"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.48e-3)"	"unprognostic (3.37e-3)"	"unprognostic (1.78e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.66e-2)"	"unprognostic (6.19e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.52e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.37e-1)"	1.0	0.4	0.3	0.2	0.4	0.3	0.8	1.4	1.6	0.4	0.5	0.1	31.6	1.5	0.8	13.0	0.2	0.6	0.2	2.1	1.1	1.0	7.4	2.4	2.4	0.5	1.0	0.0	0.3	0.3	4.2	0.1	0.5	2.0	0.5	0.2	6.7	0.2	19.1	0.6	2.5	4.5	0.4	0.7	1.8	0.2	0.9	0.0	0.0	0.3	0.0	0.1	0.8	0.3	0.6	0.5	2.0	0.5	0.3	0.4	0.0	0.1	0.5	3.1	0.2	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.4	0.7	0.2	0.4	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.4	0.3	0.2	0.3	0.1	0.2	0.5	0.1	0.0	0.4	0.0	0.7	0.2	0.6	0.0	1.0	0.1	0.1	0.0	2.0	0.3	0.3	0.3	0.1	0.2	0.3	0.2	0.2	0.1	0.6	0.4	0.4	1.8	0.3	0.5	0.5	0.2	0.0	0.3	0.4	1.4	1.6	1.1	1.0	1.0	0.0	2.0	0.0
ZBBX	FLJ23049	ENSG00000169064	"Zinc finger B-box domain containing"	A8MT70	3	167240287-167381346	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.0;epididymis: 14.2;fallopian tube: 23.4;testis: 33.3"	"Cell line enhanced"	"Detected in some"		"AF22: 2.9;CAPAN-2: 2.2;NTERA-2: 1.5;PC-3: 1.2;SCLC-21H: 1.9;U-138 MG: 1.4;U-87 MG: 2.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA036327, HPA036328"	Enhanced									"HPA036327: AB_10672240, HPA036328: AB_2675063"	"unprognostic (2.68e-3)"	"unprognostic (4.49e-2)"		"unprognostic (6.94e-2)"	"unprognostic (3.99e-1)"			"unprognostic (4.08e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"		0.3	0.6	2.5	0.3	12.9	0.3	0.3	0.0	3.3	1.3	0.4	4.5	0.0	0.3	1.1	14.2	0.3	23.4	0.3	0.3	4.7	3.9	0.5	0.3	7.2	0.4	0.4	2.6	6.9	0.3	0.8	5.3	0.4	22.0	0.4	0.3	0.0	0.3	0.4	0.4	0.3	0.3	0.4	0.5	0.3	0.4	33.3	3.4	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.5	1.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.5	0.0	0.0	1.4	0.7	0.0	0.1	0.8	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	12.9	0.0	3.3	4.7	3.9	0.4	2.6	22.0	3.4
ZMAT1	KIAA1789	ENSG00000166432	"Zinc finger matrin-type 1"	Q5H9K5	X	101882288-101932031	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"epididymis: 38.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 12.4;U-266/70: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA012827	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA012827: AB_1859070"	"unprognostic (9.30e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-5)"	"unprognostic (1.20e-3)"	"unprognostic (2.22e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.09e-2)"	"prognostic favourable (1.72e-5)"	"unprognostic (6.33e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.38e-2)"	6.1	13.0	11.4	9.9	12.4	10.0	9.9	7.1	12.8	5.0	4.9	16.5	7.0	4.0	7.4	38.7	3.0	7.3	7.2	7.6	11.1	9.6	9.6	6.5	10.8	10.9	10.2	11.4	11.9	7.3	14.5	31.4	2.3	9.2	9.3	3.4	13.6	7.9	14.2	5.1	4.3	5.4	8.3	12.0	10.7	4.1	5.9	11.3	7.0	18.8	3.2	7.5	3.3	3.7	3.7	3.2	2.6	1.1	0.6	1.6	0.6	0.4	0.0	1.4	1.5	0.0	0.0	0.2	0.6	0.1	0.0	0.7	0.0	1.8	2.7	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.4	0.7	0.0	0.0	0.0	0.3	1.1	0.0	12.4	0.9	0.0	0.1	0.2	1.9	0.2	2.1	0.0	0.1	3.3	0.0	0.6	1.7	1.0	0.0	0.1	2.1	3.0	3.0	0.9	0.0	0.0	0.1	6.2	0.4	0.0	0.6	2.9	0.9	2.6	1.1	1.7	0.9	0.4	1.6	2.0	1.3	1.4	0.2	3.7	1.6	1.4	0.8	0.6	0.7	3.2	0.6	0.6	11.4	12.4	7.1	12.8	11.1	9.6	10.2	11.4	9.2	11.3
ZNF157	HZF22	ENSG00000147117	"Zinc finger protein 157"	P51786	X	47370583-47414305	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;epididymis: 4.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.5;SH-SY5Y: 2.9;U-266/84: 6.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.7"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA003319	Uncertain									"HPA003319: AB_1080677"	"unprognostic (1.85e-1)"	"unprognostic (3.99e-1)"		"unprognostic (7.24e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-2)"		"unprognostic (7.38e-4)"	"unprognostic (2.99e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.59e-4)"	"unprognostic (5.36e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.51e-2)"	"unprognostic (7.15e-2)"	"unprognostic (4.92e-2)"	0.1	0.3	0.8	0.2	1.0	0.4	0.3	4.4	1.6	0.6	0.1			0.2	0.7	4.4	0.2	3.8	0.1	0.1	0.8	1.0	0.6	0.0	0.1	1.4	0.8		1.0	0.1	2.3	3.0	0.0		0.5	0.1		0.2	0.7	0.1	0.3	0.2	0.5	0.9	0.4	0.1	0.8			1.4		0.8	0.3	0.3	1.4	0.7	1.3	0.3	0.7	2.8	0.9	0.0	0.3	1.0	0.1	0.3	0.3	0.2	0.0	0.0	0.2	0.5	0.1	0.3	1.4	0.7	0.3	0.0	2.5	1.3	0.2	0.1	1.1	0.5	0.4	0.0	0.0	0.0	0.5	0.3	0.0	1.4	0.1	0.0	0.1	3.5	0.4	0.0	1.0	0.3	2.1	0.1	0.3	0.0	0.0	0.5	0.2	2.6	2.9	0.0	0.3	0.2	1.6	0.3	0.0	1.1	1.1	0.1	0.1	1.9	6.0	1.7	0.3	0.1	0.0	0.7	0.3	0.4	0.4	0.3	0.2	1.4	0.5	2.2	0.1	1.2	2.8	1.8	1.3	0.7	0.3	0.7	0.8	0.9										
ZNF185	SCELL	ENSG00000147394	"Zinc finger protein 185 with LIM domain"	O15231	X	152914442-152973480	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 93.5;esophagus: 67.6"	"Cell line enhanced"	"Detected in many"		"A-431: 31.0;EFO-21: 36.9;HBEC3-KT: 25.6;PC-3: 22.7;TIME: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 21.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 21.6;monocytes: 13.9"					"Low region specificity"	"Detected in all"			"HPA000400, HPA016438"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"		5400	5400	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA000400: AB_1080685, HPA016438: AB_1859109"	"unprognostic (1.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.75e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (7.94e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavourable (3.30e-5)"	"unprognostic (5.18e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	3.9	1.7	1.8	2.0	3.2	0.8	1.8	2.7	2.0	14.3	1.8	1.4	10.7	0.0	3.8	93.5	67.6	3.1	2.0	1.9	1.7	0.8	2.0	1.1	3.3	3.1	2.1	1.1	1.2	0.9	0.1	2.3	4.0	1.7	4.2	0.3	1.3	10.1	28.1	1.5	9.9	1.2	1.4	1.2	3.7	0.8	1.9	2.0	1.2	3.9	1.4	6.6	2.1	22.8	0.4	3.8	21.6	13.9	0.2	0.6	10.2	31.0	6.6	0.6	0.4	0.8	1.0	1.4	1.5	0.1	3.9	0.5	0.2	9.4	0.4	36.9	2.3	4.4	0.9	25.6	15.9	0.3	0.6	2.0	2.7	1.0	1.8	0.1	0.1	0.7	18.4	0.4	15.1	19.7	0.1	0.3	0.1	7.3	0.1	0.1	0.4	22.7	0.1	0.1	0.2	2.0	2.9	0.2	2.1	0.0	5.9	0.9	6.0	0.6	60.4	0.2	13.4	0.7	1.1	0.3	0.2	0.2	0.4	2.2	0.4	21.6	13.9	5.7	0.5	12.9	0.3	0.4	0.4	0.6	3.8	0.3	0.6	0.3	9.5	0.2	10.2	2.5	0.5	10.2	1.8	3.2	2.7	2.0	1.7	0.8	2.1	1.1	1.7	2.0
ZNF189		ENSG00000136870	"Zinc finger protein 189"	O75820	9	101398873-101410660	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 61.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034814	Uncertain		Approved	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA034814: AB_10601030"	"unprognostic (3.87e-2)"	"unprognostic (3.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"prognostic favourable (5.32e-4)"	"unprognostic (3.31e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.57e-2)"	15.6	15.8	15.1	6.3	28.2	2.8	11.6	13.9	15.9	9.5	9.0	16.8	9.0	8.6	10.0	61.6	5.5	7.8	16.3	10.9	18.7	9.3	10.6	12.5	6.8	6.8	15.4	11.4	11.8	23.0	11.2	23.6	6.3	14.1	10.3	7.5	5.0	6.7	9.4	11.6	4.4	9.7	9.7	25.1	9.9	8.7	9.3	16.1	8.5	9.6	3.7	10.2	6.1	8.0	3.6	2.2	4.1	3.0	3.6	4.7	1.9	5.4	4.5	14.8	10.8	13.2	9.3	7.1	7.8	12.1	9.2	8.0	9.5	4.3	7.4	5.4	9.4	10.8	7.3	7.4	8.2	9.7	5.1	8.1	7.1	20.3	9.9	8.4	7.1	11.3	10.3	8.2	12.8	11.5	9.5	10.7	13.5	3.0	10.1	3.6	10.7	5.1	7.2	21.2	5.6	8.8	6.4	15.4	9.7	8.5	5.9	8.5	4.8	10.7	9.6	9.1	6.6	7.5	6.0	10.2	15.7	3.6	7.8	3.3	9.1	1.3	2.5	4.1	2.3	3.0	2.4	2.8	4.0	4.7	2.2	3.6	4.7	4.1	1.4	3.6	2.3	1.7	2.0	1.9	15.1	28.2	13.9	15.9	18.7	9.3	15.4	11.4	14.1	16.1
ZNF280A	"3'OY11.1, SUHW1, ZNF280, ZNF636"	ENSG00000169548	"Zinc finger protein 280A"	P59817	22	22513736-22520270	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.6;epididymis: 5.6;retina: 2.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;K-562: 12.7;SK-MEL-30: 3.4"	"Cancer enhanced"	"Detected in some"		"melanoma: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA044475			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA044475: AB_10960420"			"unprognostic (7.53e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-2)"		"unprognostic (3.14e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.65e-3)"			"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"			0.0	5.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.1	5.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.5	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	1.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	12.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.5	0.3	0.5	0.2	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0
ZNF648	FLJ46813	ENSG00000179930	"Zinc finger protein 648"	Q5T619	1	182054570-182061712	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.8;liver: 1.7;ovary: 3.0;testis: 2.2"	"Cell line enriched"	"Detected in single"	80	"HMC-1: 28.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053897	Uncertain									"HPA053897: AB_2682297"	"unprognostic (3.52e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.30e-1)"		"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-2)"	"unprognostic (8.16e-6)"	"unprognostic (4.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.83e-1)"	0.0	0.0	0.1	0.0	0.3	0.0	0.8	0.0	0.3	0.2	0.0			0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0		3.0	0.4	0.0	1.0	0.0		0.0	0.0		0.5	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	2.2			0.0		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ZNF705E		ENSG00000214534	"Zinc finger protein 705E"		11	71814045-71821548	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"epididymis: 3.0"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (3.65e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.80e-1)"	"unprognostic (7.34e-3)"	"unprognostic (8.00e-5)"	"unprognostic (6.79e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.13e-4)"	"unprognostic (9.18e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.34e-2)"	0.0	0.0		0.1		0.5	0.6		0.0	0.0	0.0			0.6	0.1	3.0	0.0	0.1	0.2	0.0			0.0	0.1	0.0	0.1			0.6	0.0	0.0		0.0		0.2	0.0		0.1	0.4	0.0	0.3	0.1	0.0		0.0	0.1	0.1			0.0		0.1	0.0		0.7	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.8	0.7	0.0	0.3	0.0	0.2	0.0	0.8	1.0	0.4	0.9	1.1	0.4	0.1	0.7	0.9	0.1	0.7	0.8	0.1	0.1	0.5	1.1	0.1	1.2	0.4	0.1	0.2	0.1	0.2	0.1	0.2	1.3	0.1	0.8	0.8	1.8	0.1	0.3	0.4	1.6	0.0	0.4	0.0	0.6	1.2	0.7	0.2	0.4	0.3	0.4	0.5	0.0	0.8	0.2	0.2	1.1	0.5	0.5	0.5	1.2	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0										
ZP1		ENSG00000149506	"Zona pellucida glycoprotein 1"	P60852	11	60867562-60875693	"Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.5;epididymis: 2.2;pituitary gland: 3.3"	"Group enriched"	"Detected in some"	36	"RPMI-8226: 15.8;SK-BR-3: 4.5"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	66	"plasmacytoid DC: 6.5"	"Lineage enriched"	"Detected in single"	66	"dendritic cells: 6.5"	"Region enriched"	"Detected in single"	7	"basal ganglia: 0.7"										"Secreted in female reproductive system"						"unprognostic (6.40e-3)"	"unprognostic (2.18e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.02e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.94e-2)"	"unprognostic (8.15e-3)"	"unprognostic (2.52e-1)"	"unprognostic (9.25e-4)"	"unprognostic (5.31e-13)"	"unprognostic (4.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.61e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.7	0.0	0.0			0.0	0.0	2.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.8	3.3	0.0		1.3	0.0		0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.2	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.1										
ZSCAN1	"FLJ33779, ZNF915"	ENSG00000152467	"Zinc finger and SCAN domain containing 1"	Q8NBB4	19	58034032-58054631	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.7;epididymis: 16.4;pituitary gland: 15.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.2;HMC-1: 4.3;NTERA-2: 4.4;T-47d: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA007938	Uncertain		Approved	Nucleoli				Nucleoli	Nucleoli	"HPA007938: AB_1080768"	"unprognostic (1.60e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-1)"	"prognostic favourable (7.36e-4)"	"unprognostic (1.41e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.60e-1)"	0.9	2.2	7.0	0.7	9.5	0.9	3.2	4.0	13.7	2.2	0.8	6.5	1.0	0.8	1.7	16.4	0.8	4.3	1.3	1.6	6.3	9.7	2.8	0.7	1.4	0.8	6.0	6.7	0.9	2.1	7.3	15.8	1.3	8.2	3.7	0.7	3.4	1.6	3.0	0.8	0.8	1.0	1.1	3.7	0.9	1.0	13.3	2.4	0.9	8.1	0.0	0.7	1.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	0.0	1.5	0.1	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.4	0.0	0.0	0.0	0.0	0.0	1.3	0.4	1.3	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	9.5	4.0	13.7	6.3	9.7	6.0	6.7	8.2	2.4
